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ABSTRACT 
Background: Evidence from the USA and Europe suggests that women with many 
births have roughly a 50-80% increase in the risk of developing CHD. The mechanisms 
underlying this association are unclear, but plausible biological pathways (changes in 
adiposity, blood glucose and lipid levels associated with pregnancy and continuing after 
reproduction has ceased) exist. Palestinian women have a greater exposure to high 
parity than do women in most populations where heart disease and parity have 
previously been studied, so are expected to be at higher risk. 
Objectives: To examine the association of parity with CHD risk factors including 
obesity, lipids, diabetes and hypertension; MS and reported CHD in a sample of women 
with a high parity. 
Methods: A population based cross sectional survey of 515 Palestinian women aged 40- 
65 years from two refugee camps communities in the West Bank. 
Results: Mean parity was 7.3 (3.69) with a range of 0-21. Prevalence of overall obesity 
(BMI>30) was 69.2%, abdominal obesity (WC2: 88 cm) was 84.2%, and central obesity 
(W/H ratio>0.85) was 51.9%. Prevalence of diabetes was 22.3% and hypertension was 
42.7%. After adjustment for covariates (age, own education, husband's education, 
marital status), regression analyses showed that each extra birth was associated with an 
increase of 0.30 kg/m2 in BMI (p< 0.0001), 0.58 in waist circumference (p< 0.001), and 
an increase of 0.036 mmol/L in triglycerides (p= 0.033). Gravidity, but not parity was 
associated with fasting blood sugar (FBS); after adjustment for covariates, each extra 
pregnancy was associated with an increase of 0.14 mmol/L (95% Cl: 0.05 to 0.23, 
p=0.002) in FBS. The metabolic syndrome presented in 58.3% of the women. Women 
with the metabolic syndrome had significantly higher parity and gravidity, (p= 0.003 
and p= 0.024 respectively); each extra birth was associated with a 7% increase in the 
prevalence of the metabolic syndrome (p= 0.042). Parity was not found to be 
significantly associated with systolic or diastolic blood pressure or with self-reported 
CHD. 
Conclusion: Among these Palestinian women, increased parity is significantly 
associated with obesity (as measured by BMI and waist circumference), triglycerides 
and an increased risk of the metabolic syndrome. Any of these, alone or in combination, 
could result in increased CHD risk for this group of women. 
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ORGANIZATION OF THESIS 
The thesis is divided into fourteen chapters. Chapter one provides a brief background, 
aim, rationale, and research objectives of the study. Chapter Two reviews the 
geopolitical environment and the demographic characteristics particular to Palestine and 
the Palestinian refugee camps. Chapter Three focuses on the development of the 
Palestinian health care system in the second half of the 20th century under different 
administrations, the role of non governmental institutions, improvements under the 
Palestinian Authority since 1994, recent difficulties in health care in Palestine, and the 
consequences of the unstable political situation and its impact on the health sector. 
Palestinian women's health and cardiovascular diseases in Palestine are discussed in 
Chapter Four. 
Chapter Five presents the review of literature in two parts: the first part highlights the 
literature review search strategy and then discusses cardiovascular diseases, the major 
classical risk factors for coronary heart disease and addresses the question, "why are 
women special? " 
The second part of the literature review covers the epidemiological association between 
high gravidity, high parity and early age at first birth and increasing risk of coronary 
heart disease in women (CHD morbidity and mortality in women). It goes on to discuss 
some of the likely biological mechanisms between reproduction and coronary heart 
disease, as well as the methodological difficulties involved in interpreting the results 
from such studies. Based on the results found in the literature reviewed, a conceptual 
framework for the thesis was developed with justification, objectives and research 
hypotheses. 
In Chapter Six, some of the difficulties of undertaking research in the Palestinian 
context and particularly in the fieldwork for this study are presented. It summarizes the 
research methodology and the preparatory work prior to work in the field, describes the 
targeted refugee camps and the study population, the sampling frame, the data collection 
methods and instruments used. This is followed by a description of the data collection 
logistics, the analytical framework and the statistical methods used. 
The results of the study begin in Chapter Seven by presenting the demographic, socio- 
economic and health characteristics of the study population and how some 
characteristics are linked to parity. Chapters Eight to Thirteen explore in more depth 
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how parity is associated with each variable under analysis using different statistical 
models: Chapter Eight indicates the characteristics associated with different 
anthropometric measurements and presents further analyses for each anthropometric 
indicator with parity. Chapter Nine presents the characteristics associated with elevated 
lipid levels and presents further analysis for the various elevated lipid levels with parity. 
In Chapter Ten Type II diabetes mellitus is investigated by looking at its associated 
characteristics and then by further analysis of its development with parity and also 
gravidity. The chapter gives a justification for taking gravidity (number of pregnancies) 
rather than parity (number of children) when looking at the case of fasting blood sugar 
and diabetes, and expands the analysis to explore other characteristics and mediators. 
Chapter Eleven presents the characteristics associated with elevated SBP, DBP and 
hypertension, then discusses further analysis of each of the blood pressure components 
(SBP and DBP) with parity. Chapter Twelve describes characteristics associated with 
women's reports of CHD and then presents further analysis of parity with reported 
CHD. Chapter Thirteen gives the characteristics associated with the metabolic 
syndrome and continues to present further analysis of the metabolic syndrome and 
parity, considering other characteristics and mediators. 
The concluding chapter presents a general discussion of the thesis, including the 
relevance of the work carried out, beginning with a summary of the main findings 
followed by a description of the uniqueness of the study. Methodological considerations 
are addressed including the strengths and limitations of the approaches used. This is 
followed by a discussion of the common themes in the association between parity and 
each of the CHD risk factors, as well as reported CHD and the metabolic syndrome. 
Finally the implications for public health are presented and discussed. 
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FUTURE PUBLICATIONS 
1. Number of children and risk of metabolic syndrome among Palestinian women 
living in refugee camps. 
2. Does educational attainment play a role in the development of the MS among 
Palestinian women? 
3. Parity, Gravidity and the development of type II diabetes in Palestinian refugee 
women. 
4. Is it failed pregnancies rather than parity that predict the development of type II 
diabetes mellitus among Palestinian women? 
5. Does parity increases the risk of CHD in women? 
6. Does women's education decrease the risk of CHD? 
7. Does women's education reduce parity and gravidity? 
8. Which anthropometric indices predict the MS in women? 
9. Which of the anthropometric indices BMI, WHR and WC could predict CHD 
risk in women? 
10. Parity and coronary heart disease risk factors among Palestinian women in two 
Refugee camps of the West Bank. 
11. Gravidity, rather than parity and incomplete pregnancies predict diabetes 
mellitus in women. 
21 
Chapter 1 
INTRODUCTION 
1.1 Background to the Study 
Coronary heart disease (CHD) is the most common cause of mortality in many 
developed and developing countries [1]. Research and major intervention trials in the 
United States and Europe have focused primarily on men, since they, on average, 
develop CHD earlier than women. This has been the case also because women are 
considered relatively protected from CHD until menopause as sex hormones appear to 
modify the impact of risk factors on the disease [2]. 
New research has increased the profile of CHD as an important issue for women. More 
women die of circulatory diseases than from all forms of cancer, including breast 
cancer, ovarian cancer and cervical cancer [3] [1]. Epidemiological studies have 
indicated that women in the West share major CHD risk factors with men. These 
include elevated serum cholesterol levels, hypertension, and cigarette smoking. Yet 
women may have additional risks unique to their gender including exposure to 
endogenous and exogenous hormones through menstruation, pregnancy, breastfeeding, 
menopause, oral contraceptives and hormone replacement therapy [4] [5]. 
Reproductive factors have been extensively studied in the context of diseases that occur 
exclusively in women. Large numbers of studies have examined the aetiological roles of 
reproduction in breast and ovarian cancers. Yet there has been relatively little 
examination of childbearing and other reproductive factors as risk factors for CHD. 
Evidence from the USA and Europe suggests that women with many births have 
roughly a 50-80% increase in the risk of developing CHD. The mechanisms underlying 
this association are unclear, but plausible biological pathways exist (changes in 
adiposity, blood glucose and lipid levels associated with pregnancy and continuing after 
reproduction has ceased) [6] [7] [8]. Confounding factors such as socio-economic status 
which could be related to both the exposure (gravidity/parity) and the outcome of 
Interest (CHD morbidity and mortality) may account for at least some of the reported 
association as well. 
What little evidence exists, suggests that like many other developing countries, Palestine 
has at least partially broken the cycle of poor sanitation, malnutrition, high infant 
mortality rate and modest life expectancy, to create a "health transition" characterized 
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by a growing adult and elderly population and an increasing incidence of chronic 
disease. Routine statistics as well as small scale studies (cited below) show high 
prevalence rates of CHD, diabetes, hypertension, and obesity for all areas of Palestine 
including the West Bank and Gaza Strip. 
According to the Palestinian National Authority (PNA), Ministry of Health Annual 
Report [9], heart diseases are the first leading cause of death among the general 
population, males and females, at 55.3% and 44.7% respectively in the West Bank and 
Gaza Strip. Ischemic heart disease is the leading cause of cardiovascular mortality 
(36.1%) with a rate of 36.4 per 100,000 population. Mortality among males is higher 
than females (57.7% vs. 42.3%) with a rate per 100,000 in males 41.5 and 31.2 in 
females. The data here though is not segregated by age group [9]. 
Risk factors for CHD and CVD appear to be common among Palestinians. The 
prevalence rate of Diabetes Mellitus in Palestine was 9% [10]. According to the United 
Nations Relief and Works Agency (UNRWA) department of health annual report [11], 
the prevalence of diabetes mellitus among refugee camps population of the West Bank 
was 6.03%. The prevalence of hypertension was reported to be 8.22% among the adult 
refugee population above 40 years of age in the West Bank. The report also stated that 
68% of individuals with hypertension or diabetes were obese (BMI >30). A population 
based cross sectional survey showed that the prevalence of obesity (BMI >_ 30) was 
36.8% and 18.1% in rural Palestinian women and men respectively [12]. Recent 
statistics from UNRWA indicates prevalence rates of diabetes mellitus and hypertension 
among refugees attending UNRWA clinics 40 years and above at 10.5% and 14.3% 
respectively [13]. 
Very little systematic information is available in the area of adult women's health in 
Palestine. A cross-sectional household survey of the socio-economic and health profile 
of Palestinian Arab Inhabitants of the old city of Jerusalem showed that 15% of the 
sampled 1334 individuals of all ages reported suffering from diabetes, hypertension, 
orthopaedic problems, CHD and arthritis [14]. Women in the sample aged 40 and above 
reported higher rates of diabetes, hypertension, and a combination of one or more of 
chronic diseases, such as diabetes and hypertension, hypertension and CHD compared 
to men of the same age. 
Despite evidence for a big burden of chronic disease which appears to affect women as 
well as men, the national and international development programmes have overlooked 
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long term health needs of women. Women's health for many years has been equated 
with only pregnancy and childbirth in Palestine. This functional view of the role and 
cause of existence of women has led to the omission of a whole range of health services 
needed by women at different stages in their lives. 
The focus on childbearing may in part stem from the high annual birth rate. The 
Palestinian Central Bureau of Statistics (PCBS) reported a crude birth rate of 45.9 per 
1000 population for the West Bank and 53.9 for the Gaza Strip during 1993 [15], and a 
total fertility rate of 6.84 births per woman [16]. In comparison, the total fertility rate in 
the UK was 1.8 at the time this study was conceived in 1997. In 2006, the crude birth 
rate in Palestine was 36.7 (41.7 in Gaza Strip and 33.7 in West Bank) per 1000 
population [17]. The fertility rate in 2006 was also high at 4.6 births per woman (5.4 in 
the Gaza Strip and 4.2 in the West Bank) [18] [19]. 
The available data on the health of Palestinian women suggests the largest gaps in 
research and services exist in the area of chronic diseases. Nevertheless, Palestinian 
women's childbearing patterns are different from those typically seen in North America 
and Europe and may play a different role in contributing to chronic diseases. 
1.2 Aim of the Study 
This study aims at exploring the relationship between parity and coronary heart disease 
risk factors among Palestinian women in the refugee camps. To our knowledge, it is the 
first of its kind in the Middle East region in general and Palestine in particular to look at 
the long term effect of reproduction on women's health. Numbers in the age group at 
risk are increasing, thus requiring additional efforts aimed at health promotion and 
primary prevention of coronary heart disease among Palestinian women. It also provides 
an extra rationale for reducing high fertility. 
1.3 Rationale for the Study 
Most of the epidemiological studies which have looked at the relation between parity 
and risk factors for CHD have been conducted either in Europe or the USA. However in 
those settings few women give birth to 5 or more children, which may make it difficult 
to detect any association. In addition, it is unclear whether one can extrapolate findings 
from these countries to the Arab world where women have different life styles, diets and 
different exposure to reproductive and environmental factors. 
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The present study examines the association between parity and known risk factors for 
CHD among Palestinian women, against a background of a total fertility rate of 6.84 
births per woman at the time the study was conceived [16]. The most recent report states 
that the rate is now 4.6; 5.4 in Gaza Strip and 4.2 in West Bank [19]. Palestinian women 
have had and still have a greater exposure to high parity; gravidity and early age at first 
live birth than most populations where heart disease and parity have been studied, which 
makes it an ideal population for extending studying of this issue. In addition, as has 
been shown above, chronic diseases, in particular CHD, are the leading cause of 
mortality and morbidity among Palestinian women as well as its associated risk factors 
obesity, hypertension and diabetes. Although Palestinian society is characterized as 
being youthful, it is becoming older and both the proportion and the absolute number of 
middle aged and obese women is increasing [20]. Fertility is falling, so this trend to a 
larger proportion will continue. There will be more women in the high-risk age groups 
for chronic diseases including CHD. Additionally, Palestinian women may be at excess 
risk of CHD and diabetes relative to women elsewhere because of a childbearing pattern 
of early age at first pregnancy as well as high parity. Results from this study can provide 
population-based estimates of the prevalence of CHD risk factors in Palestinian women. 
It is the first study in the Middle-East in general and Palestine in particular, to look at 
the long term effect of reproduction on women's health. Understanding the unique 
aspects of risk for Palestinian women will increase the awareness of women and 
medical caregivers and will pave the way for primary prevention efforts. 
Further to the above points, this research falls within three priorities: unstable areas, 
reproductive health, and chronic diseases. As the Palestinian Authorities have taken 
over responsibility of health, they face a severe lack of basic health data. Such a 
situation makes them particularly susceptible to international donor priority setting. For 
example, the international reproductive health agenda in the Middle East promotes work 
on STD, HIV, female circumcision and family planning. The limited data available in 
Palestine suggest that only the latter (family planning) is a major problem. By contrast, 
anecdotal data and statistics from the Palestinian Ministry of Health suggest chronic 
diseases are common. By describing the prevalence of CHD risk factors, showing their 
impact on women's lives, and clarifying the relationship between reproduction and 
CHD risk factors, basic data to support the Palestinian Ministry of Health will be 
provided, which is useful in evidence-based decision making and allocation of health 
care resources, and can contribute to health promotion and primary prevention of CHD 
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among Palestinian women, both to increase public awareness to the burden placed by 
chronic diseases, and to provide one more health rationale for reducing high fertility. 
Given the limited availability of resources, this research can also help prioritise the most 
effective interventions for prevention and treatment of these women. 
1.4 Research Objectives 
" To measure blood pressure, serum lipids, body height and weight, body fat 
distribution and diabetes mellitus among Palestinian women. From these 
measurements to derive standard risk scores for these women. 
0 To estimate the prevalence of obesity, diabetes mellitus, hyperlipidemia and 
blood pressure among these women. 
9 To assess the relationship between parity and the above mentioned risk factors 
for CHD. 
" To identify women at greatest overall risk of developing coronary heart disease 
(CHD) using the derived standard risk scores. 
" To examine if parity contributes to the development of the metabolic syndrome 
in these women. 
" To examine if parity contributes to the development of CHD events in the form 
of women's reports of present or past CHD. 
" To estimate CHD risk for the next 10 years by using the Framingham risk score. 
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Chapter 2 
PALESTINE: GEOPOLITICAL ENVIRONMENT AND 
DEMOGRAPHIC CHARACTERISTICS 
The structure and capacity of the Palestinian health system have been marked sharply by 
the country's political history. The recent development and planning for the health 
sector have been always effectuated under uncertain and very difficult conditions, 
sometimes under emergency situations lasting for long periods. To understand the root 
causes of the current obstacles faced, a description is necessary first of the geopolitical 
context and historical evolution of the Palestinian health system. 
2.1 Geopolitical Environment 
The Palestinian territories are compromised Map 2-1: The West Bank & Gaza Strip 
of two separate geographic areas with 
different demographic, economic and even 
legal status: the West Bank and the Gaza 
Strip separated by the State of Israel (See 
Map 2-1). 
The population density in the Gaza Strip is 
ten times more than that in the West Bank. 
The population of Gaza Strip lives in 28 
towns, villages and refugee camps, with 
one of the highest population density in the 
world of 3,505 inhabitants per square 
kilometre, with 66.1% refugees. In the 
West Bank, there are about 600 towns, 
villages and refugee camps with 380 
inhabitants per square kilometres with 
about 28.9% of the population consisting of 
refugees [21 ]. 
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Health inequalities are obvious between the West Bank and the Gaza Strip. The current 
total fertility rate is 4.6: 5.4 in the Gaza Strip and 4.2 in the West Bank [19]. The infant 
mortality rates are 28.8 and 22.9 per 1000 live births in the Gaza Strip and the West 
Bank respectively [19]. 
Poverty rates in Gaza remained higher than those in the West Bank. The estimates by 
the World Bank for September 2006 demonstrate that poverty rates have been 
increasing significantly from 43% in 2005 to 67% in 2006 [22] and the Bank states 
further that Palestinians living in the Gaza Strip are far more likely to be poor (23%) 
than individuals living in the West Bank [23]. 
In addition, urbanization has been increasing as more people move to urban centres 
seeking their livelihood or to avoid the need for travelling from and to workplaces with 
considerable access problems. 
These geographical disparities are exasperated by the political development of the past 
several years, which have affected health planning in Palestine, in general, and planning 
for women's health in particular, especially when two separate de facto health systems 
have been created (see below). 
2.2 Demographic Characteristics of Palestine 
In 2008, the total Palestinian population reached 3,761,646 [24]. According to the 
population pyramid, Palestinian society is one of the youngest in the world, with 45.5% 
at an age less than 15 years old [24]. The pattern of the age distribution is similar to the 
patterns of countries of high fertility rate. Life expectancy during the year 2006 was 
72.6 years and the median age remained the same during the period between 1995 and 
2006 at 16.7 years. Females constitute 49.3% [19]. 
It is worth noting that the total fertility rate in Palestine is still among the highest, at 4.6. 
Because Palestine is among those societies where women marry at relatively early ages 
fertility rates tend to be high. 
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2.3 Demographic Characteristics of Palestinian Refugee Camps 
According to UNRWA, "Palestine refugees are persons whose normal place of 
residence was Palestine between June 1946 and May 1948, who lost both their homes 
and means of livelihood as a result of the 1948 Arab-Israeli conflict. " UNRWA provides 
services "to all those living in its area of operations who meet this definition, who are 
registered with the Agency and who need assistance. UNRWA's definition of a refugee 
also covers the descendants of persons who became refugees in 1948. " The number of 
registered Palestine refugees in Jordan, Lebanon, Syria, Gaza Strip and the West Bank 
has grown from 914,000 in 1950 to more than four million in 2002, and continues to rise 
with natural population growth. [25]. Population growth continues; in 2005, this number 
reached 4,349,946 representing an overall increase of 2.7% since 2004. In 2007, the 
number of the refugee population reached 4,562,820 representing an increase of 2.5% 
compared to 2006 [26]. More than 45% of the population are registered refugees. One 
third of these registered refugees live in 58 official camps, in Jordan, Lebanon, Syria, 
and the Gaza Strip and the West Bank. The remaining population lives in unofficial 
camps, towns and villages of various host countries [27]. 
The demographic profile of Palestinian refugees is that of a young population with 
children below 18 years of age constituting 39.3% of the total population, and as high as 
48% in the Gaza Strip . Women of reproductive age (15-49 years) constitute 
24.7% of 
the total refugee population. 
The specificities of the refugee population in the West Bank and the Gaza Strip are 
unique and vary from other host countries (Lebanon, Syria and Jordan). According to an 
UNRWA study conducted in 2005, the average family size for the refugee populations 
in all these countries dropped from 5.85 in 1995 to 5.26 in 2005. But the largest family 
sizes were in the West Bank at 5.77 and in Gaza at 5.75. Total fertility rates showed a 
significant decline as well over the last two decades reaching 3.2 amongst all refugee 
population in all countries, with the highest rate of 4.6 in the Gaza Strip [28]. 
The refugee population in all countries has witnessed improvement in fertility rates, a 
decline in infant and child mortality rates and an increased life expectancy, but is facing 
increased poverty and unemployment rates, which will most likely result in higher 
dependency ratios, reaching 77.1 % in the West Bank and 100% in the Gaza Strip [27]. 
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Chapter 3 
PALESTINIAN HEALTH CARE SYSTEM 
The current Palestinian health system with its main players has been formed by the long 
years of colonization and military occupation. 
During the British Mandate (1920-1948), some government hospitals and health clinics 
were provided for the Palestinians but the British colonial policy aimed at limiting the 
development of health services [29]. And this system collapsed in 1948 at the aftermath 
of the Arab-Israeli War resulting in the emergence of two separate health systems, as 
Jordan ruled the West Bank while Egypt administered the Gaza Strip [30]. Moreover at 
that time, three quarters of a million Palestinians became refugees [29] which led to the 
creation of the UNRWA in 1949 by the United Nations General Assembly. This started 
its' operations in 1950 to "carry out direct relief and works programmes for Palestine 
refugees" [31]. UNRWA therefore began providing more modern health services 
(mainly curative and rudimentary) to refugees. 
Following the 1967 occupation of the West Bank and the Gaza Strip, the Israeli 
occupation represented by the Israeli Civil administration managed the governmental 
health care system. Another two important periods were the establishment of the 
Palestinian Authority in 1994 and the start of the second Popular Uprising (Intifada) in 
September 2000. 
3.1 Israel's Administration of the Health Sector (1967-1994) 
Before the 1967 occupation of the West Bank and Gaza by Israel, three different health 
systems were operating. The government of Jordan supervised the public health system 
in the West Bank, Egypt managed the system in the Gaza Strip and UNRWA provided 
health services for refugees. In addition, the private sector, including at that time 
charitable organizations administered main hospitals, diagnostic centres and primary 
care centres. 
Following the occupation, the governmental health care system was taken over by the 
Israeli Civil Administration and the system remained totally dependent on the Israeli 
health system due to Israel's policy of severe budget restrictions, referral to Israeli 
hospitals for tertiary care and restrictions on licenses for new health care projects. 
Hospitals and health facilities were closed and institutions were not developed to meet 
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the changing local needs of the Palestinian population. The health system was 
characterized also by the disempowerment of Palestinians in decision-making and top- 
level management [32]. 
The overall health status was inadequate. During the late 1970's and early 1980's, infant 
mortality was high, estimated at 50-100 deaths per 1000 live births. Morbidity levels 
were also high and the rate of malnutrition was 50% among children in some 
communities [33]. 
This period was mainly characterized by the complete control and dominance of the 
Israeli occupation and its policy towards the health sector of not allowing any future 
development to take place. This led to health civil society movements appearing as a 
reaction to the severe restriction by the Israeli occupation. 
3.2 Independent Palestinian Initiatives 
In response to the acute needs of the population, grassroots popular health committees, 
affiliated with Palestinian political movements, emerged in the late 1970s and took root 
in the early 1980s. They aimed at building independent Palestinian institutions to 
respond to the health needs reaching out to underprivileged populations with volunteer 
health providers and building an independent Palestinian health infrastructure [34]. 
These initiatives concentrated mainly on preventive and health education activities 
while advocating for people's participation in addressing health problems. As a result, 
new concepts and methods in health care provision were introduced based on enhancing 
mainly primary health care. 
Currently, these non-governmental initiatives compromise one of the major health care 
providers in Palestine and participate actively in national policy making and model 
developments in cooperation with the Ministry of Health. 
3.3 Improving the Palestinian Health Sector under the PA (1994-2000) 
Following the signing of the Oslo agreement in September 1993 between Israel and the 
Palestine Liberation Organization (PLO), the governmental health system of the Gaza 
Strip previously managed by the Israeli Civil Administration was managed by the 
Palestinian National Authority (PNA) in 1994 [35]. This period marked the first health 
planning at a national level and development efforts focused on cooperation between 
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various health care providers (government, UNRWA, NGO, and private), upgrading and 
expanding heath infrastructure, institution building within the Ministry of Health, 
quality control and human resource development in the West Bank and Gaza. Moreover, 
a national health information system was developed. A government health insurance 
scheme was initiated and training was carried out in certain areas such as women's 
health. Different policies, guidelines and protocols in various national health issues, 
such as maternal and child health, were also developed. Participatory planning with the 
four service providers was undertaken intensively. 
The first health planning processes at a national level emerged and led to the 
formulation of a first National Health Plan (NHP) produced in April 1994. However, it 
was only an initial plan with little connection with reality. The political, social and 
professional context contributed to the limited ability of the MOH to implement the 
original plan. In May 1999 a new version of the NHP was published [36]. 
It is important to highlight three significant indicators as examples underlining the 
accomplishments prevailing during this period: the increase in the number of hospitals 
and primary health care centres, the extended coverage of health insurance as well as the 
cooperation initiatives between NGOs and the government. These had a direct impact 
on the status of Palestinian women and accessibility to health services for this group. 
3.3.1 Increase in the Number of Primary Health Care Clinics and Hospitals 
There have been considerable efforts in constructing new hospitals. Currently, there are 
76 governmental, non-governmental, UNRWA and private hospitals in Palestine. The 
population/hospital ratio is 45,586 population per hospital and the total number of beds 
is 4203 (excluding psychiatric hospitals). As indicated in Figure 3-1 below, the number 
of beds has increased sharply since 1995 [37]. 
32 
Figure 3-1: Number of Beds and Population per bed in Palestine, 1993-2001 
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The number of governmental primary health care clinics also increased from 207 to 365 
between 1994 and 1998 in the West Bank and Gaza. Due to the decrease in NGO 
primary health care clinics during this period, the increase was greater in Gaza and the 
overall number of clinics in the West Bank did not change as much. 
Several NGO/MOH clinics functioned jointly and this period saw increased efforts of 
coordination between the four service providers [38]. Figure 3-2 shows numbers of PHC 
centres by provider in Palestine since 1996 until 2000. It is clear from this graph that the 
number of NGO clinics, decreased considerably between 1996 and 1997, whereas 
governmental clinics increased throughout the period [39]. 
Figure 3-2: Number of PHC Centres by Provider, 1996-2000 
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Many new services were introduced into governmental centres among which were 
family planning services, which were gradually integrated into about one hundred of the 
newly established governmental clinics. 
3.3.2 Expanded Coverage of Governmental Health Insurance 
Between 1994 and 1998, the Ministry set up as a priority expanding government health 
insurance and succeeded in increasing the number of adherents from 25% of households 
to 48% to include mandatory participation of governmental employees. 
However, in the second half of 1997, the Ministry of Health faced a serious financial 
crisis because the Ministry of Finance failed to allocate the expected budget to the 
Ministry of Health. This led to deterioration of government services including a lack of 
essential drugs and supplies and this situation affected public participation in the 
governmental health insurance programme, which then decreased considerably [40]. 
The health insurance system lost further one of its major contributors at the beginning of 
the second popular uprising in September 2000: workers with jobs in Israel who lost 
their work due to Israeli restrictions to enter Israel and the need for special permits. 
Voluntary enrolments also decreased and there was a massive increase in social 
hardship cases enrolled automatically in the insurance system, which led to a decrease in 
the general revenues of health insurance. 
3.3.3 Cooperation and Coordination among Health Care Providers 
Since 1994, relations between service providers have been mainly characterized by 
cooperation and coordination among health care providers, leading to partnerships made 
between the Palestinian MOH and a number of NGO service providers. These 
partnerships aimed at avoiding duplication of services and at achieving complementarity 
within a comprehensive national health plan. Attention was given to national health 
planning, the optimal use of the available resources, influencing health policies as well 
as the standardization of operational systems, protocols and standards. National systems 
have been achieved in school health, women health and other areas. 
3.4 The Turning Point: From September 2000 up to date 
From September 2000 until 2004, a health system crisis emerged with around 4,000 
Palestinians dead and around 45,000 injured, also with infrastructure, including 
hospitals and clinics, being destroyed and shelled by the Israeli army. This situation led 
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to very severe undermining of already fragile public institutions and services and 
influenced greatly the health of Palestinians as well as the nature of the Palestinian 
health care system. 
On top of this, in July 2002 the Israeli government began the construction of its West 
Bank Separation Wall (See Map 3-1). The wall redefines the occupied territories 
creating new humanitarian problems and needs since mostly it does not follow the 1967 
borders, "the Green Line". And according to the latest maps published by Israel, the 
total length of the Wall, when completed, is estimated to be 622 kilometres [41]. The 
wall penetrates deep into Palestinian territory resulting in the creation of an isolated 
zone between the Green Line and the wall. This zone has been designated by Israel a 
`closed zone' implementing a permit system for those living or owning land in the area. 
This zone has also effected the Israeli confiscation and annexation of large tracts of 
lands, impacting severely on Palestinian agriculture, trade and economy. The 
construction itself has also led to large-scale destruction of Palestinian property. Olive 
and citrus trees have been uprooted and agricultural land reduced to wasteland. The 
Wall isolates thousands of Palestinians into enclosed enclaves cut off from the West 
Bank presenting problems of inaccessibility to medical, health, social and educational 
services. 
The impact of the Wall affects the health status of Palestinian communities and damages 
the entire structure of the Palestinian health care system [421. According to HDIP's 
estimates, the Wall will affect 750,000 Palestinian people (including Palestinians in East 
Jerusalem) in nearly 40% of Palestinian communities and has had a serious effect on 
Palestinian healthcare. The healthcare system in the Palestinian Territories has been 
developed according to models proposed by the World Health Organization, whereby 
clinics providing differing levels of healthcare are located in various villages, towns and 
cities and are supported by a carefully planned referral system. With the Wall's 
construction, this referral system has been almost completely destroyed because, 
whereas in the past patients would have been referred to alternative clinics to seek 
specialized health care, now they are unable to reach. these clinics due to the movement 
restrictions created by the Wall. 
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Map 3-1: West Bank, the Wall Map, November 2004 
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3.5 Consequences of the Unstable Political Situation and its Impact on the Health 
Sector 
3.5.1 The Double Nature of Health Problems in Palestine 
Palestine is located midway between addressing illnesses characteristic to poor third 
world countries (infectious diseases, malnutrition, etc) and the increasing rates of 
modern diseases (cardiovascular diseases, diabetes, hypertension and cancer). But also 
malnutrition among children has increased. A survey conducted by Johns Hopkins 
University and AI-Quds University for CARE International in 2002 found global acute 
malnutrition (GAM) protein-calorie malnutrition of 9.3% of children across the West 
Bank and Gaza. The study also revealed that 17.5% of children aged 6-59 months 
suffered from chronic malnutrition. 53% of women of reproductive age and 44% of 
children were found to be anaemic [43]. Also according to MOH statistics, 9.6% of total 
births were low birth weight (under 2500 gm), there was 9% prevalence of stunting in 
children <5 years, 2.5% prevalence of wasting; 6.2% of the population didn't have 
access to safe drinking water and 54.2% of population of Palestine was not connected to 
sewer networks. The 2006 Palestinian Family Health Survey reports that one in 10 
children less than five years of age is chronically undernourished (stunted), meaning 
that about 50,000 children will not reach the optimal standards for growth and 
development. The heaviest burden falls on children between the ages of 1 and 2 (almost 
16%), a critical moment in shaping a child's future development [19]. Moreover, as half 
the Palestinian population has no medical insurance, many Palestinians are now unable 
to afford medical care [44]. 
On the other hand, according to PMRS's estimates, 18% of the population has abnormal 
sugar metabolism, 12% of them suffer from diabetes, 27% hypertension, 27% 
Dyslipidemia and 75% are overweight [45]. In 2005, the leading cause of death in 
Palestine was heart diseases, with a proportion of 54.5% [46]. 
3.5.2 Direct Impact on People's Life 
The majority of the population has been living under the severe conditions of 
unemployment for prolonged times, which has forced many of them to rely totally on 
assistance to ensure livelihood. Often for coping with such conditions people are forced 
to resort to borrowing, selling their properties, spending their savings, or decreasing 
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their spending and consumption of foods and clothing. Seeking health services has 
become at the top of the list of population needs. 
3.5.3 Medical Care: Access Denied 
Road blockades have directly prevented patients in need from receiving emergency 
medical care. More than 1798 incidents of denial of access to Palestinian ambulances 
have been reported [47]. According to the Palestinian Ministry of Health, between 
September 2000 and 2004,129 patients died at Israeli checkpoints and at least 61 
women gave birth at Israeli checkpoints. Of these, 5 mothers died while giving birth at 
Israeli checkpoints and 39 newborns died or were delivered stillborn. Mobile clinics 
have been regularly obstructed by closures of access roads; with medical staff forced to 
carry equipment over checkpoints. 
In addition, medical personnel often face serious difficulties in reaching workplaces: 
non-attendance at rural clinics due to closure has been reported at 35-40% in some cases 
[48]. In 2003, this continued to be the primary reason for health service suspension 
[49]. Furthermore, promotional and preventive activities such as antenatal care, child 
monitoring for development as well as vaccination programmes were the most affected. 
Although several reports indicate that there has been only a slight drop in vaccination 
coverage, the efficacy of vaccination has been affected from 2000 until 2002 [50]. The 
increase in measles cases in Gaza, for example, is indicative to the problem linked to 
efficacy of vaccination programmes during a crisis. 
3.5.4 Attacks on Medical Services 
Attacks by the Israeli army have been reported on medical personnel, establishments 
and health related vehicles. Between the 29th September 2000 and May 2006, the Israeli 
occupying forces carried out the following attacks on Palestinian medical services [51]: 
  846 attacks on ambulances. 
  139 ambulances damaged 28 beyond repair. 
  206 personnel injured. 
  12 medical personnel killed. 
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3.5.5 Blockade of Materials 
The Israeli blockade on goods entering the Occupied Palestinian Territories has had 
further serious ramifications for Palestinian health services [51]. Health providers have 
faced great difficulties in the distribution of medical supplies to Palestinian towns and 
villages. In November 2003, Medicins du Monde reported that UNFPA delivery kits had 
been held up at Tel Aviv customs since April, and were unable to reach the West Bank. 
The branch of the Palestinian Ministry of Health in Nablus has been waiting for delivery 
kits from February until September 2003, during which time they have been delayed 
[52]. 
Medical aid has been consistently detained by Israeli border control coming from both 
Jordan and Egypt. Israeli restrictions have closed the pharmaceutical market to 
international competition therefore the prices paid by the Palestinian Ministry of Health 
are notably expensive. The delay of drug deliveries from suppliers and the lack of 
contact between MOH in Gaza and the MOH in the West Bank, due to movement 
restrictions have a direct impact on drug procurement. Towards the end of 2002 MOH 
reported that its facilities were operating at about 30% of their capacity only. 
3.6 Funding for the Palestinian Health Sector: Increase of Emergency Aid 
Of the total international aid to Palestine, 8% was allocated to the health sector, nearly 
half of this support coming from Japan (33%) and Spain (15%) [53]. Between 1994 and 
2003, US$ 6.7 billion were committed to the West Bank and Gaza Strip by the 
international community at an average of US$ 670 million per year [54]. But although 
since the beginning of the Intifada, there has been an unprecedented international 
commitment by donors providing about US$ 315 per person per year [55], the ability to 
sustain external support at this level is rather weak. Increasing the size of external donor 
assistance to reach 2 billions USD during 2003 and 2004 would help decrease poverty 
only by about 7% [56]. 
Although several countries have stopped funding the health sector, particularly after 
1999, there was a sudden interest of Arab and other foreign countries in donating 
humanitarian and medical aid supplies from 2000. This included ambulances, medical 
equipment, blood units, medicines and tetanus vaccinations. Relying on information 
provided by the Italian Cooperation [57], it was noticed that all health projects 
throughout the years 2000-2002 were implemented mainly in four areas: the provision 
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of medical equipment and medical supplies to health facilities, health infrastructure 
assistance and counselling and psycho-social in projects mainly from Saudi Arabia, 
Oman, Qatar, Bahrain, United Arab Emirates, Egypt, Algeria, France, Spain and 
Turkey. Medical teams from Jordan, Saudi Arabia, United Arab Emirates, Egypt, 
Kuwait, Morocco, Qatar and France arrived in the West Bank and Gaza Strip with 
equipment to operate in Palestinian hospitals and help treat injuries. 
The danger in this context is the continuous pumping of emergency aid consisting of the 
provision of medical supplies, equipments upgrading infrastructure to cope with an 
"emergency situation" that has continued for more than six years without attempting to 
shift towards a more long-term approach of developing the health sector. Specifically 
during the period October 2000 to midyear 2001, the health sector received US$ 19 
million as a humanitarian assistance and US$ 34 million as development assistance [58]. 
40 
Chapter 4 
WOMEN'S HEALTH AND CARDIOVASCULAR DISEASES IN PALESTINE 
4.1 Palestinian Women's Health 
Since September 2000 and as a direct result of the Israeli-imposed restrictions on the 
freedom of movement of Palestinians, there has been a continuous decline in women's 
access to health care. Amongst other things, this has had severe repercussions on 
women's reproductive health. From September 2000 until October 2004,61 Palestinian 
women gave birth at checkpoints, out of which 36 were stillbirths, due to delays or 
prohibition on travel to medical facilities [59]. Equally, between 2000 and 2003, home 
deliveries increased from 5.2 percent to over 30 percent [59]. There has been an almost 
a fivefold increase in the number of pregnant women receiving no pre-natal care due to 
movement restrictions, and up to 31 percent of pregnant women are anaemic [59]. 
There has been an increase in births that take place in unsafe conditions or unsupervised 
by a skilled health worker, all of which has lead to drastic increases in the dangers posed 
to women during pregnancy and whilst giving birth, and has directly contributed to the 
infliction of enormous psychological strain on women [60]. 
The quality of healthcare services has also deteriorated. Overcrowding and overwork in 
hospitals, particularly government-run hospitals, affect the quality of care given to 
pregnant women. In addition, the number of female health professionals is low, with 
female physicians constituting just 11 percent of all physicians, and the ratio of 
registered midwives per 10,000 people standing at only 0.5. These conditions are 
exacerbated by a poor referral system, a lack of communication between primary and 
secondary health care providers, an emigration of skilled workers, and internal obstacles 
faced by women in terms of enforcing their reproductive rights. 
Alongside other vulnerable groups, pregnant women are particularly seriously affected 
by Israel's construction of the Wall in the West Bank that began in 2002. The 
Palestinian Ministry of Health estimated that 117,600 pregnant women, including 
17,640 high-risk pregnant women, may not be able to access antenatal care, hospital 
delivery services and postnatal care [61]. As such, the dangers posed to women during 
pregnancy and whilst giving birth have increased drastically, indirectly contributing to 
the infliction of enormous psychological strain on women [60]. 
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Many patients, including chronic and disabled patients, as well as health personnel and 
medicines, consequently have trouble reaching clinics. Forty-one primary health care 
clinics located in the West Bank will be isolated totally from the rest of other urban and 
rural centres. Labs, women and child health programmes, vaccinations, and health 
education have also been severely weakened, and 55% of clinics have difficulties 
procuring drugs and medical equipment. 
It is estimated 80,000 Palestinians have difficulty accessing emergency care and 
curative medical services, a further 80,000 have trouble reaching hospitals, and 35,000 
lack sufficient health care services. 6,000 more suffer deficiency in vaccination 
programmes, availability of general practitioner, preventive dentistry, and labs. Four 
communities in the Qalgiliya/Salfit area, Al-Za'im and Kalandia villages in Jerusalem, 
and Al-Walaja village in Bethlehem, 5,300 people in all, have no medical services 
whatsoever. Before the Wall was built, people in these areas could travel on back roads 
to bypass checkpoints and reach medical care, but this is now impossible [62]. 
External obstacles affecting women's health are compounded by the prevalence of 
socio-cultural and religious beliefs and practices based on the patriarchal system that, 
amongst other things, serve to restrict women's ability to obtain their reproductive and 
productive rights. Women's limited bargaining power within the household plays a 
significant role in the high fertility rates found in Palestine [63]. In addition, family and 
community attitudes often prevent women from receiving proper care during pregnancy 
and delivery. As a result, women rarely consider their own health as a priority, 
particularly in the context of high levels of poverty, where women seek care only in 
cases of serious complications or illnesses [64]. 
These attitudes have been exacerbated since September 2000. Restrictions on the 
freedom of movement by Israeli policies are matched by restrictions imposed on girls by 
their families, who become increasingly protective in order to avoid potential risk and 
harassment at checkpoints. This lies at the heart of rising school dropout rates amongst 
girls and women, particularly at the university level [65], and women's general 
disappearance from the public sphere. According to the UN, it is also directly related to 
increasing rates of early marriage, as families compel their daughters to marry at an 
early age rather than send them to school: "Reports of increasing early marriage 
suggest a higher drop out rate past compulsory levels of education, eventually leading 
to worsening economic security and family health. Early marriage contributes to 46 
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percent of the drop-out rate for female students, particularly at the secondary level, due 
to the limitation of compulsory". In this context, mobility restrictions placed on women 
under the patriarchal system are exacerbated by the security concerns above, related to 
Israel's military occupation of the Palestinian territory. As such, women face three-fold 
difficulties in accessing reproductive health services, in terms of gender, poverty and the 
occupation. Statistics on the number of women and infants who have died in childbirth 
at checkpoints highlight the serious impact the socio-political, religious and security 
situation has on women and children's health, on top of existing problems associated 
with poverty and underdevelopment. 
4.2 Cardiovascular Diseases in Palestine 
At this crucial junction of Palestine's health system transition, cardio-vascular diseases 
contribute a significant proportion of total deaths. Cardiovascular diseases and diabetes 
are extremely widespread. In 2006, heart disease was the first leading cause of death in 
the population [9]. Cerebrovascular disease was the third leading cause of death in the 
total population constituting 11.0% of total deaths, with rate (29.8% per 100,000 
population), the third in males (9.9%) and the second in females (12.4%) [9]. 
Hypertensive disease was the eight leading cause of death in total population at 4.8% of 
total deaths, the ninth leading deaths in males and females (2.7% and 3.8%) of males 
and females deaths respectively. 
Hypertension and dyslipidaemia, although common, are inadequately detected and 
treated. Tobacco consumption among Palestinians is common, especially among the 
poor and related cancer account for a large proportion of all cancers. 
Demographic and socioeconomic factors are speeding up the health transition, with 
sharp escalation of cardiovascular disease burdens expected over the next ten years. One 
of the challenges, however, is the availability of data that could estimate the overall 
prevalence of cardiovascular diseases, hypertension or diabetes. mellitus. Information is 
obtained from mortality data through the different health centres and the current system 
counts only the visits of the patients to these centres, hence not reflecting the real 
prevalence or incidence. Due to the lack of a computerized system, classification by age 
and gender or any information on disabilities resulting from any of the chronic diseases 
are not available. 
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Chapter 5 
LITERATURE REVIEW AND DEVELOPMENT OF CONCEPTUAL 
FRAMEWORK 
The literature review was carried out at two distinct times, and in two different phases. 
The first phase was carried out during the preparation phase in 1997 which was updated 
in 2006/2007, and the second phase, was carried out after the data collection and during 
the final write-up. 
In the first phase, Popline, Medline and Pubmed were the main literature databases 
searched; the WHO website was also used and suggestions from key informants were 
followed up. 
In the second phase, the same sources were used, as well as Embase, the Cochrane 
collaboration, CAB direct, Eldis and Web of Knowledge. The last of these was also 
used to follow up on citations. 
During both phases, the following keywords were used: 
Reproductive history, gravidity, parity, age at first birth, coronary heart disease, CHD 
risk factors, lipids and lipoproteins, obesity, body mass index, waist-hip ratio, waist 
circumference, blood pressure, diabetes, metabolic syndrome and Framingham risk 
score. The geographical context (Palestine, Middle East, Arab countries etc) and other 
generic descriptors, such as women, old age, adult, etc were also applied in appropriate 
combinations. MESH terms based on these keywords were also applied. The terms 
applied are listed in Appendix 1. 
Articles were inspected on the basis of titles and abstracts. For relevant articles, the full 
text was obtained and was included in the review. The results are reported in sections, 
as presented in the review chapter below. 
5.1 Cardiovascular Diseases and Risk Factors 
This first chapter of the literature review discusses the major classical risk factors for 
coronary heart disease and responds to the question "why women are special"? 
According to the WHO report [66], an estimated 16.7 millions, or 29.2% of total global 
deaths, are due to the various forms of cardiovascular disease (CVD), including 
coronary (or ischaemic) heart disease (heart attack), cerebrovascular disease (stroke), 
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hypertension (high blood pressure), heart failure and rheumatic heart disease. Many of 
these CVDs are preventable by ensuring needed action on the major primary risk 
factors: unhealthy diet, physical inactivity, and smoking. More than 50% of the deaths 
and disability from heart disease and strokes, which together kill more than 12 million 
people each year, can be prevented by a combination of simple, cost-effective national 
efforts and individual actions to reduce major risk factors such as high blood pressure, 
high cholesterol, obesity and smoking [66]. 
These risk factors are no longer diseases of the developed world; some 80% of all CVD 
deaths worldwide took place in developing, low and middle-income countries, while 
these countries also accounted for 86% of the global CVD disease burden. It is 
estimated that by 2010, CVD will be the leading cause of death in developing countries 
[66]. 
Of the 16.7 million deaths from cardiovascular diseases (CVDs) every year, 7.2 million 
are due to ischemic heart disease, 5.5 million to cerebrovascular disease, and an 
additional 3.9 million to hypertensive and other heart conditions. CVD affects people in 
their mid-life years, thus undermining the socioeconomic development, not only of 
affected individuals, but families and nations [66]. Lower socioeconomic groups 
generally have a greater prevalence of risk factors, diseases and mortality in developed 
countries, and a similar pattern is emerging as the CVD epidemic matures in developing 
countries. In 2005, an estimated 17.5 million people died from CVD, representing 30% 
of global deaths [67]. 
This rise in CVDs reflects a significant change in diet habits, physical activity levels, 
and tobacco consumption worldwide as a result of industrialization, urbanization, 
economic development and food market globalization. People are consuming a more 
energy-dense, nutrient-poor diet and are less physically active. Imbalanced nutrition, 
reduced physical activity and increased tobacco consumption are the key lifestyle 
factors. High blood pressure, high blood cholesterol, overweight and obesity - and the 
chronic disease of type II diabetes - are among the major biological risk factors. 
Unhealthy dietary practices include high consumption of saturated fats, salt and refined 
carbohydrates, and low consumption of fruits and vegetables. When risk factors are 
combined, risk for CVD can increase. These risk factors tend to cluster and when they 
are combined risk for CVD can increase and can lead to disability and death. 
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5.2 Risk factors for CVD 
There are a variety of risk factors that contribute to CVD morbidity and mortality. 
Through extensive research, many of these risk factors for CVD have been identified 
and are well documented and understood. Each of these risk factors can be categorized 
as preventable (those over which the individual has control) or non-preventable (those 
over which the individual has no control) as detailed in Table 5-1. 
Table 5-1: Preventable and Non-preventable Risk Factors 
Type II diabetes Increased age 
High blood cholesterol Gender 
High blood pressure Race/ethnicity 
Lack of physical activity Family history 
Overweight and obesity 
Unhealthy eating 
Smokinq 
Fortunately, one can assume that research has identified almost all of the risk factors for 
CVD and has shown that most are modifiable through apparently simple lifestyle 
choices. While extensive efforts have been made in recent decades to improve these 
risk factors, many of these efforts have not been successful. 
5.3 Coronary Heart Disease 
This part of the literature review will focus on Coronary Heart Disease (CHD) and its 
associated risk factors especially those related to women. Coronary heart disease has 
been defined as a disorder of cardiac function due to an imbalance between myocardial 
function and the capacity of the coronary blood vessels to supply sufficient now (to the 
heart muscles) for normal function [68]. Clinical syndromes related to coronary heart 
disease are angina pectoris, myocardial infarction (non-fatal and fatal), and sudden 
cardiac death [68]. 
Angina is the most common form of presentation among women with CHD [69]. While 
heart attacks (myocardial infarction) are less common among women than heart attacks 
in men, painless heart attacks are common in women, particularly in old ages [70]. If 
world-wide proportions are similar to those in the United States, approximately 40 
percent of CHD presents as angina pectoris, 40 percent as myocardial infarction, and 20 
percent results in sudden cardiac death [69]. 
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Although the rates for CHD are declining in North America and Western Europe at the 
time the study was conceived, It is still unclear how much of the decline is due to a 
reduction in the incidence of disease and how much is due to improved survival [71]. 
Yet CHD remains the major cause of disability and death in women [72]. In the United 
Kingdom, coronary heart disease is the single leading cause of death among women 
above and below the age of 65 years [73] [74]. It accounts for over 40% of deaths in 
women at all ages [74]. Little is known about the distribution of CVD risk factors and 
their control in women [74]. In a study conducted by Lawlor et at on geographical 
variation in CVD risk factors and their control in older British women, found that 
although geographical variation in CVD is explained to some extent by differences in 
major risk factors and/or socioeconomic factors and health services utilization, some 
geographical variation remained even after adjustment for these factors which required 
further explanation [74]. This is not the case for Eastern Europe, where CHD rates have 
increased steadily without evidence of stabilization or decline [75] [76] [77]. 
Rates in the developing world are much less documented. It has been speculated that by 
the year 2000-2015, CHD will increase sharply and will be the leading cause of death 
for many developing countries. [78] [69] [79] 
5.4 Major Classical Risk Factors for CHD 
The major classic risk factors for coronary heart disease are the same for women as for 
men. Smoking, high blood cholesterol and hypertension all predict CHD in women but, 
for any given level, constitute a much smaller risk for women than for men [80]. 
However, among older ages, the prevalence of these classical risk factors is higher 
among women than among men [81]. At younger ages, women have lower coronary 
heart disease mortality than men, as women may be biologically more resistant to CHD 
with protection from higher levels of HDL-C and oestrogen, but the sex difference 
reduces after about age 50 years [82]. This hypothesis stemmed from the fact that male 
to female ratio for fatal CHD is consistently around 2: 1 in various countries with 
different life styles and rates for heart disease. This sex difference in CHD incidence 
persists after taking into account common CHD risk factors [83]. Another hypothesis 
lead by Lawlor et al showed that secular, geographical and age related trends, highlight 
the importance of environmental factors in determining sex differences in CHD 
occurrence and which could not be explained solely by a cardio protective effect of 
oestrogen in women [84]. However, the underlying mechanisms for these associations 
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remain unclear, but plausibly include genetic, biological, environmental and 
socioeconomic factors acting along the life course [80]. It is interesting to note that 
biologically the classic risk factors confer the same magnitude of risk in relative terms. 
Thus a woman who smokes, or who has a high blood cholesterol level, has a greater risk 
of CHD Than a woman who does not, and the proportional increase in this risk is the 
same as with men [82]. Other important risk factors in women include obesity and 
diabetes. 
5.4.1 Smoking 
In women, smoking has been shown to be a risk factor for CHD, and its adverse effect 
persists into older age [72] [85]. The effect of smoking on CHD risk is dose-dependent 
[81]. Premenopausal women who smoke have three times the risk of heart attack of non- 
smokers, and women who smoke more than 40 cigarettes a day increase their risk 20- 
fold [86]. Cigarette smoking is inversely associated with low socio-economic status, 
high educational level and income in both men and women [81]. 
5.4.2 Cholesterol 
Total cholesterol rises with age in both men and women. Women have lower cholesterol 
value at younger ages, but a sharp rise occurs in the fifth decade, so that from age 50 
onwards the average cholesterol level in women is higher than in men. [72] [87,88] 
5.4.3 Low Density Lipoprotein Cholesterol (LDL-C) 
Levels of LDL-C follow a similar pattern with age to that of total cholesterol, rising 
with age in both sexes during adult life. LDL-C levels are consistently lower in women 
than in men until about the age of 50, when a cross-over occurs [89] [88]. 
5.4.4 High Density Lipoprotein Cholesterol (HDL-C) 
Average levels of HDL-C are consistently higher in women than in men, throughout 
adult life, although this sex difference is reduced after middle age [89] [88]. HDL-C 
inversely predicts CHD in both middle-aged men and women, and in older women but 
less convincingly in older men [72]. 
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5.4.5 Triglycerides 
Triglycerides levels rise with age in women, although women's average triglycerides 
levels are consistently lower than those in men at all ages [89]. The sex difference is 
most marked in middle age and disappears during the later years of life [90] [89]. 
In both women and men, the risk of CHD increases as the level of total cholesterol rises 
[89]. The relation between the cholesterol fractions and CHD risk is stronger, 
particularly for HDL-C [89]. HDL-C is inversely and independently associated with 
CHD risk: the higher the HDL-C level, the lower the CHD risk. However the 
association of HDL-C with CHD risk is twice as strong in women aged over 50 years 
[89]. LDL-C is positively associated with the risk of CHD: the higher the LDL-C level, 
the higher the risk of CHD. The relationship between triglyceride and CHD risk is less 
clear, and it is uncertain whether there is a sex difference in this relationship [89]. 
5.4.6 Blood Pressure 
In most populations, blood pressure rises with age in both men and women [72]. 
Systolic pressure rises throughout life while diastolic pressure tends to plateau around 
the sixth decade [72]. At younger ages, blood pressure in women is lower than in men, 
but after the menopause the rate of rise of systolic pressure with age is greater in women 
than men, leading to a higher prevalence of hypertension in older women [72]. Several 
observational studies in women have demonstrated the importance of both systolic and 
diastolic pressure in predicting CHD [91] [92] [93]. Although at all ages the risk is 
lower for women compared to men, the relative risk associated with a particular level of 
blood pressure is the same in women as in men [72] [80]. 
5.4.7 Diabetes 
Diabetes imposes a greater risk of CHD in women than in men [72] [94]. The impact of 
diabetes on CHD in women is considerable, with relative risks of up to fivefold 
compared with non-diabetic women [95] [96] [97]. A meta-analysis of prospective 
cohort studies found that diabetes had a greater impact in women than men (relative risk 
2.54 (95% Cl: 2.08- 3.09) in women and 1.76 (95% Cl: 1.51-2.05) in men, p= 0.004 
comparison between women and men [98]. Diabetic women seem to lose protection 
from CHD as a result of the metabolic disturbances associated with non-insulin 
dependant diabetes mellitus [99]. It is possible that a high waist to hip ratio increases the 
likelihood of diabetes and also of CHD. McKeigue et al [100], showed that the insulin 
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resistance syndrome, associated with a striking tendency to central obesity in South 
Asian women and men, is the most plausible explanation for their high CHD mortality. 
Women with a higher waist to hip ratio have increased risk of impaired glucose 
tolerance and adult onset diabetes. In addition, total cholesterol and triglycerides 
increase and HDL-C levels decrease compared to non-diabetic women [81]. 
5.4.8 Obesity 
Obesity is also associated with an increased risk of CHD, and sex differences in body fat 
distribution may partly explain the differences in CHD risk [81] [99]. Body fat 
distribution appears to be more significant than body weight with regard to CHD risk [2] 
[1011. Although obesity measured by BMI, has been associated with CHD risk in 
women [102], abdominal or central 'obesity (male fat pattern), appears to be more 
powerful CHD risk factor for women [103] [104]. The distribution of body fat is 
recognized as a contributing factor in the development of CHD, independent of relative 
body weight. There are links between central adiposity, insulin resistance, raised 
triglycerides and decreased HDL-C which may relate to CHD risk. The male pattern of 
obesity, with a high waist to hip ratio, is associated with higher risk of CHD than the 
female pattern of lower waist to hip ratio, which may partly explain the sex differences 
in CHD. It has been suggested that oestrogen protects younger women from CHD via an 
influence on body fat distribution [105]. The Gothenburg study in Sweden [106], found 
that differences in blood pressure, smoking, blood cholesterol and BMI only explained a 
small part of the sex difference in CHD rates, but when waist to hip ratio was also 
considered, the sex difference in CHD risk almost disappeared. In a cross sectional 
survey using data from the British regional heart study, Lawlor et al [101 ] suggested that 
sex differences in lifestyle risk factors (alcohol consumption, smoking and physical 
inactivity) do not explain sex differences in CHD occurrence, although they increase 
waist to hip ratio. In this same study, Lawlor et al. suggested an important role for 
abdominal obesity in explaining sex differences in CHD risk. Adjustment for waist to 
hip ratio removed the sex differences in CHD occurrence [101]. Therefore, the study 
concluded that sex differences in body fat distribution may explain sex differences in 
arterial atherosclerosis. Body fat distribution, or factors closely related to it, may thus be 
part of the explanation for sex differences in CHD. 
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Other factors may contribute to the increased risk of CHD such as low socio-economic 
status, stress, lack of physical activity and high cholesterol, high fat diet among both 
women and men. 
5.5 Are Women Special? 
Women may have additional risk factors for CHD not found in men, namely those 
related to reproductive function: pregnancy, hysterectomy, menopause, and use of 
steroid hormones. Although childbearing is a major biological and social event in the 
lives of most women, little is known about the relationship between the pattern of 
childbearing and total mortality and morbidity [107]. A women's risk of developing 
various diseases is altered during the course of pregnancy and in the immediate 
postpartum period [108]. It has been very well documented that pregnancy confers long 
term protection against certain cancers such as breast and ovary, but its long term effect 
on other conditions such as CHD has been less extensively studied [7]. 
Among women of reproductive age, the atherosclerotic process is lessened, as compared 
with men of the same age range, possibly due to an influence of circulating oestrogen on 
the incorporation of LDL-C into atherosclerotic plaques [2]. Therefore, women seem to 
be less susceptible to CHD at least until perimenopause. However, Lawlor et al [84], 
does not totally agree with this hypothesis. In an attempt to examine secular trends and 
geographical variations in sex differences in CHD mortality and how these relate to 
distributions in risk factors, Lawlor et al found that a protective effect of oestrogen alone 
could not explain the variation over time and between countries among the sex 
differences in mortality from CHD. They suggested that these secular and geographical 
trends indicate that sex differences in mortality from CHD are driven primarily by 
environmental factors. In an attempt to explain why women develop acute MI later than 
men, the INTERHEART study [109] a global case-control study including participants 
from 52 developed and developing countries, investigated if differences in risk factor 
distributions exist between women and men across various age categories. They found 
that women experience their first myocardial infarction (MI) on average ten years later 
than men in all regions of the world. Nine modifiable risk factors are associated with 
incidence of Ml and explain more than 90% of the population attributable risks of acute 
MI among women and men from all regions of the world. Similar risk factor 
associations with MI are present in women and men for abnormal lipids, current 
smoking, abdominal obesity, dietary intake and psychosocial stress factors. However, 
risk factor MI associations for hypertension, diabetes, physical activity, alcohol use, and 
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former smoking differ between sexes. They also found that these associations are 
stronger in younger individuals both in women and men. The younger age of onset of 
acute MI in men, is largely explained by higher levels of risk factors including abnormal 
lipids, and smoking before the age of 60 years. Therefore they concluded from the 
INERHEART data, that the lower MI burden among women at younger ages is largely 
explained by a lower risk factor burden. The reasons why the risk factors are lower in 
women at younger ages compared to men are still unclear and continue to be an area of 
controversy. 
Identification of the factors responsible for sex differences in occurrence of CHD would 
have important public health implication in identifying preventive strategies, 
particularly in countries where rates of CHD are currently increasing. 
Reproductive history, is generally thought of as beginning with menarche and ending at 
menopause [7]. This time period may be punctuated by timing and number of 
pregnancies and their outcomes: live births, stillbirths, miscarriages, and breast feeding. 
The full description also includes ages at menarche and menopause, regularity of 
menstruation, fertility, gynaecological or obstetric problems, and contraceptive use. For 
the purpose of this study parity was used as the exposure variable. Parity is defined as 
the number of offspring the woman has born. It is contrasted with gravidity which refers 
to the number of pregnancies regardless of outcome. 
5.6 Parity and Coronary Heart Disease Risk Factors 
The second part of the literature review covers the epidemiological association between 
high gravidity, high parity and early age at first birth and increasing risk of coronary 
heart disease in women, as well as likely biological and behavioural mechanisms 
between reproduction and coronary heart disease. Epidemiological research relating 
reproductive history and coronary heart disease risk has used population, cohort, cross- 
sectional and case-control studies. 
Section 5.6.1 provides a review of epidemiological evidence relating high gravidity, 
high parity and early age at first birth and CHD morbidity and mortality in women and 
discusses some of the methodological difficulties involved in interpreting the results 
from such studies. 
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Section 5.7 discusses links between reproductive history and known risk factors. These 
include studies of gravidity, parity and age at first birth as the exposure variables and 
obesity, lipid levels, diabetes and hypertension as the outcome variables. 
Section 5.8 discusses parity with the metabolic syndrome as an outcome variable. 
Section 5.9 discusses proposed mechanisms for the association between gravidity/parity 
and CHD risk among women. 
5.6.1 Reproductive History and Coronary Heart Disease (CHD) Morbidity and 
Mortality 
An increased risk of CHD morbidity and mortality among women with high gravidity, 
high parity, and early age at first pregnancy or live birth was found in most studies in 
which these relationships were examined (Tables 5-2,5-3 and 5-4). Of the eight 
published cohort studies in women [107,110-115], all except for the Nurses' Health 
Study [116], showed small but consistent associations between gravidity/parity and an 
increased risk of CHD. The magnitude of the relative risk, which must depend on which 
parity groups are compared as well as other study-specific factors, is of the order of 1.2- 
2.5. However, only three studies - the Framingham [110], the NHEFS [110], and the 
Norwegian study [113] - showed statistically significant results after adjustment for 
socio-economic status and other confounders (Table 5-2). The adjusted relative risks for 
these studies were 1.7,1.9, and 1.2 respectively, comparing nulligravid/nulliparous 
women to those of 6+ and 5+ pregnancies / child births. The Nurses' Health Study 
showed an adjusted relative risk of 1.2,95% CI (0.8-1.8) but this was not significant 
[116]. Steenland et al showed an increase of 1.18 in the risk, 95% Cl (1.04-1.34), for 
those women with six or more live births adjusting for age only. But when a number of 
CHD risk factors were included as confounders, no increased trend in heart disease with 
increased parity was observed [115]. 
Six of eleven case-control studies [108,117-122] showed increases in CHD risk with 
gravidity/parity in the order of 1.5-1.8, while five studies [123-127] have shown 
negative associations. Only Palmer et al demonstrated statistical significance after 
adjusting for many variables [117] (Table 5-3). The adjusted relative risk was 1.8 for 
comparing parous 1+ to nulliparous and 1.4 for comparing para 5+ to para 1-4. Beral 
found a 20% increase in mortality from CHD among parous women compared to 
nulliparous. 
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A significant increase in risk of CHD morbidity and mortality has been reported for age 
at first live birth less than 20 years, and to a lesser extent with age at first pregnancy less 
than 20 years. Relative risk estimates from five case-control studies [117,118,122,124, 
128], range from 1.7-3.4. The association was evident in both younger and middle-aged 
women, and was not explained by allowance for several identified potential 
confounding factors. 
A nearly 3-fold increase in relative risk (2.7) was observed in studies where early age at 
first live birth and high parity (5+ children) were combined [117] (Table 5-4). This 
suggests that high parity and early age at first birth are independent risk factors for 
CHD. However, the one cohort study of Colditz et al, did not show an increased risk 
(RR = 0.6) for high parity and early age at first live birth [116]. 
Two of the three cross sectional studies showed J-shaped and a U-shaped relationships 
between the number of children and coronary heart disease and carotid Intima-Media 
Thickness (IMT) respectively [8,129]. Lawlor et al found a positive association 
between parity and CHD for those with at least 2 children, and each additional child 
increased the age-adjusted odds of CHD by 30% (OR: 1.30; 95% Cl: 1.17-1.44) for 
women. Adjustment for obesity and the metabolic risk factors attenuated the association 
between greater number of children and CHD in both sexes, although in women some 
association remains [8]. In both women and men, there was a J-shaped associations 
between number of children and age-adjusted prevalent CHD, with the prevalence being 
lowest among those with 2 children [8]. Wolff et al [129] found a U-shaped association 
between the number of children (from 0-z 4) and mean and maximum IMT. Nulliparity 
and higher number of children are associated with increased carotid IMT. Nulliparous 
women had the highest age-adjusted mean (0.81 mm [95% Cl, 0.78-0.84]) and 
maximum IMT (1.04 mm [95% CI, 1.00-1.09]), whereas women with single parity had 
the lowest (mean IMT, 0.73 [95% Cl, 0.72-0.74]; maximum IMT, 0.91 mm [95% Cl, 
0.89 to 0.93]). Stepwise multivariate adjustment for socio-economic factors, lifestyle 
variables and biological variables attenuated the magnitude of this association yet 
significance remained [129]. 
The Rotterdam study [130] showed a significant association between parity and risk of 
carotid artery plaques in elderly women where parous women compared to nulliparous 
women had 36% (1.09-1.71) greater risk of carotid atherosclerosis, rising to 64% (1.19- 
2.27) in women with z4 children. Adjustment for known cardiovascular risk factors, 
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including insulin resistance and current lipid levels, did not diminish the magnitude of 
the association [130]. 
Most of the studies that have considered the association between number of children and 
CHD risk among women, have found increasing disease, mortality and increased carotid 
intima-media thickness with increasing number of children as mentioned above. 
Biological mechanisms were proposed including pregnancy lowering lifetime oestrogen 
exposure and pregnancy resulting in permanent changes to lipid and carbohydrate 
metabolism. 
Some authors such as Lawlor et al [8] and Hardy et at [131], proposed an alternative 
explanation which says that that social and behavioural factors associated with child 
rearing and family life might underlie any association between number of children and 
CHD risk factors). In order to prove their explanation, they have included men as a way 
to assess the relative contribution of social and biological factors when studying the 
association between number of children and CHD risk. Lawlor et al concluded that the 
association between number of children beyond two and increased CHD and risk factors 
could be explained by socio-economic factors in men but could not explain the same 
association in women and therefore concluded that the association among women is 
explained by biological factors [8]. Hardy et at found that although BMI, WHR and type 
II diabetes showed a linear increasing trend with increasing number of children in 
women compared to men, yet these associations were largely explained by adjustment 
for behavioural and lifestyle factors. They found that women with four or more children 
were more likely to be smokers, inactive and come from manual social classes in 
childhood and adulthood [131]. 
The largest cohort, cross-sectional and case-control studies showed significant positive 
associations. Conflicting findings and some of the differences arise from the limitation 
of methods used in some of these studies. In the following sections, we will shed light 
on some of the methodological issues related to the association investigated. 
5.6.1.1 Cohort studies 
In cohort studies, lack of power may possibly differentiate between studies showing 
positive results and those that are not. Three factors, age of women, length of follow-up 
and the range of outcome studied all contribute to the results. 
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Age of women participating in the studies: The age of women studied ranges from 16- 
84 years. The moderate but consistent association was seen mostly in the older aged 
cohorts (; ->50 years), an age range 
by which more women develop CHD (Table 5-2). 
Young women <50 years old, are known to be protected from CHD as a result of 
oestrogen action. The inclusion of young women, who experienced a low rate of CHD, 
might have masked an association between high gravidity/parity and CHD among older 
women by reducing the likelihood of a positive association. Alternatively, parity may 
act differently in pre-menopausal women. 
Years of follow-up: The longer the follow-up period, the greater the number of CHD 
events in the study. Studies with long follow-up periods (12-28 years), showed positive 
associations compared to studies with shorter follow-up period (6 years) (Table 5-2). 
Inclusion of angina in defining the outcome: Two of the three studies that showed a 
positive association after adjusting for multiple confounders (Table 5-2, the 
Framingham study and the NHEFS), included angina as a component of CHD end 
points. This led to an increase in the number of women who had a positive outcome. 
Exclusion of angina from the definition of CHD diminished the strength of the 
association in the Framingham study (rate ratio for women with 6+ pregnancies, 1.4; 
95% CI, 0.9-2.2) but had no effect on the association in the NHEFS (rate ratio for 
women with 6+ pregnancies, 1.3; 95% CI, 1.0-1.7). This could be because half the cases 
of CHD among women in the Framingham study were due to angina, whereas this was 
only 14% in the NHEFS. An alternative explanation is the failure to adjust for 
confounders and mediators. 
Confounders and Mediators: Most likely confounding and mediating factors include 
age, CHD risk factors, social class and life style variables. Most of the cohort studies 
have controlled for either CHD risk factors or social class and life style variables or all 
of them combined. Studies that extensively adjusted for CHD risk factors, socio- 
economic status and life style variables showed a positive association [110] (Table 5-2, 
Ness et at, the Framingham study and the NHEFS). Studies that managed to control for 
measured CHD risk factors at baseline [110] showed a positive association compared to 
others where information on CHD risk factors was based on self reports (the Nurses' 
Health Study) [116]. All these studies suggest that parity is an independent risk factor 
for CHD even after controlling for confounders. 
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A confounder is a variable that distorts the association or the relationship between an 
exposure and an outcome and must be a risk factor for both the outcome and the 
exposure, while not being on the causal path between the two. Therefore a confounder 
does diminish or eliminate the importance of parity related risk. Not allowing for a 
confounder can lead to an erroneous assessment of the role of the risk factor on account 
of confounding bias. Not every factor that is associated with both the exposure and the 
outcome is a confounding variable. A mediator is also associated with outcome and risk 
factor but may be part of the causal chain between them. Therefore finding a mediator 
doe not diminish the importance of parity as a risk factor, it just assists in explaining 
parity related risk. Allowing for a mediator can help understand the risk factor outcome 
relationship but is not needed to establish that the risk factor is a genuine correlate. In 
some of the papers reviewed the distinction between confounders and mediators is not 
always made when adjustments are made. 
Men with high parity and CHD morbidity: The relation between the number of 
children and risk of CHD in men has been explored in two cohort studies [112,114] and 
one cross-sectional study [8] for two reasons: first, to explore potential risk factors in 
men; and second, to evaluate the role of potential mediators of this association in 
women [8,112,114], e. g. biological plausibility via pregnancy vs. exogenous factors 
such as stress and life-style factors. Men with 6+ children (Table 5-2) showed a slight 
increase in the relative risk compared to those with no children in the Framingham 
study, adjusted relative risk, RR =1.2 (0.8-1.8), and men with 4+ children compared to 
none [114]. The Dekker and Schouten study [112] showed a relative risk of RR= 1.6 
(0.9-2.6). In Lawlor et al each additional child, for those with at least two children, 
increased the age-adjusted odds ratio of CHD by 12% for men (odds ratio, 1.12; 95% 
Cl, 1.02-1.22) compared to 30% (OR: 1.30; 95% Cl: 1.17-1.44) for women. Adjustment 
for obesity and the metabolic risk factors attenuated the association between greater 
number of children and CHD in both sexes, although in women some association remain 
[8]. This association among men with high parity and CHD morbidity and mortality did 
not attain significance levels but was similar to results for women in Dekker and 
Schouten study, which suggests some impact of non-biological factors. The NHEFS, on 
the other hand, showed no association (RR 0.7 [0.4-1.3]) [114]. 
The consistency of the results among different studies using various adjustments for 
socio-economic status and lifestyle variables suggests that the association between 
gravidity/parity and CHD cannot be explained entirely by the factors mentioned above, 
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although they may make an important contribution to the association among women 
[114]. It suggests that (biological plausibility) the process of being pregnant and 
therefore having children has an independent impact on the risk of CHD. But there is a 
room for social or emotional factors associated with raising up children that may 
differentially affect men and women [8,132]. The lack of significant association in men 
contrasts with the previous positive association found between pregnancy/parity and 
CHD in women, independent of other known risk factors. 
5.6.1.2 Case-control studies and cross-sectional studies 
Conflicting findings among the different case-control studies may have resulted from 
the following sources: 
Age of women participating in the studies: Ages of women studied varied greatly 
among the case-control studies and ranged from 16-84 years. It is interesting to note that 
the case-control studies that failed to show an association between high gravidity/parity 
and CHD are those studies that included women who were less than 50 years of age 
(Table 5-3), an age range in which few women develop CHD. Studies that showed 
positive associations included women of peri- or postmenopausal age, or women of all 
ages. 
Sample size: Studies with large sample sizes (Table 5-3) showed positive association, 
especially when different categories of the exposure and the outcome have enough cases 
to allow for associations to be seen. In general large sample sized studies will have 
greater power to detect small associations compared to studies with smaller sample size. 
Measurement of exposure: Exposure has been measured by a questionnaire and was 
stratified to different categories. Some studies measured parity, others gravidity, 
pregnancy loss, age at first pregnancy/birth or more than one exposure combined 
(Tables 5-3 and 5-4). Age at first pregnancy has been used many times to mean age at 
first birth and vice versa, although the two terms give different end products. Women 
might have many abortions before they can have their first live birth which might affect 
the association between parity and CHD risk (e. g. Beard et at 1984 used the term parity 
as an exposure but in the analyses, the authors used the number of pregnancies to 
compare 4+ pregnancies vs. nulligravid). 
Comparison of the risks occurring from each of these exposures discussed above, may 
be impeded by the inaccuracy of patient's recall [7]. Pregnancy losses and thereby 
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gravidity are less likely to be fully recalled compared to parity. This applies to all 
studies using gravidity as an exposure in both case-control and cohort studies. 
Definition of exposure: Definition of the cut-off points for the exposure has not been 
consistent throughout the studies. Some defined high parity/gravidity as having 6+ 
children/pregnancies, or 5+ children/pregnancies or 4+ children/pregnancies. Some 
studies only mentioned high parity/gravity without further categorization, whereas 
others used increase in risk per one child [8,130], which makes it difficult to compare 
(Table 5-3). 
Most studies have used nulliparous or nulligravid women as the referent group. 
Nulliparous/nulligravid women were defined as married women with no children or 
never being pregnant, except for 3 studies (the Framingham, the NHEFS and Beard et al 
1984 (Tables 5-2 and 5-3) where they included single in addition to married women in 
their definition. But when the single women were excluded from the analysis, the results 
did not change. In all these studies, clear explanations or definitions of nulliparous/ 
nulligravid women (other than being married with no children or never being pregnant) 
was missing. It remains difficult to know if these women are nulliparous/nulligravid 
because they have an early menopause or married at a later age? Are they infertile 
women? Are they single or divorced? The answer remains unclear. Different categories 
of nulliparity or nulligravidity may not have a uniform association with risk of CHD. 
This was clear in the Humphries et al study which showed that childless women in the 
Rotterdam study were socially well situated and deliberately childless [130], in contrast 
to the SHIP study by Wolff et al, where most women had grown up in the former East 
Germany, where childbearing was strongly encouraged and generously subsidized and 
where childless was hence uncommon [129]. Therefore the group of childless women 
was in the first case made up of well educated more affluent women, who are 
voluntarily childless, and for the second case was made up much more of women who 
for unknown reasons were incapable of getting children. With both group of women, the 
risk of IMT increased [129]. 
Definition of outcome: Definition of outcome varied among the studies. Some used 
CHD mortality [108,126], while others used CHD morbidity. Among the CHD 
morbidity studies different end points were used. Some used angina, others used 
myocardial infarction, ischaemic heart disease, or a combination of all. Two studies 
have used sudden cardiac death [118,122], but the sample size was small with low 
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power to detect associations. Two studies used Carotid Intima-media Thickness as an 
outcome [129,130]. Using different definitions for the outcome makes comparison 
between studies a difficult task. 
Definition of a positive relation between parity and CHD: The positive association in 
the studies reviewed has been defined in different ways. Some investigators consider 
that CHD is related to parity if the disease rates differ in the parous (regardless of the 
number of children the woman has) compared to nulliparous [118,120,127], whereas 
others look for a trend in risk with increasing numbers of pregnancies or live births [8, 
117,123,124,129,130] (Table 5-3). Others have examined relationships between 
miscarriage and disease [119]. Marital status has been used as a proxy for parity in some 
studies, and the lower mortality of married compared to single women has been 
attributed to the different life style, working conditions and the beneficial effects of 
childbearing on health, or to selective factors leading women to marry [108,122]. 
Controlling for confounders and mediators: Croft and Hannaford, found that women 
with 5+ pregnancies had a 1.8 increased risk of myocardial infarction before adjusting 
for social class and cigarette smoking. After adjustment, the relative risk was 0.9, 
suggesting confounders may well explain, or at least contribute to any association seen 
[123]. The control for confounding factors and mediators varied among the studies. 
Some studies controlled for mediators that could act on the causal pathway such as 
known CHD risk factors: hypertension, body mass index, cholesterol etc [117,124], but 
others did not [118,121,122,126,127]. Some studies controlled for confounders such 
as socio-economic class [117,123,124], and others did not [108,118,122,125]. For 
more details please see Table 5-3. Some controlled for both confounders and mediators 
such as socio-economic factors, lifestyle variables and metabolic risk factors [8,129, 
130]. In some of the cited literature, results are given with adjustment for both 
confounders and mediators, and there is a basic difficulty of interpretation when this 
occurs. 
Selection of controls: Selection of controls is often an issue in case-control studies e. g. 
community controls vs. hospital controls. In the studies reviewed (Table 5-3), the choice 
of controls from either the community or the hospital did not seem to affect the 
association between gravidity/parity and CHD risk. 
Age at first pregnancy/ live birth: Age at first pregnancy/live birth less than 20 years 
has shown to be an independent risk factor for CHD morbidity and mortality. All studies 
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showed significant association except for the Nurses' Health Study [116], where only 
1% of the nurses had an age at first birth 5 19 years, and therefore if any effect for such 
an early age at first birth exists, the study design might not have been able to detect it. 
Alternatively, age at first birth might be confounded by socio-economic status. The 
study of Nurses is by definition looking at a cohort with similar socio-economic status 
and may be less confounded. 
In summary, most of the prospective studies and the well designed and thought-out 
case-control studies have shown a consistent and significant association between 
multigravidity, multiparity and age at first live birth of less than 20 years with CHD 
morbidity and mortality. When results were adjusted for potential confounders and 
mediators, including social class, CHD risk factors, and life style variables, the 
relationships remained significant. 
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5.7 Links between Parity and Coronary Heart Disease Risk Factors among 
Women 
The evidence discussed above suggests that women with many pregnancies and live 
births have a modestly increased risk of developing coronary heart disease (tables 5-2 
and 5-3). The ways in which parity lead to an increase in the risk of CHD in women is 
unclear, but plausible biologic pathways, including changes in adiposity [6,134-138], 
blood glucose [110,139] and lipid levels [140-142], which may occur during pregnancy 
or persist after reproduction has ceased, may exist[6-8]. The following sections will 
discuss the different plausible pathways and the mediating conditions on them. 
5.7.1 Parity, Body Size and Body Fat Distribution 
Obesity is a significant public health problem in many developed and developing 
countries. Each year an estimated 300.000 adults die of causes related to obesity [143]. 
The prevalence of overweight (Body Mass Index (BMI ? 25 kg/m2) among women is 
high in developed countries; 62% of women aged 20-74 years in the United States of 
America (USA) are overweight [144]. And in developing countries, the prevalence of 
overweight among childbearing age women (15-49 years) is highest in the Middle East 
and North Africa, estimated at 45.9%, followed closely by Latin America and the 
Caribbean at 42.5% and 42.1% in Central Europe [145]. Excess body fat among older 
women has been linked to the development of type 2 diabetes, hypertension, 
dyslipidemia, cardiovascular disease, some cancers, osteoarthritis, and all cause 
mortality [7,104,146-151]. This high prevalence rate of overweight and obesity has 
major implications for any nation's health care system and the population quality of life 
[152]. 
When researching overweight and obesity among women, it is important to note that the 
female body undergoes changes in fat distribution during the different phases of 
reproductive life. This has led to the focus on reproductive history as a predictor for 
obesity and regional fat distribution. And because genetics could partially determine fat 
distribution, factors associated with differential deposition of fat in the abdomen versus 
the gluteal region are not well understood. However, Kaye et al and Bjorkelund et al, 
found that certain lifestyle and reproductive factors were cross-sectionally associated 
with body fat distribution in women [6,134]. Rodin and Heliovaara have also identified 
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parity as a risk factor not only for increased weight but also for abdominal adiposity 
indicated by increased waist to hip ratio (WHR) [135,153]. 
Lately, emphasis has been put upon the location of adipose tissue as a risk factor for 
cardiovascular disease and premature death (deposition of fat on trunk rather than on the 
hips or limbs, intra abdominal adipose tissue) rather than adiposity per se [154,155]. In 
both men and women, abdominal adiposity, measured as an increased W/H ratio and/or 
increased WC, is a strong risk factor for coronary heart disease and overall mortality. 
Moreover, female hormonal secretion in regular menstruation, parity and lactation all 
influence fat cell numbers and sizes as well as the location of regional fat depots [6,134, 
156] and levels of serum lipids [140]. 
The first period of major hormonal changes in women is menarche, which is known to 
be affected by body fat stores [6]. Although early menarche might indirectly influence 
parity via a longer total fertile period, and thus possibly influence subsequent adiposity, 
it can also act as a situation where adiposity influences reproduction by decreasing 
fertility. Also, reproduction can also affect adiposity as it is widely asserted that 
pregnancy is a major contributor to permanent weight gain in women and that the higher 
prevalence of overweight in women compared to men is partly due to child bearing 
[134,153,157-160]. 
Long term postpartum weight retention has been identified by many investigators as a 
cause of overweight and obesity. Table 5-5 summarises findings of studies that 
examined the association between body size, body fat distribution and parity among 
women of childbearing and beyond childbearing age. All studies on women of child 
bearing age have shown that postpartum weight retention significantly contributes to the 
development of overweight and obesity. And greater numbers of live births are 
associated with greater postpartum body size [134,153,157,160-164]. The risk factors 
for this long term weight retention includes high pre-conceptual weight, excessive 
gestational weight gain, frequent reproductive cycles, race (white vs. black women) and 
lower levels of education [152,165]. 
During pregnancy an average of 3.5 -4 kilograms of maternal fat tissue accumulates 
preferentially in the femoral area [166]. This fat reserve is thought to serve as a store to 
be mobilised in feeding the new-born by lactation [167]. However, breast feeding does 
not seem to promote weight loss in well-nourished women [168,169]. Quandt reported 
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that the number of women increasing in body fatness during lactation exceeded those 
experiencing fat loss [169]. Thus excessive gestational weight gain and the inability to 
lose this weight in the postpartum period are thought to be two of the main pathways in 
which reproduction contributes to overweight [144]. Excess gestational weight gain has 
constantly been shown to increase postpartum weight retention in the short term and has 
also been associated with increased weight gain in the long term [144,165,170]. The 
persistence of the post gestational weight gain as demonstrated in several cross-sectional 
and longitudinal studies examining women during and after childbearing demonstrated 
that, on average, weight is at best partially lost in lactation. However, one study revealed 
that although breastfeeding may not have an immediate short term weight loss benefit 
for the mother, at long term follow up, women who breast-fed their child for at least 3 
months had a significantly lower weight gain over an average of 8.5 years [165]. In 
another study attempting to estimate how much of the weight change after pregnancy 
could be attributed to parity and breast feeding, it was concluded that lactation has a 
negligible role in the reduction of obesity particularly among multiparous overweight 
women. Weight change associated to reproduction was highly dependent on BMI 
previous to pregnancy. The situation gets worse among overweight women with 
multiple pregnancies that feature short interconceptional lengths [164]. However, 
Bastian et al, found that cumulative months of breastfeeding attenuated the parity effect 
on obesity (a positive relationship between cumulative months of breastfeeding and 
rates of obesity) among older women [171]. 
During menopause, another change in hormonal balance takes place. Menopause 
commences later in women with more adipose tissue [172]. But menopause per se may 
influence changes in body composition [6]. The increase in body weight in women 
approaching menopause is interrupted after menopause [173]. This pattern of change in 
body mass and regional fat distribution during menopause may be influenced by 
oestrogen medication around menopause [6]. 
Several mechanisms have been proposed to explain the association between number of 
children and obesity among women, such as insulin resistance associated with 
pregnancy [110,139], hormonal alterations secondary to fewer ovulatory cycles [ 174- 
176], increased gloco-corticoid activity and the excess deposit of fat tissue that 
accumulates preferentially in the femoral area during pregnancy [134-136]. Many of 
these physiological changes associated with pregnancy have been shown to persist years 
after childbearing (14). In addition, motherhood and parenthood may also be associated 
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with changes in diet and physical activity to accommodate living with small children 
[143,152]. Parents with many children may have gained weight as a result of increased 
food intake and changes in physical activity due to being busy and overwhelmed with 
rising up children. 
All authors agree in the studies reviewed that among older women there is a modest 
relation between parity and BMI independent of age. BMI is a measure of overall body 
fat and is defined as weight kg/height m2. Body mass index increases with age. Age and 
parity effects on body weight are highly correlated, but both effects exist independently 
[1771, Table 5-5. In one study though, Brown et al, concluded that age had a much 
larger effect than parity on weight gain, and that parity was only associated with an 
increase in body weight of 0.55 kg per live birth after adjusting for age, education, 
marital status and smoking status [158]. In most of the studies reviewed, mean weight 
gain per child for women with one or more children range from 1.4-5.0 kg above age 
related increases [104,135,153,162], and independent of the pre-pregnancy weight or 
BMI [170]. 
Several authors found an association between higher rates of obesity with increasing 
number of children among older women that was independent of socioeconomic status 
and other confounders. A cross sectional study from Finland found that the number of 
children among women aged 25-84 was closely related to the prevalence of obesity 
independent of marital status, occupation and smoking habits [153]. The strongest 
relationship between number of children and BMI was in the youngest age group (25- 
34), although the relationship persisted even among women aged 75-84. In another 
study from Sweden, the number of children was also associated with obesity among 
5464 women aged 45-73 years [178]. In the USA nurses Health Study, an increase in 
BMI was found with increasing number of children among women aged 42-67 [158]. 
Among 41,000 Iowa women, mean BMI increased linearly with the number of children 
after adjustment for age, education, marital status and smoking [158]. Palmer et al, in a 
case control study found that women aged 45-69 years, with 5 or more births were more 
frequently obese compared with women with no births [117]. Moreover, Ness et al, 
found among US women aged 45-74 years who participated in the first NHANES 
follow-up study as well as among women aged 35-68 years who participated in the 
Framingham Heart Study, a significant increase in BMI with an increase in number of 
children [110]. The Rancho Bernardo study found as association with number of 
children and obesity among women many years after childbearing [179,180]. The mean 
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age adjusted BMI was positively associated with number of biological children in this 
cohort study of women and men aged 55-84 [179]. Among men aged 50-89 years, those 
with 5 or more biological children were significantly more obese than men with no 
biological children, as estimated by BMI and W/H ratio [179]. 
Furthermore, Lawlor et al found a positive linear relationship between number of 
children and body mass index (BMI) and waist to hip ratio among both women and men 
[8]. The association remained significant before and after adjustment for potential 
confounders among women, while for men the association with BMI was weaker than 
women and with the W/H ratio, the association attenuated to the null after adjustment 
for confounders and became not significant. It was concluded that life style risk factors 
associated with child-rearing lead to obesity and result in increased CHD in women and 
men, yet biological responses of pregnancy may have additional adverse effects in 
women [8]. They reported that age adjusted BMI increased by 0.36 kg/m2 per each 
additional child in British women, while Lao et at reported that age adjusted BMI 
among Chinese women increased by 0.24 kg/m2 per child increase [181]. Hardy et at, 
reported that mean BMI (95% CI) increased with increasing numbers of children 
(P=0.01) in British women from 27.4 kg/m2 (26.6-28.2) in those with one child to 28.6 
kg/m2 (27.6-29.6) in those with four or more children [131]. Similarly, each live birth 
in the Chinese women was associated with 0.45 kg, which was similar to the US women 
study by Brown et at, who gained 0.55 kg per live birth [158]. These variations of 
increase in BMI and overall obesity with the increased number of children might reflect 
ethnic differences among women. 
Bastian et al, using data from the Cache County Study on Memory, Health, and Aging, 
demonstrated a dose response effect of increasing number of children on obesity after 
adjusting for socio-economic status, reproductive factors and important health 
behaviours among older women aged 66-102 years [171]. Weng et al, found a 7% 
increase in risk of obesity for each additional child adjusting for age, race, household 
income, work status, physical activity, tobacco use, and alcohol use. Moreover, they 
found 4% increase in risk of obesity for each additional child among men adjusting for 
the same covariates and the sex differences were not significantly different, which 
suggests physiological and behavioural mechanisms of obesity among married couples 
[143]. Furthermore, some investigators have proposed socioeconomic status as a 
significant confounder in the number of children and obesity relationship [182]. Women 
of less education or of lower socioeconomic class are at higher risk for obesity [183], 
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and that this effect may be related to personal habits such as excessive caloric intake as 
well as the number of children. 
Less is known about changes in measures of central and abdominal adiposity associated 
with childbearing among women of childbearing age. A positive correlation of W/H 
ratio with parity has been reported in large cross sectional studies [1841. In a prospective 
study by Smith et al, they reported increases in W/H ratio among women who gave 
birth during follow up compared to those who did not [185]. The same authors in 
another study found that increases in waist girth were cumulative with both first and 
higher order births among overweight as well as normal weight women [184]. 
Post partum weight retention has been identified as a contributor, and studies indicate 
that these associated increases in WHR and WC tend to be cumulative with each 
pregnancy [135]. The accumulation of central adiposity, particularly that which is 
deposited intra-abdominally, has proven to be metabolically active and to carry more 
significant health risks than fat accumulation in other parts of the body [137]. WC is 
used as a surrogate marker for adipose tissue because it correlates well with Intra- 
abdominal Adipose Tissue (IAAT). Although circumference measures provide some 
insight into where fat is deposited with regard to girth and are considered in 
epidemiological studies as good measures of body fat, yet they cannot tell whether the 
deposition is subcutaneous or intra-abdominal [137]. So Sohlstrom et al used magnetic 
resonance imaging (MRI) to quantify centrally located fat and identify it as either 
subcutaneous or non-subcutaneous (intra abdominal adipose tissue) fat volume [186]. 
Their results suggested that IAAT may increase following pregnancy, potentially 
increasing metabolic disease risk [186]. Blaudeau et al, suggested that IAAT increases 
with increasing parity among women aged 18-76 years, even after adjusting for 
potential confounders age, percentage of body fat, physical activity and smoking [137]. 
This IAAT is the body fat depot most strongly related to the metabolic abnormalities of 
obesity [154,187]. 
As stated previously, parity has also been associated with an increase in abdominal body 
fat distribution among older women (Table 5-5) measured by WHR. All authors agreed 
that the association is independent of age and BMI (table 4). The positive association of 
abdominal body fat distribution (high waist to hip ratio) with parity is most pronounced 
in pre- and peri-menopausal women, after adjustment for age and degree of obesity [6, 
161], whereas post-menopausal women become more similar in their WHR [161]. 
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In some studies examining the association between abdominal body fat distribution 
(WHR) and parity results were adjusted for BMI [134,135,161]. Ness et al reported 
that it is possible that the association between waist to hip ratio and parity in older 
women reflects an increase in overall, rather than site-specific adiposity, despite 
adjustments for BMI, as body mass index is a measure of body size and not of adiposity 
and so may not fully control for adiposity [7]. In turn, abdominal body fat distribution is 
related to an atherogenic lipid profile [150], hypertension [151], diabetes [158], and 
elevation in coronary heart disease [104]. 
The studies reviewed in Table 5-5, have adjusted for age and socio-economic variables. 
There could be other confounders and mediators that could have affected the association 
between greater parity and weight gain such as diet and food availability, lack of 
physical activity, stress levels, or parity associated changes in weight could be 
influenced by breastfeeding, inter-pregnancy interval, and body weight prior to each 
pregnancy [158]. Measures of physical activity were used in some studies. Hardy et al, 
found that WHR and Type II diabetes in women exhibited a linear increasing trend with 
increasing number of children, but these associations were largely explained by 
adjustment for behavioural and life style variables [131]. In this study, Hardy et at had 
to group women with four or more pregnancies into a single group because of lack of 
women with five or more children and they concluded that may be biological effects of 
pregnancy could be seen in women with a large number of pregnancies [131]. 
We can conclude from the above that social, behavioural, cultural, and biological factors 
are integrated in the aetiology of obesity for both women and men, but women may 
have additional risk due to their childbearing. Gestational weight gain and post partum 
weight retention (measured as increase in body weight and/or BMI and/or WC and for 
W/H ratio) have a positive association with parity that may persist into later life. Among 
older women, BMI, WC and W/H ratio increase with increasing parity independent of 
age. Lifestyle factors associated with child rearing lead to obesity among women and 
men. Higher rates of obesity were associated with increasing number of children 
independent of socio-economic status and other covariates. These studies have shown 
that reproduction is a contributor to overweight and obesity in women of childbearing 
age and beyond reproductive age. Parity was positively associated with obesity. Most of 
the studies that have looked at the association between parity and obesity were 
performed either in Europe or the USA. The main mechanism by which reproduction is 
thought to contribute to obesity in women is through cumulative cycles of pregnancy, 
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weight gain and post partum weight retention in the short and long term which persists 
later after reproduction has ceased. 
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5.7.2 Gravidity/Parity, Cholesterol and Lipoproteins 
Another possible mechanism by which pregnancy could be related to the subsequent 
development of coronary heart disease is through the alteration of lipid levels [140,190, 
191]. Marked increases in lipoprotein concentrations occur during pregnancy [192]. 
Total and low density lipoprotein cholesterol (LDL-C) and triglyceride levels 
progressively increase during gestation and especially during the third trimester of 
pregnancy [190,193-195]. Although triglycerides have been reported to decrease 
rapidly during the postpartum period, total and LDL-C levels may require several 
months to return to baseline [190,194]. High density lipoprotein cholesterol (HDL-C), 
which has been shown to be inversely associated with coronary heart disease risk in 
women and may be considered as the best predictor of cardiovascular risk in women 
among all the lipids and lipoproteins [140,196-198], peaks at mid-gestation and then 
falls to levels below that found prior to pregnancy [192,193]. This decline continues 
until approximately one year postpartum [7]. Gunderson et al 2004, in the largest 
prospective study examining the long term changes in plasma lipids associated with 
childbearing found that HDL-C declines associated with a first birth persist over several 
years, while higher order births were not associated with greater declines in HDL-C 
[142]. A study performed in Thailand [199] found that maternal HDL-C and TG at 
delivery didn't attain statistical significance with increasing parity, while total 
cholesterol and LDL-C increased with increasing parity. 
Few studies are available on the long-term effects of pregnancy on lipoproteins; 
however two cross-sectional studies and three prospective studies have examined the 
associations among gravidity/parity, cholesterol and lipoproteins at times other than 
pregnancy (Table 5-6). Although there has been disagreement regarding the 
relationships of gravidity/parity, total cholesterol, LDL-C and triglycerides, all studies 
agreed that multigravid/multiparous women have lower HDL-C levels than 
nulligravid/nulliparous women. The magnitude of the effect between gravidity/parity 
and HDL-C across studies has been shown to be of the order 1 mg/dl decrease with each 
pregnancy or birth after controlling for potentially confounding factors such as age, 
smoking, alcohol use, physical activity, oral contraceptive use, education and marital 
status. 
There has been some disagreement about the form of this association. Ness et [7], study 
not shown in table, and Hubert et al [200] reported a linear effect of gravidity/parity on 
94 
HDL-C levels, whereas Kritz-Silverstein et al [140], reported that for women with five 
or more pregnancies, HDL-C was 4.9 mg/dl (0.13mmol/L) lower than that for women 
with four or fewer pregnancies, whereas pregnancy was unrelated to HDL-C in women 
with four or fewer pregnancies. Kritz-Silverstein et al was the first to study and report 
the association between parity and lipoprotein among women at a time distant from their 
pregnancies. 
Three more recent studies have reported on parity and CHD risk and risk factors. These 
studies are presented in Table 5-2. Lawlor et al [8] found that in women with at least 
two children, the number of children was associated with lower high-density lipoprotein 
cholesterol and higher triglyceride levels, and each additional child decreases the age- 
adjusted mean HDL-C by 0.02mmol/L, 95% CI (-0.03 to -0.01, p=0.001), and increases 
the age-adjusted mean Triglycerides by 0.02mmol/L, 95% CI (0.01 to 0.03, p=0.001). In 
the Rotterdam study, Humphries et at [130], described a significant trend towards lower 
HDL-C levels and higher total/HDL-C ratio with increasing parity, p<0.001. The study 
also found that additional adjustment for BMI, smoking and socioeconomic status did 
not alter this association. This study was consistent with other studies by Lewis et al 
[141] and Van Stiphout et al [193] where they identified significantly lower HDL-C 
levels in parous women than nulliparous women at I and 2 years after childbirth. Wollf 
et al [129] in the SHIP study found that women with 1 or 2 children had somewhat 
lower LDL-C levels whereas their HDL-C levels were minimally higher compared to 
parity >_ 4. Studies of gravidity/parity and serum lipids are presented in Table 5-6. 
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5.7.3 Gravidity/Parity, Glucose Intolerance, and Diabetes Mellitus 
Pregnancy is associated with increased resistance of peripheral tissues to insulin and 
increased insulin secretion [203-207]. These effects may lead to worsening of glycemic 
control in persons with established diabetes and to gestational diabetes in the susceptible 
individual when maternal insulinogenic capacity is exceeded [208]. Although it is well 
established that obese women or women of normal weight who have had gestational 
diabetes are at increased risk of having type 2 diabetes in later life [207], it is still unclear 
whether repeated pregnancies predispose to hyperglycaemia in women without gestational 
diabetes [7]. 
Studies examining the association between gravidity/parity and subsequent incidence of 
non-insulin-dependant diabetes mellitus (type II diabetes) among women have been 
conducted since the early 50s and 60s. Some (such as Pyke) showed positive association 
[209], whereas others showed none [210]. However, more recent studies (Table 5-7) 
showed no association between gravidity/parity and NIDDM (type II diabetes) after 
adjusting for age and obesity [211,212], family history of diabetes [213], as well as 
education and income [214]. The exception was a study by Kritz-Silverstein, where a 
cohort of women of relatively high socio-economic status over age 40 years showed a 
positive association between gravidity/parity and abnormal glucose tolerance (defined as 
impaired glucose tolerance and NIDDM), after adjusting for the effects of age and obesity 
[139]. The increased prevalence of NIDDM was confined to a small number of women with 
a parity of more than five. The prevalence of impaired glucose tolerance actually decreased 
in this group, possibly because many of these women were already defined as having 
NIDDM [7,214]. The study was unable to answer the question of whether the association 
between parity and diabetes is linear or whether it increases exponentially after a number of 
pregnancies [139]. If as suggested by this study, parity 5+ is diabetogenic, it might be 
important to study this association. On the other hand, Simmons found a J-shaped 
relationship between type II diabetes and parity among Asian and European women living 
in the UK, where the prevalence of type II diabetes was highest among nulliparous and 
parity >5 among both ethnic groups compared to women who had 1 or 2 children adjusted 
for age and BMI [215]. 
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Most studies have not considered the role of potential confounders such as age, obesity, 
history of diabetes and socio-economic status. These potential confounders have proved to 
play a very important role in the magnitude of the association between gravidity/parity and 
NIDDM in the more recent studies (Table 5-7), despite a temporary diabetogenic effect of 
pregnancy [211]. And there is still more controversy and debate, as Hanely et al found no 
association between the number of births and risk of type II diabetes when parity was 
analyzed as a continuous variable [204]. Cheung, however, from Australia found a 
significant association between parity and age at diagnosis of diabetes for women with type 
II diabetes mellitus, but when further adjustments were made in the same study for year of 
birth, BMI and positive family history, the effect in the overall cohort disappeared, but it 
persisted when subjects with parity >5 were compared with nulliparous [216]. In another 
study conducted in Qatar, the authors found parity to be a risk factor for type II diabetes and 
that type II diabetes increased with increasing parity adjusting for age and gender [217]. 
Nicholson et al, found in a study among Caucasian and African American women that 
parity incidence rates were highest among women with five or more live births and lowest 
among women with one to two live births, adjusting for socio-demographic factors and 
higher obesity. And after adjustment for all covariates (socio-demographic, clinical, 
lifestyle factors and inflammatory markers), grand-multiparity >_ 5 was still associated with 
a 27% increased risk for diabetes (hazard ratio 1.27,95% CI (1.02-1.57) [203]. 
On the whole, the studies reviewed showed little or no association between parity and the 
development of type II diabetes after controlling for the effects of confounders. This 
suggests that the association between gravidity/parity and diabetes might be confounded or 
mediated by other factors such as age, obesity and socio-economic status. On the other 
hand, many studies had shown the association remained significant at parity ? 5. 
High parity is unlikely to have an important impact on development of chronic diseases in 
the USA and other industrialised countries, where few women have more than six children. 
Exposure to high parity may be very relevant however for a number of developing countries 
where many more women bear 6 or more children. Studies of parity and chronic disease 
risk have not been done in many developing countries. Therefore in this study, the 
association between parity and risk of type II diabetes have been investigated where women 
bear many children and chronic diseases are on the rise. 
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5.7.4 Gravidity/Parity and Hypertension 
The relationship between gravidity/parity and subsequent hypertension in women has 
been studied in various populations. The reports of these relationships have been 
inconsistent. Tables 5-8 and 5-9 present a summary of these results. 
Of these 19 studies, conducted since 1945, nine found no association between 
gravidity/parity and blood pressure [8,130,218-224]. The remaining ten studies fall in 3 
patterns: an inverse association between gravidity/parity and blood pressure [225-229]; 
blood pressure tending to be lowest in women with two to five children and rising in 
women with six or more children [230,231]; or blood pressure tending to be higher with 
less than 2 children and more than two children [129]; or a protective effect of 
gravidity/parity that interact with age to give an inverse association for younger 
subgroups of women [223,224,232,233], and none for older women. Few studies have 
adjusted for the effects of age, obesity, cigarette smoking, alcohol consumption, socio- 
economic status, exercise and oestrogen use, which may affect blood pressure and be 
correlated with parity. 
The physiological mechanisms for a negative association between number of 
pregnancies and blood pressure are unknown. A speculative possibility is that it may be 
related to the repeated adaptation of the vascular system to the increase in plasma 
volume that occurs during pregnancy [232]. Therefore, a better understanding of this 
relationship might help to elucidate both the mechanisms of blood pressure control and 
the long term effects of repeated pregnancies on women's health [232]. 
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5.8 Parity and the Metabolic Syndrome 
The metabolic syndrome is described as the co-occurrence of abnormalities in glucose 
and lipid metabolism, abdominal fat distribution and blood pressure [235]. It is defined 
by a high value of a score based on waist circumference ? 90 cm for men or >_ 80 cm for 
women, plus any two of: (a) raised triglycerides (TG) level (>_150 mg/dl) equivalent to 
(1.7 mmol/L) or specific treatment for this lipid abnormality; (b) reduced high density 
lipoprotein (HDL-C) (<40 mg/dl (I mmol/L) in males and <50 mg/dl {1.3 mmol/L) in 
females) or specific treatment for this lipid abnormality; (c) raised blood pressure (BP, 
systolic BP >130 mmHg or diastolic BP >85 mmHg) or hypertension therapy; and (d) 
raised fasting glucose (? 100 mg/dl) equivalent to {5.6 mmol/L} or previously diagnosed 
type II diabetes. The metabolic syndrome has been linked to the development of CVD, 
diabetes and overall mortality [236-239]. 
People with abnormal glucose and lipid metabolism, obesity and abdominal fat 
distribution and hypertension constitute a major challenge facing health systems in 
developed countries. The situation is more complex in developing countries where 
resources are scarce and limited. These people are at substantial risk of developing 
diabetes and cardiovascular diseases including coronary heart disease, cerebrovascular 
disease and stroke that requires long term care [240]. 
Several studies performed among the Arab populations in the Middle East and Gulf 
countries, illustrated high prevalence of diabetes, impaired glucose tolerance, obesity 
and hypertension [241-248]. However, all of these studies have focused on estimating 
the population distribution of major risk factors for CVD and only two studies estimated 
the clustering of such risk factors in individuals in the form of the metabolic syndrome 
[240,249]. Although these studies have used different definitions of the metabolic 
syndrome, they both found the metabolic syndrome to be more prevailing among 
women. Abdul-Rahim and colleagues used the WHO definition [250], while Al-Lawati 
et al, used the national Cholesterol Education programme - Third Adult Treatment Panel 
III definition to estimate the prevalence of the metabolic syndrome [235]. However, 
none of these studies have examined reproductive history and in particular parity as a 
risk factor for the development of the metabolic syndrome. 
Most of the studies that have examined the association between parity and or 
pregnancies and each component of the metabolic syndrome were performed in Europe 
109 
and USA. Few were performed in developing countries. Only two recent studies [181, 
251] have assessed the relationship between parity and the combination of these risk 
factors as part of the current definition of the metabolic syndrome using two different 
definitions. The study that was performed in China has shown that higher parity was 
associated with a consistent increase in the risk of the metabolic syndrome among 
women and men after adjustment for age, socio-demographic, reproductive and 
behavioural factors. When the association was adjusted for BMI, it attenuated in men 
but not in women suggesting that the association with metabolic syndrome in women is 
likely to represent a biological response to pregnancy [181]. On the other hand, the 
second study conducted in the USA, found that the rate of the metabolic syndrome was 
significantly higher with increasing numbers of children, demonstrating a dose response 
relationship P<0.0001. The odds of the metabolic syndrome increased 13% with each 
additional child after controlling for age, race/ethnicity, income, education, reproductive 
and behavioural risk factors. After adjustment for BMI, the strength of the association 
was decreased suggesting that weight might be an important mediator of the effect of 
parity on the risk of the metabolic syndrome [251]. Both studies have used different 
definition for the metabolic syndrome in assessing the association between parity and 
the metabolic syndrome. The Chinese study used the International Diabetes Federation 
(IDF) definition 2005 [252], while the American study used the Third Report of the 
National Cholesterol Education Programme Expert Panel on the Detection, Evaluation 
and Treatment of High Blood Pressure in Adults definition (ATP III) [235]. 
The International Diabetes Federation in 2005 formulated a new worldwide definition of 
the metabolic syndrome that addresses both clinical and research needs in different 
countries and across various ethnic groups. This definition was endorsed by WHO. 
Using different definitions for the metabolic syndrome makes comparison of results 
from different studies difficult. 
Understanding the role parity plays in the development of the metabolic syndrome 
would have implications for preventing CVD, diabetes and other conditions associated 
with the metabolic syndrome. To our knowledge, no prior study has examined the 
relationship between parity and the clustering of these components as part of the current 
worldwide IDF definition of metabolic syndrome among Palestinian women living in 
refugee camps. 
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5.9 Proposed Mechanisms for the Association between Gravidity/Parity and 
Coronary Heart Disease Risk Factors in Women 
Women with many pregnancies and live births and early age at first birth have a modestly 
increased risk of developing CHD according to studies reviewed in Tables 5-2,5-3, and 
5-4. Specific mechanisms by which the association is mediated are not known. As a result 
of the uncertainty, four explanations have been proposed: 
  Repeated pregnancies lead to metabolic and physiologic changes that elevate CHD risk. 
  Pregnancy results in lifestyle changes and stress that cannot be measured by biologic 
assays but tend in turn to elevate CHD risk [7] 
  Physiological effects of pregnancy and childbearing interact with stress and lifestyle 
factors. Hormonal alterations occurring during pregnancy in combination with stress 
occurring during childbearing could lead to CHD morbidity and mortality [110,112, 
114]. 
  Confounding factors such as socio-economic status, which could be related to both the 
exposure (gravidity/parity and age at first birth) and the outcome of interest (CHD 
morbidity and mortality) may account for the reported association. If the association is 
confounded by socio-economic status, then it is not the number of pregnancies per se 
that is causing CHD but the confounding effect [133]. 
5.9.1 Biological Plausibility for an Association 
All observational studies examining the association between gravidity/parity and body 
weight gain and fat distribution have shown positive effects, suggesting that the association 
is real. Parity related weight gain and fat deposition may have different metabolic effects: 
they can raise blood pressure, increase serum total cholesterol, decrease HDL-C levels, and 
induce glucose intolerance [158]. Since each of these factors can increase the risk of CHD, 
the influence of obesity might be explained by its action on these known factors. 
Another mechanism by which gravidity/parity could be related to the subsequent 
development of CHD is through the direct alterations of lipid levels. Marked fluctuation in 
lipoprotein concentration occurs during pregnancy. Studies examining the long-term effects 
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of pregnancy on lipoproteins showed that multigravid/multiparous women have lower 
HDL-C levels than nulligravid/nulliparous women. Changes in HDL-C are particularly 
important to any discussion of CHD risk in women, since low HDL-C is the most powerful 
predictor of heart disease in women [140]. Most studies that have examined the association 
between gravidity/parity and the development of diabetes mellitus in women have shown 
that the association might not be a cause-effect relation, but rather it has been mediated by 
other factors in particular obesity, despite a temporary diabetogenic effect of pregnancy. 
Only one study has shown an association but with 5+ children [140]. The same applies to 
the association between gravidity/parity and hypertension where most studies showed no or 
negative association. 
Alternatively, it has been proposed that pregnancy represents one type of weight variability 
or weight cycling [253]. Weight variability has been shown to relate to greater upper body 
fat distribution [135], and higher CHD incidence [254] perhaps through the mechanism of 
hyperinsulimia. The atherogenic risk factors associated with gravidity/parity includes 
reductions in HDL-C, increases in body size, and changes in body fat distribution [7]. 
5.9.2 Stress and Lifestyle as Potential Explanations 
Pregnancy and rearing many children may be associated with changes in behavioural 
factors such as eating a high fat diet, sedentary lifestyle and smoking which in turn 
increases the risk of CHD. Ness et at [7], proposed that caring for young children resembles 
a stressful occupational situation. Karasek et al, showed that when a job is very demanding, 
and where one can't control the job situation, such stressful environment could lead to CHD 
risk [255]. Ness et al [7], proposed that stress experienced during childbearing may be 
associated with anatomic changes in coronary arteries which do not present as clinical 
disease until later life, when compounded by the events of ageing. 
Stress and lack of sense of control may elevate blood pressure and blood cholesterol levels, 
and contribute to behaviours that are considered as stress reducing, but which can increase 
CHD risk such as smoking, overeating and in certain cases, excessive drinking [256]. 
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5.9.3 Confounding as a Potential Explanation 
When only observational data are available, it is difficult to discount the role of unmeasured 
confounding factors, which may, rather than gravidity/parity and age at first birth, result in 
the observed effect on CHD. For example some women are compelled to have many 
children as a result of religious beliefs or political conflict as in the case of the Palestinian 
women and these factors themselves may be independently associated with CHD risk. 
It has been found that socio-economic status plays a very important role in determining the 
magnitude of the association between gravidity/parity, age at first birth and CHD risks 
[117,162,166]. Lower social-class women tend to have an early age at first pregnancy, and 
age at first pregnancy is a major determinant of multiparity [94]. Thus social class could be 
the attribute associated with heart disease. for example, Croft and Hannaford, found that 
women with 5+ pregnancies had a 1.8 fold increased risk of myocardial infarction before 
adjusting for social class and cigarette smoking; after adjustment, the relative risk was 0.9 
[123]. There have been some inconsistencies among the studies reviewed concerning 
adjustments for socio-economic status. Ness et al, adjusted for education and income, but 
the magnitude of the association between gravidity/parity and CHD risk remains the same 
[110]. 
In summary, the studies reviewed have shown that parity and gravidity have been 
associated with increased body weight and greater central body fat distribution as well as 
decreased HDL-C level and CHD. Although the magnitude of the association is often small 
and despite the inconsistencies in the different studies regarding the association between 
parity/ gravidity and CHD risk, yet this review had shed light on the proposed mechanisms 
or risk factors by which the association is mediated and by which CHD develops in women. 
5.10 Development of the Conceptual Framework and Research Hypotheses 
5.10.1 Conceptual Framework 
Based on the results of the literature review of studying the association between gravidity/ 
parity as an exposure variable and CHD risk factors (obesity, hyperlipidemia, diabetes and 
hypertension) as outcome variables, the following conceptual framework (Figure 5-1) was 
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developed. This conceptual framework discusses the different pathways that 
gravidity/parity exerts its effects on CHD morbidity and mortality. It also views the 
association between gravidity/parity and CHD risk to be a result of a combination of 
demographic, biological, physiological, socio-economic, and environmental factors. This 
conceptual framework constitutes the basis for the analytical framework used for all the 
analysis in the thesis. 
Figure 5-1: Conceptual Framework 
Non modifiable risk factors Exposure Confounders & Mediators 
" Age " Behavioural risk factor 
" Gender (low estrogen) " Stressful life events 
" Family history GravldltyfParity " Socio-economic risk 
factor 
I Obesity 
Hypertension Elevated LDL-C 
Elevated Decreased 
Diabetes Triglycerides HDL-C 
r 
.r' 
% 
CHO morbidity and mortality 
As discussed in the literature review, repeated pregnancies and childbirths will lead to 
metabolic and physiological changes that elevate CHD. The process can go via different 
scenarios: 
Scenario one: Gravidity/parity leads to increase in body weight and body fat 
distribution. Parity related weight gain and fat deposition may have different metabolic 
effects: 
a. It raises Blood pressure 
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b. It increases TG, T-Cholesterol, LDL-C and decreases HDL-C 
c. It induces glucose intolerance 
Since all these factors can increase the risk of CHD, the influence of obesity, promoted by 
higher parity, might be explained by its action on these risk factors. 
Scenario two: Pregnancy is a state of insulin resistance and the process of being 
pregnant and having children induces a lot of metabolic and physiological changes on the 
lipid and the carbohydrates metabolism that leads to subsequent development of CHD 
through 
L Alterations of the lipid profile which causes HDL-c to decrease and TG, 
T-Cholesterol, LDL-C to increase and which in turn will lead to CHD 
morbidity and mortality. 
2. It also produces changes on the carbohydrates metabolism and will make 
women more susceptible to diabetes especially if they have a family history of 
diabetes. The association between gravidity/parity and the development of 
type II diabetes in women might not be a cause effect relation, but rather it is 
mediated by other factors such as obesity, despite a temporary diabetogenic 
effect. 
Scenario three: Pregnancy and child raising may lead to a stressful environment 
and changes in behavioral factors such as changes in dietary patterns, sedentary lifestyle 
and smoking which interact with the metabolic and physiological changes of pregnancy and 
in turn increases the risk of CHD. 
Scenario four: Socio-economic status could play an important role in the 
association between gravidity/parity and CHD risk. Women of lower social class will marry 
at a younger age and will have an early age at first pregnancy and childbirth and therefore 
will bear more children. They will have lower educational attainment, higher 
unemployment and therefore lower income, and will smoke more and therefore will be at 
increased CHD risk. In observational studies, there will be always a space for unmeasured 
confounding factors which may result in the observed effect on CHD rather than gravidity/ 
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parity. Some women might have more children as a result of religious beliefs or political 
conflict. 
5.10.2 Research Hypotheses 
Based on the literature review presented in Chapter Five, eight hypotheses were developed 
relating gravidity/parity with CHD risk mortality and morbidity. These hypotheses will be 
tested in the results chapter. The following are the hypotheses investigated: 
Hypothesis one: an increasing number of children is associated with an increasing 
risk of obesity among Palestinian women aged 40-65 years independent of socioeconomic 
status, other reproductive and lifestyle factors. 
Hypothesis two: an increasing number of children is associated with increasing 
waist circumference and therefore increasing central obesity among Palestinian women 
living in refugee camps independent of socioeconomic status, other reproductive and 
lifestyle factors. 
Hypothesis three: an increasing number of children is associated with an increasing 
waist to hip ratio among Palestinian women living in refugee camps independent of 
socioeconomic status, reproductive and lifestyle factors. 
Hypothesis four: An increasing number of children is associated with an increasing 
risk of elevated lipids and lipoproteins among Palestinian women living in refugee camps 
independent of socioeconomic status, reproductive and lifestyle factors. 
Hypothesis five: An increasing number of children is associated with an increasing 
risk of developing type 2 diabetes mellitus among Palestinian women living in refugee 
camps independent of socioeconomic status, reproductive and lifestyle factors. 
Hypothesis six: An increasing number of children is associated with an elevation in 
SBP, DBP and hypertension among Palestinian women living in refugee camps 
independent of socioeconomic status, reproductive and lifestyle factors. 
Hypothesis seven: An increasing number of children is associated with an 
increasing risk of developing CHD in the form of women's reports of present or past CHD 
events. 
Hypothesis eight: An increasing number of children is associated with the 
development of the metabolic syndrome among women in the refugee camps. 
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Chapter 6 
RESEARCH METHODOLOGY 
6.1 Research Context 
The prevailing conditions under which this research was prepared and conducted were 
strongly shaped by the political and economic development within the Palestinian territories 
as well as the psychological status of the women participating in the research. 
6.1.1 Political Developments 
Preparation for the field work and the actual implementation took place at a very difficult 
time in the history of the Palestinian people as the Second Popular Uprising (Intifada) 
started in September 2000. From September 2000 to 2004, a health system crisis emerged 
as around 4,000 Palestinians died and around 45,000 were injured; infrastructure including 
hospitals and clinics were destroyed and shelled by the Israeli armed forces. This situation 
led to very severe undermining of already fragile public institutions and services and 
influenced greatly the health of the people as well as the nature of the Palestinian health 
care system. 
Another major factor contributing to the difficulty of conducting the research was the 
Israeli closure policy with its restrictions on movement. There have also been extensive 
curfews imposed on towns, villages and refugee camps for prolonged periods. The peak of 
these Israeli measures was reflected in the large-scale destruction, killing and restrictions 
during the Israeli incursion into the main towns of the West Bank and Gaza Strip from 
March to April 2002. The situation since the re-invasion of Palestinian-controlled areas has 
become even more critical. 
All these factors made the mobility needed to conduct the research very difficult, even to 
travel to nearby cities and villages from my residence area in Ramallah city. Moreover, 
living near an Israeli settlement in the West Bank led to our exposure to continuous gunfire 
and shelling from Israeli tanks. For five consecutive months, our living room was 
transformed to a kitchen and bedrooms, and we used to sleep on mattresses on the floor. My 
bedroom was burned and my eldest son was shot twice in his shoulder and foot with rubber 
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bullets. My children were young and I faced many psychological problems with them due 
to the sound of the shelling from guns and tanks as well as the gunfire from Apache 
helicopters and F16's. 
6.1.2 The Psychological Status of Women 
In spite of this difficult situation, it was a challenge to go ahead with the fieldwork, 
particularly as the study area was Palestinian refugee camps that were the constant target of 
the Israeli army: Many families had lost their children as well as their bread winners. 
Nevertheless, data collection was conducted under gunfire and curfews. It was time 
consuming as often only two interviews or even none could be conducted within a day due 
to the unpredictability of the situation. 
As mentioned above, many of the women participating in the study had lost one or more of 
their children or their husbands or relatives. However, in spite of their mourning and 
sadness, they agreed to participate actively in the study revealing their resilience and hope 
for a better future even when their lives appeared so totally reduced. For example, Huda 
living in Kalandia refugee camp had a husband imprisoned for 8 years and a son 
imprisoned for 4 years. She was left with no breadwinner in the family and the only son that 
could help the family survive was injured by Israeli shelling of the camp. In spite of that she 
still had hope for a better future. Alia from the same camp had her 14 years old son arrested 
by Israeli soldiers at a checkpoint. The soldiers blindfolded him and took him to a nearby 
airport and started kicking him all over his body. Every half an hour, she would be told that 
her son will be killed and that she should be prepared. After two days living in terror and 
horror, Alia's child was released, but had tremendous psychological problems and 
disturbances the extent that Alia wished her son was injured or dead to reduce his current 
suffering. 
Another case was of a woman participating in the research whose house seemed in good 
condition. However, during the interview and when asked about the frequency of 
consuming particular food items, the woman burst into tears. Her family had left Hebron, 
south of the West Bank and settled in Kalandia as her husband was working inside Israel; 
but he was later denied access to his work because of the Intifada and the Israeli refusal to 
give permits to Palestinian workers to enter Israel. Sixteen people were currently living in 
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the house. But as her husband became unemployed, they could only eat if the children 
searched in the garbage for pieces of iron and sold them to buy lentils or rice. These stories 
could continue as each woman in the camp has a different story but all were full of 
sufferings. 
The living conditions of these Palestinian women should be considered as a significant 
component of the research as it influences their mental and physical health and these 
influenced the progress of fieldwork and their readiness to be involved in the research. 
6.2 Preliminary Work 
Preparation for the field work took place while the study protocol was developed in London 
and Palestine in 1997. This involved contacting the responsible authorities and health care 
providers to get their approval. The Palestinian Ministry of Health and UNRWA officials in 
the headquarters (Jordan) and the West Bank had been approached and had in principal 
agreed to the study. A copy of the study protocol was sent to them for final approval. 
Contacts were also made with officials from UNRWA regarding choice of survey areas and 
it was initially agreed in principal that three Palestinian refugee camp locations would be 
randomly selected: from the north, middle and south camps of the West Bank. But because 
of the political situation and the difficulty of movement to and from the different areas of 
the West Bank, and because of scarcity of funding, the study was conducted in two refugee 
camps in the middle of the West Bank: the Amaari and Kalandia refugee camps. 
Contacts were also made with two research laboratories: one in Ramallah (the West Bank) 
and the other in Herzelia (Israel). The research laboratory in Ramallah is a member of the 
Randox International Quality Assessment Schemes in Haematology, Clinical Chemistry 
and Immunoassays, while that in Israel is an American Medical Laboratory under the 
continuous standardization programme of the CDC in the USA. The Ramallah laboratory 
was chosen for reasons mentioned above, as the mobility of goods and people was very 
difficult to and from Israel which would have affected the movement of blood samples to 
Israel. 
Meetings were conducted with cardiologists, diabetologists and obstetric/ gynaecologists to 
emphasize the significance of conducting such a study in Palestine. Additionally, two 
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Palestinian universities were approached for possibilities of co-operation; Birzeit and Al- 
Quds universities. Finally, however, due to logistical and administrative issues, the 
fieldwork was conducted without their involvement. 
6.3 Consultative Process 
Co-operation and input was sought at various levels as an important step in implementing 
this study. Community advisory groups including both men and women from the Amaari 
and the Kalandia refugee camps were formed. Their initial role was to appoint a liaison 
person between the community and myself, the principal investigator. Later, their role 
included providing feedback results to the community and input in future programmes 
arising from the study. 
A multi-disciplinary technical review group was also established, consisting of various 
professionals from the West Bank in the following fields: gynaecology/obstetrics, 
cardiology, diabetology and medical laboratory (see above). The role of this group was to 
review the methodology, provide written feedback and participate in a one day workshop to 
discuss the methodology and data collection instruments. 
6.4 Study Setting 
The study was conducted in two 
refugee camps, the Amaari refugee 
camp and the Kalandia refugee 
camp as Mar 6-1 showw, ý: 
Map 6-1: The Location of Amaari and Kalandia 
Refugee Camps 
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6.4.1 Description of the Targeted Refugee Camps 
6.4.1.1 The Amaari Refugee Camp 
The Amaari Refugee Camp was established in 1949 on an area of 92 dunums (4 
dunums= I acre), within the municipal boundaries of Al-Bireh city. By 1957, all tents in 
the camp had been replaced with cement block shelters. Like most of the West Bank 
camps, Amari suffers from overcrowding, poor sewerage and water networks. 
Following the redeployment of the Israeli army in 1995, the camp came under 
Palestinian Authority control. 
The camp is about 18 km north of Jerusalem. The people in the camp came originally 
from different localities but the great majority lived in the coastal plain of Palestine. As 
of December 1995, the population of the camp comprised of 6500 individuals living in 
around 920 families. The average household size was about 7.1 persons per family. The 
population has since increased to 8805 registered refugee population (inhabitants) in 
2005. The camp is severely overcrowded with cramped housing, unpaved streets and 
open sewers. UNRWA is responsible for the refugees in the camp. UNRWA provides 
health and education services, water and electricity supply, sanitation and building 
control. There is one health clinic in the camp which serves the camp inhabitants and an 
additional 22,000 people, who are largely refugees living outside the camp, basically in 
Al-Bireh and Ramallah cities. The clinic provides maternal and child health services, 
general medicine, dental services, a diabetes and hypertension clinic and laboratory 
services [257]. 
6.4.1.2 The Kalandia Refugee Camp 
Kalandia Refugee Camp was established in 1949 on 353 dunums, 11 kilometers north of 
Jerusalem. The main Jerusalem-Ramallah road runs through the camp. The Israeli 
authorities consider this area as part of Greater Jerusalem, and the camp was excluded 
from the redeployment phase in 1995. Kalandia camp remains under Israeli control in 
"zone C". In 1997, the Israeli authorities resealed the main entrance to the camp, which 
had been previously sealed during the Intifadah, with large cement blocks, allegedly to 
prevent stone throwing at passing Israeli cars on the main road. The camp still witnesses 
clashes with Israeli soldiers with frequent stone throwing incidents. 
The number of the registered Refugee Population in Kalandia refugee camp is 10,024. 
The clinic provided the same health services as the Amaari refugee camp [258]. 
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6.5 Description of the Subject Population 
6.5.1 Sample Size 
This cross-sectional household survey of 515 Palestinian women aged 40-65 years, of 
any marital status, was conducted in the Amaari and Kalandia refugee camps. All 
women living in the two camps and aged 40-65 years were selected from UNRWA 
registration records, which cover the population living in refugee camps within the West 
Bank, UNRWA being responsible for the refugees in the camps. The figures of 
registered Palestine refugees are regarded as comprehensive demographic data, and they 
are updated regularly. 
The original plan was to perform the study in the Amaari refugee camp only because it 
is very close to where I lived during the uprising and therefore gave me relatively easy 
mobility to and from the camp. But when I had identified the total number of women 
aged 40-65 in the UNRWA registration records living in the Amaari refugee camp, this 
came to 205 women. So after consultation with UNRWA staff and my supervisor, I 
decided to include Kalandia refugee camp as it is very close to the Amaari refugee 
camp, has almost the same environmental and socio-economic conditions but is larger. 
The total number of women aged 40-65 years in the Kalandia refugee camp came to 382 
women and therefore the total number of women in both camps came to 587 women at 
the time the study was conducted in 2001. The names of these women were listed and 
they were assigned random numbers. Then these random numbers were put in a basket 
and a sample of 515 women was selected randomly from this basket. 
6.5.2 Sample Size Calculations 
At the time the study was planned, it was not certain which of the various CHD risk 
factors were of prime interest, or exactly which groups of women would be compared to 
demonstrate an effect of parity. Literature suggested that HDL-C (High Density 
Lipoprotein-Cholesterol) was likely to be an important factor and a change of 4.9mg/dl 
(0.13 mmol/L) would represent a sufficiently important gradation in risk (see below). 
To focus the sample size calculation on the comparison of two groups, a cut-point of 
parity 6, being reasonably close to median parity, was chosen. 
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HDL-C levels are inversely associated with CHD [259], and may be the best lipoprotein 
predictor of CHD in women [93,260,2611. HDL-C has shown a strong inverse relation 
to CHD in women in the Framingham Heart Study [262], and the Lipid Research 
Clinics Study [263]. In the Framingham study, aI mg/dl (0.03 mmol/L) increase in 
HDL-C was related to a significant 3% decrease in CHD risk, and in the Lipid Research 
Clinics Study, aI mg/dl (0.03 mmol/L) increment was associated with a 4.7% 
decrement in cardiovascular mortality rates. Kritz-Silverstein et al, [140] found that 
women with 5 or more pregnancies had HDL-C levels that were 4.9 mg/dl (0.13 
mmol/L) lower than those with less than 5 pregnancies, and 4.0 mg/dl (0.10 mmol/L) 
lower than nulliparous women). This difference of 4.9mg/dl (0.13 mmol/L) was taken as 
clinically significant for risk of CHD [264] [259]. 
The following formula (comparison of two means) is needed for calculating the sample 
size: (u+v)2 (a12 + 622) / (111- 112)2 
ß is the standard deviation of the distributions of HDL-C level in each group (parity 6+ 
vs. parity < 6). µi- µ2 is the assumed true difference in the means of HDL-C. 
This formula is implemented in the STATA command sampsi, 
To apply this formula, some idea of the likely sampling variation is required. In the 
reference quoted above, the difference of 4.9 is significantly different from zero, with t= 
7.24. The SE can be calculated approximately from this as 4.9/7.24 which is 0.677. 
Given also the numbers in the groups being compared, the standard deviation is 
calculated as 12.4. The formula was then applied in a variety of possible scenarios; 
Table 6-1 below shows the results for these different scenarios: 
Table 6-1 Different Scenarios for the sample size calculation: 
p1-µ2 2 3 4 5 2 3 4 5 
Power 80 80 80 80 90 90 90 90 
Significance level 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 
a (mg/dl) 12.4 12.4 12.4 12.4 12.4 12.4 12.4 12.4 
Number of women in 
each group 
600 266 150 96 804 357 200 129 
Total number of women 1200 532 300 192 1608 714 400 258 
The difference in the reference above is 4.9. However, to derive a sample size for this 
difference is to ignore the uncertainty in the value 4.9. It seems more reasonable to plan 
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to be able to detect a difference equal to the lower end of the confidence interval on 4.9. 
This is 3.6 (4.9 - 1.96*SE). With 90% power, the table suggests a sample size between 
400 and 700 in the two parity groups combined. Using the formula for a difference of 
3.6, suggests that 250 women are needed in each group, or 500 altogether. The 515 
selected give a small margin for non-response. 
6.6 Selection Criteria 
6.6.1 Inclusion Criteria 
Women aged 40-65 years living in both the Amaari and Kalandia refugee camps were 
included irrespective of their marital status. (See selection procedure, above). Current 
users of antihypertensive medication were included in the sample, but allowance for this 
medication was made later in certain statistical analyses. A similar strategy was used for 
women on diabetic medication. 
6.6.2 Exclusion Criteria 
Currently pregnant women and women aged less than 40 and above 65 years were 
excluded. Women who were currently breastfeeding or who had a pregnancy ending 
within the past 12 months were also excluded; and women who had not fasted for 12 
hours were omitted from the blood tests. 
6.7 Recruitment of Women 
The selected women were sent a letter explaining the purpose of the project with an 
invitation to participate in the study. They were then approached individually by the 
principal investigator (I) and the community leader and a brief description of the study 
and its importance to women's health was explained. The women were asked to give 
their written consent before entering the study. Those who accepted the invitation were 
given a set of written and verbal instructions about all study measurements including 
preparation for blood tests. An appointment was set for a trained interviewer and the 
principal investigator, to visit the women at home and administer the questionnaire. 
Furthermore, information about the study objectives and its importance to women's 
health was disseminated through the community leaders, UNRWA officials and clinic 
staff, and women activists in the camps. 
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The 15 cases of non-responders (those who filled the questionnaire but refused to come 
to the clinic for the blood withdrawal and the laboratory tests), were invited repeatedly 
and after 3 reminders were contacted to fill in a brief questionnaire so as to identify their 
reasons for not attending and to assess whether they differed from participants. It 
emerged that 33.3% of these women were out of the country, 20% forgot to fast each 
time they had an appointment, and 46.7% could not bear the idea of giving a blood 
sample. 
6.8 Definition of Exposure 
Parity was defined as the total number of live births. Women were asked to report the 
total number of live births as well as other pregnancy outcomes (gravidity including 
abortions and still births). Parity was analyzed as both a continuous variable and a 
categorical variable. Women were grouped in five categories by number of live births 
(0,1-3,4-6,7-9, and 10+). Parity 10+ was chosen as the baseline in the analyses relating 
parity group to CHD risk factors. 
6.9 Definition of Outcome 
Four groups of outcome variables were considered: obesity, lipids and lipoproteins, 
diabetes and hypertension. The categorical outcome variables obesity and abnormal 
lipid levels were defined according to WHO criteria [265] [266]. Diabetes was defined 
according to WHO criteria [266] [267] [268] . 
Hypertension was defined according to 
the Joint National Committee on Prevention, Detection, Evaluation and Treatment of 
High Blood Pressure (JNC7) [269]. These outcome variables are defined more fully 
below, and were analyzed both as continuous variables and as categorical variables as 
appropriate. 
6.9.1 Obesity 
Three obesity indices were used in measuring body size and body fat distribution. 
1. Body Mass Index (BMI; kg/m2) was used to assess overall obesity. 
2. Waist Circumference (WC; in cm) was used to assess central obesity. 
3. Waist to hip ratio (W/H ratio) was used to assess abdominal obesity. 
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Overall obesity was defined by using the Body Mass Index (BMI) classification 
suggested by the WHO expert committee [265] see Table 6-2. BMI is a measure of the 
weight in kilograms divided by the square of the height in meters (kg/m2). 
Table 6-2 Body Mass Index Classification 
Lowest-18.49 Chronic energy deficiency 
18.5-24.99 Normal 
25.0-29.99 Overweight 
30.0-39.99 Obese 
40.0-highest Severely obese 
Overweight women were defined as having BMI between 25.0 and 29.99 kg/m2. Obese 
women were defined as having BMI >_ 30.0 kg/m. 2 
Waist circumference is considered as a suitable indicator of central adiposity, and a 
surrogate of visceral adipose tissue in adults. [270]. Increased waist circumference, a 
value > 88 cm in women indicates intra-abdominal fat, indicating central obesity. 
Abdominal adiposity: The waist to hip ratio (WHR), defined as waist circumference 
(cm)/ hip circumference (cm), is considered as a useful index for describing 
quantitatively adipose tissue distribution [265]. WHR > 0.85 is generally considered 
indicative of an android fat distribution and abdominal obesity. Women with WHR > 
0.85 can be significantly at increased risk of developing CHD and Type II diabetes 
[2711. 
Throughout the thesis, I have used WC > 88 cm as indicative of central obesity and W/H 
ratio > 0.85 cm as indicative of abdominal obesity. In summary: overall obesity was 
defined as BMI > 30.0 kg/m2; central obesity or adiposity was defined as WC > 88 cm 
and Abdominal adiposity was defined as WHR > 0.85 cm. 
6.9.2 Lipids and Lipoproteins 
For plasma total cholesterol, HDL-C, LDL-C and Triglycerides, the WHO criteria for 
the choice of "cut-point" lipids and lipoprotein levels was followed as indicated in Table 
6-3. 
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Table 6-3 WHO Criteria for Lipids and Lipoproteins 12571 
Definition Value 
Elevated Cholesterol > 5.2 mmol/L (200 mg/dl) 
Elevated LDL-C > 3.5 mmol/L (135 mg/dl) 
Elevated Triglycerides 2: 1.7 mmol/L (150mg/dl) 
Decreased HDL-C <1 mmol/L (40 mg/dl) 
A ratio of T-Chol/ HDL-C > 0.13 mmol/L, (5 mg/dl) 
Quantitative values of these outcomes were also used in the statistical analysis 
6.9.3 Diabetes 
Diabetes mellitus is defined internationally as fasting plasma glucose of 126 milligrams 
per deciliter (mg/dl) or more, which is > 7.00 mmol/L; or a history of physician 
diagnosed diabetes with or without current use hypoglycaemic agents. Fasting is defined 
as no calorific intake for at least eight hours. 
Impaired fasting glucose is defined as 110 to 125 mg/dl (6.1 to 7.00 mmol/L). This 
denotes "pre-diabetes" as a condition in which blood glucose levels are higher than 
normal but not yet diabetic, 6.1 to 7.00 mmol/L, (110-125 mg/dl). Women with no 
history of diabetes and whose plasma levels do not meet the above criteria are 
considered as non-diabetic. 
Table 6-4 WHO Criteria for Diagnosis of Diabetes Mellitus 12571 
Definition Value 
Fasting plasma glucose or on Z 7.0 mmol/L (126 mg/dl) 
medication 
Impaired fasting glucose z 6.1-7.00 mmol/L 
(Pre-diabetic) (110-125 mg/dI) 
Quantitative value of fasting blood sugar was also used in the statistical analysis. 
6.9.4 Hypertension 
High systolic blood pressure was defined as a mean systolic blood pressure >_140 mmHg 
and/or on medication. High diastolic blood pressure was defined as a mean diastolic 
blood pressure >_90 mmHg and/or on medication. Hypertension was defined as having a 
mean systolic blood pressure >_140 and/or a mean diastolic blood pressure >_90 mmHg or 
taking anti hypertensive medication [269] [272] [1]. Quantitative values of systolic and 
diastolic blood pressure were used in the statistical analysis. 
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Additional analysis were performed with women's report of coronary heart disease as an 
outcome variable, the metabolic syndrome as another outcome variable and the 10 years 
Framingham risk score as a third outcome variable in order to evaluate the risk of 
coronary heart disease the women might face. Definitions of these additional outcome 
variables as well as other covariates are shown in Appendix 2. 
6.10 Data Collection Methods and Instruments 
The data collection in this study consisted of a structured interview divided into health 
status, life style and reproductive health risk factors, plus blood pressure and 
anthropometric measurements and blood samples. 
6.10.1 Health Status, Life Style and Reproductive Health Risk Factors 
Questionnaire 
A standardized face to face interview using a structured questionnaire was employed in 
the home. The questionnaire was translated into Arabic by the principal investigator and 
the responses translated back into English. The questionnaire included the exposure 
variable of interest and other variables that were potential confounders or covariates 
potentially to be controlled for in the analysis. These included the demographic and 
socio-economic status of these women (age, education of women and their husbands, 
marital status, employment, occupation of women and their husbands, income sources, 
housing condition and crowdedness, possession of household amenities such as an 
automatic washing machine and a car); their lifestyle risk factors (smoking habits, 
passive smoking, physical activity, hours watching TV and assistance in housework as 
proxy to physical activity, stress status and dietary patterns); and their reproductive 
health associated factors (age at menarche, age at first marriage, age at first pregnancy, 
and age at first live birth, parity, gravidity, history of miscarriages, pregnancy 
terminations, breastfeeding, age at menopause, hysterectomy and/or removal of one or 
two ovaries, use of oral contraceptives, use of hormone replacement therapy, regularity 
of menses, and history of infertility). In addition, questions on health status, medical 
history and use of medication as well as the family history of chronic diseases were 
included. For more details of the questionnaire, see Appendix 3. 
No questions were asked on alcohol consumption, as this is not culturally appropriate 
especially as women participating in the study were all Muslims, and were unlikely to 
consume alcohol anyway. 
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The dietary data and all nutrition related data was not used in the analysis following the 
recommendations of the upgrading panel and time constraints. This data will be looked 
at in subsequent analysis and reports. 
6.10.2 Interviewer Selection and Training 
Four female interviewers (two from each camp) were selected based on motivation and 
interest as well as their ability to follow instructions and conduct the interviews exactly 
according to the protocol. Other selection criteria included good communication skills, 
completion of at least high school, knowledge of the local community, and preferably 
being a camp resident. 
The selected interviewers were trained by the principal investigator in questionnaire 
interviewing techniques, questionnaire completion, accuracy verification, and handling 
problems usually encountered in the field. Interviewers worked in pairs as it was more 
culturally appropriate. It was expected that they would complete 4 questionnaires per 
day, though this was not usually met due to curfews and Israeli invasions in the two 
sites. 
The questionnaire was pilot tested as described below (section 6.12). 
6.10.3 Blood Pressure Measurements 
Blood pressure was measured with a mercury sphygmomanometer, after at least 5 
minutes of rest, in a sitting position by a trained nurse according to a standardized study 
protocol. Blood pressure was recorded in mmHg. Two seated blood pressure 
measurements were averaged to obtain mean systolic and diastolic blood pressures. For 
more details on blood pressure measurements, see Appendix 4. The interview nurse 
recorded information on participant's current medication. Women were informed about 
the results and in case of a problem; they were referred to the UNRWA general 
practitioner for further medical advice. 
6.10.4 Anthropometric Measurements 
Anthropometry covered weight, height, waist circumference, and hip circumference. All 
anthropometric measurements were taken according to standardized instructions based 
on the recommendations of WHO consultancy groups [273] [265]. The reproducibility 
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of the anthropometric measurements (intra-observer) was assessed at the beginning of 
the study. Repeated reproducibility checks were conducted every day for standardization 
and correctness of the instruments. 
Body Mass Index (BMI) 
Weight and height measures were recorded by the principal investigator with the 
subjects wearing very light clothing and without shoes. Body weight was measured to 
the nearest 0.1 kg using a balance scale. Women were asked to remove their shoes and 
heavy outer clothing, stand upright on the centre of the scale without touching any 
object, and the weight was recorded. Body height was measured with a stadiometer to 
the nearest 0.1 cm. Women were asked to stand erect against the wall, with feet parallel 
and heels, buttocks and back of head touching the wall behind them. The head was held 
straight looking forward, arms hung loosely at the sides. The head piece of the 
stadiometer was gently lowered, crushing the hair, making contact with the top of the 
head and the measurement was read. BMI was calculated as weight in kilograms 
divided by the square of the height in metres, weight/height2 (kg/m2). 
Waist-Hip Measurements (W/H Ratio) 
The waist and hip measurements were recorded by the principal investigator as well. 
Women were asked to stand relaxed. The principal investigator knelt at an appropriate 
height in front of the woman surveyed. Waist circumference was measured to the 
nearest 0.5 cm at the level midway between the lower rib margin and the iliac crest 
using a flexible tape measure (dress-maker's measuring tape). 
Hip circumference was measured in the same way at the widest point between the iliac 
crest and buttock. The circumferences were measured with women standing. The Waist 
Hip Ratio (WHR) was calculated as waist circumference divided by hip circumference. 
Two measurements were taken for each parameter and if there was a difference between 
the two (more than 0.5 kg for weight and more than 1 cm for height, waist and hip) a 
third measure was recorded. 
6.10.5 Blood Samples: Blood Specimens' Collection, Handling and Processing 
Blood samples were taken in the clinic lab between 8.00 am and 11.00 am after an 
overnight fasting of 12 hours, by a trained lab technician. The period of fasting was 
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ascertained by questioning the women prior to registration for the blood sample. After 
registration, 10cc of fasting venous blood were collected from all women. Part of the 
blood was drawn in sodium fluoride tubes for the estimation of fasting blood sugar and 
the other part in plain tubes for lipids (Cholesterol, Triglycerides, HDL, and LDL) and 
insulin assays. All labelled test tubes were put in ice boxes and sent within one hour to 
the laboratory in Ramallah for analysis. In the laboratory, plasma was separated from 
blood cells by centrifugation. Fasting blood sugar and lipid profiles were estimated 
immediately. All different lipid parameters (T-cholesterol, HDL-C, LDL-C and 
triglycerides) as well as glucose assay were measured using enzymatic techniques. The 
Elisa technique was used for the insulin test. 
Specific lipid controls were used for the quality control when performing lipid tests 
(lipid high and lipid normal), and regular control (high and normal) for glucose test. The 
controls and reagents used were ordered from the same manufacturer. For the insulin 
test, plasma samples were frozen and the tests carried out at least twice a week 
depending on the number of samples that were collected. Quality controls were carried 
out with each run. 
6.11 Data Collection Logistics 
6.11.1 Interviews 
On the day of the appointment, the two female trained interviewers introduced 
themselves, obtained informal consent and collected information on several 
demographic and socio-economic variables, detailed reproductive and gynaecological 
histories, use of oral contraceptives and hormone replacement therapy, medical and 
family history, smoking habits, exercise, diet and dietary patterns. Information on 
current use of medication such as antidiabetic and antihypertensive medications was 
also collected. To avoid information bias, neither the interviewers nor the participating 
women were informed about the study hypotheses. Women were asked to go the next 
morning to the UNRWA clinic for blood withdrawal. They were given instructions 
about how to be prepared for blood testing and overnight fasting. Those women who 
could not make it for one reason or another, they were given another chance and another 
appointment for blood testing. If that particular evening was not a good one for fasting, 
the woman was given another appointment that would be convenient for her. 
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6.11.2 Biochemical Analysis of Blood Samples 
Upon arrival at the UNRWA clinic, the research nurse registered the women and 
directed them to the laboratory where a medical laboratory technician took fasting blood 
samples for glucose level, total cholesterol, LDL-C, HDL-C, triglycerides and plasma 
insulin. 
6.11.3 Blood Pressure Measurements 
Women were then asked to go to the other room where the research nurse who has been 
trained in using a standard mercury sphygmomanometer measured their blood pressure. 
6.11.4 Anthropometric Measurements 
In the same room body weights, heights, waist and hip circumferences were measured 
with women wearing light clothing and without shoes, by the principal investigator. 
6.12 Pilot Study 
A pilot study of one month duration tested the feasibility of the study protocol (data 
collection methods and instruments). The questionnaire was pilot tested on women who 
were from the Amaari and Kalandia camps, but were not part of the study, in order to 
test the acceptability and clarity of the questionnaire to women. 
Particular attention was paid to the recruitment and response rates of women who were 
invited for laboratory investigation as well as filling in a questionnaire. The pilot study 
sample consisted of 11 women from the Amaari refugee camp and 19 women from 
Kalandia refugee camp. 
6.13 Ethical Considerations 
The study objectives and protocol were explained to all women prior the study by 
UNRWA officials and the principal investigator. Informed consent for performing 
interviews and drawing blood samples was obtained. When cases were identified 
among women, they were informed about the results of the tests and they were referred 
to UNRWA clinic in the camp for further investigation and free of charge treatment. All 
women participating in the study were informed about the biometric results. 
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Consent of the ethics committees at the London School of Hygiene and Tropical 
Medicine and at the appropriate local centres including UNRWA was obtained. 
Women's names selected from UNRWA registration records, which were confidential 
records, were coded to ensure confidentiality. Names were replaced with a numerical 
identifier. All study procedures including the laboratory tests that were performed, the 
administration of the questionnaire, and ensured privacy of women participating in the 
study as stated in the data collection logistics section. All names were removed from 
fill-out questionnaires and laboratory results, and were coded numerically. For informed 
consent, please see next section. 
All personnel involved in the study (the interviewers, the nurse, and the lab-technician) 
were supervised directly by the principal investigator who had good experience with 
data collection methods. 
6.14 Informed Consent Procedures 
Three types of informed consent procedures were employed: a first informed consent 
form that was presented to women indicating the purpose of the study and participation 
implication (Appendix 5), a second form was prepared by UNRWA detailing again the 
importance of the study and presenting me as the researcher performing the study on 
women's health (Appendix 6). Finally, a third consent form was signed by participants 
indicating their acceptance to be volunteers in the study under the supervision of the 
principal investigator (me). The form also explained that the study has been defined and 
fully clarified to participants by UNRWA's medical officer and the principal 
investigator (Appendix 7). 
6.15 Statistical Details of the Study 
6.15.1 Data Entry and Data Management 
During the fieldwork phase, all questionnaires were checked and edited daily by the 
principal investigator. All data which were generated through the interview, body 
measurements, blood pressure measurements as well as laboratory measurements were 
entered using an Access 2000 programme prepared by an expert in data entry. The data 
entry programme included a number of characteristics such as: 
0 Reproduction of the questionnaire on the computer screen. 
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" Rules for logical and consistency checks on the data. 
" Possibility for internal editing of answers. 
" Maintaining a minimum of digital data entry and field work errors. 
" User friendly handling 
" Possibility of transferring data to a data analysis platform such as SPSS or 
STATA. 
Data was entered once by the same person. Then all data entered into the computer was 
cleaned and checked by the principal investigator for further errors and missing data. 
The questionnaires were subjected to standard quality control procedures in terms of 
editing and coding with the help of a specialized person who reviewed the 
questionnaires again with the principal investigator. 
6.15.2 Data Coding and Statistical Analysis 
6.15.2.1 Statistical Analysis 
The data was analyzed using the STATA 9 for Window statistical package and SPSS 14. 
Different statistical approaches were used to assess the relationship between parity and 
coronary heart disease risk factors (obesity, lipids and lipoproteins, diabetes and 
hypertension) as well as reported CHD, the metabolic syndrome and the 10 years risk of 
developing a CHD. The primary exposure of interest, parity was analyzed as a 
categorical variable with several categories (0,1-3,4-6,7-9, and 10+) and as a 
continuous variable. The outcome variables of interest were analyzed both as continuous 
and as categorical variables as appropriate. 
Descriptive Analysis 
The distribution of each variable was examined to get a good understanding of the 
characteristics of the study population with respect to the exposure and other variables 
measured. Simple cross-tabulations were then produced. Categorical variables were 
summarized by grouping data appropriately and calculating frequency distribution. 
Continuous variables were summarized by calculating means and standard deviations. 
Continuous variables with non-normal distribution were summarized using the log- 
transformation. Risk of a particular outcome was calculated as a proportion. 
Bivariate Analysis 
Bivariate analysis was performed to identify associations and differences and to 
facilitate interpretation of the results. Three approaches were used. The first approach 
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incorporated each outcome variable as a binary variable and parity as a categorical 
variable. Comparisons of the percentage of the outcome variables among women of 
different parity groups were assessed by the chi-square test and the use of logistic 
regression. This approach made no assumptions concerning linearity of the relationship 
of outcome with parity, in contrast to the next two approaches. 
Secondly, logistic regression on parity as a continuous variable was carried out. The 
change in odds of the outcome variable per extra child (unit change of parity) was 
estimated. This approach was used in some of the papers reviewed in the discussion 
section, and its inclusion here permitted a direct comparison of results. 
The third approach took those of the outcome variables which were measured as 
continuous variables and the exposure variable (parity) with both variables being 
continuous, using a scatter diagram and by ordinary regression. The regression 
coefficient showed the estimated change in the outcome variable for a unit change in 
parity. The line of the scatter diagram also indicated the line for regression of the 
outcome variable on parity unadjusted. If the scatter diagram suggested a curved 
relationship, then testing for curvature (J-shaped or U-shaped) was applied by adding a 
quadratic term. 
To account for the fact that some participants were taking medication for diabetes 
(n=77), and hypertension (n=111) at the time the CHD risk factor measurements were 
taken, censored regression models were fitted for fasting blood sugar and blood pressure 
which censored the outcome measure of those on medication at the observed value so 
the true value is assumed to be that observed or higher. So, when not on medication, the 
value for fasting blood sugar and mean SBP and DBP is taken as correct and exact, 
while when on medication the value for the outcome variables is taken as a minimum 
(that is, it is assumed the medication has reduced glucose level to some extent, although 
how much is not known). 
Multivariate analysis 
Multivariate analysis was used to examine the associations between parity and CHD risk 
factors with allowance for confounders (age, education of both women and their 
husband's and marital status) and other covariates (mediators such as assistance in 
housework, BMI, etc) These mediators were introduced one by one into the confounder- 
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adjusted model, using logistic regression for the categorical (binary) outcomes and 
multiple linear regression for the continuous outcomes, with parity taken as a continuous 
(not grouped) variable. 
The details of the confounders and other covariates are given below. 
Confounding and mediation 
Additional variables, as well as parity, in the multivariate analysis were either 
confounders or mediators, as follows: 
A confounder is a variable that distorts the association or the relationship between an 
exposure and an outcome. 
In order for a variable to act as a confounder, it must be: 
1. A risk factor for the outcome (predictive of disease occurrence); 
2A risk factor for the exposure, in fact it must come before the exposure; 
3. Not on the causal path between the exposure and the outcome variable. 
We have chosen the confounders in this study by applying this definition. Accordingly, 
the confounders of interest that meet the above criteria are age, women's education, 
husband's education and marital status. Adjusting for confounders in the association 
between an exposure variable and an outcome variable reduce the bias in the results. 
Mediation: Not every factor that is associated with both the exposure and the outcome is 
a confounding variable. Other factors could be mediating variables. A mediator is also 
associated with both the independent and dependent variables, but may be part of the 
causal chain between the exposure and the outcome. 
The confounding and the mediation effects cannot be distinguished on statistical 
grounds in the analysis of cross-sectional data. They can only be separated from each 
other based on the understanding of the total disease process. 
For example, the mediator "assistance in housework" reduces the association between 
the exposure (parity) and the outcome (obesity). However, we should not conclude that 
parity is less a real cause of obesity, because assistance in housework as a proxy to 
physical inactivity may be part of the causal pathway from parity to obesity. So the 
mediator is along the causal pathway between parity and obesity. 
Multiple testing: 
A large number of statistical tests are expected to be carried out for the several outcomes 
variables. There is always a chance of getting false positives when doing multiple 
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statistical tests. If one carries out one test and set the p value at 0.05 level, then the 
chance of getting a significant result when there is no underlying effect is I in 20 or 5%. 
So a significant result is still possible if actually there is no effect with this chance, and 
this would be a false positive result. When doing several tests, this applies to each one. 
So doing several tests and accepting significant results as indicating an effect, one might 
go wrong more often than the p-value suggests and the chance for one or more false 
positives will be greater. 
One can use a statistical strategy to get around this and the one often quoted is the 
"Bonferonni Correction". When this is used, results are accepted as significant only 
when the P-value of the test is much smaller than the usual 0.05. It is calculated by 
dividing 0.05 by number of tests. In our study, this approach would be difficult to apply, 
as we are not sure how many tests will be carried out, it must be more than 100 and at 
this stage it is hard to plan for. But, even if we adopt it and accept as statistically 
significant only those effects that get a very small P-value, then the power to detect an 
effect that does exist is much reduced and the study as a whole is weakened. 
In summary it is not a good idea to rely only on statistical tests to show if an effect 
exists or not; rather one must use the P-value as contributing to the strength of evidence 
for an effect. One must look for the combination of the evidence from the P-value with 
other evidence such as the findings from other studies in the literature that have shown 
evidence for the effect and from applying what is scientifically known about the 
plausibility of the effect. This broadly is the approach adopted here. 
6.16 Quality Assurance and Quality Control 
Quality assurance and quality control activities were performed at all the different 
phases of the study in order to maximize the reliability and validity of the data collected. 
The field workers recorded the responses on to the questionnaires at the households. 
They then reviewed the questionnaires and the principal investigator also reviewed the 
questionnaires with the field workers at the site, on a daily basis, then filed and stored 
them at home. The nurse filled in the blood pressure measures and the principal 
investigator filled in the anthropometric measurements at the time the women came to 
the clinic on appointment. The laboratory technician recorded all the lipid profiles as 
well as the fasting and plasma insulin results on official laboratory forms. The principal 
investigator received the forms at the end of the week and after checking and reviewing 
the lipid, insulin and sugar profiles for any inconsistencies, the principal investigator 
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transferred the data from the official laboratory forms to the questionnaires before it was 
entered into the computer programme. 
The quality control of the forms and questionnaires were carried out routinely 
throughout the period of the field work. Cross checking of information was frequently 
made by the field workers and the nurse under the supervision of the principal 
investigator. If inconsistencies were detected and could not be resolved by the field 
workers at the site, then they were requested to repeat checking the questionnaire with 
the subject to correct or complete it as appropriate. 
In addition to the initial training programme, the fieldwork team had regular meetings 
with the supervisor (I), who was the principal investigator of the study, during the whole 
period of data collection, in order to share experiences and discuss difficulties 
encountered in the work. All equipment used in this survey was checked to ensure 
quality results of the measurements. 
Quality control of laboratory analysis was performed according to established 
programmes, based on the scientific standards of the laboratory involved in the analysis. 
Before submission to keyboard data entry, the questionnaires were reviewed for 
completeness, consistency and other errors. After data entry, computer programmes 
were run to verify the consistency of responses within each questionnaire and between 
them. 
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Chapter 7 
DEMOGRAPHIC, SOCIO-ECONOMIC AND HEALTH 
CHARACTERISTICS OF WOMEN SURVEYED 
Chapters seven to thirteen discuss the actual results from the data analysis. The first five 
sections of chapter seven describes the general demographic, socio-economic, and 
health characteristics of the women surveyed in the Kalandia and Amaari refugee 
camps. Section 7.6 describes the prevalence of principal characteristics by parity groups 
and section 7.7 describes the mean and standard deviation of coronary heart disease risk 
factors by parity groups. 
7.1 Demographic Characteristics 
A total of 515 women from the Amaari and Kalandia refugee camps participated in the 
study. Their age ranged from 40 to 65 years, with a mean of 49.4 years. The majority 
were married and living with their husbands, (Table 7-1) 
The basic socio-demographic characteristics are shown in Table 7-1. Since the refugee 
camps are very populated, around 45% of the women lived in cramped houses, where 
the average family size is 7.43 with a maximum of 30 people. Around 50% of them 
were born in the camps and had been living there ever since. Thirty-four percent were 
born inside Mandatory Palestine, but were forced to migrate with their families after the 
Arab Israeli war in 1948 and had lived since then in these refugee camps, assuming that 
one day they will go back to their homeland. 
Table 7-1: Socio Demographic Characteristics of the Study Population 
Socio Demographic Characteristics 
Number of women participating in the study 515 
Variable name N Mean SD , or 
% 
Age of women in categories, % Frequency_ Percent 
<45 159 30.9 
45 - 49 115 22.4 
50 - 54 110 21.4 
55- 59 95 18.5 
60+ 35 6.8 
Total 514 100 
Mean age in years 514 49.4(6.43) 
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Marital status, % Frequency Percent 
Single 21 4.1 
Married 382 74.2 
Divorced 17 3.3 
Separated 11 2.1 
Widowed 84 16.3 
Total 515 100 
Family size 
Number of people living in the household (average 
family size) 512 7.43 3.89 
Place of birth, % Frequency Percent 
Jerusalem 34 6.6 
West Bank 256 49.7 
Gaza Strip 24 4.7 
Palestine 1948 173 33.6 
Arab Countries 26 5 
Other Countries 2 0.4 
Total 100 100 
Mean number of years lived in the camps 515 33.7 13.15 
7.2 Socio-Economic Status 
7.2.1 Education 
The women had a mean of 5.62 years of education. Twenty-three percent had no formal 
education, in comparison to 38.6% with elementary education, 32.4% with secondary 
education and only 5.8% with higher education, (Table 7-2). This low number of better 
educated women is probably due to early marriage being common, as well as the social 
and economic constraints obliging parents to favour marriage over education. Around 
47% of women surveyed were married below 18 years of age, of whom 23.7% were 
married at an early age below 16 years. 
7.2.2 Occupation 
Women's participation in the labour force was low and the vast majority (84.7%) were 
unemployed. Out of the 79 women employed, 20.3% were unskilled workers and 31.6% 
worked in small private businesses. Following the Palestinian uprising and due to 
movement restriction and checkpoints as well as curfews, many people, both men and 
women, lost their jobs in Israel and became unemployed. This situation has compelled 
families living in the camps to establish their own small private businesses as an 
alternative to losing their jobs. However, these businesses are very small. 
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This low participation of women in the labour force does not however accurately reflect 
women's economic contribution as a working force since the formal definition of 
"employment" excludes household work performed by women. This is unpaid and 
therefore seen as unproductive despite the fact that many hours are spent in such tasks in 
food production and clothes making, all of which produce consumable items and 
contribute directly and indirectly to the welfare of the family [14]. 
Women's participation in the labour force is limited by a variety of factors including 
this lack of job opportunities, low levels of education, high fertility rates and early 
marriage. There is no comprehensive community support system that encourages 
women to work beyond household work, as there is a lack of quality kindergartens or 
nurseries, day-care centres for the elderly or other facilities that would liberate women 
from some of their many household responsibilities. 
Around 49% of the husbands were employed, of which 31 % were unskilled workers, 
while another 30% worked at UNRWA. Most of the women interviewed depended on 
salaries of employed household members as their primary source of income. As 
indicated in Table 7-2,46.3% of the families have one member currently working, 
27.5% have two and 8.9% have three family members currently working. However, 
around 14% of households have none of their members working. 
Table 7-2: Education and Economic Status of the Study Population 
Percent (%) or 
Years of schooling in categories, % Frequency mean (SD) 
No formal education 119 23.1 
Elementary 199 38.6 
Secondary 167 32.4 
Higher 30 5.8 
Total 515 100 
Mean years of schooling 515 5.62 (4.29) 
Currently employed, %I 79 15.3 
Occupation, % Frequency Percent (%) 
Unskilled worker 16 20.3 
Skilled worker 14 17.7 
Employee 24 30.4 
Private business 25 31.6 
Total 79 100 
Husband's years of schooling, % Frequency Percent (°/a) 
No formal education(0) 85 17.7 
Elementary (1-6) 166 34.7 
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Secondary (7-12) 170 35.5 
Higher (12+) 58 12.1 
Total 479 100 
Mean Husband's years of schooling 479 6.87 (4.67) 
Husband's currently employed, % 241 48.8 
Husband's occupation, % Frequency Percent (%) 
Unskilled labour 75 31.1 
Skilled Labour 36 14.9 
Employee 56 23.2 
International organization 73 30.3 
Private business 1 0.4 
Total 241 100 
Number of people working in the household Frequency Percent (%) 
0 69 13.7 
1 234 46.3 
2 139 27.5 
3 45 8.9 
4 8 1.6 
5 10 2 
Total 505 100 
7.2.3 Wealth Status 
In order better to assess the financial situation of the families interviewed, questions 
were asked pertaining to household amenities, real estate and landholdings. In general, 
people were unwilling to respond frankly to questions directly related to property and 
income, in part because this discussion is culturally sensitive, but also because many of 
them fear that the information will somehow reach the ears of the tax collector and 
cause them problems. Hence, the information gathered in the course of this survey with 
regard to household amenities and property may not be completely accurate, but 
ownership of certain appliances can reflect overall economic status to a certain degree 
(e. g., owning a deep freeze, clothes drier, microwave oven, satellite dish and /or private 
car can be relatively sound indicators of the family's financial status). Within this 
framework, we have created a variable called the family affluence scale where we have 
combined possession of amenities and household crowdedness to reflect a fair 
distribution of wealth among families. Details are found in Appendix 2. 
In general most people living in the camps are more or less similar in their socio- 
economic status. Those who become financially better off try to move to the outskirt of 
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the camp and those who are ever better off might live in cities such as Ramallah and Al- 
Bireh where they can still have access to all UNRWA services but have a better quality 
life. It is interesting to note that although the majority of households own a house 
(89.9%), a coloured television (94.6%) and a fridge (95.9%) as shown in Table 7-3, 
these do not actually reflect entirely the wealth of a family since the status of the house 
and its' space as well as the condition of other available utilities determine more the 
family's wealth. Moreover, refugee population houses used to belong to UNRWA but 
were offered later to them as a temporary arrangement leaving the refugees with small 
houses built with low quality material. Forty-five percent of families interviewed lived 
in definitely crowded conditions and 34.6% lived in moderately crowded conditions as 
shown also in Table 7-3. 
Table 7-3: Distribution of Amenities at the Household and the Crowding Scale 
The availability of some amenities at the household. % Freauencv Percent (%) 
Own house 
Coloured TV 
Video 
Fridge 
Deep freeze 
Full automatic washing machine 
Clothes dryer 
Dish washer 
Microwave 
Air condition 
TV satellite 
Private car 
Crowding Scale, % (1) 
Crowded 
Moderate 
Not Crowded 
Total 
vav 
463 89.9 
487 94.6 
152 29.5 
494 95.9 
24 4.7 
115 22.3 
19 3.7 
11 2.1 
47 9.1 
9 1.7 
153 29.7 
91 17.7 
Frequency Percent (%) 
231 45.2 
177 34.6 
103 20.2 
511 100 
Poor 225 43.7 
Average 164 31.8 
better off 126 24.5 
Total 515 100 
(') Based on the number of persons per room; crowded is I or less, moderate crowding is 
between I and 2 and not crowded is more than 2. 
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Taking all the above mentioned indicators into consideration, the family affluence scale 
reveals that 43.7% of households are poor in comparison to 31.8% of average status and 
24.5% are better off as indicated in Table 7-3. 
7.3 Reproductive History of the Women 
7.3.1 Early Marriage 
Around 59% of women, all of whom were ever married, had married young, below or at 
the age of 18 years (the minimum age at first marriage was 11.5 and maximum age was 
41 years). Of these 23.7% married early, below 16 years of age, as shown in Table 7-4 
This relatively high rate of early marriage is due largely to custom and to the economic 
and social constraints which oblige parents to marrying their daughters in order to lessen 
household expenditures. In addition many families believe that their daughters, once 
they are married, will be safe from any temptation to "deviant" or societal unacceptable 
behaviour. 
Early marriage forces young women to assume parental responsibilities at a time they 
are growing and need supervision. The mean age at first birth in this study was 20.1 
years with a median of 19.2 years. Table 7-4 presents age at first birth and indicates that 
13.5% of women had their first birth when they were less than 16 years old. 
There was little practice of birth spacing. Frequent births can adversely affect overall 
health of women. Mean age at menarche was 13.4 and mean age at menopause was 
48.2 years. 
7.3.2 Number of Births and Pregnancies 
Palestinian families in the West Bank and the Gaza Strip have a high annual birth rate. 
The crude birth rate in 2006 was 36.7 (41.7 in Gaza Strip and 33.7 in West Bank) per 
1000 population [17]. The fertility rate in 2006 was also high at 4.6 births per woman 
(5.4 in the Gaza Strip and 4.2 in the West Bank) [18] [19]. Not only do Palestinians 
marry young, but their traditional values favour large families, as children are thought to 
help maintain the wealth and support system of the family. In addition, the political 
environment (the Intifada and the death of so many male children) has created in people 
a sense of responsibility about contributing to the population. 
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The number of children per woman ranged from 0 to 21. The women surveyed were 
found to have born on average 7.3 live children in their lifetime (median 8). The survey 
was carried out in 2001,4 years before 2005, and "captured" fertility over several 
decades before that time. The mean number of pregnancies the women ever had was 
8.86 (median 9). Sixty one percent of the women surveyed had 7 or more children, and 
only 8.1 % had no children at all. This small group of parity 0 consisted of 42 women 
out of whom 21 were single, 11 were married and living with their husbands, 4 were 
divorced and 6 were widowed. In Palestinian culture, women have little choice of not 
becoming pregnant as it is not widely accepted in the society. So beside the 21 single 
unmarried women, 15 out of the other 21 were most probably either infertile or their 
husbands were infertile. On this basis, probable infertility among the parity 0 group was 
28.3% compared to infertility among the study population which was 8.7%. In general, 
Palestinian women do not have a say on how many children they will have or on their 
birth spacing. Society, relatives and husbands exert enormous pressure on women 
regarding the number of children, not taking into consideration the huge burden that 
large families impose, or whether women concur or not. Maternal mortality and 
morbidity is not yet an aspect given importance by health policy makers, despite the 
value placed on the woman's role as a mother. 
Table 7-4: Reproductive History of Women 
Variable name N Mean (SID) or % Age at first marriage in years, % Frequency Percent (%) 
<16 117 23.7 
16-18 174 35.2 
> 18 203 41.1 
Total 494 100 
Mean age at first marriage 494 18.8 (4.6) 
Mean age at first pregnancy, years (min 13.17 & max 42.08) 477 19.37 (4.29) 
Age at first birth in years, % Frequency Percent 
< 16 64 13.5 
16 -18 109 23 
> 18 301 63.5 
Total 474 100 
Mean values of further variables 
Age at first birth, years 474 20.09 (4.26) 
Age at last birth, years (min age 16.50 and max 49) 469 35.5 (5.03) 
Number of children women ever had (parity) 515 7.30 (3.69) 
Number of pregnancies women ever had (gravidity) 515 8.86 (4.56) 
Pregnancies ended as a miscarriage or abortion 313 2.40 (1.88) 
Pregnancies ended as still birth 65 1.31 (0.61) 
Age at menarche, years 508 13.36 (1.39) 
Age at menopause, years 229 48.19 (5.45) 
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Variable name N Mean (SD) or % 
Years since last birth 469 15.4 (6.04) 
Fertility related variables 
Number of women 515 
History of infertility, % 43 8.70% 
Periods stopped, % 229 44.6% 
Ever use oral contraceptive pills, % 208 40.4% 
Ever use Hormone Replacement Therapy (HRT), % 6 1.2% 
Pol c stic ovaries, % 13 2.6% 
7.4 Health Status 
7.4.1 Women's General Health Status 
In spite of the fact that 48% of women described their health as being good, another 
43% described it as being average or below. The burden of large families leads to 
women not putting their health as a first priority, as Palestinian women tend to place the 
health needs of their children and husbands before their own [14]. They tend to 
minimize the importance of any adverse health conditions they have. This is partially 
due to their cultural upbringing where "girls are taught to endure physical pain and 
suffering especially that related to reproductive functions, in menstruation, pregnancy, 
and child-birth, since this related to fertility, which is the overriding symbol by which 
women gain their socio-economic status within the family and the community at large" 
[274]. In addition to their daily workload and caring for the children, once they become 
grandparents, they focus their energy in turn on their grandchildren. 
When women were asked whether they ever had a cervical smear test and a 
mammogram X-ray test, only 20% reported a smear test and 8% a mammogram. 
Twenty percent reported they had had their triglyceride measured while 31.8% reported 
they had their cholesterol level measured during their lifespan. Around 40.4% of women 
had ever used the contraceptive pill, and 1.2% ever used HRT. 
7.4.2 Family History of Certain Diseases 
When women were asked about family history of diseases, 40.6% had a family history 
of hypertension, 41.6% had a family history of diabetes, 8.5% had a family history of 
hyperlipidemia and 24.5% had a family history of heart diseases as in Table 7-5. 
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Table 7-5: Family History of Diseases among Women 
Family History of diseases Frequency Percent (%) 
Number of women 515 
Family history of blood pressure 209 40.6 
Family history of diabetes 214 41.6 
Family history of hyperlipidemia 44 8.5 
Family history of heart diseases 126 24.5 
Blood relationship (consanguinity) between father and mother 224 43.5 
7.4.3 Risk Factors for CHD among Women 
Table 7-6 shows mean values for the different anthropometric measures and Table 7-7 
shows the prevalence of obesity, central and abdominal obesity among women. The 
women weighed on average 80.6 kg, and had a mean height of 1.56 meters. Their mean 
BMI (overall obesity) was 33.3 kg/m2 and 69.2% were obese (BMI > 30 kg/m2). Their 
mean waist circumference was 98.0 cm. The prevalence of central obesity (WC > 88 
cm) was 84.2% and the prevalence of abdominal obesity, W/H ratio > 0.85 was 51.9%. 
The majority of the women were obese whether in terms of overall obesity or abdominal 
adiposity. It has been documented by many studies that overall and abdominal obesity 
are associated with many non-communicable diseases such as type II diabetes mellitus, 
cardiovascular and cerebrovascular diseases, digestive disorders, and cancer [275]. 
Furthermore obesity is a major independent risk factor for the development of 
hypertension, type II diabetes and dyslipidemia [276]. Please refer to earlier chapters in 
literature review. 
Table7-6: Mean Height, Weight, Hip, Waist, and Thigh Circumferences, BMI, and W/H ratio 
Variable Name 
Mean values of anthropometric measurements 
N Mean (SD) 
Standing height, meters 513 1.56 (0.06) 
Weight, kg 513 80.6 (15.1) 
BMI, kg/m2 513 33.3 (6.0) 
Waist circumference, cm 513 98.0 (12.0) 
Thigh circumference, cm 513 119.3 (12.4) 
Hip circumference, cm 513 115.5 (11.8) 
Waist/hip ratio, cm 513 0.85 (0.06) 
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Table 7-7: Prevalence of Obesity, Central and Abdominal Obesity 
samnna Wnmen_ (N=5131 
Frequency Percentage 
Number of women 513 
Overall Obesity (BMI z 30 kg/m2 ), % 355 69.2 
Central Obesity (WC z 88 cm), % 432 84.2 
Abdominal Obesity (W/H ratio 2: 0.85 cm), % 266 51.9 
Tables 7-8 and 7-9 show the prevalence and the mean values for hypertension, diabetes, 
hyperlipidemia, plasma insulin and the metabolic syndrome among women. The 
prevalence of hypertension and diabetes was 15.7% and 16.7% respectively without 
taking into consideration those women who are on medication for being hypertensive or 
diabetic. 123 out of 157 women, who were diagnosed as having hypertension, were on 
anti-hypertensive drugs, whereas 83 out of 89 women, who were diagnosed by a 
physician to have diabetes, were on diabetic medication. Therefore, when anti- 
hypertensive and diabetic medication was included in the definition of hypertension and 
diabetes, and using a censored regression model to account for the fact that some 
women were taking medications for hypertension and diabetes at the time the CHD risk 
factors were measured, the prevalence of hypertension and diabetes became 42.7% and 
22.3% respectively. This censored mean assumes the true value for FBS is that observed 
or higher for those on medication - for women not on medication, the value for FBS is 
taken as correct and exact but for those on medication, the value for FBS is taken as at 
least that observed, since it is assumed that the medication has reduced the FBS level to 
some extent, but how much is not known. The same applies (later) to blood pressure 
measurements. The women's lipid profile was as follows: 24.3% had elevated total 
cholesterol, 31.1% had elevated triglycerides, 49.6% had their HDL-C levels below 
I mmol/L, and mean fasting plasma insulin of 9.5 ulU/ml. 
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Table 7-8: Prevalence of Hypertension, Diabetes, Hyperlipidemia, the Metabolic Syndrome and 
10 Years Risk for CHD among Women 
Frequency Percentage 
Number of women 515 
Hypertension SBP z 140/ DBP z 90 mmHg, % 81 15.7 
Hypertension SBP 2: 140/ DBP Z 90 mmHg/ medication, % 220 42.7 
FBS z 7mmol//L (Diabetic), % 83 16.7 
FBS Z 7mmol/L (Diabetic) or on medication, % 115 22.3 
Elevated Cholesterol > 5.2mmol/L, (200 mg/dl), % 121 24.3 
Elevated Triglycerides Z 1.7mmol/L, (150 mg/dl), % 155 31.1 
Elevated LDL > 3.5mmol/L, (135 mg/dl), % 99 19.9 
Decreased HDL-C <1 mmol/L (40 mg/dl), % 247 49.6 
Ratio of T-Chol / HDL-C at high risk > 0.13mmol/L, 5mg/dl 173 34.7 
Metabolic syndrome, % 289 58.3 
10 years risk for CHD, % 
Low risk (< 10%) 354 77.5 
Medium risk (10-20%) 77 16.8 
High risk (>20%) 26 5.7 
Total 457 100 
Table 7-9: Mean Values for Serological Measurements 
N Mean (SD) 
Fasting blood glucose, mmol/L 498 6.0 (3.3) 
Censoring-adjusted fasting blood sugar, mmol/L 498 6.3 (4.5) 
Total Cholesterol, mmol/L 498 4.6 (1.1) 
Triglycerides, mg/dI 498 1.6 (1.1) 
LDL-C, mmol/L 498 2.8 (1.0) 
HDL-C, mmol/L 498 1.1 (0.3) 
Ratio of T-Chol / HDL-C 498 0.1 (0.04) 
Insulin, ulU/ml 498 9.5 (6.7) 
7.5 Life Style Risk Factors 
7.5.1 Physical activity 
The women tended to lead a sedentary life. When they were asked about whether they 
practice any kind of physical activity, only 13.4% answered yes. Of these 69 women, 
Calculated from the Framingham risk score 
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almost half of them walked for almost 3 hours/week. On average, all the women spent 
17.4 hours/week watching TV, this being their only connection to the outside world. 
7.5.2 Smoking 
When women were asked about their smoking habits, 93.4% said they did not smoke. 
Smoking is more prevalent among younger ages and in men more than women [10]. 
Table 7-10: Life style risk factors among Women 
Variable Name 
Life style risk factors 
Frequency Percent 
Number of women 515 
Physically inactive, % 445 86.6 
Smoking habits, % 
Never smoked 481 93.4 
Ex-smoker 6 1.2 
Current smoker, % 28 5.4 
Stress level measurements, % Frequency Percent 
Human loss and trauma to study subject 229 44.5 
Human loss and trauma to family member 187 36.3 
Property loss to subject 5 1 
Work related problems 117 22.7 
Any of the above stress events 361 70.1 
7.5.3 Psychosocial Stress 
The women where asked about certain life events during the last six months, such as 
death of a family member, marital separation, loss of a job, changes in financial 
conditions, imprisonments, threats, etc. All these questions were grouped into four 
categories as shown in the second part of Table 7-10. For more information, please see 
Appendix 2. Seventy percent of the women had been exposed to at least one of the 
above stress events of psychosocial stressors. Several studies have accumulated giving 
evidence that life events may be predictive of increased risk of heart diseases [277] 
[278] [279] [280]. 
7.6 Principal Characteristics and Parity 
This section details the prevalence of CHD risk factors, potential confounders and other 
covariates by number of children for women in the sample. The number of children 
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(Parity) has been divided into 5 groups 0,1-3,4-6,7-9 and 10+ to create more stable 
estimates. 
7.6.1 Age and Parity 
Table 7-11 shows the distribution of parity among the different age categories of 
women. Older women had more children in particular parity category 10+ compared to 
lower age categories. This reflects clearly the drop in fertility rate over time as discussed 
previously in section 7.1. 
Table 7-11: Women's Age and Parity, numbers and percentages by parity 
Age groups No. of 
Number of live births Total *P 
in years women 0 1-3 4-6 7-9 10+ % 
< 45 159 19 11 43 59 27 
12.0% 6.9% 27.0% 37.1% 17.0% 100% 
45-49 115 11 9 22 39 34 
9.6% 7.8% 19,1% 33.9% 29.6% 100% 
50-54 110 6 8 27 35 34 0.007 
5.4% 7.3% 24.6% 31.8% 30.9% 100% 
55-59 95 5 7 20 22 41 
5.2% 7.4% 21.0% 23.2% 43.2% 100% 
60+ 35 1 3 4 10 17 
2.8% 8.6% 11.4% 28.6% 48.6% 100% 
All ages 514 42 38 116 165 153 
8.2% 7.4% 22.6% 32.0% 29.8% 100% 
*P values for comparison between groups used in this section for all tables are results of x` statistics tor 
categorical variables. 
7.6.2 Women's Educational Level and Parity 
Do women's educational levels contribute to determining the number of children? As 
Table 7-12 and Figure 7.1 indicate women with no formal education tended to be the 
highest among those of parity 10+. In contrast, the proportion of women with university 
education fell across the parity groups, where no women with parity 10+ had university 
or college education at all compared to the other parity groups. Parity groups 1-3 and 4- 
6 seemed to have the highest university levels of or college education. This is consistent 
with the effect of education being to lead women to tend to reduce the size of their 
families and bear fewer children; however education did not lead to women having no 
children, as this is not the norm in Palestinian culture. 
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Table 7-12: Women's Educational Level and Parity 
Ed No. of 
Number of live births Total *P 
ucation level o women 0 1-3 4-6 7-9 10+ 0 
No formal education 119 9 11 20 29 50 
7.6% 9.2% 16.8% 24.4% 42.0% 100% 
Elementary (1-6) 199 19 10 36 69 65 
9.6% 5.0% 18.1% 34.7% 32.7% 100% 
<0.0001 
Secondary (7-12) 167 9 7 50 63 38 
5.4% 4.2% 29.9% 37.7% 22.8% 100% 
Higher education 13+ 30 5 10 11 4 0 
16.7% 33.3% 36.7% 13.3% 0.0% 100% 
Total 515 42 38 117 165 153 
8.2% 7.4% 22.7% 32.0% 29.7% 100% 
7.6.3 Women's Employment and Parity 
The majority of women did not work. The percentage of employed women decreased 
with increasing parity as seen in Table 7-13. (In this and later tables, the percentages are 
given by parity groups, since working status etc may be influenced by parity; in the 
previous tables, parity was more likely to be a consequence of age and education. ) The 
higher the parity, the less likely it was for women to work and around 9% of women in 
the 10+ parity group were working compared 26% and 34% among parity 0 and parity 
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1-3 respectively. Women with many children will have less time to seek a job as they 
most probably will be busy looking after a large family, compared to women with 
smaller family sizes. One should bear in mind that women of higher parity tended to be 
older, less educated and therefore their chances of getting a job were less; parity may be 
a consequence of these adverse factors as well as a contribution to non-employment. In 
addition, these women appeared most probably to be seeking employment through 
private business ventures, as shown in Table 7-13. One notes that private businesses 
allow them to stay at home and at the same time contribute to their family income. 
There were women in all parity groups except the nulliparous who worked as unskilled 
workers. Employed women were more frequently found among the lowest parity 
groups, 0,1-3 and 4-6, and being in skilled jobs was more frequent in these parity 
groups also. Moreover, women in the parity 10+ group worked mostly as unskilled 
labourers and in private business. 
Table 7-13: Women's Employment and Parity 
Number of live births *P 
Ri kf s actor 
0 1-3 4-6 7-9 10+ 
Currently employed, % <0.0001 
Number of women 42 38 117 165 153 
No and Percent not employed 31 25 94 147 139 
73.8% 65.8% 80.3% 89.1% 90.9% 
No and Percent employed 13 13 23 18 14 
26.2% 34.2% 19.7% 10.9% 9.1% 
Total 100% 100% 100% 100% 100% 
Occupation, %* 0.013 
Number of women 11 13 23 18 14 
No and Percent Unskilled worker 0 3 6 4 3 
0.0% 23.1% 26.1% 22.2% 21.5% 
No and Percent Skilled worker 3 3 5 2 1 
27.3% 23.1% 21.7% 11.1% 7.1% 
No and Percent Employee: clerical & 6 6 8 4 0 
professional 54.6% 46.1% 34.8% 22.3% 0.0% 
No and Percent Private business 2 1 4 8 10 
18.2% 7.7% 17.4% 44.4% 71.4% 
Total 100% 100% 100% 100% 100% 
* Percentages of those in employment. 
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7.6.4 Husband's Educational Level and Employment with Parity 
The total number of schooling years completed by the husbands was used as a proxy 
indicator of longer term socio-economic status (SES). The husband's schooling years 
was inversely associated with parity as shown in Table 7-14: the higher the parity the 
less educated the husband was. Parity 10+ and parity 0 has the highest percentages of 
husbands with no formal education amounting to 21% for parity 10+ and 45% for 
parity 0. In addition, parity 10+ had the least percentages of husbands completing 
college or university education. 
On the other hand, the husband's employment for women who have ever been married 
tended to increase with increasing parity. It is important to note that husbands seldom 
owned any private business, instead their occupation varied from unskilled workers to 
employees and working in international organizations. The lack of focus on private 
business by husbands can be an indicator of women's participation in supporting their 
families through the establishment of their own private businesses, which has been 
mentioned in the sections above 
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Table 7-14: Husband's Educational Level and Employment with Parity 
Number of live births 
*P Risk factor 
0 1-3 4-6 7-9 10+ 
Husband's education, % <0.0001 
Number of women 20 36 112 162 149 
No and Percent No formal education 9 8 14 22 32 
45.0% 22.2% 12.5% 13.6% 21.5% 
No and Percent Elementary (1-6) 8 13 30 53 62 
40.0% 36.1% 26.8% 32.7% 41.6% 
No and Percent Secondary (7-12) 1 8 46 68 47 
5.0% 22.2% 41.1% 42.0% 31.5% 
No and Percent Higher education 2 7 22 19 8 
(13+) 10.0% 19.4% 19.6% 11.7% 5.4% 
Total 100% 100% 100% 100% 100% 
Husband currently employed, % <0.0001 
Number of women 21 38 117 165 153 
No and Percent husband employed 5 12 59 93 72 
23.8% 31.6% 50.4% 56.4% 47.1% 
No and Percent husband not 6 9 22 44 60 
employed 28.6% 23.7% 18.8% 26.7% 39.2% 
No and Percent not applicable 10 17 36 28 21 
(divorced, separated and widowed 47.6% 44.7% 30.8% 17.0% 13.7% 
women where there is no husband) 
Total 100% 100% 100% 100% 100% 
Husband's Occupation % 0.108 
Number of women 5 12 59 93 72 
No and Percent Unskilled worker 2 3 9 30 31 
40.0% 25.0% 15.25% 32.3% 43.1% 
No and Percent Skilled worker 0 0 7 18 11 
0.0% 0.0% 11.9% 19.4% 15.3% 
No and Percent Employee 1 5 20 18 12 
20.0% 41.7% 33.9% 19.4% 16.7% 
No and Percent International 2 4 23 26 18 
organization 40.0% 33.3% 39.0% 28.0% 25.0% 
No and Percent Private business 0 0 0 1 0 
0.0% 0.0% 0.0% 1.1% 0.0% 
Total 100% 100% 100% 100% 100% 
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7.6.5 Marital Status with Parity 
Table 7-15 shows marital status by parity groups. The majority of women, except 
among the nulliparous were married and only 21 were single - all nullipars. Being 
married was more frequent among those of higher parity. Women in parity groups 1-3 
and 4-6 had the highest percentage of being widowed: 23.8% and 21.4% compared to 
the other parity groups. Also parity 1-3 had the highest percentage of being separated or 
divorced compared to the other parity grouping. If husbands were alive, or present, the 
number of children would have definitely increased. 
Table 7-15: Marital Status with Parity 
Number of live births 
Ri kf *P s actor 
0 1-3 4-6 7-9 10+ 
Marital status, % <0.0001 
Number of women 42 38 117 165 153 
No and Percentage married 11 21 81 137 132 
26.2% 55.3% 69.2% 83.0% 86.3% 
No and Percentage single 21 0 0 0 0 
50.0% 0.0% 0.0% 0.0% 0.0% 
No and Percentage divorced 4 5 6 2 0 
9.5% 13.2% 5.1% 1.2% 0.0% 
No and Percentage separated 0 3 5 1 2 
0.0% 7.9% 4.3% 0.6% 1.3% 
No and Percentage widowed 6 9 25 25 19 
14.3% 23.7% 21.4% 15.2% 12.4% 
Total 100% 100% 100% 100% 100% 
7.6.6 Family Affluence Scale with Parity 
The women in the 10+ parity group were relatively poor compared to the other parity 
groups as shown in Table 7-16. Wealth status decreased with increasing parity and the 
percentage of women with the lower parity groups 0 and 1-3 were better off at 54.7% 
and 50.0% respectively, compared to women in the higher parity groups. 
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Table 7-16: Family Affluence Scale with Parity 
Number of live births 
Ri kf *P s actor 
0 1-3 4-6 7-9 10+ 
Family affluence scale, % <0.0001 
Number of women 42 38 117 165 153 
No and Percentage Poor 13 7 40 81 84 
31.0% 18.4% 34.2% 49.1% 54.9% 
No and Percentage Average 6 12 39 61 46 
14.3% 31.6% 33.3% 37.0% 30.1% 
No and Percentage Better off 23 19 38 23 23 
54.7% 50.0% 32.5% 13.9% 15.0% 
Total 100% 100% 100% 100% 100% 
7.6.7 Physical Activity 
Physical activity decreased with increasing parity. Women among the 1-3 and 0 parity 
groups had the highest percentage of being relatively physically active, 23.7% and 
19.0% respectively compared to the other parity groups, 4-6,7-9 and 10+, where the 
percentages were 16.2%, 11.5% and 9.2% respectively as shown in Table 7-17. These 
trends, however, were of much less statistical significance 
Table 7-17: Physical Activity with Parity 
Number of live births 
*P Risk factor 
0 1-3 4-6 7-9 10+ 
Physical activity, % 
Number of women 42 38 117 165 152 
No and Percentage Active 34 29 98 146 138 
19.0% 23.7% 16.2% 11.5% 9.2% 
No and Percentage Inactive 8 9 19 19 14 0.084 
81.0% 76.3% 83.8% 88.5% 90.8% 
Total 100% 100% 100% 100% 100% 
7.6.8 Household Crowded Scale 
Living in crowded houses, which accommodates more than 2 persons per room, 
increased with increasing parity where it reached 55.5% among parity 10+ group 
compared to 21.6% among parity 1-3 and 31.0% among parity 0 as shown in Table 
7-18. 
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Table 7-18: Household Crowded Scale with Parity 
Number of live births 
*P Risk factor 
0 1-3 4-6 7-9 10+ 
Crowdedness 
<0.001 
persons/ room, % 
Number of women 42 37 116 163 153 
No and Percentage not Crowded 23 15 28 17 20 
51 54.7% 40.5% 24.1% 10.4% 13.1% 
No and Percentage Moderate 6 14 47 62 48 
>1&: s 2 14.3% 37.9% 40.5% 38.0% 31.4% 
No and Percentage Crowded >2 13 8 41 84 85 
31.0% 21.6% 35.4% 51.6% 55.5% 
Total 100% 100% 100% 100% 100% 
7.6.9 Smoking Status 
The majority of women did not smoke and the trend with parity was far from 
statistically significant. Women with parity 10+ were most likely to be the highest 
passive smokers as they spent most of their time at home. 
Table 7-19: Smoking Status with parity 
Number of live births 
*P Risk factor 
0 1-3 4-6 7-9 10+ 
Smoking status, % 0.395 
Number of women 42 38 117 165 153 
No and Percentage never 39 36 105 153 148 
smoked 92.8% 94.7% 89.7% 92.7% 96.7% 
No and Percentage current 2 2 11 10 3 
smoker 4.8% 5.3% 9.4% 6.1% 2.0% 
No and Percentage ex-smoker 1 0 1 2 2 
2.4% 0.0% 0.9% 1.2% 1.3% 
Total 100% 100% 100% 100% 100% 
Passive smoker, % 0.004 
Number of women 42 38 117 165 153 
No and Percentage said Yes 18 20 69 118 101 
42.9% 52.6% 59.0% 71.5% 66.0% 
No and Percentage said No 24 18 48 47 52 
57.1 % 47.4% 41.0% 28.5% 34.0% 
Total 100% 100% 100% 100% 100% 
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7.6.10 Stress Status 
Table 7-20 shows the distribution of stress status with parity groups. Apart from parity 
0, stress from all events among the study population increased significantly with 
increasing parity where it reached 73.3% and 78.4% among parity 7-9 and parity 10+ 
groups respectively. 
Table 7-20: Stress Status with Parity 
Number of live births 
Ri f *P sk actor 
0 1-3 4-6 7-9 10+ 
Stress status: any one of the <0.0001 
stress events 
Number of women 42 38 117 165 153 
Number and Percentage 22 18 80 121 120 
said Yes to one or more 52.4% 47.4% 68.4% 73.3% 78.4% 
Number and Percentage 20 20 37 44 33 
said No to all 47.6% 52.6% 31.6% 26.7% 21.6% 
Total 100% 100% 100% 100% 100% 
7.6.11 History of Infertility 
History of infertility was defined as "if a woman ever tried for one straight year or more 
to become pregnant and during that time did not become pregnant". History of infertility 
was high among the parity 0 group compared to other parity groups. Fifteen out of the 
21 married women stated they were infertile. Infertility is negatively regarded in 
Palestinian society and places women under considerable stress whether from their 
husbands, their families or society at large. Infertile women normally end up being 
divorced or separated where the husband will marry another that supposedly can bear 
many children to maintain the name and wealth of the family. 
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Table 7-21: History of Infertility with Parity excluding single women 
Number of live births 
Ri kf t *P s ac or 
0 1-3 4-6 7-9 10+ 
History of Infertility, % Number of women 21 38 117 165 153 
No and Percentage said Yes 15 7 11 8 12 
71.4% 18.4% 9.4% 4.8% 7.8% 
No and Percentage said No 6 31 106 157 141 <0.0001 
28.6% 81.6% 90.6% 95.2% 92.2% 
Total 100% 100% 100% 100% 100% 
Lýý: j 
* P-value for ever-married women. Excluding nulliparous women, p= 0.044 
When the analysis of history of infertility was repeated excluding nulliparous women, 
the history of infertility gave same results except for p value. As shown in the footnote 
to Table 7-21. 
7.6.12 Ever Used Oral Contraceptive Pill and Menopausal Status 
Table 7-22 shows percentages of women who reported they had ever used the oral 
contraceptive pill and menopausal status. Apart from parity 0, the percentage of women 
in the different parity groups who reported ever use of contraceptive pills increased with 
increasing parity. On the other hand, menopausal status increased with increasing parity. 
Women with many children seem to have gone into menopausal status before those with 
less parity. The women with high parity were older and the non-menopausal women 
younger, yet all women participated in the study had finished their childbearing. The 
changes in contraceptive use may be more associated with behavioural differences 
between the generations. 
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Table 7-22: Ever Used Oral Contraceptive Pill, Menopausal Status and Parity 
Number of live births 
Ri kf *P* s actor 
0 1-3 4-6 7-9 10+ 
Ever used oral contraceptive % 
Number of women 42 38 117 164 153 
No and Percentage never used 38 29 69 89 81 
90.5% 76.3% 59.0% 54.3% 52.9% 
No and Percentage ever used 4 9 48 75 72 <0.0001 
9.5% 23.7% 41.0% 45.7% 47.1% 
Total 100% 100% 100% 100% 100% 
Menopausal status, % Number of women 41 38 117 165 153 
No and Percent not menopausal 30 18 66 97 74 
73.2% 47.4% 56.4% 58.8% 48.4% 
No and Percent menopausal 11 20 51 68 79 0.039 
26.8% 52.6% 43.6% 41.2% 51.6% 
Total 100% 100% 100% 100% 100% 
* P-value for ever-married women 
7.6.13 Type II Diabetes Mellitus 
Diabetes (measured as raised fasting blood sugar or using medication) increased with 
parity. Apart from parity 0, diabetes prevalence increased across parity categories 
starting from parity 1-3 group onward ranging from 15.8 % to 25.5 %. The prevalence 
of diabetes among nulliparous women was 21.4%. This may imply a J-shaped 
relationship between diabetes with parity; however the differences were not statistically 
significant, as shown in Table 7-23. The increasing trend excluding parity zero is also 
not significant. In section 7.7, it is, however, shown that there was a significant 
increase in mean fasting blood sugar with parity. 
Table 7-23: Type 11 Diabetes Mellitus with Parity 
Number of live births 
Ri kf *P s actor 
0 1-3 4-6 7-9 10+ 
Diabetic 2! 7mmol/L or on 
medication, % Number of women 42 38 117 165 153 
No and Percentage normal 
33 32 92 129 114 0.749 
0 78.6% 0 84.2% 0 78.6% 78.2% 74.5% 
9 6 25 36 39 
No and Percentage diabetic 0 21.4% 0 15.8% 0 21.4% 0 21.8% 0 25.5% 
Total 100% 100% 100% 100% 100% 1 = 
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7.6.14 Hypertension 
Hypertension varied rather less among the different parity groups, although mean SBP 
and DBP showed significant increases with increasing parity. (Mean values are not 
shown in this table, but are in Section 7.7 and Table 7-28) 
Table 7-24: Hypertension with Parity 
Number of live births 
kf Ri *P s actor 
0 1-3 4-6 7-9 10+ 
Hypertension SBP z 140 mmHg I 
DBP 2 90 mmHg/ medication, % 
Number of women 42 38 117 165 153 
No and Percentage normal 
29 
69.1% 
240 
63.2% 
68 
58.1% 
930 
56.4% 
810 
52.9% 
0.382 
No and Percentage 13 14 49 72 72 
hypertensive 30.9% 36.8% 41.9% 43.6% 47.1 % 
Total 100% 100% 100% 100% 100% 
7.6.15 Overall Obesity 
Table 7-25 shows overall obesity with parity in groups. BMI ? 30 is increasing with 
increasing parity, except for parity 4-6 where it showed a decline compared to the other 
parity groups. 
Table 7-25: Overall obesity with parity 
Number of live births 
Ri kf *P s actor 
0 1-3 4-6 7-9 10+ 
BMI, % Number of women 42 38 116 164 153 
No and Percentage Non-obese 19 14 52 40 33 <0.0001 
45.2% 36.2% 44.8% 24.4% 21.6% 
No and Percentage Obese 23 24 64 124 120 
54.8% 63.2% 55.2% 75.6% 78.4% 
Total 100% 100% 100% 100% 100% 
7.6.16 Central and Abdominal Obesity 
Apart from parity 0, waist circumference increased significantly with increasing parity. 
The higher level for zero parity might imply a J-shaped relationship. On the other hand, 
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abdominal obesity did not show a significant association with parity as shown in Table 
7-26. 
Table 7-26: Central and abdominal obesity with parity 
Number of live births 
*P Risk factor 
0 1-3 4-6 7-9 10+ 
Central obesity, % Waist circumference z 88 cm 
Number of women 42 38 116 164 153 
No 11 12 27 19 12 
26.2% 31.6% 23.3% 11.6% 7.8% 
Yes 31 26 89 145 141 <0.0001 
73.8% 68.4% 76.7% 88.4% 92.2% 
Total 100% 100% 100% 100% 100% 
Abdominal obesity, 
WIH ratio 2: 0.85 cm 
Number of women 42 38 116 164 153 
No 17 22 58 83 67 
40.5% 57.9% 50.0% 50.6% 44.8% 
Yes 25 16 58 81 86 0.385 
59.5% 42.1% 50.0% 49.4% 56.2% 
Total 100% 100% 100% 100% 100% 
7.6.17 The Metabolic Syndrome and 10-years risk 
The association between parity and the Metabolic Syndrome, which is defined 
according to the International Diabetic Federation as the clustering of the most 
dangerous heart attack risk factors: diabetes and pre-diabetes, abdominal obesity, high 
cholesterol and high blood pressure, tended to show a U-shaped relationship; p= 0.003, 
with a drop at parity 1-3 children. Also the metabolic syndrome increased with 
increasing parity as shown in Table 7-27.10-years risk for CHD, on the other had did 
not show changes with overall statistical significance. 
Table 7-27: The Metabolic Syndrome and 10 Years Risk for CHD with Parity 
Number of live births 
Ri kf *P s actor 
0 1-3 4-6 7-9 10+ 
Metabolic Syndrome (MS), % 
Number of women 40 33 110 160 153 
No and Percentage without MS 19 22 48 70 48 
47.5% 66.7% 43.6% 43.8% 31.4% 
No and Percentage with MS 21 11 62 90 105 0.003 
52.5% 33.3% 56.4% 56.3% 68.6% 
Total 100% 100% 100% 100% 100% 
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10 years Risk For CHD, % 
Number of women 40 33 109 161 153 
No and Percentage, low risk 32 26 81 122 93 
86.5% 86.7% 77.9% 79.7% 69.9% 
No and Percentage, medium 4 4 19 23 27 0.199 
risk 10.8% 13.3% 18.3% 15.0% 20.3% 
No and Percentage, high risk 1 0 4 8 13 
2.7% 0.0% 3.8% 5.3% 9.8% 
Total 100% 100% 100% 100% 100% 
7.7 Parity and Coronary Heart Disease Risk Factors Shown as Mean Values 
This section details the association of those CHD risk factors which can be expressed as 
mean values and covariates with parity in groups. The following table shows the means 
(SD) values for these risk factors, other covariates and potential confounders by number 
of children among women aged 40-65 years. 
Table 7-28: Means (SD) of CHD risk factors, potential confounders and other covariates by number 
of children among women aged 40-65 years 
Risk Factor Numb 
0 1-3 
er of Live B 
4-6 
irths 
7-9 10+ 
*P 
Number of women 42 38 116 164 153 
Age 47.0 49.5 48.4 48.5 51.7 <0.001 (6.23) (6.6) (6.1) (6.3) (6.2) 
Reproductive history 
Age at 1st marriage 
26.0 
(9.6) 
23.4 
(6.6) 
20.0 
(4.1) 
18.1 
(3.0) 
16.5 
<0.001 (2.3) 
Age at 1st pregnancy 
29.4 25.3 20.9 18.7 17.2 <0.001 (9.7) (6.4) (4.2) (2.9) (2.2) 
Age at 1st birth 
26.0 21.7 19.4 18.0 
<0.001 
(6.4) (4.2) (2.9) (2.2) 
Age at last birth 30.9 33.5 
35.5 38.2 
<0.001 (7.7) (4.9) (3.9) (3.8) 
Years between 1 s' and last 4.8 11.9 16.0 20.2 001 <0 birth (3.9) (4.9) (3.6) . (3.9) 
Years since last birth 
18.5 14.9 12.9 13.5 
<0 001 (10.2) (7.5) (6.7) . (6.8) 
Miscarriage/ abortion 
2.3 2.3 2.3 2.3 2.6 0.801 
(1.3) (2.9) (1.9) (1.9) (1.7) 
Stillbirths 1.0 1.4 1.4 1.2 0 560 
(0.0) (0.7) (0.7) . (0.4) 
Age at menarche 
13.3 13.3 13.3 13.4 13.4 0.958 
(1.4) (1.4) (1.4) (1.4) (1.4) 
Age at menopause 
46.5 45.7 47.4 48.3 49.5 0.029 
(6.7) (7.7) (6.1) (4.9) (4.3) 
CHD risk factors 
Censored Systolic BP, 126.4 129.7 133.1 135.9 139.9 
<0 0001 mmHg (3.2) (4.5) (2.6) (2.1) . (2.7) 
Censored DBP, mmHg 
80.7 84.1 83.5 84.9 84.9 
<0.0001 (1.9) (2.4) (1.4) (1.0) (1.1) 
Censored Fasting Blood 5.7 4.9 6.0 6.5 6.7 
<0 0001 Sugar, mmol/L (0.4) (0.3) (0.3) (0.3) . (0.3) 
Cholesterol, mmol/L 
4.4 4.7 4.6 4.5 4.7 0.411 1.1 1.3 1.0 1.0 1.2 
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Numb er of Live B irths *P Risk Factor 
0 1-3 4-6 7-9 10+ 
Triglycerides mmol/L 
1.35 1.33 1.51 1.55 1.75 0.080 
, (0.6) (1.2) (1.0) (1.0) (1.3) 
HDL-C mmol/L 
1.10 1.14 1.08 1.06 1.04 0.378 
, (0.3) (0.3) (0.3) (0.3) (0.3) 
LDL-C, mmol/L 
2.5 
(1.0) 
2.6 
(1.1) 
2.8 
(1.0) 
2.7 
(1.0) 
2.9 
(1.1) 0.225 
Chol/HDL-C ratio, mmol/L 
0.11 
(0.03) 
0.11 
(0.5) 
1.2 
(0.04) 
0.12 
(0.05) 
0.12 
(0.04) 0.242 
Insulin uIU/mI 
8.4 
(4.6) 
10.7 
(8.8) 
9.3 
(6.2) 
10.2 
(8.2) 
8.9 
(5.2) 
0.305 
Anthropometric Risk factors 
Height m 
1.6 1.6 1.6 1.6 1.6 0.385 
, (0.01) (0.08) (0.06) (0.07) (0.06) 
Weight kg 76.4 79.3 
77.2 82.3 82.6 0.006 
, (13.9) (22.8) (14.6) (14.1) (14.0) 
BMI kg/m2 31.9 32.7 
31.6 33.8 34.5 0.001 
, (6.5) (7.3) (5.6) (5.5) (5.9) 
Waist circumference, cm 
94.5 
(11.3) 
95.8 
(14.7) 
95.1 
(12.8) 
98.7 
(11.5) 
101.1 
(10.5) <0.001 
Thigh circum, cm 
114.6 
(12.7) 
118.4 
(16.1) 
116.3 
(11.1) 
120.9 
(11.3) 
121.4 
(12.5) <0.001 
Hip circum cm 
110.3 114.9 112.6 117.0 117.7 <0.001 
, (12.3) (15.4) (10.8) (10.5) (11.9) 
W/H ratio, cm 
0.86 
(0.04) 
0.83 
(0.06) 
0.84 
(0.07) 
0.86 
(0.06) 
0.85 
(0.06) 
0.066 
Other Covariates 
Years of schooling 
6.0 
(4.7) 
7.1 
(6.2) 
6.8 
(4.4) 
5.8 
(3.7) 
4.1 
(3.4) <0.001 
Husband's ears of y 3.6 6.8 8.3 7.4 5.6 <0 001 
education (4.6) (5.4) (5.0) (4.4) (4.1) . 
Rooms/ household 2.8 
(1.3) 
3.6 
(1.3) 
3.5 
(1.2) 
3.8 
(1.1) 
3.9 
(1.0) <0.001 
Hours/week practice 1.8 3.9 3.4 2.6 3.8 0 356 
physical activity (1.4) (4.3) (2.5) (2.5) (2.7) . 
Hourstweek watch TV 
19.0 
(12.4) 
16.6 
(10.3) 
17.9 
(11.5) 
16.6 
(11.8) 
17.6 
(13.5) 
0.786 
CHD Risk Score 
10-years CHID risk score 
0.05 
(0.05) 
0.05 
(0.04) 
0.07 
(0.06) 
0.07 
(0.07) 
0.09 
(0.08) 
0.0004 
Log 10-years CHD risk -3.6 -3.5 -3.2 -3.2 -2.9 0004 0 
score (1.14) (0.93) (1.0) (1.1) 1.1 . 
*P values for comparison between groups are results of a one way analysis (ANOVA) for continuous 
variables. 
Continuous variables are mean ±SD 
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Women with higher parity tended to have married at an early age and accordingly to 
have had an early age of first pregnancy and age at first birth compared with women of 
lower parity and nulliparous women as shown in Table 7-28. 
Higher parity women tended to be older and parity increases with increasing age, (see 
also Table 7-11). Those women in the sample who were older tended to have had more 
children than younger women in spite of the fact that all women participating in the 
study had finished their child bearing. This reflects the fall in total fertility among 
women over the past years. 
Mean Systolic Blood Pressure increased significantly with increasing parity. Women 
with parity 10+ children had higher mean systolic blood pressures compared to parity 0 
and parity 1-3, and accordingly there were a greater percentage of higher parity women 
with hypertension. 
Mean Fasting Blood Sugar tended to increase with increasing parity except for parity 0 
where it was higher than parity 1-3, which might imply a J-shaped relationship. Mean 
FBS was lower among parity 1-3. The association between mean fasting blood sugar 
and parity in groups was also statistically significant as shown in Table 7-28. 
Triglycerides tended to increase with increasing parity except for parity 0 where it was 
more elevated than parity 1-3 group. Starting from parity 1-3, mean HDL-C levels 
decreased slightly with increasing parity. However, it is worth mentioning that the 
association between parity and all the lipid profile risk factors was not statistically 
significant. 
Women in all parity groups tended to be obese with more than half with a BMI ? 30 
kg/m2 (Table 7-28); mean BMI increased significantly with increasing parity. The same 
applies to waist circumference among the different parity groups, where it increased 
with increasing parity. The trend in W/H ratio was much less strong and did not seem to 
be significant. The W/H ratio was higher among the parity 0 group and was similar to 
the higher parity groups 7-9 and 10+, though the lack of statistical significance should 
be noted. 
There was a significant association between increased parity and educational level. 
Women in the lower parity groups tended to have higher levels of education compared 
to the higher parity groups. Husband's years of schooling which is a longer term proxy 
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indicator of the SES of the family, showed more or less the same pattern as women's 
education. Husband's education decreased with increasing parity except for parity 0 
group where the husband's had the least years of education. 
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Chapter 8 
PARITY AND ANTHROPOMETRIC MEASUREMENTS 
The presentation of results is now focused on particular risk factors for coronary heart 
disease (CHD), starting with those based on anthropometric measures. Chapter 8 is 
divided into four sections. Section 8.1 discusses characteristics associated with obesity, 
central and abdominal adiposity. Section 8.2 discusses obesity with parity. Section 8.3 
discusses parity with central obesity and section 8.4 discusses parity with abdominal 
obesity. 
Several anthropometric measurements were used in assessing the association between 
parity and obesity as they represent different aspects of body fat distribution and 
therefore relate differently to health outcomes [270]. BMI was used to assess overall 
obesity, waist circumference was used to assess central obesity, and W/H ratio was used 
to assess abdominal obesity. Hence, in this chapter, we investigated each of these 
obesity indices risk factors in relation to parity. 
As has been stated above, the mean BMI was 33.3 kg/m2 and 69.2% of women were 
obese (BMI > 30 kg/m2). The women's mean waist circumference was 98 cm and the 
prevalence of central obesity (WC > 88 cm) was 84.2%. Their mean waist to hip ratio 
was 0.85 cm and 51.9% of women were having abdominal obesity (W/H ratio >_ 0.85 
cm), (see sections 7.4.3 Risk Factors for CHD in Women). Table 8-1 shows these 
characteristics associated with obesity, central and abdominal obesity in relation to other 
variables. 
Obese women tended to be older, married or widowed, had more pregnancies and 
children, and were less likely to be educated, more often unemployed, and less 
physically active. They tended to have more assistance at home from their daughters or 
daughters-in-laws, which encourages a sedentary life style. Obese women tended to 
have decreased HDL-C levels, elevated triglycerides, elevated diastolic, systolic blood 
pressure and hypertension. 
Women with central obesity shared many of the characteristics that obese women had. 
They tended to be older and of menopausal status, living with their husbands and or 
widowed. They got married at an early age and had an early age at first birth and 
therefore had more gravidity and parity. Women with central obesity were less likely to 
be educated, more often unemployed, spending more hours watching TV, and getting 
169 
household assistance and therefore tended to be physically inactive. Women with central 
obesity reported having more polycystic ovary syndrome, having elevated metabolic 
risk factors and a decreased HDL-C level, elevated SBP, DBP, and hypertension, and 
elevated fasting blood sugar. 
Women with abdominal obesity tended to be older and more frequently menopausal, 
married and / or widowed, use more oral contraceptive pills, and have elevated 
triglycerides, DSP, SBP and elevated fasting blood sugar. Women with abdominal 
obesity tended to have decreased HDL-C and less education. 
When women were asked about how they perceive their weight and their self rating of 
obesity, 19.1% of women who had BMI > 30kg/m2 rated themselves as being 
underweight and 33.3% of women with central adiposity WC > 88 cm rated themselves 
as being underweight. 
Table 8-1: Characteristics associated with potential risk factors 
ä1V1I > 3Uk /mZ, WC > ä8 cm & W/H ratio >- U. 52o cm 
Number Obese WC 2: 88 W/H ratio aP 
Characteristic of BMI 2: P cm, % P-value 0.85 cm, % 
women 
30kg/m2 value n% value 
n%n% 
Demographic and socio-economic variables 
Age I 0.069 <0.0001 <0.0001 
<45 158 I (98) 62.0 ý (117) 74.1 (64) 40.5 
45-49 115 (85) 73.9 (97) 84.4 (57) 49.6 
50.54 109 (74) 67.9 (95) 87.2 (63) 57.8 
55-59 95 (69) 72.6 (90) 94.7 (55) 57.9 
60+ 35 (29) 82.9 (33) 94.3 (27) 77.1 
Women's 
<0.0001 0.004 
education, % 
0.015 
No formal 
119 (78) 73.1 (111) 93.3 (77) 64.7 
I 
education 
Elementary 198 (140) 70.7 I (168) 84.9 (96) 48.5 
Secondary 166 (115) 69.3 (137) 82.5 I (83) 50.0 
Higher 
30 (13) 43.3 (16) 53.3 (10) 33.3 
education 
Marital status 0.074 I 0.004 0.028 
Married 382 (265) 69.4 (325) 85.1 (186) 48.7 
Single 21 (11) 52.4 (14) 66.7 (14) 66.7 
Divorced/ 
28 (16) 57.1 (19) 67.9 (13) 46.4 
separated 
I 
Widowed 82 (63) 76.8 (74) 90.5 (53) 64.6 
Currently I 
0.022 0.001 
I 
0.352 
employed 
No 434 (309) 71.2 I (375) 86.4 (229) 52.8 
Yes 79 I (46) 58.2 I (57) 72.2 (73) 46.8 
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Characteristic 
Number 
of 
women 
BMI z 
30kg/m2 
n oha 
P 
value 
Wm, 
% 
86 
n% 
P-value 
WIH ratio 2 
0.85 cm, /o 
n /o 
P 
value 
Occupation 0.478 0.163 0.400 
Unskilled 
worker 
16 (11) 68.8 (13) 81.3 (9) 56.3 
Skilled worker 14 I (9) 64.3 (9) 64.3 (5) 35.7 
Employee 24 (11) 45.8 (14) 58.3 (9) 37.5 
Private 
business 25 (15) 60.0 
I 
(21) 84.0 (14) 56.0 
Husband's 
education 
I 
0.002 0.001 0.056 
No formal 
education 
85 (53) 62.4 (76) 89.4 (47) 55.3 
Elementary 165 (130) 78.8 
_ 
(150) 91.9 (91) 55.1 
Secondary 170 (120) 70.6 (139) 81.8 I (86) 50.6 
Higher 
education 
57 (31) 54.4 (40) 70.2 (20) 35.1 
__ __ Husband 
( 
currently 0.717 0.660 0.059 
employed 
Yes 241 (170) 70.5 (202) 83.8 (112) 46.5 
No I 141 (95) 67.4 (123) 87.2 (74) 52.5 
Not applicable 110 (79) 71.8 
T 
(93) 84.6 (66) 60.0 
Own automatic 
washing 0.004 0.004 0.577 
machine 
No 398 I (298) 72.4 I (345) 86.7 (209) 52.5 
Yes 115 (67) 58.3 (87) 75.7 (57) 49.6 
Family 
affluence scale 
0.068 0.075 0.788 
Poor 223 (158) 70.9 (186) 83.4 I (118) 52.9 
Average 164 (120) 73.2 I (146) 89.0 (86) 52.4 
Better off 126 (77) 61.1 (100) 79.4 (62) 49.2 
Behavioural Ris k Factors 
Physical 
activity <0.0001 
0.071 0.139 
No 443 (320) 72.3 (378) 85.3 (235) 53.1 
Yes 69 (34) 49.3 (53) 76.8 (30) 43.5 
Smoking habits I I 0.180 0.699 0.642 
Never smoked 479 (336) 70.2 (405) 84.6 (250) 52.2 
Ex-smoker 6 (4) 66.7 (5) 83.3 (2) 33.3 
C 
smoker 
urrent 28 (15) 53.6 (22) 78.6 (14) 50.0 
( 
Watch TV 0.166 I 0.336 0.278 
No 31 (18) 58.1 (28) 90.3 61.3 (19) 
Yes 482 (337) 69.9 (404) 83.8 I _ (247) 51.2 
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Number Obese WC;! 88 W/H ratio Z 
Characteristic of 
BMI 22P cm, % P-value 0.85 cm, %P 
women 
30kg/m value 
n oho 
value 
n%n% 
Hours week 0.393 0.009 0.430 
watch N 
4 24 (18) 75.0 (23) 95.8 (15) 62.5 
5-10 149 (97) 65.1 (114) 76.5 (72) 48.3 
11-20 132 (92) 69.7 (110) 83.3 (64) 48.5 
21+ 
_ý. 
177 (130) 73.5 (157) 88.7 (96) 54.2 
Assistance in 
<0.0001 <0.0001 0.242 house-work 
No 141 (75) 53.2 (101) 71.6 I (66) 46.8 
Yes 371 (279) 75.2 (330) 89.0 I (199) 53.6 
Stress level 0.219 0.309 I 0.949 
All events combined (1-16) 
No ý 153 (100) 65.4 Iý (125) 81.7 1 (79) 51.6 
Yes 360 (255) 70.8 1, (307) 85.3 I (187) 51.9 
Reproductive Health Factors 
Parity <0.0001 <0.0001 0.385 
0 42 (23) 54.8 (31) 73.8 I( (25) 59.5 
1-3 38 (24) 63.2 (26) 68.4 (16) 42.1 
4-6 116 (64) 55.2 (89) 76.7 (58) 50.0 
. 7-9 164 (124) 75.6 (145) 88.4 (81) 49.4 
10+ 153 (120) 78.4 (141) 92.2 (86) 56.2 
Age at 1Sr 0.492 0.050 0.227 
marriage, 
II 
<18 231 (165) 71.4 (204) 88.3 (125) 54.1 
18+ 261 (179) 68.6 (214) 82.0 (127) 48.7 
Age at 1st birth 0.093 I 0.004 0.266 
18 172 (129) 75.0 
_(157) 
91.3 (94) 54.7 
> 18 300 (203) 67.7 ý (244) 81.3 (148) 49.3 
Gravidity 5 0.005 0.002 0.837 
0 38 (21) 55.3 (28) 73.7 (21) 55.3 
1- 3 33 (22) 66.7 (24) 72.7 (16) 48.5 
4- 6 65 (36) 55.4 (48) 73.8 (30) 46.2 
7-9 135 ý (92) 68.2 I (116) 86.0 (73) 54.1 
10+ 242 I (184) 76.0 I (216) 89.3 (126) 52.1 
Age at 0.071 0.554 0.160 
menarche 
I I 
s 11 39 (31) 79.5 (34) 87.2 (17) 43.6 
12 106 (81) 76.4 (93) 87.7 (64) 60.4 
13 138 (95) 68.8 (111) 80.4 (63) 45.7 
14 ý 133 (88) 66.2 (110) 82.7 (72) 54.1 
15+ 90 (54) 60.0 ý (77) 85.6 (46) 51.1 
History of I 0.765 
I 
0.423 0.739 infertility 
No 439 (306) 69.7 (371) 84.5 (226) 51.5 
Yes 53 (38) 71.7 (47) 88.7 (26) 49.1 
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Characteristic 
Number 
w 
men 
O 
BMI 
bese 
s 
30kg/m2 
n% 
P 
value 
WC ?. 88 
% 
n 
P-value 
W/H ratio Z 
0.5 cm%/o 
P 
value 
Pregnancy 
ended as 
abortion or 
0.230 0.222 0.759 
miscarriage 
No 164 (121) 73.8 (144) 87.8 (83) 50.6 
Yes 311 (213) 68.5 (260) 83.6 (162) 52.1 
Pregnancy 
ended as a 0.066 0.077 0.144 
stillbirth 
No 410 (282) 68.8 (344) 83.9 (206) 50.3 
Yes 65 (52) 80.0 (60) 92.3 (39) 60.0 
Have you ever 
had polycystic 0.057 0.004 0.456 
ovaries 
No 493 (346) 70.2 (421) 65.4 (255) 51.7 
Yes ý 13 (6) 46.2 (8) 61.5 (8) 61.5 
Ever used OC I I 0.410 0.710 0.004 
No 304 (215) 70.7 (258) 84.9 (174) 57.2 
Yes 208 (140) 67.3 (174) 83.7 I (92) 44.2 
Have your 
periods 0.108 0.001 <0.0001 
stopped now 
No 284 ý (188) 66.2 (226) 79.6 (124) 43.7 
Yes 228 I (166) 72.8 I (205) 89.9 (141) 61.8 
Age at 
menopause in 0.687 0.364 0.374 
years 
5 44 44 (34) 77.3 (42) 95.5 I (23) 52.3 
45-49 75 (55) 73.3 (68) 90.7 (51) 68.0 
50-54 94 (65) 69.2 (81) 86.2 (57) 60.6 
55+ 15 (12) 80.0 (14) 93.3 (10) 66.7 
Ever used 
HRT 0.056 0.021 
0.465 
No 507 (353) 69.6 1 (429) 84.6 (262) 51.7 
Yes 6 (2) 33.3 (3) 50.0 (4) 66.7 
Cholesterol 
647 0 0.009 0.170 (mmol/i ) . 
Normal 376 (258) 68.6 (307) 81.7 (186) 49.5 
Elevated 
cholesterol 
120 
I 
(85) 70.8 
I 
(110) 91.7 (68) 56.7 
LDL- 
Cholesterol 0.430 0.042 0.389 
(mmolA) 
Normal 398 (272) 68.3 (328) 82.4 (200) 50.3 
Elevated LDL- 
chol 
I 
98 
I 
(71) 72.5 
I I 
(89) 90.8 (54) 55.1 
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Characteristic 
Number 
Women 
Obese z 
30kg/m2 
n% 
P 
value 
WC 
cm, % 
?_ 88 
n% 
P-value 
W/H ratio z 
0.85 cm, % 
% 
P 
value 
HDL- 
Cholesterol 0.034 <0.0001 <0.0001 
(mmol/1) 
Decreased 
HDL-Choi 246 (181) 73.6 
(223) 90.7 (150) 61.0 
Normal 250 (162) 64.8 (194) 77.6 (104) 41.6 
Tide riglycer 
MMOM) 
0.001 <0.0001 <0.0001 
Normal 341 (220) 64.5 I (270) 79.2 (154) 45.2 
Elevated TG 155 (123) 79.4 (147) 94.8 (100) 64.5 
TChol/HDL-C 0.149 0.007 0.003 
Normal 324 (217) 67.0 (262) 80.9 (150) 46.3 
High risk 172 (126) 73.3 (155) 90.2 (104) 60.5 
DBP mmHg 0.001 <0.0001 <0.0001 
Normal 332 (213) 64.2 (261) 78.6 (151) 45.5 
Elevated DBP 
Z 90 mmHg/ 181 (142) 78.5 (171) 94.5 (115) 63.5 
or medication 
SBP mmHg 0.002 <0.0001 <0.0001 
Normal 318 (204) 64.2 (249) 78.3 (139) 43.7 
Elevated 
SBP a 140 
mmHg/or 
195 (151) 77.4 (183) 93.9 (127) 65.1 
medication 
Hypertension ý <0.0001 <0.0001 <0.0001 
Normal 295 (186) 63.1 (228) 77.3 (130) 44.1 
Hypertensive 218 (169) 77.5 I (204) 93.6 (136) 62.4 
Diabetic, % 
1 mmol/1 
0.102 0.004 <0.0001 
No 399 (269) 67.4 (326) 81.7 (181) 45.4 
Yes 114 (86) 75.4 (106) 93.0 (85) 74.6 
Central obesity, <0 0001 <0.0001 WCa88cm . 
Normal 1 81 1 (2) 2.5 1 1 1 (18) 22.2 
WC z 88 cm 432 (353) 81.7 1 (248) 57.4 
BMI <0.0001 0.037 
Non-obese 158 (79) 50.0 (71) 44.9 
Obese BMI Z 
30kg/m 355 (353) 99.4 (195) 54.9 
Abdominal 
obesity, WIH 0.037 <0.0001 
ratioz0.85cm 
Normal 247 (160) 64.8 (184) 74.5 
WHR z 0.85 266 (195) 73.3 (248) 93.2 
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Characteristic 
Number 
of 
women 
Obese 
BMI z2 
30kg/m 
n% 
P 
value 
WC Z 88 
cm, % 
n% 
P-value 
W/H ratio z 
0.85 cm, % 
n% 
P 
value 
Self rating of 
obesity <0.0001 <0.0001 
0.100 
Underweight I 
_-21 
(4) 19.1 
- 
(7) 33.3 I (11) 52.4 
Normal weight 141 (60) 42.6 (95) 67.4 (66) 46.8 
Overweight 227 (175) 77.1 (207) 91.2 (111) 48.9 
Obese 94 (89) 94.7 I ( (94) 100.0 I (60) 63.8 
Very obese 25 (25) 100.0 ý __ (25) 100.0 (14) 56.0 
8.1 Further Analysis of Obesity with Parity 
In this section, we aim to investigate the hypothesis that an increasing number of 
children is associated with an increasing risk of obesity among Palestinian women aged 
40-65 years independent of socioeconomic status, other reproductive and lifestyle 
factors. The initial results were shown in sections 7.6 and 7.7 and this section takes the 
relationship of BMI and parity further. For each of these outcomes, initial results of the 
relationship with parity and other characteristics of the women were shown in Chapter 
7. Here the relationships are explored further with the outcome taken both as proportion 
above the cut-point for obesity and as a mean, and with explicit allowance for 
confounders. In the case of BMI and WC measures where a relationship with parity was 
found, mediation of this relationship via other factors is explored in sections 8.2 and 8.4. 
The effect of parity on obesity (BMI > 30 kg/m2) was assessed in a model controlling 
for the woman's age, education and that of their husbands as well as their marital status 
as seen in Tables 8-2. For comparison with a "baseline" group, parity 10+ was chosen as 
the baseline rather than parity 0 because the latter was small in number entailing very 
limited precision and wide confidence intervals. Comparisons with parity 0 would lack 
statistical power to detect any association, and the changes in these comparisons 
between higher parity groups would be less certain. Parity 10+ was a much larger group. 
The choice of this group as baseline, rather than 7-9 (the group that covers the mean 
parity) was arbitrary. 
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Table 8-2: Unadjusted and adjusted odds ratios for the effect of parity in groups on obesity 
linereaced RMI1 
Obesity BM IZ 30 k /m2 
Parit n 
% Unadjusted Adjusted 
y Obese 95% Cl OR 
Lower Upper OR Lower Upper 
0 42 54.8 0.33 0.16 0.68 0.34 0.12 1.012 
1-3 38 63.2 0.47 0.22 1.01 0.46 0.19 1.11 
4-6 116 55.2 0.34 0.20 0.58 0.35 0.19 0.63 
7-9 164 75.6 0.85 0.50 1.44 0.80 0.46 1.40 
10+ 153 78.4 1 1 
P-value < 0.0001 0.0040 
Adjustment for age, woman's education, husband's education, and marital status 
Table 8-2 shows that there was a strong trend for obesity to increase with increasing 
parity, p< 0.0001. From the highest parity group, obesity decreased with less parity, but 
rose slightly at parity 1-3, then decreased at parity 0. The Cls suggests that this slight 
increase in parity 1-3 is not statistically significant and could be due to chance. 
Adjustment did not make much difference in the magnitude of the trend. As in the 
unadjusted results obesity decreased with less parity, increased at parity 1-3, and then 
decreased at parity 0. Again, the Cl suggests that this slight increase at parity 1-3 is not 
statistically significant. 
When parity was fitted into the regression model as a continuous variable and BMI was 
kept as a categorical variable, the change in unadjusted odds of BMI > 30 (obesity) per 
extra child (unit change in parity) was 1.13 (95% Cl 1.07 to 1.19, 
p< 0.000 1). 
176 
Table 8-3: The change of unadjusted and adjusted odds of BMI > 30 per extra child 
Odds SE 
95% Cl Statistical 
ratio Lower Upper significance 
Unadjusted 1.13 
. 
03 1.07 1.19 < 0.0001 
Adjusted for age, educational 
level, husband's years of 
schooling and marital status 
1.14 
. 
04 1.07 1.22 <0.0001 
(fully adjusted model 
After adjustment for age, women's educational level, husband's years of schooling and 
marital status, the risk of obesity increased by 14% with each additional live birth. 
The relationship between BM[ and parity was finally examined with both variables 
being continuous, using a scatter diagram and by ordinary regression. The regression 
slope was 0.28 kg/m2 denoting the predicted increase in BMI for a unit increase in 
parity. The standard error of this slope was 0.07 and it was significantly different from 
zero, p<0.0001. Adjustment for age, women's educational level, husband's schooling 
and marital status did not noticeably reduce the magnitude of change, although 
education did so slightly, but the association between parity and BMI remained 
significant. The scatter diagram with the fitted line is shown in Figure 8-1 indicating the 
scatter plot of the two variables BMI and parity with the regression line. 
Table 8-4: The unadjusted and adjusted regression slopes of BMI on parity 
Slope 95% Cl ti ti l St 
(regression SE Lower Upper 
s ca a 
significance 
coefficient) 
Unadjusted 0.28 0.07 0.15 0.42 < 0.0001 
Adjusted for age, educational 0.30 0.09 0.14 0.47 <0.0001 
level, husband's years of 
schooling and marital status 
(fully adjusted 
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Figure 8-1: Scatter Plot of BMI and Parity 
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This diagram confirms the linear relationship between parity and obesity and suggests 
strongly that the linear model is adequate. 
8.2 Other Characteristics and Mediators: 
In the remaining part of this section, we assess the role of mediators that could act along 
the casual pathway between parity and obesity in the model fully adjusted for age, 
educational level, husband's schooling and marital status. Results for each mediator are 
presented in Table 8-5. 
Of all the variables thought of as eligible to act as mediators, assistance in housework 
seems to produce enough change to be considered as a predominant one. When the 
assistance in housework variable was introduced into the regression model, the 
regression coefficient of BMI on parity decreased noticeably from 0.30 to 0.23 kg/m2 
per each additional child, suggesting that the influence between parity and BMI is 
mediated partially by assistance in housework. Moreover, the regression coefficient of 
BMI was 2.51 kg/m2 per unit increase (daily) of assistance at housework. It has been 
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remarked above that assistance in housework reduces physical demands, with resultant 
reduction in physical activity. 
When reported physical activity was introduced into the model, the regression 
coefficient of BMI on parity decreased only slightly from 0.3 kg/m2 to 0.28 kg/m2 per 
each additional child. This suggests that physical activity may have slightly mediated 
the association between parity and BMI and that physical activity took a small part of 
the effect of parity on BMI. However, this change is small and its meaning is uncertain. 
In this model, the regression coefficient for physical activity was 2.67 kg/m2 for women 
who are physically active compared to women who are physically inactive. 
When central obesity (WC > 88 cm) was introduced into the regression model, the 
coefficient of BMI on parity decreased sharply from 0.3 kg/m2 to 0.17 kg/m2, but the 
association between parity and BMI remained significant. Although central obesity 
reduced the regression coefficient very noticeably, one can assume it acted as a correlate 
to BMI rather than a mediator. 
Other possible mediators, such as hours watching TV, age at menarche and abdominal 
obesity, made only very small changes to the regression coefficient of parity. Hence, 
their mediating effects were non-existence or slight. Table 8-5 shows potential 
mediators that can act along the causal pathway between parity and BMI, on the fully 
adjusted regression coefficient. 
Table 8-5: Effect of mediators along the causal pathway between parity & obesity (BMI) on the 
fully adjusted regression coefficient 
Cý 
.2 0m 95% Cl 
C 
0 N- 95% Cl Additional o (D ö 
characteristi . ic P 2= ar 0 P a . l cs ° value va ue 
(mediators) d .ýö 
öyö 
o tea, Lower Upper ö"°v Lower Upper 
0 U) 
Unadjusted 0.28 0.145 0.421 <0.0001 
Fully adjusted 0.30 0.137 0.471 <0.0001 
Assistance in 
house 0.23 0.060 0.400 0.008 2.51 1.30 3.72 <0.0001 
Physical 
activity 
0.28 0.112 0.443 0.001 -2.67 -4.221 -1.120 0.001 
Hours 
watchin TV 
0.31 0.131 
. 487 
0.001 0.066 0.022 0.110 0.003 
Age at 
menarche 
0.29 0.121 0.457 0.001 -0.494 -0.872 -0.116 0.011 
Central 
obesity WC 0.17 0.026 0.315 0.021 8.67 7.354 9.993 < 0.0001 
Abdominal 
obesity W/H 0.30 0.128 0.461 0.001 1.17 0.104 2.238 0.032 
ratio 
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None of these variables fully mediated the association between parity and obesity 
suggesting that the association between parity and obesity is real and is independent of 
any effect of these covariates. This suggests a physiological effect of parity on obesity. 
Assistance in housework could partially explain some of the effect, yet the association 
between parity and BMI remained significant. 
We conclude that childbearing in addition to life style factors, physical inactivity and 
leading sedentary habits contributes to obesity in this group of women. 
8.3 Further Analysis of Waist Circumference with Parity 
In this section, we aim to test the hypothesis that an increasing number of children is 
associated with increasing waist circumference and therefore increasing central obesity. 
This association was assessed using the same statistical models as in parity and BMI. 
Table 8-6: Unadjusted and adjusted odds ratio for the effect of parity in groups on increased waist 
rirrnniforenro 
Abdominal obesit WC 2: 88 cm 
Parity n % 
Unadjusted Adjusted 
95% Cl 9 5% Cl OR 
Lower Upper OR Lower Upper 
0 42 73.8 0.24 0.10 0.59 0.42 0.10 1.79 
1-3 38 68.4 0.18 0.08 0.46 0.22 0.08 0.65 
4-6 116 76.7 0.28 0.14 0.58 0.39 0.17 0.89 
7-9 164 88.4 0.65 0.30 1.39 0.79 0.35 1.77 
10+ 153 92.2 1 1 
P-value < 0.0001 0.03 
Adjustment for age, woman's education, husband's education, and marital status 
Table 8-6 shows that there is a strong trend for WC to increase with increasing parity, 
p< 0.0001. Waist circumference decreases with less parity as the odds ratios show, and 
rises again at parity 0. 
The table also shows that adjusted WC decreases with less parity with a slight increase 
at parity 0. But, as with the analysis for BMI, the Cis suggest that the upward trend from 
parity 1-3 to parity zero is not statistically significant, so a suggestion of a J-shaped 
relationship is not supported. 
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['he effect of confounders on the relationship of central obesity and parity is also shown 
in Table 8-6. In contrast to the results for BMI, there appears to be some weakening of 
the effect of parity, which however remains definite. 
When parity was fitted into the regression model as a continuous variable and WC is 
kept as a categorical variable as in Table 8-7 the change in odds of WC? 88 (central 
obesity) per extra child (unit change in parity) is 1.18 (95% Cl 1.10 to 1.26, p< 0.0001. 
Table 8-7: The change of unadjusted and adjusted odds of WC> 88 cm per extra child 
Odds 95% Cl Statistical 
ratio 
SE 
Lower Upper significance 
Unadjusted 1.18 0.04 1.10 1.26 <0.0001 
Adjusted for age, educational level, 
husband's years of schooling and 1.18 0.06 1.07 1.29 0.001 
marital status 
After adjustment for age, women's educational level, husband's years of schooling and 
marital status, the risk of central obesity increased by 18% with each additional child. 
Again, adjustment made very little difference. 
When parity was measured on a continuous scale using ordinary regression the mean 
WC increased by 0.69 cm per extra child as shown in Table 8-8. When the association 
was adjusted for confounders, the magnitude of change was reduced slightly to 0.58 but 
the association remained significant 
Table 8-8: The Unadjusted and Adjusted Regression Slopes of WC on Parity 
Slope 95% Cl Statistical 
(regression SE Lower Upper significance 
coefficient) 
Unadjusted 0.69 0.14 0.41 0.96 < 0.0001 
Adjusted for age, educational 
level, husband's years of 0.58 0.17 0.25 0.91 0.001 
schooling and marital status 
Figure 8-2 shows the scatter plot of the two variables waist circumference and parity 
with the regression line. The scatter plot suggests strongly that the linear model is 
adequate, and to represent the relationship of mean WC there is no need to look at parity 
in groups. 
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Figure 8-2: Scatter Plot of WC and Parity 
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8.4 Other Characteristics and Mediators 
In this section, potential mediators that could act along the casual pathway between 
parity and central obesity are assessed in the fully adjusted model for age, educational 
level, husband's schooling and marital status. Results are presented in Table 8-9. When 
the assistance in housework variable was introduced into the regression model, the 
regression coefficient of WC on parity decreased noticeably compared to the effect of 
the other life-style mediators, except for physical activity. The slope of WC on parity 
was reduced from 0.58 to 0.43 cm per each additional child, suggesting that some of the 
influence between WC and parity is mediated partially by assistance in housework. The 
regression coefficient of assistance in housework was 5.00 cm being the average 
increase in WC among those who reported assistance in housework compared to women 
who did not. 
Abdominal obesity W/H ratio > 0.85 reduces the magnitude of the slope of WC from 
0.58 cm to 0.51 cm, but again W/H ratio is a correlate of WC and might not be 
considered as a mediator. 
The same applies to BMI. When obesity (BMI> 30 kg/m2) was introduced into the 
regression model, the regression coefficient of WC on parity decreased sharply from 
0.58 cm to 0.19 cm, and the association between WC and parity disappeared. 
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Other possible mediators were considered, but their mediating effects were non- 
existence or slight such as age at menarche, physical activity and fasting blood sugar. 
Table 8-9: Effect of mediators along the causal pathway between parity and central obesity (WC) 
nn the filly adi.. cterl r&arCCinn enpffig'irnt 
C 
0 L- w 95% Cl 
C 
: r, 95% Cl 
Additional cCM U) ° 'r 
h t i ti l P ,0v c arac er s cs C ° -va 
ue d value (mediators) 
_ ß ööm lower upper 
ö0 1O lower upper 
N Cl) 
Unadjusted 0.69 0.41 0.96 < 0.0001 
Fully adjusted 0.58 0.25 0.91 0.001 
Physical activity 0.55 0.22 0.88 0.001 -3.01 -6.12 -. 09 0.057 
Hours watching 
. 60 25 95 001 0 17 09 
257 < 0.0001 TV . . . . . . 
Assistance in 
house 0.43 0.09 0.76 0.013 5.00 2.60 7.44 <0.0001 
Obesity BMI 0.19 -0.08 0.46 0.164 15.5 13.59 17.36 < 0.0001 
Abdominal 
obesity W/H 0.52 0.21 0.83 0.001 8.24 6.24 10.24 < 0.0001 
ratio 
Fasting blood 
62 
. 
28 
. 
95 <0 0001 . 
02 
. 
004 
. 
039 0.016 
sugar . 
Assistance in housework seems to carry some of the influence of parity on WC, yet the 
association between WC and parity remained significant as shown in table 8-9, 
suggesting that the association could be due to the biological consequences of 
pregnancy and sedentary lifestyle. 
8.5 Further Analysis of the Waist Hip Ratio with Parity 
In the following section, we aim to test the hypothesis that an increasing number of 
children was associated with an increasing waist to hip ratio. The association between 
parity and waist to hip ratio was assessed using the same statistical models as for parity 
and BM!. 
The relationship between unadjusted and adjusted increased W/H ratio (>_ 0.85) ratio 
with parity in groups is shown in Table 8-10. All the CIs show no significant 
association, p= 0.3891 and p= 0.7821 respectively. 
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Fable 8-10: Unadjusted and adjusted odds ratios for the effect of parity in groups on increased W/H 
rsitin 
W/H ratio z 0.85 
Parity n %o 
Unadjusted Adjusted 
95% CI 9 5% Cl 
OR 
Lower Upper OR Lower Upper 
0 42 59.5 1.15 0.57 2.29 0.42 0.10 1.79 
1-3 38 42.1 0.57 0.28 1.16 0.22 0.08 0.65 
4-6 116 50.0 0.78 0.48 1.26 0.39 0.17 0.89 
7-9 164 49.4 0.76 0.49 1.18 0.79 0.35 1.77 
10+ 153 56.2 1 1 
P-value 0.3891 0.7821 
Adjustment for age, woman's education, husband's education, and marital status 
When parity was fitted into the regression model as a continuous variable and W/H ratio 
was kept as a categorical variable as in Table 8-11 the change in odds of W/H ratio > 
0.85 (abdominal obesity) per extra child (unit change in parity) was 1.026 (95% Cl . 
979 
to 1.075, p=0.292). 
Table 8-11: The change of unadjusted and adjusted odds of Will ratio > 0.85 per extra child 
Odds 95% Cl Statistical 
ratio 
SE 
Lower Upper significance 
Unadjusted 1.026 0.025 0.979 1.075 0.292 
Adjusted for age, educational 
level, husband's years of 1.035 0.0320 0.9740 1.010 0.268 
schooling and marital status 
After adjustment for confounders age, women's educational level, husband's years of 
schooling and marital status the association remained non significant. Finally, no 
statistically significant association was seen when parity was measured on a continuous 
scale using ordinary regression, see Table 8-12. 
Table 8-12: The Unadjusted and Adjusted Regression Slopes of W/H Ratio on Parity 
95% Cl Statistical 
Slope SE 
Lower Upper significance 
Unadjusted 0.0013 0.0008 -0.0002 0.0028 0.090 
Adjusted for age, educational 
level, husband's years of 0010 0 0 0009 -0 0009 0028 0 0.308 schooling and marital status . . . . 
(fully adjusted) 
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Because there was no evidence of any association between parity and W/H ratio, effects 
of mediators were not investigated. 
Figure 8-3 shows the scatter plot of the two variables waist/hip ratio and parity with the 
regression line at the same level. 
Figure 8-3: Scatter Plot of W/H Ratio and Parity 
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Chapter 9 
PARITY ANI) LINII) LEVEL s 
One possible pathway by which the number of pregnancies and the number of children 
could be related to the subsequent development of coronary heart disease is through the 
alteration of lipid levels. Results on the association between parity and the lipid levels 
(the metabolic risk factors) are presented in this chapter. Section 9.1 focuses on the 
general characteristics associated with the elevated metabolic risk factors. Sections 9.2 
to 9.6 discuss each of the metabolic risk factors with parity. 
9.1 Characteristics Associated with Elevated Fasting Plasma Lipid Levels 
Fasting plasma lipid measurements and analysis were restricted to 498 women out of the 
515 who were recruited for the study as 17 women did not provide blood samples. The 
percentages and the mean values of total cholesterol, LDL-C, HDL-C, triglycerides and 
TCHOL/HDL-C ratio were presented earlier in section 7.4.3. Table 9-1 shows the 
characteristics associated with elevated plasma lipid levels. 
Women with elevated total cholesterol and LDL-C tended to be older, less educated, 
diabetic, in the menopausal state with elevated SBP, DBP and Hypertension, and central 
obesity. A decreased HDL-C level was inversely associated with husband's education 
and family affluence scale, and was positively associated with diabetes, central and 
abdominal obesity. Women who had assistance in housework tended to have decreased 
HDL-C level. 
In addition, women with elevated triglycerides tended to be unemployed, physically 
inactive, have ever used oral contraceptive pill, diabetic with elevated BMI, central and 
abdominal obesity and a family history of diabetes. Women with elevated T- 
CHOL/HDL-C ratio tended to be less educated, more likely to marry at an early age, 
diabetic and have elevated central and abdominal obesity. 
It is interesting to note that neither parity nor gravidity had a significant association with 
the elevated plasma lipid levels among the women surveyed. The characteristics 
potentially associated with elevated fasting plasma lipid levels are presented in Table 9- 
l. 
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Fhe following sections, 9.2 to 9.7, test for and examine the relationships between 
increasing parity and Total Cholesterol, LDL-C, HDL-C, Triglycerides and the Total 
Cholesterol to HDL-C ratio. For each of these outcomes, initial results of the 
relationship with parity and other characteristics of the women were shown in Chapter 
7. Here the relationships are explored further with the outcome taken both as proportion 
above (and below) the cut-point for normality and as a mean, and with explicit 
allowance for confounders, the same way as was done for parity and BMI and other 
anthropometric outcomes. In the case of Triglycerides, where a relationship with parity 
was found, mediation of this relationship via other factors is explored in section 9.6 
9.2 Total Cholesterol with Parity 
Table 9-2 shows the unadjusted and adjusted association between raised cholesterol 
level and grouped parity. At no stage of this analysis was the association statistically 
significant and all the Cis confirm this. 
Table 9-2: Unadjusted and adjusted odds ratios for the effect of parity in groups on raised 
('Iinlocfnrnl Int'E'I 
Raised Total Cholesterol mmol/L 
Parit n % 
Unadjusted Adjusted 
y 
95% Cl OR _ Lower Upper OR Lower Upper 
0 40 17.5 0.53 0.22 1.28 0.65 0.16 2.60 
1-3 33 21.2 0.67 0.27 1.65 1.05 0.38 2.90 
4-6 111 25.2 0.84 0.48 1.45 1.08 0.58 2.02 
7-9 161 21.7 0.69 0.41 1.15 0.84 0.49 1.46 
10+ 153 28.8 1 1 
P-value 0.490 0.898 
Adjustment for age, woman's education, husband's education, and marital status 
When parity was fitted into the regression model as a continuous variable and T- 
Cholesterol level was kept as a categorical variable as in Table 9-3, the change in odds 
of T-Chol > 5.2 mmol/L per extra child (unit change in parity) was 1.04 (95% CI 0.99 to 
1.11, p=0.123). With adjustment for age, women's educational level, husband's years 
of schooling and marital status it remained non significant. 
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Table 9-3: The change of unadjusted and adjusted odds of T-Cholesterol > 5.2 mmol/L per extra 
rtiiiil 
95% Cl Statistical 
Odds ratio SE 
Lower Upper significance 
Unadjusted 1.04 0.03 0.99 1.11 0.123 
Adjusted for age, educational level, 
husband's years of schooling and 1.00 0.04 0.94 1.08 0.928 
marital status 
With parity and Total Cholesterol both measured on continuous scales, using ordinary 
regression, the association was still not significant, unadjusted or adjusted, as shown in 
Table 9-4. 
Table 9-4: The unadjusted and adjusted regression slopes of T-('hol (mmol/L) on parity 
Slope 95% Cl ti St ti l 
(regression SE Lower Upper 
a s ca 
significance 
coefficient 
Unadjusted 0 016 0.014 -0.011 0.043 0.25 
Adjusted for age, educational 
level, husband's years of -0.001 0.017 -0.034 0.032 0.946 
schooling and marital status 
Since there was no evidence for an association between T-Cholesterol and parity, the 
effects of mediators were ignored. No evidence was found of an association between 
gravidity and total cholesterol. 
Figure 9-1 below shows the scatter plot of the two variables Total Cholesterol and 
parity with the regression line. 
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Figure 9-1: Scatter plot of Total Cholesterol and Parity 
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9.3 LDL-C with Parity 
Table 9-5 shows the unadjusted and adjusted relationships between raised LDL-C level 
and parity in groups. Neither was significant (p= 0.264, and 0.699 respectively), 
supported by the confidence intervals. 
Table 9-5: Unadjusted and adjusted odds ratios for the effect of grouped parity on raised LDL-C 
Parity n ý% 
Raised LDL-C mmol/l 
Unadjusted Adjusted 
o 95% CI 
OR 
Lower Upper OR Lower Upper 
0 40 10.0 0.34 0.11 1.01 0.23 0.03 1.87 
1-3 33 15.2 0.54 0.20 1.50 0.75 0.24 2.33 
4-6 111 19.8 0.75 0.41 1.35 0.86 0.44 1.67 
7-9 161 18.6 0.69 0.40 1.19 0.82 0.46 1.46 
10+ 153 24.8 1 1 
P-value 0.264 0.699 
Adjustment for age, woman's education, husband's education, and marital status 
0 
I I I 
" 
1 " 
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When parity was fitted into the regression model as a continuous variable and LDL-C 
level was kept as a categorical variable as shown in Table 9-6, the unadjusted change in 
odds of LDL-C > 3.5 mmol/L per extra child (unit change in parity) was 1.05 (95% CI 
0.996 tol. 13, p=0.066). In addition, adjustment for age, women's educational level, 
husband's years of schooling and marital status did not change the magnitude of the 
association and it remained non significant. 
Table 9-6: The change of unadjusted and adjusted odds of LDI. -C -- 3.5 mmol/L per extra child 
95% Cl Statistical 
Odds ratio SE Lower Upper significance 
Unadjusted 1.05 0.03 0.996 1.13 0.066 
Adjusted for age, educational level, 
husband's years of schooling and 1.03 0.04 0.95 1.11 0.0485 
marital status 
Table 9-7 further shows no statistically significant association when both variables, 
parity and LDL-C, were taken on a continuous scale, using ordinary regression. 
Table 9-7: The unadjusted and adjusted regression slopes of LDI. -(' (mmol/L) on parity 
Slope 95% Cl l ti ti St 
(regression SE Lower Upper 
s ca a 
significance 
coeff icient 
Unadjusted 0.021 0.013 -0.004 0.046 0.104 
Adjusted for age, educational 
level, husband's years of 0.004 0.016 -0.028 0.033 0.817 
schooling and marital status 
The effect of mediators was not considered in a further analysis as an existing 
association between parity and LDL-C level was not evident. 
The same conclusions applied to the association between gravidity and LDL-C (detailed 
results not shown). 
Figure 9-2 shows the scatter plot of the two variables LDL-C and parity with the 
regression line 
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Figure 9-2: Scatter Plot of LDL-C and Parity 
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9.4 H DL-C with Parity 
Table 9-8 shows the unadjusted and adjusted odds ratios (OR) for the effect of parity on 
decreased HDL-C level. It reveals no statistically significant association, (p=0.882 and 
0.951 respectively). 
Table 9-8: Unadjusted and adjusted odds ratios for the effect of grouped parity on decreased HDL- 
i~ IPVPIC 
Parit n %ý 
HDL-C <I mmol/l 
Unadjusted Adjusted 
y 0 95% CI 
OR _ Lower _ Upper OR Lower Upper 
0 40 50.0 0.91 0.46 1.83 0.82 0.29 2.3 
1-3 33 57.6 0.67 0.32 1.44 0.82 0.34 1.9 
4-6 111 51.4 0.86 0.53 1.41 1.0 0.59 1.7 
7-9 161 50.9 0.88 0.57 1.37 0.87 0.54 1.4 
10+ 153 47.7 1 1 
P-value 0.882 0.951 
Adjustment for age, woman's education, husband's education, and marital status 
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When parity was fitted into the regression model as a continuous variable and HDL-C 
level was kept as a categorical variable as shown in table 9-9, the unadjusted change in 
odds of HDL-C <I mmol/L per extra child (unit change in parity) was 1.00 (95% Cl 
0.96 to 1.1, p=0.700). Moreover, adjustment for age, women's educational level, 
husband's years of schooling and marital status did not change the magnitude of the 
association and it remained non significant. 
Table 9-9: The change of unadjusted and adjusted odds of HDL-C <I mmol/L per extra child 
95% Cl Statistical 
Odds ratio SE Lower Upper significance 
Unadjusted 1.0 0.02 0.96 1.1 0.700 
Adjusted for age, educational level, 
husband's years of schooling and 1.0 0.03 0.94 1.1 0.911 
marital status 
With HDL_C and parity was measured on continuous scales, using ordinary regression, 
HDL-C decreased by 0.006 mmol/1 per extra child, but this association was not 
statistically significant (95% Cl -0.013 to 0.001, p= 0.093). After adjustment for 
confounders the association remained not significant as seen in Table 9-10. 
Table 9-10: The unadjusted and adjusted regression slopes of HDL-C (mmol/L, ) on parity 
Slope 95% Cl tistical St 
(regression SE Lower Upper 
a 
significance 
coefficient) 
Unadjusted -0 006 0.004 -0.013 0.001 
0.093 
Adjusted for age, educational 
level, husband's years of -0.005 0.004 -0.014 0.004 0.267 
schooling and marital status 
In the absence of a statistical association in the above analyses, analysis of mediators is 
not presented. 
Figure 9-3 shows the scatter plot of the two variables HDL-C and parity with the 
regression line. 
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Figure 9-3: Scatter Plot of HDL-C and Parity 
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9.5 Triglycerides with Parity 
0 
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Table 9-11 shows the unadjusted and adjusted relationship between raised triglycerides 
and parity in groups, which was insignificant, (p= 0.225 and 0.658 respectively). 
Table 9-11: Unadjusted and adjusted odds ratios for the effect of grouped parity on raised 
Trialvrarirlnc I'll :l I--Ic 
Raised Tri I cerides mmol/L 
Parity n % 
Unadjusted Adjusted 
95% CI 
OR 
Lower Upper OR Lower Upper 
0 40 27.5 0.64 0.30 1.38 0.78 0.25 2.46 
1-3 33 18.6 0.37 0.15 0.96 0.48 0.17 1.35 
4- 111 28.8 0.68 0.40 1.15 0.84 0.47 1.51 
7-9 161 30.4 0.74 0.46 1.18 0.78 0.47 1.28 
10+ 153 37.3 1 1 
P-value 0.225 0.658 
Adjustment for age, woman's education, husband's education, and marital status 
0 
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When parity was fitted into the regression model as a continuous variable and TG level 
was kept as a categorical variable as shown in Table 9-12, the unadjusted change in 
odds of TG _> 
1.7 mmol/L per extra child (unit change in parity) was 1.06 (95% Cl 1.01 
tol. 12, p=0.021) depicting an evidence of an association between parity and 
triglycerides in unadjusted analysis. This association was however attenuated after 
adjustment for age (data not shown), and was completely abolished after adjustment for 
women's educational level, husband's years of schooling and marital status as in table 
9-12. 
Table 9-12: The change of unadjusted and adjusted odds of TC _> 
1.7 mmol/L per extra child 
95% Cl Statistical 
Odds ratio SE Lower Upper significance 
Unadjusted 1.06 0.03 1.01 1.12 0.021 
Adjusted for age, educational level, 
husband's years of schooling and 1.05 0.03 0.981 1.12 0.169 
marital status 
With parity and triglycerides measured on continuous scales, using ordinary regression, 
mean TG increased by 0.038 mmol/L per extra child, p= 0.003. Adjustment for age, 
woman's education and husband years of schooling and marital status reduced slightly 
the magnitude of change in mean TG, but the association remained significant as in 
shown in Table 9-13. 
Table 9-13: The unadjusted and adjusted regression slopes of TG (mmol/L) on parity 
Slope 95% Cl 
ti ti l St 
(regression SE Lower Upper 
s ca a 
significance 
coefficient) 
Unadjusted 0.038 0.013 0.013 0.06 0.003 
Adjusted for age, educational 
level, husband's years of 0.036 0.017 0.003 0.068 0.033 
schooling and marital status 
Figure 9-4 shows the scatter plot of TG and parity with the regression line. 
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Figure 9-4: Scatter Plot of Triglycerides and Parity 
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There was also an association between gravidity and Triglycerides, when the latter was 
regressed on gravidity using the fully adjusted model, the regression coefficient was 
0.033 mmol/L, with a S. E. of 0.013 (95% Cl 0.007 to 0.059, p= 0.013). 
9.6 Mediators of the Parity-Triglyceride relationship 
We now assess the role of mediators that could act along the casual pathway between 
parity and Triglycerides in the model fully adjusted for the confounders, age, 
educational level, husband's schooling and marital status. Results for each potential 
mediator which was separately associated with the outcome are presented in Table 9-14. 
Of all the variables that were thought of as likely to act as mediators, assistance in 
housework, waist circumference, BMI, diabetes and to a lesser extend W/H ratio seem 
to exert enough change to be considered in this role. When the "assistance with 
housework" variable was introduced into the regression model, the regression 
coefficient of Triglycerides on parity decreased strongly from 0.036 to 0.025 mmol/L 
per each additional child, suggesting that the influence between parity and Triglyceride 
is mediated partially by assistance with housework. 
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the regression coefficient for assistance with housework was 0.31 mmol/L, suggesting 
an average increase of mean Triglycerides levels among those with assistance. When 
waist circumference and BMI were introduced into the model, each individually, the 
regression coefficient of Triglycerides on parity decreased from 0.036 to 0.025 and to 
0.027 mmol/L respectively. With diabetes added to the model, the regression 
coefficient of Triglycerides on parity dropped from 0.036 to 0.028 mmol/L. 
Other possible mediators made only small changes to the regression coefficient of 
parity, so their mediating effects were non-existence or slight. These were abdominal 
obesity (W/H ratio) and fasting insulin level as shown in Table 9-14. 
Table 9-14: Effect of mediators along the causal pathway between parity and Triglycerides on the 
fully idincted rparpecinn enefficient 
Slope Slope 95% Cl 
Additional (regression 95% Cl (regression p 
characteristics coefficient) 
P 
l coefficient) value (mediators) for TG on va ue of additional 
parity L U characteristic L U 
Unadjusted 0.038 0.013 0.06 0.003 
Fully adjusted 0.036 0.003 0.068 0.033 
Assistance in 
house 0.025 -0.009 0.058 0.147 0.31 0.063 0.55 0.013 
Diabetic 0.028 -0.003 0.059 0.078 0.87 0.61 1.13 <0.0001 
Waist 
circumference 
0.025 -0.008 0.057 0.137 0.61 0.32 0.91 <0.0001 
W/H ratio 0.033 0.0003 0.066 0.047 0.28 0.08 0.49 0.008 
BMI 0.027 -0.006 0.060 0.111 0.33 0.10 0.56 0.005 
Insulin 0.035 0.001 0.066 0.041 0.015 0.002 0.030 0.053 
In summary, there was a definite association between Triglycerides and parity with both 
variables taken as continuous variables. Confounders could not explain this association. 
There seem to be a strong mediating effect of BMI, WC, assistance in housework and 
being diabetic, and with each of these included, the association between parity and 
Triglycerides became non significant. 
9.7 T-CHOL/ IIDL-C Ratio and Parity 
Table 9-15 shows the relationship between raised T-CHOL/ HDL-C ratio and parity in 
groups. No significant association with parity was shown before or after adjustment. 
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Table 9-15: Unadjusted and adjusted odds ratios for the effect of grouped parity on raised T- 
C'HOIJ Hn1. -C ratio> 0.13 mmol/1. 
Ratio of T-CHOL/ HDL-C > 0.13 mmol/L 
Parity n % 
Unadjusted Adjusted 
95% CI 
OR 
Lower Upper OR Lower Upper 
0 40 25.0 0.49 0.22 1.07 0.28 0.07 1.06 
1-3 33 24.2 0.47 0.20 1.11 0.57 0.22 1.48 
4-6 111 35.1 0.80 0.479 1.32 0.97 0.55 1.70 
7-9 161 33.5 0.74 0.468 1.17 0.79 0.48 1.28 
10+ 153 40.5 1 1 
P-value 0.235 0.287 
Adjustment for age, woman's education, husband's education, and marital status 
When parity was fitted into the regression model as a continuous variable and T-Chol/ 
HDL-C level was kept as a categorical variable as in Table 9-14, an apparent association 
between T-CHOL/ HDL-C ratio and parity was observed. The unadjusted change in 
odds of T-CHOL/ HDL-C > 0.13 mmol/L per extra child (unit change in parity) was 
1.06 (95% CI 1.00 to 1.11, p=0.039), an evidence of an association between parity and 
triglycerides in unadjusted analysis. This association was completely abolished after 
adjustment for age, women's educational level, husband's years of schooling and 
marital status as in Table 9-16. 
Table 9-16: The change of unadjusted and adjusted odds ofT-CHOL/ HDL-C ratio> 0.13 mmol/L 
ner PYtra child 
95% Cl Statistical 
Odds ratio SE Lower Upper significance 
Unadjusted 1.06 0.03 1.00 1.11 0.039 
Adjusted for age, educational level, 
husband's years of schooling and 1.04 0.03 0.98 1.11 0.168 
marital status 
With both variables, parity and T-CHOL/ HDL-C ratio, on continuous scales, using 
ordinary regression, the mean T-CHOL/ HDL-C increased by 0.001 mmol/L per extra 
child, p= 0.020. But this association was attenuated after adjustment for age, and was 
completely abolished after adjustment for women's educational level, husband's years 
of schooling and marital status as in Table 9-17. 
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Fable 9-17: The Unadjusted and Adjusted Regression Slopes of T-CHOL/ HDL-C Ratio on Parity 
Slope 95% Cl 
i S (regression SE tat stical 
coeff icient 
Lower Upper significance 
Unadjusted 0.001 0.0005 0.0003 0.002 0.020 
Adjusted for age, educational 
level, husband's years of 0.0008 0.0005 0.0006 0.002 0.282 
schooling and marital status 
Figure 9-5 shows the scatter plot of the two variables T-CHOL/ HDL-C and parity with 
the regression line. 
Figure 9-5: Scatter Plot of T-CHOL/ HDL-C and parity 
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There was an association between gravidity and T-CHOL/ HDL-C ratio when T-CHOL/ 
HDL-C ratio was regressed on gravidity. This association was attenuated when adjusted 
for age. 
In the absence of a statistical association in the above adjusted analysis, analysis of 
mediators is not presented. 
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Chapter 10 
I'ARITYAND THE DEVELOPMENT oi' TYI'u: 11 DIABETES 
Does parity contribute to the development of type 11 diabetes in women? Does the 
association between parity and type II diabetes exists independently or is it confounded 
by socio-economic status, or mediated by behavioural factors and / or obesity? 
Results on the association between parity and type II diabetes mellitus are presented in 
this chapter. Section 10.1 focuses on the general characteristics associated with type II 
diabetes and section 10.2 discusses the association between parity and the development 
of type 2 diabetes among women aged 40-65 years. 
10.1 Characteristics Associated with Type II Diabetes Mellitus 
Of the 515 women recruited for the study, 17 did not provide blood samples for fasting 
blood sugar (FBS). Therefore the results presented here refer to 498 women. Diabetes is 
defined here as a fasting blood sugar (FBS) of 7.0 mmol/L or more. Eighty three 
women (16.7%) had type II diabetes, 26 women (5.2%) had impaired fasting blood 
glucose (defined as a level between 6.1 and 7.0 mmol/L) and 398 women (78.1 %) had 
normal fasting blood sugar. These cut-point levels are in accordance with the WHO 
criteria for diabetes based on FBS. The mean value for fasting blood sugar was 5.98 
mmol/L (107.8 mg/dl). 
However, these results do not take account of the fact that some women said they were 
on medication for diabetes. Scoring these also as positive for diabetes, regardless of the 
measured FBS, changes the number of women with diabetes to 1l5,22.3%. Taking the 
FBS level for these women as "at least" as measured, a censored regression model for 
the mean allowing for censoring (see above) was 6.3 mmol/L among the 498 women. 
Characteristics associated with diabetes are shown in Table 10-1. A higher risk of 
diabetes among women was observed with increasing age, and menopausal status. Both 
WC and W/H ratio were positively and significantly associated with diabetes while BMI 
was not. Women with diabetes had elevated cholesterol, elevated LDL-C, elevated 
triglycerides, elevated T-CHOL/HDL-C levels and had a decreased level of HDL-C. 
Family history of diabetes was positively associated with type II diabetes. Diabetic 
women have elevated DBP, SBP and hypertension compared to non-diabetic women in 
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the survey. Type II diabetes was more prevalent among the less educated and the 
physically inactive, widowed and married women, but the association did not reach the 
significant level. 
Table 10-1: Characteristics associated ýýith Diabetes (Fasting Blood Sugar) 
Number 
of 
women 
Diabetic 
> 7.0 mmol/L/ 
n 
medication/o 
Statistical 
significance 
P- value 
Demographic and socio-econ omic varia bles 
Age in years < 0.0001 
< 45 159 (19) 12.0 
45-49 115 (20) 17.4 
50-54 110 (31) 28.2 
55-59 95 (32) 33.7 
60+ 35 (13) 37.1 
Years of schooling 0.076 
No formal education 119 (32) 26.9 
Elementary 199 (51) 25.6 
Secondary 167 (27) 16.2 
Higher 30 (5) 16.7 
Current employment 0.438 
No 436 (100) 22.9 
Yes 79 (15) 19.0 
Women's Occupation 0.536 
Unskilled worker 16 (3) 18.8 
Skilled worker 14 (2) 14.3 
Employee 24 (3) 12.5 
Private business 25 (7) 28.0 
Marital status 0.370 
Single 21 (4) 19.1 
Married 382 (83) 21.7 
Divorced/separated 28 (4) 14.3 
Widowed 84 (24) 28.6 
Husband's years of schooling 0.241 
No formal education 85 (25) 29.4 
Elementary 166 (41) 24.7 
Secondary 170 (34) 20.0 
Higher 58 (10) 17.2 
Husband's currently 082 0 
employed . 
No 141 (39) 27.7 
Not applicable 112 (28) 25.0 
Yes 241 (44) 18.3 
Own automatic washing 0 272 
machine . No 400 (85) 21.3 
Yes 115 (30) 26.1 
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Number 
of 
women 
Diabetic 
z 7.0 mmol/L/ 
medication/ 
Statistical 
significance 
P- value 
Family affluence scale 0.209 
Poor 225 (42) 18.7 
Average 164 (42) 25.6 
Better off 126 (31) 24.6 
Behavioural risk factors 
Physical activity 0.286 
No 445 (103 23.2 
Yes 69 (12) 17.4 
Smoking habits 0.689 
Never smoked 481 (108) 22.5 
Current smoker 28 (5) 17.9 
Ex-smoker 6 (2) 33.3 
Watch TV 0.906 
No 31 (7) 22.6 
Yes 484 (108) 22.3 
Hours week watch TV 0.603 
<=4 hours 24 (7) 29.2 
5- 10 hours 150 (36) 24.0 
11- 20 hours 133 (25) 18.8 
21 + hours 177 (40) 22.6 
Assistance in house-work 0.174 
No 142 (31) 21.8 
Yes 372 (83) 22.3 
Stress level 0.710 
No 154 (36) 23.4 
Yes 361 (79) 21.9 
Reproductive health variables 
Parity 0.749 
0 42 (9) 21.4 
1-3 38 (6) 15.8 
4-6 117 (25) 21.4 
7-9 165 (36) 21.8 
10+ 153 (39) 25.5 
Age at Ist marriage 0.686 
<18 232 (54) 23.3 
18+ 262 (57) 21.8 
Age at Ist birth 0.224 
518 173 (44) 25.4 
> 18 301 (62) 20.6 
Gravidity 0.638 
0 38 (8) 21.1 
1-3 33 (5) 15.2 
4-6 65 (13) 20.0 
7- 9 136 (28) 20.6 
10+ 243 (61) 25.1 
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Number 
of 
women 
Diabetic 
2t 7.0 mmol/U 
n 
medication0 
Statistical 
significance 
P- value 
Age at menarche 0.091 
<= 11 39 (8) 20.5 
12 108 (32) 29.6 
13 138 (32) 23.2 
14 133 (27) 20.3 
15+ 90 (12) 13.3 
History of infertility 0.704 
No 441 (98) 22.2 
Yes 53 (13) 24.5 
Pregnancy ended as abortion 0.268 
or miscarriage 
No 164 (32) 19.5 
Yes 313 (75) 24.0 
Pregnancy ended as a 0.274 
stillbirth 
No 412 (89) 21.6 
Yes 65 (18) 27.7 
Have you ever had polycystic 0.369 
ovaries 
No 495 (114) 23.0 
Yes 13 (1) 7.7 
Have your periods stopped <0.0001 
now 
No 285 (46) 16.1 
Yes 229 (68) 29.7 
Age at menopause 0.011 
<= 44 44 (7) 15.9 
45- 49 75 (18) 24.0 
50- 54 95 (39) 41.1 
55+ 15 (4) 26.7 
Ever use CP 0.336 
No 306 (64) 20.9 
Yes 208 (51) 24.5 
Serological variables 
T-Cholesterol 0.016 
Normal 377 (65) 17.3 
Elevated T-Chol 121 (33) 27.3 
LDL-Cholesterol 0.001 
Normal 399 (67) 16.8 
Elevated LDL_C 99 (31) 31.3 
HDL-Cholesterol 0.003 
Decreased HDL 247 (62) 25.1 
Normal 251 (36) 14.3 
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Number 
of 
women 
Diabetic 
>_ 7.0 mmol/U 
medication 
n% 
Statistical 
significance 
P- value 
Triglyceride level <0.0001 
Normal 343 (42) 12.2 
Elevated 155 (56) 36.1 
Ratio of T-chol/HDL-Chol < 0.0001 
Normal 325 (47) 14.5 
High risk 173 (51) 29.5 
Hypertensive <0.0001 
No 295 (45) 15.3 
Yes 220 (70) 31.8 
Diastolic BP 0.002 
Normal 332 (60) 18.1 
Elevated 2: 90 mmHg or 183 (55) 30.1 
on medication 
Systolic BP < 0.0001 
Normal 318 (46) 14.5 
Elevated 2140 mmHg or 197 (69) 35.0 
on medication 
Central obesity, waist circum 0.004 
z 88 cm 
Normal 81 (8) 9.9 
WC Z 88 cm 432 (106) 24.5 
BMI 0.102 
Non-obese 158 (28) 17.7 
Obese BMI 2: 30kg/m2 355 (86) 24.2 
Abdominal obesity, WM ratio <0.0001 Z0.85cm 
Normal 247 (29) 11.7 
WHR z 0.85 266 (85) 32.0 
Family History of diabetes 0.009 
No 301 (55) 18.3 
Yes 214 (60) 28.0 
Table 10-1 shows associations of diabetes with various categorical variables. Table 10-2 
shows the means of continuous variables in the groups with and without type 11 diabetes 
mellitus. Women with type II diabetes were significantly older and with less years of 
education than women with normal glucose tolerance. BMI was not significantly 
different between the two groups of women, which was not the case with central obesity 
measured by waist circumference and abdominal obesity measured by W/H ratio. 
Women who were diabetic had higher WC and higher W/H ratio compared to women 
with normal glucose tolerance. Women with type 11 diabetes had a significantly higher 
systolic BP, and hypertension compared to women with normal glucose tolerance. 
212 
Diabetic women reported significantly more pregnancies on average, with an excess of 
1.2 pregnancies. The excess in number of children 0.6 was much less, and not 
statistically significant. 
Of the blood lipids, Triglycerides were significantly higher in women with type II 
diabetes than those with normal glucose tolerance. Women with normal glucose 
tolerance had lower total cholesterol, LDL-C and T-CHOL/DHL-C ratio but a higher 
HDL-C than women with type II diabetes. Moreover, women with type II diabetes were 
significantly more likely than normoglycemic to have a family history of diabetes. 
Table 10-2: Mean values of selected characteristics associated with diabetic status among 
P; ilectininn Wnmen 
Characteristic 
Normal glucose 
tolerance (NGT 
(N) Mean ± SD 
Diabetes Mellitus 
1DM1 
- (N) Mean ± SD 
P 
value 
Age (years) (399) 48.6 ± 6.3 (115) 52.0 ± 6.2* <0.0001 
Education (years) (400) 5.9 ± 4.3 (115) 4.7 ± 4.1 0.0108 
Body Mass Index (BMI) (399) 33.0 ± 6.0 (115) 34.0 ± 5.9 0.1390 
Waist circumference (399) 97.0 ± 12.3 (115) 101.8 ± 10.2 < 0.0001 
W/H ratio (399) 0.84 ±. 07 (115) 0.88 ±. 05 < 0.0001 
Systolic BP (mm Hg) (399) 128.4 t 22.9 (115) 140.4 t 23.2 < 0.0001 
Diastolic BP (mm Hg) (1) (399) 81.6 t 11.3 (115) 83.6 t 12.1 0.0962 
Triglycerides (mmol/L) (400) 1.42 ±. 96 (98) 2.2 t 1.26 < 0.0001 
Total Cholesterol (mmol/L) (400) 4.51 ± 1.1 (98) 5.0 t 1.13 < 0.0001 
LDL-C (mmol/L) (400) 2.67 ± 1.01 (98) 3.11 t 1.09 0.0002 
HDL-C (mmol/L) (400) 1.09 ±. 29 (98) 0.99 ±. 26 0.0018 
Total CHOL/HDL-C ratio (400) 0.11±. 04 (98) 0.14±. 04 < 0.0001 
Number of pregnancies (400) 8.6 ± 4.4 (115) 9.8 ± 4.9 0.0134 
Number of children (400) 7.2 ± 3.6 (115) 7.8 ± 3.8 0.1077 
(1) Adjusted for censoring among those on medication fur hypertension 
10.2 Further Analysis of Parity and the Development of Type 11 Diabetes Mellitus 
In the following section, we aim to test the hypothesis that an increasing number of 
children was associated with an increasing risk of developing type Il diabetes among 
these older Palestinian women living in refugee camps. The initial results were shown in 
sections 7.6,7.7 and 10.1 but this section takes further the relationship of parity and the 
risk of developing type II diabetes mellitus. This association was assessed using the 
same statistical models as in parity and lipids. 
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The effect of grouped parity on type II diabetes (defined as raised fasting blood sugar 
and/or on medication) was assessed in models controlling for age, women's education, 
husband's years of schooling and marital status and as seen in Table 10-3. The 
unadjusted and adjusted models show no overall statistically significant association, 
p=0.753 and p=0.763 respectively. 
Table 10-3: Unadjusted and adjusted odds ratios for the effect of parity in groups on Diabetes 
(raised FRS > 7.00 mmnl/1. or on medication) 
Raised fasting Blood u gar (FBS) or medication 
Parit n % 
Unadjusted Adjusted 
y 
95% Cl 
OR 
Lower Upper OR Lower Upper 
0 42 21.4 0.80 0.35 1.81 1.12 0.35 3.58 
1-3 38 15.8 0.55 0.21 1.41 0.51 0.17 1.55 
4-6 117 21.4 0.79 0.45 1.41 1.08 0.57 2.04 
7-9 165 21.8 0.81 0.49 1.37 1.01 0.58 1.76 
10+ 153 25.5 1 1 
P-value 0.753 0.763 
Adjustment for age, woman's education, husband's education, and marital status 
In the next two statistical models, the association between parity and fasting blood sugar 
was assessed with parity measured on a continuous scale using ordinary regression with 
FBS introduced into the regression model as both categorical and as a continuous 
variable as in Tables 10-4 and 10-5. When parity as a continuous variable and FBS kept 
as a categorical variable, an apparent non-significant association between parity and 
diabetes was observed in the unadjusted analysis. The change in unadjusted odds of FBS 
>_ 7.00 mmol/L (diabetic) per extra child (unit change in parity) was 1.05 (95% Cl 0.99 
to 1.11, p= 0.108). 
Table 10-4: The change of unadjusted and adjusted odds of increased diabetes per extra child 
95% CI Statistical 
Odds ratio SE 
Lower Upper 
----- 
significance 
Unadjusted 1.05 0.3 0.99 1.11 0.108 
Adjusted for age, educational level, 
husband's years of schooling and 1.02 0.04 0.97 1.1 0.492 
marital status 
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Adjustment for age, women's educational level, husband's years of schooling and 
marital status, did not make noticeable difference to the association and it was 
insignificant as seen in Table 10-4. 
The relationship was next examined with both variables being continuous, using 
censored ordinary regression, and by a scatter diagram as in Table 10-5 and Figure 10-1. 
The scatter diagram does not allow for censoring for those on medication, but 
nevertheless does give a useful picture. The unadjusted regression slope was 0.13 
mmol/L, denoting the predicted rise in fasting blood sugar for a unit rise in parity, (95% 
Cl: 0.04 to 0.22, p=0.004). 
Table 10-5: The Unadjusted and Adjusted Regression Slopes of censored FBS mmol/l, on Parity 
Slope 95% Cl Statistical 
(regression 
coefficient 
SE 
Lower Upper significance 
Unadjusted 0.13 0.05 0.04 0.22 0.004 
Adjusted for age 0.09 0.05 -0.0004 0.18 0.051 
Adjusted for age, educational 
level, husband's years of 
schooling and marital status 
0.10 0.06 -0.02 0.21 0.092 
When adjusted for age, the slope was reduced and the significance of the association just 
disappeared. The adjusted mean increase in censored FBS per additional child was 0.09 
mmol/L, (95% Cl -0.0004 to 0.18, p= 0.051). Adjustment for the other confounders did 
not change the magnitude of the association but it became less significant. Since this left 
us with no evidence of an association between parity and the development of type II 
diabetes mellitus or with fasting blood sugar, investigating the effect of mediators was 
disregarded. 
We also carried out a separate analysis to see if the mean FBS differed among those 
who reported having diabetes, between those taking medication and those not. Results 
indicated higher FBS among those who reported they were taking the medication 
compared to those who did not. These results suggest that, although women reported 
they were meant to be taking these drugs, adherence may have been patchy at best. 
When FBS was regressed on gravidity, the regression coefficient of censored FBS 
increased by 0.015 mmol/L per extra child, (95% Cl: 0.08 to 0.22, p<0.0001). 
Adjustment for confounders did not change the magnitude of the association, and it 
remained significant, while with parity the association disappeared after adjustment, as 
shown above. This led to taking the analysis further as detailed in section 10.3. 
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Figure 10-1 shows the scatter plot of the two variables FBS and parity with the 
regression line and suggests strongly that the linear model is adequate. 
Figure 10-1: Scatter Plot of Fasting Blood Sugar (FBS) and parity 
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10.3 Justification for Taking Gravidity Rather than Parity in the Case of Fasting 
Blood Sugar and Diabetes 
The analysis of fasting blood sugar and diabetes with parity did not suggest any 
evidence of association. However, one observes in Table 10-2 that there appears to be 
an association with gravidity. This contrast between parity and gravidity was not shown 
for the other metabolic outcome measurements, total cholesterol, LDL-C, HDL-C, and 
total cholesterol/HDL-C ratio, which did not show a significant association with either 
parity or gravidity. Triglyceride was the exception as it showed an association with 
gravidity as well as with parity. When medication was included in the definition of 
diabetes, the analysis suggested no significance association between (binary) diabetes 
and gravidity. However in censored regression analysis, a significant association was 
observed between diabetes and gravidity. 
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Purely speculatively, given that the decision to do this was made after the previous 
analysis, this relationship was pursued further. 
As a preliminary to this, the association of FBS with number of failed pregnancies, 
taken as the difference between gravidity and parity was examined. FBS is special in 
that it is related to failed pregnancies, whereas no other metabolic outcome appears to be 
so except for Triglycerides, (p= 0.028 for Triglycerides). When fasting blood sugar was 
regressed in fully adjusted models allowing for censoring, with number of failed 
pregnancies and parity (live births) in the same model, the adjusted coefficient for parity 
was 0.07 mmol/L, p=0.191, and non-significant, whereas that for failed pregnancies was 
0.29 mmol/L, and statistically significant (p= 0.001). 
The relationship between fasting blood sugar and gravidity was then examined with 
both variables being continuous using censored ordinary regression as in Table 10-6. 
The same approach and analysis that was performed in the previous tables looking at 
effects of confounders and role of mediators in the association between gravidity and 
type II diabetes was followed. 
Table 10-6: The unadjusted and adjusted regression slopes of FBS in mmol/L including medication 
.,., . -.,.,;. I; +. 
Slope 95% Cl Statistical 
(regression SE 
Lower Upper significance 
coefficient) 
Unadjusted 0.15 0.04 0.08 0.22 <0.0001 
Adjusted for age, educational 
level, husband's years of 0.14 0.05 0.05 0.23 0.002 
schooling and marital status 
The unadjusted regression slope was 0.15 mmol/L, denoting the predicted rise in fasting 
blood sugar for a unit rise in gravidity, (95% Cl: 0.08 to 0.22, p <0.0001). Adjustment 
for age, women's education, husband's education and marital status reduced slightly the 
magnitude of the association but it remained significant. So confounders could not 
explain the association between gravidity and type 11 diabetes. 
10.4 Other Characteristics and Mediators 
Results for the role of mediators and other correlates are shown in Table 10-7. In these 
regression models, all variables that were significantly associated with type 11 diabetes 
were introduced to test their roles individually and to test if they act as mediators in the 
relationship between gravidity and diabetes. 
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Table 10-7: Effect of mediators along the causal pathway between gravidity (number of 
nreansinriecl sand diahotPe (FRQmmnI/1.1 with medientinn nn the fuliv ssdincterl reoreccinn coefficient 
öö 
Vl w 
95% Cl 
yö 
95% Cl 
Additional 
.ý 
Cä p 
V 
tt p 
characteristics 
(mediators) 
d °' c 
C9o E U) L U 
value 
L U 
value 
4) CD m ao 
U- o 
4) ao c 
ov U M 
Unadjusted 0.15 0.08 0.22 <0.0001 
Fully adjusted 0.14 0.05 0.23 0.002 
FH of diabetes 0.13 0.05 0.22 0.003 1.33 0.63 2.0 <0.0001 
Age at menarche 0.14 0.05 0.23 0.003 -0.26 -0.51 -. 02 0.038 
Failed pregnancy 0.07 -0.04 0.19 0.191 0.21 -0.005 0.43 0.055 Central obesity WC 0.12 0.03 0.22 0.007 0.04 0.007 0.07 0.015 
Abdominal obesity 0 13 0 04 22 0 005 0 12.39 7.01 17.8 <0.0001 W/H ratio . . . . 
Failed pregnancies (the difference between gravidity and parity) seem to have the 
highest mediating effect amongst all mediating variables since it has reduced the 
magnitude of the association to a great extent. This is to be expected as failed 
pregnancies is the component of gravidity that predicts FBS The result here confirms 
that association between gravidity and type 11 diabetes goes through failed pregnancies. 
On the other hand, WC and W/H ratio have slightly reduced the magnitude of the 
association between gravidity and type II diabetes as well, which indicates a partial 
mediating effect for WC and W/H ratio. 
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Chapter 11 
PARITY, DIASTOLIC, SYSTOLIC BLOOD PRESSURE ANI) 
HYPERTENSION 
This chapter examines the relationships among parity, systolic blood pressure (SBP), 
diastolic blood pressure (DBP) and hypertension, investigating the independent relation 
of the number of children to blood pressure and hypertension. Section 11.1 focuses on 
the general characteristics associated with elevated systolic, diastolic blood pressure and 
hypertension. Sections 11.2 and 11.3 explore whether increasing parity leads to a 
subsequent elevation of diastolic and systolic blood pressure in these women. 
11.1 Characteristics Associated with Elevated SBP, DBP and Hypertension 
Results presented in the analysis of blood pressure refer to 513 women out of the 515 
women recruited for the study, two records containing information on SBP and DBP not 
being available. Systolic blood pressure ranged from 78 mmHg to 221 mmHg, with a 
mean of 131 mmHg. Diastolic blood pressure ranged from 53 mmHg to 123.5 mmHg, 
with a mean of 82 mmHg. On the basis of these measurements 434 women were 
classified as normotensive and 81 women (15.7%) as hypertensive. After the inclusion 
of antihypertensive medication in the definition, 295 women were classified as 
normotensive and 220 women (42.7%) as hypertensive, and the mean SBP and DBP 
with correction for censoring among those on medication became 135 mmHg and 84 
mmHg respectively. The characteristics associated with elevated SBP, DBP and 
hypertension is shown in Table 11-1. 
Women with elevated SBP, DBP and hypertension were significantly older, more often 
widowed, less educated, and physically less active with more central and abdominal 
obesity and more frequently menopausal. They had elevated total cholesterol, elevated 
triglycerides and were more frequently diabetic. Women with elevated systolic blood 
pressure tended to be also more obese, diabetic with higher levels of total cholesterol 
and LDL-C. They tended to have more pregnancies that ended as still births and were 
less educated. It is interesting to notice that neither parity nor gravidity has a significant 
association with elevated SBP and DBP. 
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Table 11-1: Characteristics associated with potential risk factors SBP >_ 140 mmHg or on 
medication, DBP? 90 mmHe or on medication, hvpertension > 140/90 mmHe or on medication 
Characteristic 
No 
of 
ome 
n 
SBP > 140 
mmHg or 
on 
medicatio 
n 
(n) % 
P 
DBP>_ 90 
mmHg or 
on 
medicatio 
n 
(n) % 
P 
Blood 
pressure 
z 140/90 
mmHg or 
on 
medicatio 
n 
(n) 
P 
Demographic and so cio-ec onomic varia bles 
Age 0.000 <0.0001 corrected <0.0001 
<45 159 
(28) 
17.6 
(31) 19.5 (34) 21.4 
45-49 115 (42) 
36.5 
(37) 32.2 (47) 40.9 
50.54 110 
49. 
) (47) 42.7 (60) 54.6 
55-59 95 (50) (47) 49.5 (54) 56.8 52.6 
60+ 35 (23) 
65.7 (21) 
60.0 (25) 71.4 
Women's education 0.000 <0.0001 
<0.000 
No formal 119 (55) (49) 41.2 (60) 
education 46.2 50.4 
Elementary 199 (93) 
46.7 (87) 
43.7 
(101) 
50.8 
Secondary 167 264) (42) 25.2 
313) 
Higher education 30 
(5) 
16.7 (5) 16.7 
(6) 20.0 
Marital status 
080 <0.0001 
<0.000 
1 
Married 382 (135) 35.3 (123) 32.2 
(149) 
39.0 
Single 21 (7) 33.3 (6) 28.6 
(7) 
33.3 
Divorced/separat 
ed 
28 (9)32.1 (7) 25.0 
(10) 
35.7 
widowed 84 (46) 54.8 (47) 56.0 
(54) 
64.3 
Currently employed 
0.28 8 0.121 0.241 
No 436 (171) 39.2 (161) 36.9 
(191) 
43.8 
Yes 79 (26) 32.9 (22) 27.9 
(29) 
36.7 
Occupation 0.06 6 0.106 0.144 
Unskilled worker 16 (8) 50.0 (5) 31.3 (8) 50.0 
Skilled worker 14 (3) 21.4 (2) 14.3 
(3) 
21.4 
Employee 24 (4) 16.7 (4) 16.7 
(6) 
25.0 
Private business 25 (11) 44.0 (11) 44.0 
(12) 
48.0 
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Characteristic 
No 
of 
wome 
n 
SBP >_ 140 
mmHg or 
on 
medicatio 
n 
(n) % 
P 
DBP> 90 
mmHg or 
on 
medicatio 
n 
(n) % 
P 
Blood 
pressure 
z 140/90 
mmHg or 
on 
medicatio 
n 
(n) 
P 
Husband's 
education 
0.006 0.033 0.009 
No formal 
education 
85 (38) 44.7 (32) 37.7 
(40) 
47.1 
Elementary 166 (77) 46.4 (72) 43.4 
(86) 
51.8 
Secondary 170 (51) 30.0 (48) 28.2 
(58) 
34.1 
Higher education 58 (18) 31.0 (19) 32.8 
(23) 
39.7 
Husband currently 0.02 004 0 0.002 
e employed 8 . 
Yes 241 (83) 34.4 (72) 29.9 
(91) 
37.8 
No 141 (52) 36.9 (51) 36.2 
(58) 
41.1 
Not applicable 112 (55) 49.1 (54) 48.2 
(64) 
57.1 
Own automatic 0.82 802 0 0.407 
washing machine 6 . 
No 400 
(152) 
38.0 (141) 35.3 
(167) 
41.8 
Yes 115 (45) 39.1 (42) 36.5 
(53) 
46.1 
Family affluence 0.18 0 083 0.047 
scale 3 . 
Poor 225 (76) 33.8 (68) 30.2 
(84) 
37.3 
Average 164 (68) 41.5 (64) 39.0 
(72) 
43.9 
Better off 126 (53) 42.1 (51) 40.5 (64) 50.8 
Behavioural risk fact ors 
Physical activity 0.000 <0.0001 <0.0001 
No 446 (185) 41.6 (173) 38.9 
(206) 
46.3 
Yes 69 (12) 17.4 (10) 14.5 
(14) 
20.3 
Smoking habits 0.83 0.724 0858 
0 
Never smoked 481 (183) 38.1 (173) 36.0 
(204) 
42.4 
Ex-smoker 28 (11) 39.3 (8) 28.6 (13) 46.4 
Current smoker 6 (3) 50.0 (2) 33.3 (3) 50.0 
Watch TV 0.66 6 0.703 0.777 
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No 
Characteristic of 
wome 
n 
SBP >_ 140 
mmHg or 
on 
medicatio 
n 
(n) % 
P 
DBP>_ 90 
mmHg or 
on 
medicatio 
n 
(n) % 
P 
Blood 
pressure 
2: 140/90 
mmHg or 
on 
medicatio 
n 
(n) 
P 
No 31 (13) 41.9 (12) 38.7 (14) 45.2 
Yes 484 (184) 38.0 (171) 35.3 (206) 42.6 
Hourshveek watch 0.02 
TV 7 
0.111 0.201 
<4 24 (14) 58.3 (13) 54.2 
(14) 
58.3 
5-10 150 (45) 30.0 (48) 32.0 
(56) 
37.3 
11-20 133 (52) 39.1 (42) 31.6 (56) 42.1 
21+ 177 (73) 41.2 (68) 38.4 
(80) 
45.2 
Assistance in 0.11 094 0 0 167 house-work 3 . . 
No 142 (46) 32.4 (42) 29.6 (53) 37.3 
Yes 372 (150) 40.3 (140) 37.6 
(166) 
44.6 
Stress level 0.160 0.207 0.310 
No 154 (66) 42.9 (61) 39.6 
(71) 
46.1 
Yes 361 (131) 36.3 (122) 33.8 
(149) 
41.3 
Reproductive Health Factor s 
Parity 0.23 0.849 0.382 
1 
0 42 (11)26.2 (12)28.6 (13) 31.0 
1-3 38 (13) 34.2 (14) 36.8 (14) 36.8 
4-6 117 (40) 34.2 (42) 35.9 
(49) 
41.9 
7-9 165 (67) 40.6 (57) 34.6 
(72) 
43.6 
10+ 153 (66) 43.1 (58) 37.9 (72) 47.1 
Age at 13t marriage, 0.33 0 057 272 0 yrs 2 . . 
<18 232 (84) 36.2 (73) 31.5 
(94) 
40.5 
18+ 262 (106) 40.5 (104) 39.7 (119) 45.4 
Age at Ist birth 
0.98 
2 0.935 0.780 
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Characteristic 
No 
of 
wome 
n 
SBP >_ 140 
mmHg or 
on 
medicatio 
n 
(n) % 
P 
DBP>_ 90 
mmHg or 
on 
medicatio 
n 
(n) % 
P 
Blood 
pressure 
2: 140/90 
mmHg or 
on 
medicatio 
n 
(n) 
P 
:5 18 173 (68) 39.3 (62) 35.8 
(77) 
44.5 
> 18 301 (118) 39.2 (109) 36.2 
(130) 
43.2 
Gravidity 0.06 0.364 0.155 
1 
0 38 (11) 29.0 (12) 31.6 
(13) 
34.2 
1-3 33 (12) 36.4 (12) 36.4 (13) 39.4 
4- 6 65 (20) 30.8 (21) 32.3 (25) 38.5 
7-9 136 (45) 33.1 (41) 30.2 (51) 37.5 
10+ 243 (109) 44.9 (97) 39.9 
(118) 
48.6 
Age at menarche 
0. 14 0.125 0.039 
7 
s 11 39 (17)43.6 (18) 46.2 
(22) 
56.4 
12 108 (50) 46.3 (46) 42.6 
(53) 
49.1 
13 138 (52) 37.7 (49) 35.5 
(61) 
44.2 
14 133 (50)37.6 (43) 32.3 
(54) 
40.6 
15+ 90 (26) 28.9 (25) 27.8 
(28) 
31.1 
History of infertility 
0.67 7 0.759 0.965 
No 441 (171) 38.8 (157) 35.6 
(190) 
43.1 
Yes 53 (19) 35.9 (20) 37.7 
(23) 
43.4 
Pregnancy ended as 
abortion or 
0.11 0.172 0.163 
miscarriage 
6 
No 164 (56) 34.2 (52) 31.7 
(64) 
39.0 
Yes 313 (130) 41.5 (119) 36.0 
(143) 
45.7 
Pregnancy ended as 0 036 0.062 0.067 a stillbirth . 
No 412 (153) 37.1 (141)34.2 
(172) 
41.8 
Yes 65 (33) 50.8 (30) 46.2 
(35) 
53.9 
Have you ever had 0.62 0 740 0.667 
of c stic ovaries 2 . 
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Characteristic 
No 
of 
ome 
n 
SBP >_ 140 
mmHg or 
on 
medicatio 
n 
(n) % 
P 
T 
DBP> 90 
mmHg or 
on 
medicatio 
n 
(n) % 
P 
Blood 
pressure 
>_ 140/90 
mmHg or 
on 
medicatio 
n 
(n) 
P 
No 495 (191) 38.6 (175) 35.6 
(211) 
42.6 
Yes 13 (4) 30.8 (5) 38.5 
(6) 
46.2 
Ever use CP 
0.75 0.566 0.720 
1 
No 306 (119) 38.9 (112) 36.6 
(129) 
42.2 
Yes 208 (78) 37.5 (71) 34.1 
(91) 
43.8 
Have your periods 000 0 <0.0001 <0.0001 
stopped now . 
No 285 (81) 28.4 (75) 26.3 
(92) 
32.3 
Yes 229 (116) 50.7 (108) 47.2 
(128) 
55.9 
Age at menopause 0.74 0.942 0.975 in years 6 
5 44 44 (19)43.2 (21) 47.7 
(24) 
54.6 
45-49 75 (39)52.0 (36) 48.0 
(41) 
54.7 
50-54 95 (50) 52.6 (43) 45.3 
(54) 
56.8 
55+ 15 (8) 53.3 (8) 53.3 (9) 60.0 
Ever used HRT 0.150 0.014 0.043 
No 509 (193) 37.9 (178) 35.0 
(215) 
42.2 
Yes 6 (4) 66.7 (5) 83.3 
(5) 
83.3 
Metabolic risk factor s 
Cholesterol 
001 0 0.050 0.003 (mmol/L) . 
Normal 377 (129) 34.1 (125) 33.2 (147) 39.0 
Elevated 
cholesterol 121 (61) 50.4 (52) 43.0 
(66) 54.6 
LDL-Cholesterol 0.00 0 067 016 0 (mmol/L) 9 . . 
Normal 399 (141) 35.3 (134) 33.6 
(160) 
40.1 
Elevated LDL- 
chol 
99 (49) 49.5 (43) 43.4 
(53) 
53.5 
HDL-Cholesterol 0.74 
0 124 670 0 (mmol/L) 5 . . 
Decreased HDL- 247 (96) 38.9 (96) 38.9 (108) Chol 43.7 
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Characteristic 
No 
of 
wome 
n 
SBP 2: 140 
mmHg or 
on 
medicatio 
n 
(n) % 
P 
DBP>_ 90 
mmHg or 
on 
medicatio 
n 
(n) % 
P 
Blood 
pressure 
2 140/90 
mmHg or 
on 
medicatio 
n 
(n) 
P 
Normal 251 (94) 37.5 (81) 32.3 
(105) 
41.8 
Triglyceride 0.03 0.027 0.036 
(mmol/L) 0 
Normal 343 (120) 35.0 (111) 32.4 
(136) 
39.7 
Elevated TG 155 (70) 45.2 (66) 42.6 
(77) 
49.7 
TChol / LDH-chol 0.99 0.920 0.850 
Normal 325 (124) 38.2 (115) 35.4 
(140) 
43.1 
High risk 173 (66) 38.2 (62) 35.8 (73) 42.2 
Diabetic, % 
z 7.00 mmol/L or on 0.000 0.002 <0.0001 
medication 
No 400 (128) 32.0 (128) 32.0 
(150) 
37.5 
Yes 115 (69) 60.0 (55) 47.8 (70) 60.9 
Anthropometric facto rs 
Central obesity, 
waist circum a 88 0.000 <0.0001 <0.0001 
cm 
Normal 81 (12) 14.8 (10) 12.4 
(14) 
17.3 
WC Z 88 cm 432 (183) 42.4 (171) 39.6 
(204) 
47.2 
BM/ 0.00 0.001 <0.0001 
2 
Non-obese 158 (44) 
27.9 
(39) 
24.7 
(49) 
31.0 
Obese BMI 
2 355 
(151) (142) (169) 
Z30kg/m 42.5 40.0 47.6 
Abdominal obesity, 0 000 <0.0001 <0.0001 WI! -! ratio ý 0.85 cm . 
Normal 247 (68) 27.5 (66) 26.7 (82) 33.2 
WHR ? 0.85 266 (127) 47.7 (115) 43.2 (136) 51.1 
Self rating of obesity 
0.00 <01000 0.002 
Underweight 21 (7) 33.3 (7) 33.3 
(7) 
33.3 
Normal weight 141 (43) 30.5 (41) 29.1 
(51) 
36.2 
Overweight 228 (80) 35.1 (70) 30.7 
(91) 
39.9 
225 
Blood 
SBP >_ 140 DBP>_ 90 pressure 
No mmHg or mmHg or 2: 140/90 
Characteristic of on P on P mmHg or P 
wome medicatio medicatio on 
n n n medicatio 
(n) % (n) % n 
(n) 
Obese 94 (49) 52.1 (46) 48.9 
(51) 
54.3 
Very obese 26 (16) 61.5 (17) 65.4 
(18) 
69.2 
11.2 Further Analysis of Systolic Blood Pressure (SBP) and Parity 
In this section, we aim to test the hypothesis that an increasing number of children is 
associated with an elevation of systolic blood pressure. The initial results concerning 
parity and then women's principal characteristics were shown in sections 7.6 and 7.7 
and this section takes the relationship between parity and SBP further. Table 11-2 shows 
the unadjusted and adjusted effect of parity on the categorisation of raised SBP > 140 
mmHg or on medication, with no significant association seen in the unadjusted odds 
ratios. Before and after adjustment for confounders (age, women's education, husband's 
years of schooling and marital status), the association remained non-significant, p= 
0.238 and p= 0.126 respectively. 
Table 11-2: Unadjusted and adjusted odds ratios for the effect of parity in groups on raised SBP 
Parity n o / 
Raised systolic Blood Pressure (SBP) or medication 
Unadjusted Adjusted 
o 95% Cl 
OR 
Lower Upper OR Lower Upper 
0 42 26.2 0.47 0.22 1.00 0.25 0.06 0.97 
1-3 38 34.2 0.69 0.33 1.44 0.72 0.29 1.78 
4-6 117 34.2 0.69 0.42 1.13 1.05 0.58 1.88 
7-9 165 40.6 0.90 0.58 1.41 1.34 0.81 2.23 
10+ 153 43.1 1 1 
P-value 0.238 0.126 
Adjustment for age, woman's education, husband's education, and marital status 
When parity was taken as a continuous variable and SBP kept as a categorical variable 
as in Table 11-3, an apparent association between parity and SBP was observed in 
unadjusted analysis. The change in odds of SBP >_ 140 mmHg or on medication per 
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extra child (unit change in parity) was 1.06 mmHg (95% Cl 1.01 to 1.11, p=0.027). This 
association was abolished after adjustment for age (data not shown). And when 
women's educational level, husband's years of schooling and marital status were 
introduced into the model as confounders in addition to age, the association remained 
insignificant, as shown in Table ll -3. 
Table 11-3: The change of unadjusted and adjusted odds of increased SBP > 140 mmHg per extra 
rhild 
SE 
95% CI Statistical 
Odds ratio 
Lower Upper significance 
Unadjusted 1.06 0.03 1.01 1.11 0.027 
Adjusted for age, educational level, 
husband's years of schooling and 1.04 0.03 0.97 1.10 0.275 
marital status 
The relationship between systolic blood pressure and parity was also examined with 
both variables being continuous, using a scatter diagram and by censored ordinary 
regression. As with FBS, the scatter diagram does not allow for censoring for those on 
medication, but nevertheless does give a useful picture. An association between parity 
and SBP was observed in the unadjusted analysis. The regression slope was 0.98, 
denoting a predicted rise in systolic blood pressure for a unit rise in parity of 0.98 
mmHg, (95% Cl 0.32 to 1.64, p= 0.004). With adjustment for age, education of both 
woman and husband and marital status, the magnitude of the association was reduced 
and its statistical significance disappeared. The significance was lost with adjustment for 
age alone (not shown in the Table). The difference per increase of one child for age 
adjusted SBP was 0.34, (95% Cl: -0.29 to 0.96, p= 0.289. The scatter diagram with the 
regression line is shown in Figure 11-1. 
Table 11-4: The Unadjusted and Adjusted Regression Slopes of SBP on Parity 
Slope 95% Cl Statistical 
(regression SE Lower Upper significance 
coefficient) 
Unadjusted 0 98 0.34 0.32 1.64 0.004 
Adjusted for age, educational 
level, husband's years of 0.31 0.38 -0.43 1.01 0.407 
schooling and marital status 
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Figure 11-1: Scatter Plot of SBP and Parity 
C) 
04 
04 
0 r' """O"" 
" 
9 S. 
t 
0 
05 10 15 20 
Parity 
" Systolic Blood Pressure mmHg -+-- Fitted values 
There was no evidence for an association between SBP and parity after adjustment for 
confounders, and therefore the effect of mediators was not considered in further 
analysis. 
The mean SBP and DBP were compared among those who reported high blood 
pressure, between those who reported taking medication and those who did not. Women 
who reported taking the medication had higher DBP and SBP, which might suggest poor 
adherence. It is for these reasons that women reporting they were on medication were 
included in the analysis, but with the allowance for censoring to allow for some effect of 
the medication. It is reasonable to conclude that some women might not comply with 
taking the medication on regular basis to reduce their DBP and SBP, but nevertheless 
there would have been some medication effect overall. 
11.3 Further Analysis of Parity and Diastolic Blood Pressure (DBP) 
In this section, we aim to test the hypothesis that an increasing number of children is 
associated with an elevation of diastolic blood pressure. As before, initial results were 
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shown in sections 7-6 and 7-7 and this section takes the relationship between parity and 
DBP further. 
The relationship between unadjusted and adjusted odds ratios for the effect of parity on 
raised DBP (90 mmHg or over or on medication) is shown in Tables 11-5 depicting no 
significant association, p= 0.851 and p for the fully adjusted model = 0.753 respectively. 
Table 11-5: Unadjusted and adjusted odds ratios for the effect of parity in groups on raised DBP 
Raised Diastolic Blood Pressure (DBP) or medication 
Parity n % 
Unadjusted Adjusted 
95% Cl 
OR 
Lower Upper OR Lower Upper 
0 42 28.6 0.66 0.31 _ 1.38 0.70 0.21 2.29 
1-3 38 36.8 0.96 0.45 1.99 1.22 0.50 2.99 
4-6 117 35.9 0.92 0.56 1.51 1.37 0.76 2.46 
7-9 165 34.6 0.86 0.55 1.37 1.18 0.71 1.97 
10+ 153 37.9 1 1 
P-value 0.851 0.753 
Adjustment for age, woman's education, husband's education, and marital status 
When parity was fitted into the regression model as a continuous variable and DBP was 
kept as a categorical variable as in Table 11-6, the unadjusted change in odds of DBP > 
90 mmHg or on medication per extra child (unit change in parity) was 1.02 (95% CI 
0.970 to 1.071, p=0.446), an evidence of no association between parity and DBP in 
unadjusted analysis. Adjustment did not make a difference to the association and it 
remained not significant, as in Table 11-6. 
Table 11-6: The change of unadjusted and adjusted odds of increased DBP> 90 mmHg per extra 
Iii hi 
SE 
95% Cl Statistical 
Odds ratio 
Lower Upper significance 
Unadjusted 1.02 0.03 0.970 1.071 0.446 
Adjusted for age, educational level, 
husband's years of schooling and 0.98 0.03 0.92 1.05 0.572 
marital status 
The relationship between diastolic blood pressure and parity was also examined with 
both variables being continuous, using a scatter diagram and censored ordinary 
regression. The regression slope was 0.27, giving the predicted rise in diastolic blood 
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pressure for a unit rise in parity. However, the standard error of this slope coefficient 
was 0.16 and it was not significant (p=0.094), giving no evidence for an association. 
The scatter diagram does not allow for censoring for those on medication, but 
nevertheless does give a useful picture. The scatter diagram of DPB and parity with the 
regression line is shown in Figure 11-2. 
Figure 11-2: Scatter Plot of DBP and Parity 
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With adjustment for age, women's educational level, husband's years of schooling, and 
marital status, the slope on the fully adjusted model was reduced and remained 
insignificant (p=0.916). 
Table 11-7: The Unadjusted and Adjusted Regression Slopes of DBP on Parity 
Slope 95% Cl Statistical 
(regression SE Lower Upper significance 
coefficient) 
Unadjusted 0.27 0.16 -0.05 0.59 0.094 
Adjusted for age, 
educational level, 0 02 19 0 -0.35 0.39 0.916 husband's years of . . 
schooling and marital status 
There was no evidence for an association between DBP and parity and therefore effects 
of mediators were not considered in further analysis. 
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Chapter 12 
REPORTED CORONARY HEART 1) IS, EASE (CHI)) ANI) PARITY 
So far in the previous sections, we have examined the association between parity and 
CHD risk factors. In this section we investigated the association between parity and 
previous coronary heart disease as reported by the women. Section 12.1 discusses the 
characteristics associated with the reported CHD by women. Section 12.2 discusses the 
hypothesis that says increasing number of children leads to an increase in the risk of 
developing CHD. 
Characteristics associated with reported CHD are shown in Table 12-1. 
12.1 Characteristics Associated With Reported CHD by Women 
Coronary Heart disease was reported by 7.8% of the women. It increased significantly 
with increasing age and with divorced status. Women who reported to have had a CHD 
incidents tended to be older and widowed. Widowed women had the highest reported 
CHD compared to women in the other categories of the marital status. (Table 12-1) 
Moreover, reported CHD increased significantly with less education of both women and 
their husbands. Reported CHD increased with increasing parity starting at parity 4-6. 
Women with parity 0 had the second higher rates of reported CHD at 9.5% followed by 
parity 1-3. This higher incidence of CHD among the 1-3 parity might be due to the fact 
that the majority of widows had 1-3 children, and reported CHD was the highest among 
the widowed. Also reported CHD rates increased with menopausal status. The women, 
who reported that their periods had stopped, had more CHD than those whose periods 
had not. Reported CHD by women increased with elevated SBP, DBP and 
Hypertension. Although these reports of CHD may not be completely reliable, this last 
finding and the fact that less educated women reported more CHD gives support for 
some reliability. 
'f'ahle 12-1: Characteristics Associated N%ith Reported ('111) among Women Aged 40-65 Years 
Characteristics Number of Women with coronary p 
women heart disease (CHD), % value 
Socio-demographic variables 
Age 0.009 
<45 159 (3) 1.9 45-49 115 11 9.6 
50.54 110 (9) 8.2 55-59 95 12 12.6 
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Characteristics 
Number of 
women 
Women with coronary 
heart disease CHD % 
p 
value 
60+ 35 5) 14.3 
--- __ 
Women's education, % <0.0001 
No formal education 119 (19) 16.0 
Elementary 199 (15) 7.5 
Secondary 167 (6) 3.6 
Higher education 30 (0) 0.0 
Marital status 0.001 
Married 382 (24) 6.3 
Single 21 (0) 0.0 Divorced/separated 28 (1) 3.6 Widowed 84 (15) 17.9 
Currently employed 0.059 
No 436 (38) 8.7 Yes 79 2 2.5 
Occupation 0.482 
Unskilled worker 16 (0 0.0 
Skilled worker 14 (1) 7.1 Employee 24 0 0.0 
Private business 25 (1) 4.0 
Husband's education 0.016 
No formal education 85 (13) 15.3 Elementary 166 15 9.0 
Secondary 170 10 5.9 
Higher education 58 (1) 1.7 
T 
Husband currently employed 0.022 
Yes 241 (14) 5.8 No 141 (10) 7.1 Not applicable 112 (16) 14.3 
Own automatic washing machine 0.979 
No 400 (31) 7.75 Yes 115 (9) 7.83 
Family affluence scale 0.966 
Poor 225 (18) 8.0 Average 164 (12) 7.3 Better off 126 (10) 7.9 
Behavioural risk factors 
Physical actives 0.508 
No 445 (36) 8.1 Yes 69 (4) 5.8 
Smoking status 0.506 
Never smoked 481 (38) 7.9 
-_ Ex-smoker 6 1 16.7 
Current smoker 28 1 3.6 
Watch TV 0.270 
No 
L- a 
31 (4) 12.9 -a 
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Characteristics 
Number of 
women 
Women with coronary 
heart disease CHD , 
/o 
P 
value 
Yes 484 (36ý__ 
_ 
7.4 
Hours/week watch TV _ 
0.058 
4 24 (5) 20.8 
5-10 150 (8) 5.3 
11-20 133 (11) 8.3 
21+ 177 (12) 6.8 
Stress level 
Human loss and trauma to study 
subject-1 
0.163 
No 286 18 6.3 
Yes 229 (22) 9.6 
- 
Human loss and trauma to family 
member-2 
0.858 
No 328 26 7.9 
Yes 187 (14) 7.5 
Pro e loss to subject-3 0.304 
No 510 (39) 7.7 
Yes 5 (1) 20.0 
Work related problems-4 
0.412 
No 398 (33) 8.3 
Yes 117 (7) 6.0 
All events combined (1-16) 0.287 
No 154 (9) 5.8 
Yes 361 (31) 8.6 
Assistance in housework 0.721 
No 142 9 6.3 
Yes 372 (31) 8.3 
Reproductive health variables 
Parity 
0 42 (4) 9.5 
1-3 38 (3) 7.9 
0.038 
4-6 117 (5) 4.3 
7-9 165 (8) 4.9 
10+ 153 (20) 13.1 
Age at 1s marria e, years 
0.464 
<18 232 (21) 9.1 
18+ 262 19 7.3 
Aea1S birth 0.303 
s 18 173 16 9.3 
> 18 301 20 6.6 
Gravidity 5 0.293 
0 38 (2) 5.3 
1-3 33 3 9.1 
4- 6 65 (4) 6.2 
7-9 136 (6) 4.4 
233 
Characteristics 
Number of 
women 
Women with coronary 
heart disease CHD % 
p 
value 
10+ 243 
_ 
J25Z 
_- 
10.3 
Age at menarche, years 0.281 5 11 39 (3) 7.7 12 108 (6) 5.6 13 138 (8) 5.8 14 133 (16) 12.0 15+ 90 (6) 6.7 
Did you have problems getting pregnant 0.363 No 441 (34) 7.7 Yes 53 (6) 11.3 
Pregnancy ended as abortion or 
miscarriage 
0.275 
No 164 (10) 6.1 Yes 313 (28) 9.0 
Pre nano ended as a stillbirth 0.930 
No 412 (33) 8.0 Yes 65 (5) 7.7 
Have you ever had of c stic ovaries 0.548 
No 496 37 7.5 
Yes 13 2 15.4 
Ever use CP 0.463 
No 306 (26) 8.5 Yes 208 (14) 6.7 
Have your periods stopped now 0.017 No 285 (15 5.3 
Yes 229 (25 10.9 
Age at menopause in years 0.168 
544 44 (2) 4.6 4549 75 (11 14.7 
50-54 95 (12) 12.6 55+ 15 (0) 0.0 
Metabolic risk factors 
Cholesterol mmol/L 0.079 
Normal 377 (25) 6.6 Elevated cholesterol 121 (14) 11.6 
LDL-Cholesterol mmol/L 0.175 
Normal 399 [ (28) 7.0 
Elevated LDL-chol 99 (11) 11.1 
HDL-Cholesterol mmo/L 0.909 
Normal 251 (20 8.0 
Decreased HDL-Chol 247 (19) 7.7 
Triglyceride mmol/L 0.502 
Normal 343 
- 
(25ý----- 
-- 
7.3 
Elevated TG 155 14 9.0 
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Characteristics 
Number of 
women 
Wonnen with coronary 
heart disease (CHD), % 
p 
value 
T-CholesteroULDH-C ratio 0.874 
Normal 325 (25) 7.7 High risk 173 (14) 8.1 
DBP mmH g 0.007 Normal 332 18 5.4 
Elevated DBP Z 90 
mmHg/medication 
183 (22) 12.0 
SBP mmHg 
_ 
0.009 
Normal 318 _ (17) 5.4 
Elevated SBP z 140 
mmHg/medication 
197 (23) 11.7 
- 
Hypertension 0.008 
Normal 295 5.1 (15) 
Hype rtensive/med ication 220 (25) 11.4 
Diabetic a 9mmol/L or medication 0.414 
Normal 400 (29) 7.3 Elevated FBS 115 (11) 9.6 
Central obesity, WC z 88 cm 0.296 
Normal 81 4 4.9 
WC Z 88 cm 432 (36) 8.3 
BM/ 0.808 
Non-obese 158 (13) 8.2 Obese BMI Z30k m 355 (27) 7.6 
Abdominal obesity, 
W/Hratio Z0.85cm 
Normal 247 (16) 6.5 
0.283 
WHIR z 0.85 266 (24) 9.0 
Self rating of obesity 0.305 
Underweight 21 (4) 19.1 Normal weight 141 9 6.4 
Overweight 228 (16) 7.0 
Obese 94 (8) 8.5 
_ 
Very obese 26 (3) 11.5 
Family histo of heart diseases 0.642 
- No 389 7.5 (?! 
Yes 126 -_ 018.7 
12.2 Further Analysis of Parity and Reported CHI) 
In this section, we aim to test the hypothesis that increasing number of children is 
associated with an increasing risk of a woman reporting present or past CHD. We have 
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used the same statistical methods as in the previous chapters for assessing the 
association between parity and reported CHD. 
Tables 12-2 shows the unadjusted and adjusted relationships between reported CHD and 
parity in groups. The table shows that there was a significant association between parity 
and reported CHD, P=0.043 in the unadjusted model. Going from parity 10+, the odds 
ratios decreased, but increased slightly at parity 1-3 and parity 0. The confidence 
intervals suggested a statistically significant association at parity 7-9 and 4-6, and the 
percentages reporting CHD were lowest in these groups. 
Table 12-2: Unadjusted and adjusted Odds Ratio for the Effect of parity in groups on Reported 
Reported corona heart disease 
Parity n % 
Unadjusted Adjusted 
95% Cl OR 
Lower Upper OR Lower Upper 
0 42 9.52 0.7 0.23 2.17 1.70 0.42 6.90 
1-3 38 7.89 0.57 0.16 2.03 0.64 0.158 2.63 
4-6 117 4.27 0.30 0.11 0.82 0.30 0.09 0.99 
7-9 165 4.85 0.34 0.145 0.79 0.40 0.16 0.99 
10+ 153 13.07 1 1 
P-value 0.043 0.082 
Adjustment for age, woman's education, husband's education, and marital status 
Adjustment for age reduced the association between parity and reported CHD (data not 
shown in table 12-2) and it was no longer significant. Adjustment for the other 
confounders as well did not change the non significant effect. 
When parity was fitted into the regression model as a continuous variable and reported 
CHD was kept as a categorical variable as in Table 12-3, the change in the unadjusted 
odds of CHD events per extra child was 1.05 (95% Cl: 0.96-1.15, p=0.249). Adjustment 
for age, women's education, husband's years of schooling and marital status reduced 
slightly the magnitude of the association but it remained insignificant. 
Table 12-3: The Change of Unadjusted and Adjusted odds of Reported CHID per Extra Child 
Odds 95% Cl Statistical 
ratio 
SE 
Lower Upper si nificance 
Unadjusted 1.05 0.05 0.96 1.15 0.249 
Adjusted for age, educational level, 
husband's years of schooling and 1.01 0.05 0.91 1.11 0.886 
marital status 
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Chapter 13 
PARITY AN D THE METABOLIC SYNDROME 
The metabolic syndrome as defined by the International Diabetes Federation (IDF), 
describes the co-occurrence of abnormalities in glucose and lipid metabolism, central 
fat distribution and blood pressure. 
In the previous sections, we have examined the association between parity and the 
risk factors for CHD which make up the different components of the metabolic 
syndrome. In this section we aim to examine if parity plays any role in the 
development of the metabolic syndrome as such. Section 13.1 sheds lights on the 
characteristics associated with the metabolic syndrome. Section 13.2 examines the 
relationship between parity and the combination of these risk factors according to the 
IDF definition that was described in Appendix 2. 
13.1 Characteristics Associated with the Metabolic Syndrome 
The metabolic syndrome was presented in 58.3% of the women. In bivariate analysis, 
women with the metabolic syndrome had significantly higher parity and higher 
gravidity, p= 0.003 and p= 0.024 respectively. As shown in Table 13-1, women with 
the metabolic syndrome were significantly older and less likely to have secondary or 
higher education, were currently unemployed and more likely to be assisted by their 
daughters or daughters in laws at home, and therefore more likely to be physically 
inactive. They tended to have elevated DBP, SBP and hypertension and were more 
frequently menopausal. They tended to have higher rates of obesity, central and 
abdominal obesity compared to those women without the metabolic syndrome. The 
metabolic syndrome was more prevalent among married and widowed women. 
Differences between those with and without the metabolic syndrome, with respect to 
several socio-demographic, reproductive and behavioural risk factors are shown in 
Table 13-1. 
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Table 13-1: Characteristics Associated with the Metabolic Syndrome among Women 
Women 
Women 
with 
Characteristics Number of metabolic without P- value* 
women syndrome 
metabolic 
a syndrome, 
% 
do 
Socio-demographic variables 
Age <0.0001 
<45 154 (58) 37.7 (96) 62.3 
45-49 111 (66) 59.5 (45) 40.5 
50.54 105 (72) 68.6 (33) 31.4 
55-59 91 (67) 73.6 (24) 26.4 
60+ 34 (26) 76.5 (8) 23.5 
Women's education, % <0.0001 
No formal education 113 (79) 69.9 (34) 30.1 
Elementary 194 (126) 65.0 (68) 35.0 
Secondary 161 (78) 48.5 (83) 51.5 
Higher education 28 (6) 21.4 (22) 78.6 
Marital status 0.045 
Married 371 (212) 57.1 (159) 42.9 
Single 21 (11) 52.4 (10) 47.6 
Divorced/separated 26 (11) 42.3 (15) 57.7 
widowed 78 (55) 70.5 (23) 29.5 
Currently employed 0.014 
No 421 (255) 60.6 (166) 39.4 
Yes 75 (34) 45.3 (41) 54.7 
Unskilled worker 
Skilled worker 
Employee 
Private business 
Husband's education 
No formal education 
Elementary 
Secondary 
Higher education 
Husband currently employed 
Yes 
No 
Not applicable 
Own automatic washing 
machine 
No 
Yes 
Family affluence scale 
Poor 
Average 
Better off 
0.425 
15 (9) 60.0 (6) 40.0 
13 (5) 38.5 (8) 61.5 
23 (8) 34.8 (15) 65.2 
24 (12) 50.0 (12) 50.0 
80 (52) 65.0 (28) 35.0 
160 (100) 62.5 (60) 37.5 
167 (92) 55.1 (75) 44.9 
54 (25) 46.3 (29) 53.7 
237 (133) 56.1 (104) 43.9 
134 (79) 59.0 (55) 41.0 
104 (66) 63.5 (38) 36.5 
387 (232) 60.0 (155) 40.0 
109 (57) 52.3 (52) 47.7 
218 (128) 58.7 (90) 41.3 
157 (89) 56.7 (68) 43.3 
121 (72) 59.5 (49) 40.5 
0.088 
0.445 
0.152 
0.880 
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Characteristics Number of 
women 
Women 
with 
metabolic 
syndrome 
Women 
without 
metabolic 
syndrome, % 
P- value* 
Behavioural risk factors 
Physical activity <0.0001 
No 429 (266) 62.0 (163) 38.0 
Yes 66 (23) 34.9 (43) 65.1 
Smoking status 0.909 
Never smoked 463 (269) 58.1 (194) 41.9 
Ex-smoker 6 (4) 66.7 (2) 33.3 
Current smoker 27 (16) 59.3 (11) 40.7 
Watch TV 0.728 
No 29 (16) 55.2 (13) 44.8 
Yes 467 (273) 58.5 (194) 41.5 
Hour&week watch TV 0.445 
<4 23 (16) 69.6 (7) 30.4 
5-10 144 (78) 54.2 (66) 45.8 
11-20 129 (79) 61.2 (50) 38.8 
21+ 171 (100) 58.5 (71) 41.5 
Stress level 0.096 
All events combined 
No 142 (91) 64.1 (51) 35.9 
Yes 354 (198) 55.9 (156) 44.1 
Assistance in housework 0.019 
No 131 (65) 49.6 (66) 50.4 
Yes 365 (224) 61.4 (141) 38.6 
Reproductive health variables 
Parity 
0 40 
1-3 33 
4-6 110 
7-9 160 
10+ 153 
Age at 1 S' marriage, years 
<18 227 
18+ 248 
Age at Ist birth 
s 18 168 
> 18 289 
Gravidity 5 
0 36 
1-3 29 
4-6 60 
7-9 130 
10+ 241 
(21) 52.5 (19) 47.5 
(11) 33.3 (22) 66.7 
(62) 56.4 (48) 43.6 
(90) 56.3 (70) 43.7 
(105) 68.6 (48) 31.4 
(141) 62.1 (86) 37.9 
(137) 55.2 (111) 44.8 
(107) 63.7 (61) 36.3 
(161) 55.7 (128) 44.3 
(20) 55.6 (16) 44.4 
(10) 34.5 (19) 65.5 
(30) 50.0 (30) 50.0 
(76) 58.5 (54) 41.5 
(153) 63.5 (88) 36.5 
0.003 
0.129 
0.095 
0.024 
239 
Women 
Women 
Number of Characteristics 
with 
metabolic without P- value" 
women 
syndrome 
metabolic 
% a 
syndrome, % 
Age at menarche, years 0.127 
511 37 (19) 51.4 (18) 48.6 
12 103 (69) 67.0 (34) 33.0 
13 132 (81) 61.4 (51) 38.6 
14 131 (72) 55.0 (59) 45.0 
15+ 87 (44) 50.6 (43) 49.4 
Did you have problems getting 
pregnant 
No 425 (254) 59.8 (171) 40.2 
Yes 50 (24) 48.0 (26) 52.0 
Pregnancy ended as abortion 
or miscarriage 
0.110 
0.149 
No 156 (84) 53.9 (72) 46.1 
Yes 304 (185) 60.9 (119) 39.1 
Pregnancy ended as a stillbirth 0.156 
No 397 (227) 57.2 (170) 42.8 
Yes _ 63 (42) 66.7 (21) 33.3 
Have you ever had polycystic 0.359 
ovaries 
No 476 (276) 58.0 (200) 42.0 
Yes 13 (9) 69.2 (4) 30.8 
Ever use CP 0.868 
No 291 (169) 58.1 (122) 41.9 
Yes 204 (120) 58.8 (84) 41.2 
Have your periods stopped now <0.0001 
No 277 (138) 49.8 (139) 50.2 
Yes 218 (150) 68.8 (68) 31.2 
Age at menopause in years 0.056 
s 44 42 (23) 54.8 (19) 45.2 
45-49 72 (47) 65.3 (25) 34.7 
50-54 89 (69) 77.5 (20) 22.5 
55+ 15 (11) 73.3 (4) 26.7 
Metabolic risk factors 
Cholesterol (mmol/L) 0.001 
Normal 376 (204) 54.3 (172) 45.7 
Elevated cholesterol 120 (85) 70.8 (35) 29.2 
LDL-Cholesterol (mmol/L) <0.0001 
Normal 398 (214) 53.8 (184) 46.2 
Elevated LDL-chol 98 (75) 76.5 (23) 23.5 
HDL-Cholesterol (mmol/L) <0.0001 
Normal 250 (110) 44.0 (140) 56.0 
Decreased HDL-Chol 246 (179) 72.8 (67) 27.2 
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Characteristics 
Women 
Number with of 
metabolic 
women syndrome 
o 
Women 
with out 
metabolic 
syndrome, % 
P- value* 
Triglyceride (mmol/L <0.0001 
Normal 341 (137) 40.2 (204) 59.8 
Elevated TG 155 (152) 98.1 (3) 1.9 
T-Cholesterol/LDH-C ratio <0.0001 
Normal 324 (156) 48.2 (168) 51.8 
High risk 172 (133) 77.3 (39) 22.7 
DBP mmHg <0.0001 
Normal 321 (145) 45.2 (176) 54.8 
Elevated DBP z 90 175 (144) 82.3 (31) 17.7 
mmHg/or on medication 
SBP mmHg <0.0001 
Normal 308 (133) 43.2 (175) 56.8 
Elevated SBP z 140 mmHg 188 (156) 83.0 (32) 17.0 
or on medication 
Hypertension <0.0001 
Normal 285 (112) 39.3 (173) 60.7 
Hypertensive 212 (177) 83.9 (34) 16.1 
Diabetic 27.00 mmol/L or on 
medication 
Normal 399 
Elevated FBS 97 
Anthropometric Factors 
Central obesity, WC Z 88 cm 
Normal 79 
WC Z 88 cm 417 
BMI 
Non-obese 153 
Obese BMI Z30kg/m2 343 
Abdominal obesity, W/H ratio z 
0.85 cm 
Normal 242 
WHRZ0.85 254 
Self rating of obesity 
Underweight 20 
Normal weight 137 
Overweight 217 
Obese 93 
Very obese 24 
Components of the metabolic syndrome as 
Fasting glucose z 5.6 mmol/L 
(100 mg/dl) 
<0.0001 
(198) 49.6 (201) 50.4 
(91) 93.8 (6) 6.2 
<0.0001 
(16) 20.3 (63) 79.7 
(273) 65.5 (144) 34.5 
<0.0001 
(64) 41.8 (89) 58.2 
(225) 65.6 (118) 34.4 
<0.0001 
(112) 46.3 (130) 53.7 
(177) 69.7 (77) 30.3 
0.010 
(6) 30.0 
(72) 52.6 
(128) 59.0 
(61) 65.6 
(18) 75.0 
defined by IDF 
(14) 
(65) 
(89) 
(32) 
(6) 
70.0 
47.4 
41.0 
34.4 
25.0 
Normal 354 (152) 42.9 (202) 57.1 
Elevated FBS 142 (137) 96.5 (5) 3.5 
<0.0001 
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Characteristics Number of 
women 
Women 
with 
metabolic 
syndrome 
Women 
without 
metabolic 
syndrome, % 
P- value* 
DBP z 85 mmHg <0.0001 
Normal 317 (135) 42.6 (182) 57.4 
Elevated DBP Z 85 mmHg 179 (154) 86.0 (25) 14.0 
SBP z 130 mmHg <0.0001 
Normal 273 (96) 35.2 (177) 64.8 
Elevated SBP a 130 mmHg 223 (193) 86.6 (30) 13.4 
Hypertension z 130185 mmHg <0.0001 
Normal 248 (76) 30.7 (172) 69.3 
Hypertensive 248 (213) 85.9 (35) 14.1 
Fasting HDL-C < 1.3 mmol/L <0.0001 
(50 mg/dl) 
Normal 110 (21) 19.1 (89) 80.9 
Decreased HDL-Chol 386 (268) 69.4 (118) 30.6 
Fasting Triglyceride Z 1.7 <0.0001 
mmol/L (150 mg/dl) 
Normal 341 (137) 40.2 (204) 59.8 
Elevated TG 155 (152) 98.1 (3) 1.9 
Waist circumference z 80 cm <0.0001 
Normal 31 (0) 0.0 (31) 100.0 
WC Z 80 cm 465 (289) 62.2 (176) 37.8 
F value compare those with the metabolic syndrome to those without the metabolic syndrome, are 
results of x2 statistics for categorical variables. 
13.2 Further Analysis of Parity and the Metabolic Syndrome 
In this final section, we aim to test the hypothesis that an increasing number of 
children is associated with an increasing prevalence of the metabolic syndrome. The 
same statistical methods as in the previous chapter of parity and reported CHD were 
used in assessing the association between parity and the prevalence of the metabolic 
syndrome. 
A significant association between parity in groups and the prevalence of the metabolic 
syndrome was observed, p=0.024 as shown in Table 13-2. The prevalence of the 
metabolic syndrome decreases with less parity and rises again at parity 0. Adjustment 
for age increased slightly the magnitude of the association and the association 
remained significant, p=0.038. Adjustment for educational level attenuated the 
242 
association to the null hypothesis more and it became non significant, p= 0.141, 
(results not shown). Further adjustments for husband's educational level and marital 
status did not make a difference to the magnitude of the association and it remained 
non significant as shown in Table 13-2. 
Table 13-2: Unadjusted and adjusted Odds Ratio for the Effect of Parity in groups on the 
Prevolen«e of flu- 11f"t: hnIiý ýý nýlrnntc 
Prevalence of metabolic syndrome (MS) 
Parity n % 
Unadjusted Adjusted 
95% Cl 
OR 
Lower Upper OR Lower Upper 
0 40 52.5 0.51 0.25 1.02 0.56 0.18 1.70 
1-3 33 33.3 0.23 0.10 0.51 0.28 0.11 0.72 
4-6 110 56.4 0.59 0.36 0.98 0.90 0.50 1.62 
7-9 160 56.3 0.59 0.37 0.93 0.70 0.42 1.15 
10+ 153 68.6 1 1 
P-value 0.024 0.076 
Adjustment for age, woman's education, husband's education, and marital status 
When parity was fitted into the regression model as a continuous variable with the 
prevalence of the metabolic syndrome kept as a binary variable as in Table 13-3, the 
change in the unadjusted odds of the metabolic syndrome per extra child was 1.09 
(95% CI: 1.04 to 1.15, p=0.001). Adjustment for age reduced the magnitude of the 
association, but it remained significant, p= 0.028. A 7% increase in the prevalence of 
the metabolic syndrome per extra child was observed when the association was 
adjusted for age, women and husband's education and marital status, p= 0.042. 
Table 13-3: The Change of Unadjusted and Adjusted Odds of the Prevalence of Metabolic 
Cýrnrlrn 
nr. r rin r" 
V#W-a Ch l1 
Odds 95% Cl Statistical 
ratio 
SE 
Lower Upper significance 
Unadjusted 1.09 0.03 1.04 1.15 0.001 
Adjusted for age, educational level, 
husband's years of schooling and 1.07 0.04 1.00 1.14 0.042 
marital status 
13.3 Other Characteristics and Mediators 
The analysis is taken further, and details of the role of mediators and other correlates 
are shown in Table 13-4. In these regression models, all variables that were 
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significantly associated with the prevalence of the metabolic syndrome were 
introduced into the model separately to test their roles individually and to test if they 
act as mediators in the relationship between parity and the metabolic syndrome. Only 
those that still showed a significant association with metabolic syndrome were kept in 
the model. 
None of the changes in the odds ratio for parity were very marked. With physical 
activity and abdominal obesity it changed only from 1.07 to 1.06. For overall obesity 
(BMI > 30 kg/m2), the change was from 1.07 to 1.05, suggesting a possible small 
mediation from this source. It is interestingly noticeable that BMI is highly correlated 
with WC, a component of the definition of the metabolic syndrome, and therefore its 
role here is very trivial. 
Table 13-4: Effect of Mediators along the Causal Pathway Between Parity and the Metabolic 
Syndrome after Adjusting for Confounders Age, Women and Husband's Education and Marital 
cradle 
Change in 
Change in 95% Cl odds of 95% Cl 
Additional odds of positive 
characteristics positive 
P 
value 
MS for 
P 
Value (mediators) MS per lower upper change 
in Lower Upper 
extra child the 
mediator 
Unadjusted 1.09 1.04 1.15 0.001 
Fully adjusted 1.07 1.00 1.14 0.042 
Physical 
activity 
1.06 0.995 1.14 0.066 0.37 0.20 0.69 0.002 
Obese 1.05 0.979 1.12 0.175 2.23 1.42 3.51 0.001 
Abdominal 
obesity 
1.06 0.997 1.14 0.063 2.03 1.35 3.07 0.001 
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Chapter 14 
Discuss ION 
This discussion summarizes the main findings; it then addresses the uniqueness of the 
study and then some methodological considerations, including the strengths and 
limitations of the approaches used. This is followed by an interpretation of the results 
regarding the association between parity and each CHD risk factors, reported CHD 
and the metabolic syndrome. Finally the implications of the results of the study for 
public health and research are presented. 
14.1 Summary of Main Findings within the context of Arab Women 
A total of 515 women from two refugee camps, Amaari and Kalandia, participated in 
the study. The majority of the women in the study were married at a younger age than 
the national average of 19.4 years. Approximately 59% of women who were ever 
married had married young, below or at the age of 18 years (the minimum age at first 
marriage was 11.5 and maximum age was 41 years). Of these 23.7% married early, 
below 16 years of age. They were also married at a younger age than neighbouring 
Arab countries, where early marriage is seeing a downward trend-most notably in 
Kuwait, Libya, and the United Arab Emirates. For the region as a whole, women are 
marrying later (some in their late 20s or early 30s), and some women are not marrying 
at all. In Tunisia, Algeria, and Lebanon, only 1%-4% of women ages 15 to 19 are 
married, and the percentage of women ages 35 to 39 who have never married in these 
countries now ranges from 15 percent to 21 percent [281 ]. This is dramatically lower 
than the women surveyed, where over 40% were married by the age of 18, and only 
4% were not married at all. 
The majority were married and living with their husbands, and the average family size 
was 7.4. Compared to Arab women, Palestinian women share high fertility rates and 
correspondingly high birth rates; this is a direct effect of early marriage. This 
relatively high rate of early marriage is due largely to custom and to the economic and 
social constraints which oblige parents to marrying their daughters in order to lessen 
household expenditures. Early marriage has a direct correlation to higher birth rates. 
In the study, the number of children per woman ranged from 0 to 21. The women 
surveyed were found to have born on average 7.3 live children in their lifetime 
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(median 8). This is also significantly higher than the national average. The crude 
birth rate in 2006 was 36.7 (41.7 in Gaza Strip and 33.7 in West Bank) per 1000 
population [181. The fertility rate in 2006 was also high at 4.6 births per woman (5.4 
in the Gaza Strip and 4.2 in the West Bank) [17] [19]. 
Birth rates differ greatly from one Arab country to the next. The fertility rate in the 
Arab world, ie 3.5 births per woman, is higher than the world's average of 2.7 [282]. 
Some Arab countries, notably Tunisia, the United Arab Emirates, Bahrain, Kuwait 
and Lebanon, are either below or very close to that stability level of 2.1. Algeria and 
Morocco, at 2.4, are dropping fast toward it [283]. This is significantly lower than 
Palestine's average of 4.6. 
Marriage was not the only area where the Palestinian women in the study differed 
from the national average or those of their Arab neighbours. The refugee women's 
participation in the labour force was low and the vast majority (84.7%) were 
unemployed. Out of the 79 study women employed, 20.3% were unskilled workers 
and 31.6% worked in small private businesses. Compared to the national average of 
14.1%, employed women in the study are faring slightly better with a percentage 
15.3% of the women in employment. However, Palestinian women's participation in 
the labour force was much lower than their Arab neighbours. In Lebanon, 29% of 
women are employed, and almost 25% of them worked in the professional sector. 
Morocco has an even higher rate of working women, where 35% of women are 
employed. One-third of doctors and one-quarter of university professors in Morocco 
are women. In Syria and Algeria, 28% and 36% of women are employed respectively 
[284]. 
Although Palestinian women lagged behind the region in women in the labour force, 
they are faring better in the realm of education. Approximately 75% of the women in 
the refugee camp had some formal education, 23% had none, and the former only had 
a mean of 5.62 years of education. This is somewhat lower than the national average 
where 88% of Palestinian women are literate, indicating a higher rate of education 
[285]; however, it remains higher than the regional average for literacy rates. 
For the majority of Arab countries, the proportion of illiterate women constitutes 
between a third and two-thirds of adult women with a significant difference between 
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women and men. Female literacy rates for girls 15 and over in the Arab world ranges 
from 24% (Iraq) to 85.9 percent (Jordan). The most recent data reveals that such 
literacy rates range from 80% and above in ten countries (Jordan, United Arab 
Emirates, Bahrain, Saudi Arabia, Syria, Kuwait, Lebanon, Qatar, Palestine and 
Libya), which are relatively small states with the exception of Saudi Arabia, to less 
than 75% in nine other countries with large populations, with Iraq and Yemen 
standing as low as 40% and 49% respectively [286]. 
While literacy rates are improving, noncommunicable diseases are increasing across 
the board in the Arab World. In Jordan, for example, the leading cause of reported 
deaths for males (37.9%) and females (38.6%) are those related to diseases of the 
cardiovascular system [287]. 
According to the World Health Organization strategy At a Glance, amongst 
Palestinian refugees, noncommunicable diseases are the major causes of mortality 
(heart disease 19.1%, cerebrovascular conditions 8.2%, cancers 9.9%, and a sharp 
increase in accidents from 9 per 100 000 in 1995 to 32.2 per 100 000 in 2004 [288]. 
Weight, BMI, and waist circumference, are among the risk factors for cardiovascular 
disease under study for their associations with parity. In our study, the average weight 
of the women was 80.6 kg and height was 1.56 metres, resulting in a mean BMI of 
33.3 kg/m2. Using BMI> 30 kg/m2 to indicate overall obesity, the majority of the 
women (69.2%) were obese. The women's mean waist circumference was 98.0 cm, 
mean hip circumference was 115.5 cm, and mean waist to hip ratio was 0.85 cm. The 
prevalence of central obesity (WC > 88 cm) was 84.2% and the prevalence of 
abdominal obesity (W/H ratio 2: 0.85 cm) was 51.9%. The majority of women were 
obese whether in terms of overall obesity or abdominal adiposity. 
The prevalence of hypertension and diabetes including those on medication was 
42.7% and 22.3%, respectively. The women's lipid profile was as follows: 24.3% had 
elevated total cholesterol, 31.1% had elevated triglycerides, and 49.6% had HDL-C 
levels below 1 mmol/L (40 mg/dl). The women had mean fasting plasma insulin of 
9.5 Ulu/mi. 
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The metabolic syndrome was found in 58.3% of the women and 7.8% reported having 
had a CHD event. Using the Framingham risk score and excluding those women who 
already have a CHD event from the analysis, 5.7% of women were found to be at high 
risk for the development of CHD in 10 years, and 16.9% at medium risk of 
developing CHD in 10 years. 
The analysis indicates a significant association of BMI, WC with parity, independent 
of socioeconomic, behavioural and other reproductive risk factors. The adjusted 
regression coefficient of BMI on parity is 0.30 (95% CI: 0.14 to 0.47, p<0.001); and 
the adjusted regression coefficient of WC is 0.58 (95% Cl: 0.25 to 0.91, p= 0.001). 
Other covariates that may have acted as mediators did not explain these associations, 
except for assistance in housework (where it partially accounted for some effect, but 
the association still remained significant. The adjusted regression coefficient of 
assistance in household on BMI and WC is 0.23 (95% Cl: 0.060 to 0.40, p=0.008) and 
0.43 (95% CI: 0.09 to 0.76, p=0.013) respectively. The study did not provide evidence 
of an association between W/H ratio and parity. The adjusted regression coefficient of 
W/H ratio on parity is 0.0010 (95% CI: -0.0009 to 0.0028, p=0.308). 
The results also show that among the lipid and lipoproteins levels, only triglycerides 
were significantly associated with parity (adjusted regression coefficient is 0.036 
(95% CI= 0.003 to 0.068, p=0.033), and the association appears to be mediated 
partially by BMI (adjusted regression coefficient is 0.027 (95% Cl: -0.006 to 0.060, 
p= 0.111) and WC (adjusted regression coefficient is 0.025 (95% CI: -0.008 to 0.057, 
p=0.137) and sedentary life style (adjusted regression coefficient is 0.025 (95% CI: - 
0.009 to 0.058, p= 0.147); and finally by being diabetic (adjusted regression 
coefficient is 0.028 (95% CI: -0.003 to 0.059, p= 0.078). 
An unadjusted association between the T-CHOL/HDL-C ratio and parity was 
observed. However, this was attenuated after adjustment for age, and was completely 
removed (regression coefficient 0.008 [95% CI: 0.0006 to 0.002, p=0.282]) after 
adjustment for women's educational level, husband's years of schooling and marital 
status, as in Table 9-17. 
No significant association was observed between parity and type 2 diabetes mellitus 
after adjustment for age. However, a statistically significant association between 
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gravidity and type 2 diabetes was observed in unadjusted and adjusted analyses 
(adjusted regression coefficient is 0.14 (95% CI: 0.05 to 0.23, p=0.002). There was 
also an association with presumed pregnancy losses, calculated by subtracting parity 
from gravidity; this suggests a role of failed pregnancies in the risk of diabetes, 
although these results should be regarded with caution because an association of 
diabetes and gravidity, but not parity, was not expected nor supported elsewhere and 
many statistical tests were performed. 
Our results showed an association between parity and SBP in an unadjusted analysis. 
Adjustment for age and other confounders (women's education, husband's education 
and marital status) attenuated the association. Regression coefficient is 0.31 (95% CI: 
-0.43 to 1.01, p=0.407). Our results showed no evidence of an association between 
parity and DBP. Regression coefficient is 0.02 (95% CI: -0.35 to 0.39, p=0.916). 
Analyses were also aimed to determine if parity increases the risk of CHD and the 
development of the metabolic syndrome among these women. A total of 7.8% of 
women reported having had a CHD event. A marginally significant association was 
observed between parity and reported CHD events (p=0.043). Adjustment for age 
attenuated this association, which was no longer significant, p= 0.192. When parity 
was fitted in a logistic regression model as a continuous variable and reported CHD 
was kept as a categorical variable, the change in the unadjusted odds of CHD events 
per extra child was 1.05 (95% Cl: 0.96-1.15, p=0.249). No significant association 
was observed between parity and reported CHD among these women. 
The metabolic syndrome presented in 58.3% of the women. Women with the 
metabolic syndrome had significantly higher parity and higher gravidity, p= 0.003 and 
p= 0.024 respectively. A 7% increase in the prevalence of the metabolic syndrome 
per extra child was observed in logistic regression with adjustment for age, women's 
and husband's education and marital status, (p= 0.042). 
Further analysis suggested that physical inactivity, overall obesity and abdominal 
obesity factors slightly mediate the association between parity and the metabolic 
syndrome, Adjusted regression coefficients are as follows and respectively: 1.06 (95% 
CI: 0.995 to 1.14, p=0.066); 1.05 (95% CI: 0.979 to 1.12, p=0.175); 1.06 (95% Cl: 
0.977 to 1.14, p=0.063). 
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In a separate analysis excluding all women with reported CHD events, 5.7% of 
women were considered to be high CHD risk for the next 10 years and 16.9% were 
considered to be moderate CHD risk for the next 10 years. 
14.1.1 Support for the Hypotheses 
The relationship between the outcome variables of interest and parity, as summarized 
above, were assessed using different statistical models. All results were found to be 
consistent between crude and multivariate results. Most associations that were 
significant in univariate analysis were attenuated by adjustment although some 
continued to remain significant. However, not all hypotheses were supported. In so far 
as it is reasonable to expect positive relationships similar to the evidence in other 
studies, the non-significant findings could be due to lack of statistical power and the 
small sample size especially for the lowest levels of parity. 
14.1.2 Uniqueness of the Study 
This study is unique in many ways. First, it is the first time five different risk factors 
(overall obesity, central and abdominal adiposity, hyperlipidemia, diabetes and 
hypertension) for heart disease were studied. Second, this study focused on the 
association between CHD risk factors and parity among women, aged 40-65 years 
old, who have completed their child bearing. The women in this study are from a 
population with one of the highest fertility rates in the world, (with an average of 7.3 
children and a median of 8 children (range of 0-21 children), who therefore may have 
a higher risk for diseases that are associated with parity. And there is a significant lack 
of data on the health status of refugee women in particular. 
It is relevant to note that this group of Palestinian refugee women was homogeneous 
in terms of their religious beliefs (all were Moslem), educational level and general 
socioeconomic status. They shared other special features that may distinguish them 
from western populations, namely a low prevalence of smoking, no alcohol use, 
physical inactivity and frequent child births. One consequence of this, also a special 
feature of this study, is that confounding is likely to pay less of a strong effect. Of 
course, adjustment for confounders was still applied, although residual and 
unidentified confounding may well have played a smaller role. 
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The population under study also has other unusual features. It is extremely rare for a 
woman to remain single in the Palestinian society, especially in a refugee camp 
environment. Usually Palestinian women do not remain single out of choice, but due 
to an inability to marry. Likewise, it can be assumed that nulliparity is also not by 
choice. A couple that remains childless is most probably experiencing infertility. In 
this study, 42 women out of the 515 women were nulliparae; 21 nulliparae were 
single (not married) and the other 21 nulliparae were married and had either a quick 
onset of separation or widowhood or couple infertility was involved. The nulliparae 
are therefore rather different, both socially and possibly biologically, from the rest of 
the married women. This calls into question comparisons of this group with other 
societies. However, analysis is constrained by the small size of the group of 
nulliparae, so comparisons in the data analysis lack statistical power. However, 
comparisons with other studies were possible when looking at the difference in mean 
outcome variable per extra child and at the percentage of change (increase or 
decrease) in outcome variable per extra child. 
14.1.3 Methodological Limitations 
Various methodological limitations of the analysis and ways of addressing them are 
detailed below under each CHD risk factor and parity. As a cross-sectional study, the 
results of this study are susceptible to several sources of bias, such as recall bias, 
selection bias, participation bias, and survival bias. As the analyses are all cross 
sectional, it is not strictly possible to attribute causality in the associations found. 
Nevertheless observed associations between parity and CHD risk factors are unlikely 
to be due to reverse causality. Residual confounding due to unmeasured or 
unanalyzed variables related to both the exposure and the outcome variables, and thus 
responsible for the association, could not be ruled out. 
A further limitation arises because a large number of associations were tested 
statistically, so it is likely that more of them that were found significant were actually 
due to chance than the formal significance level implies, leading to an uncertainty in 
interpreting how much evidence for an association is given by the results of the tests 
of the association. Therefore the levels of significance are not the only source of 
evidence for the different associations, but also other evidence is also considered 
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alongside the results in this study. The other evidence comes when the findings agree 
with reports from other studies, and where scientifically valid mechanisms can 
support the association. 
These methodological limitations and others will be discussed in more detail in the 
following sections relating parity to CHD risk factors. 
14.1.4 Considerations for Causality 
Nine criteria for causality proposed by Hill [289] are considered here. Our study 
satisfies some of them but not all. The first criteria to show causality are: 
1. Temporal Relationships: 
Since our study is a cross sectional study, the timing of events were not directly 
observed. Some events such as age at first marriage and age at first pregnancy 
were reported as occurring earlier than some of the outcomes. The most obvious is 
that parity and childbearing occurred before the various observed levels of risk 
factors. So childbearing preceded their current HDL-C, Cholesterol, Triglycerides, 
and waist circumference, BMI, Diabetes and Hypertension. For Hypertension and 
Diabetes we have age at onset for both outcomes, so in order to make sure that 
Hypertension and Diabetes was not present before the last pregnancies when 
looking at the relationship between parity and diabetes on one hand and between 
parity and Hypertension on the other, we excluded all the women who had 
diabetes and hypertension before they were pregnant; this was so for one case for 
diabetes and 2 cases of hypertension which were excluded in order to make sure 
that pregnancies came before diabetes when we look at the association of 
pregnancy and diabetes. For the other outcomes variables such as the lipids, we 
don't have the date of onset, and therefore we might not be able to satisfy this 
criterion. But we assume that such diseases take place at older age and would 
make more sense that these women had children before developing 
hyperlipidernia. Interpreting the associations found between parity and BMI and 
WC in terms of causality is difficult in a cross-sectional study, but the high and 
independent associations observed in this study speak in favour of a causal 
relation. There might be biological mechanisms that could in part explain a causal 
relationship. For example, certain sex hormones or other internal or external 
252 
factors might both determine the distribution of adipose tissue and the degree of 
adiposity. There are also likely to be behavioural pathways, as are shown by the 
mediation by help with housework 
2. Strength: 
The strength of the association between an exposure and an outcome variable is 
measured by the magnitude of the association such as odds ratio or regression 
coefficient. The stronger the magnitude of the association the more likely that the 
relation is causal. In our study, the magnitude for associations between parity and 
each of the outcome variables was modest, so these associations are not supported 
on these grounds in terms of cause and effect. The only outcomes that show 
somehow stronger magnitudes are BMI and WC with parity. Adjusted regression 
coefficient of BMI is 0.30 (95% Cl: 0.14 to 0.47, p<0.001); and adjusted 
regression coefficient of WC is 0.58 (95% Cl: 0.25 to 0.91, p= 0.001). After 
taking into consideration mediating effect, the association remained significant. 
Adjusted regression coefficient of assistance in household on BMI and WC is 0.23 
(95% Cl: 0.060 to 0.40, p=0.008) and 0.43 (95% CI: 0.09 to 0.76, p=0.013) 
respectively. 
3. Dose Response relationship: 
In our study, increasing number of children is associated with the increasing risk of 
developing CHD risk factors. The scatter diagram for example, confirms the linear 
relationship between parity and obesity where one can see some kind of a uniform 
rise and the regression coefficient demonstrated a linear association of BMI and 
parity where one can reasonably accept an increase in BMI per additional child. 
The trends in odds ratios and mean differences with parity in ascending groups also 
suggest a dose response. The same applies to WC. 
4. Consistency: 
The association between parity and CHD risk factors has been studied in different 
settings and among different populations including the Palestinian setting. This 
study presents similarity of results to those studies in other settings. All results 
show that parity (increasing number of children) increases the risk of developing 
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raised CHD risk factors. For example, the results of this study were consistent with 
previous studies that examined the association between parity and BMI among 
women who have completed their childbearing years. Weng et al [126] found a 7% 
increase in risk of obesity for each additional child after adjusting for confounders, 
while Bastian et at [154], found an 11% increase in risk of obesity with each 
additional child that was independent of socioeconomic status and other 
confounders. Both studies used data from the Utah population where the majority 
was Mormon and women bore many children. In this study, there was a 14% 
increase (95% Cl: 1.07 to 1.22, p <0.0001) in risk of obesity with each additional 
child after adjusting for confounders. The same applies for other risk factors such 
as Triglycerides where it increases with increasing parity, where as higher parity is 
unlikely to have an important impact on the development of type II in this study 
similar to results from the US and other industrialized countries. 
5. Plausibility: 
In this study, an independent association was found between parity and BMI, on 
one hand, and parity and WC, on the other. These independent associations are not 
explained by potential confounders and mediators, and are supported in other 
studies, and are more likely to represent a biological response to pregnancy. 
Bahavioural factors are also likely to apply. Changes in lifestyle accompanying 
raising children such as assistance in housework partially mediated the association, 
but because the association remained significant it seems to have an influence 
beyond these mediators. It is always possible that the association is due to 
unmeasured or residual confounders that we could not control for in our analysis. 
Triglycerides (TG) showed a significant association with parity that was not 
explained by confounders. Increased TG levels in women with more children 
appeared to be partially mediated by BMI and assistance in housework. This 
suggests that the relationship between parity and triglycerides levels could be 
associated with the long term biological consequences of pregnancy through the 
alterations of lipid levels. The weight increase associated with pregnancy and/or 
the sedentary life style the women are leading partially took some of the effect of 
parity, but the association remained significant. 
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Also in this study, a 7% increase in the prevalence of the metabolic syndrome per 
extra child was observed when the association with ungrouped parity was adjusted 
for age, women's and husband's education and marital status, p= 0.042. The 
association between parity and metabolic syndrome appears to be present; there 
seems to be a biological side of the association that goes through pregnancy and 
childbirth, changing the lipid profile and carbohydrate metabolism, and over time 
this might lead to CHD risk, and ultimately events. This association seems to be 
confounded as well by SES and in particular education and mediated by the 
sedentary life style some women were leading. Central obesity which is a major 
component of the metabolic syndrome seems to exert a large effect, as a high 
percentage of women had central obesity. This could in part translate the higher 
rate of the metabolic syndrome among these women especially those with high 
parity. Therefore the biological association is there at least for some of the 
outcome variables, yet there is other mechanisms that could influence this 
association such as socio-demographic or lifestyle factors in response to 
pregnancy and/ or the raising of children. 
6. Consideration of Alternative explanations: 
It is always crucial to look at other possible explanations (mainly, confounders) 
and rule them out before making conclusions about a causal relationship between 
an exposure and an outcome. For example what else, other than a real effect of 
parity on risk of developing CHD could explain the results of this study? So 
confounders give the main alternatives. For example, high parity women tend to be 
older and CHD risk rises with age. Another example, women of higher social 
standing may tend to have fewer children and also to have less CHD risk. Women 
of higher parity tend to be physically inactive and CHD risk rises with less 
physical activity and sedentary life style. Adjustment for confounding is meant to 
allow for this, but the adjustment is never perfect and for some possible 
confounders, such as social standing, we don't have direct measures so we use 
proxies such as education. It is always possible that the association is due to 
unmeasured or residual confounders that we could not control for in our analysis. 
255 
7. Appropriate design: 
A cross sectional design is not ideal for capturing time related causation. This 
study is observational rather than experimental and it would not be possible to 
randomize parity. So this issue cannot be addressed in terms of design, and it 
remains a weakness. 
8. Specificity: 
The effect of parity cannot be specific in the sense of being a single cause. There 
are a number of risk factors of which parity is only one, and many of which are 
also correlated with parity. This study cannot satisfy this criterion. 
9. Coherence: 
The results of this study are coherent with those of other studies examining the 
association between parity and CHD risk factors among women. The results of the 
study suggest that childbearing in addition to life style factors, physical inactivity 
and leading sedentary habits contributes to CHD risk factors in this group of 
women. Therefore the association could be due to the biological consequences of 
pregnancy and sedentary lifestyle. 
14.2 Parity and CHD Risk Factors 
14.2.1 Parity and Obesity 
In this section, we look in more detail at the hypothesis that an increasing number of 
children is associated with an increasing risk of obesity. What is the extent of this 
relationship and what are the pathways that lead to parity-related obesity among 
Palestinian refugee women? Can the same mechanisms found in developed countries 
be applied to less developed countries such as Palestine where women are overweight 
and have different childbearing patterns (short birth intervals and multiple 
pregnancies) and lifestyles? 
14.2.1.1 BMI as a Measure of Overall Obesity (Hypothesis 1) 
The prevalence of obesity represented by BMI > 30 kg/m2 was positively associated 
with increasing parity and gravidity, current unemployment, physical inactivity, 
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having assistance with housework, elevated triglyceride level and DBP and SBP, as 
well as with central and abdominal obesity. On the other hand, the prevalence of 
obesity appeared to be negatively associated with the educational level of women and 
their husbands, and the HDL-C level. 
Women with higher parity tended to be older and less educated and their husbands 
also tended to have low levels of educational attainment. Nevertheless, an association 
between increasing parity and obesity adjusted for these confounders (age, 
educational levels, and marital status) was still evident. The results show a 14% 
increase (CI: 1.07 to 1.22, p <0.0001) in odds of obesity for each additional child after 
adjustment for age, marital status and educational level of the woman and her 
husband. Similarly the regression coefficient of BMI increased by 0.28 kg/m2 per 
extra child, (CI: 0.15 to 0.42, p<0.0001) and adjustment for the confounders (age, 
marital status and educational level of the woman and her husband) did not reduce the 
magnitude of the association. 
Adjustment for other predictors of obesity that might act along the causal pathway 
between parity and BMI, such as lifestyle factors (physical activity, hours per week 
watching TV and assistance in housework) and reproductive health variables (age at 
menarche, age at menopause, menopausal status, use of oral contraceptive pills) did 
not reduce the magnitude of the association, with the exception of assistance in 
housework, though the association with parity remained significant, as shown in 
Table 8-5. Assistance in housework decreased the regression coefficient for the 
association of BMI on parity noticeably, suggesting that some of the influence of 
parity on BMI is mediated by assistance in housework. Assuming that such assistance 
results in a more sedentary lifestyle (see above), the fact of leading this sedentary life 
is partially influenced by parity since this assistance is more common among the 
higher parity women. Reverse causality might apply here, for example because these 
women are obese as a result of having many children, they tended to seek assistance 
in households from their daughters. 
Findings in relation to existing literature: The results of this study were consistent 
with previous studies that examined the association between parity and BMI among 
women who have completed their childbearing years. Weng et at [126] found a 7% 
increase in risk of obesity for each additional child after adjusting for confounders, 
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while Bastian et at [154], found an 11% increase in risk of obesity with each 
additional child that was independent of socioeconomic status and other confounders. 
Both studies used data from the Utah population where the majority was Mormon and 
women bore many children. The number of live births per woman ranged from 0-14, 
with a mean of 4 live births, which although high is still considerably less than the 
mean for live births in this study (7.3). In this study, there was a 14% increase in risk 
of obesity with each additional child after adjusting for confounders, which is larger 
than other studies. 
Our results also agree with those from the Finnish study by Helovaara and Aromaa 
[136] that looked at the association between parity and obesity among women aged 25 
to 84 years. They found that women with 10 or more childbirths were on average 2.3 
kg/m2 heavier than women with no births. They also showed independent effects of 
age and parity on obesity. Our study found similar associations, where the mean BMI 
increases by 0.28 kg/m2 per extra child, and also independent effects of age and parity 
on obesity. 
The consistency of these results concerning parity with ours is important as 
strengthening the evidence of genuine associations; this is particularly true in view of 
the many statistical tests involved in our analysis. 
14.2.1.2 WC as a measure of central obesity (Hypothesis 2) and Will ratio as a 
measure of abdominal obesity (Hypothesis 3) 
1) WC as a measure of central obesity: While the relationship between parity and 
BMI has received much attention, relationships between parity and other measures of 
adiposity such as fat distribution have remained relatively unexplored. This study 
examined the association between parity and central obesity measured by waist 
circumference (WC > 88 cm). In this study, waist circumference >_ 88 cm was 
significantly and positively associated with increasing parity, increasing gravidity, 
increasing age, marital status, currently unemployed, early age at first marriage, early 
age at first birth, menopausal status, elevated cholesterol, LDL-C, TG, DBP and SBP, 
hypertension, diabetes, increased BMI and W/H ratio. WC > 88 was also 
significantly and inversely associated with the educational level of the women and 
their husbands, availability of assistance in housework and HDL-C level. The same 
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statistical models used with BMI were applied to assess the association between parity 
and WC. 
The mean WC and the prevalence of central obesity (WC >_ 88 cm) increased 
significantly with increasing parity. Adjustment for age, educational level of the 
women and their husbands, and marital status reduced the magnitude of the trend 
slightly but it remained significant. The unadjusted odds of central obesity (WC >_ 88 
cm) increased by 18% with each additional child. Adjustment for age and educational 
level reduced this gradient of risk to 16% and 15% respectively. With marital status 
added to the model, the risk of central obesity increased by 18% with each additional 
child. 
When parity was measured on a continuous scale and using ordinary regression, the 
mean WC increased by 0.69 cm per extra child. Adjusted for confounders, the 
magnitude of change was reduced to 0.58 cm but the association remained significant. 
Adjustment for most other predictors of central obesity that might act along the causal 
pathway did not reduce the magnitude of the association. These results show that none 
of the socio-economic status factors, behavioural and reproductive health factors 
could explain the association between parity and WC. However, when the assistance 
in housework variable was introduced into the regression model, the regression 
coefficient of WC on parity decreased noticeably compared to the effect of the other 
mediators. The slope of WC on parity was reduced from 0.58 to 0.43 cm per each 
additional child, suggesting that some of the influence between WC and parity is 
mediated partially by assistance in housework. The way this mediator might act as a 
correlate of sedentary lifestyle is discussed above. Although assistance in housework 
seems to carry some of the influence of parity on WC, the association between WC 
and parity remained significant. This suggests that the association could be due to the 
biological consequences both of pregnancy and of sedentary lifestyle. 
2) W/H ratio as a measure of abdominal obesity: Another measure of body fat 
distribution is abdominal adiposity, defined as waist to hip ratio (W/H ratio >_ 0.85). 
This indicator was positively and significantly associated with age, marital status, 
menopausal status, use of contraceptive pills, obesity and central adiposity, TG, T- 
CHOL/HDL-C ratio, SBP, DBP, hypertension and diabetes. It was negatively and 
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significantly associated with women's education and HDL-C levels. However, no 
association was found with parity before or after adjustment for socio-economic 
factors. The relationship between parity and W/H ratio remained not significant. 
In the absence of evidence of an association between parity and W/H ratio, the effects 
of mediators were not investigated. 
Findings in relation to existing literature: Tonkelaar et al [144] found an 
association between parity and W/H ratio but the strength of the association 
diminished with increasing BMI. They also found that the clearest association 
between parity and W/H ratio was seen in non-overweight women [144]. Abdominal 
obesity as shown by W/H ratio (? 0.85) is an indirect measure that predicts insulin 
resistance (hyperinsulinemia), although many studies do not show a strong 
relationship between central adiposity (WC > 88) and insulin resistance, perhaps 
because of the inclusion of only very obese subjects (there is a plateau in insulin 
resistance above a BMI > 30), or because of the use of indirect methods to measure 
abdominal adiposity and/or insulin resistance [268]. Results of the study here have 
shown that the majority of women were obese with higher rates of central and 
abdominal obesity and that might explain the plateau in insulin resistance. In our 
study the majority of women presented with central and abdominal obesity as well as 
overall obesity, yet while there was an association between parity and BMI >_ 30 
kg/m2, on the one hand, and between parity and WC >_ 88 cm, on the other, no 
significant association was found between parity and W/H ratio > 0.85 cm. 
It is important to note that most of the studies exploring the association between parity 
and central adiposity were of pregnant women or women of childbearing age [120] 
[90,147]. No studies were found that looked at WC changes associated with parity 
among older women. Although WC was measured in all of the studies of pregnant 
and childbearing-age women or older women, it was measured within the context of 
W/H ratio. Studies of pregnant and childbearing age women that explored the 
association between parity and central obesity have shown WC to increase with 
increasing parity. 
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Interpreting the associations found between parity and BMI and WC in terms of 
causality is difficult in a cross-sectional study, but the high and independent 
associations observed in this study speak in favour of a causal relation. There might 
be other biological mechanisms that could be causal and in part explain this 
relationship. For example, certain sex hormones or other internal or external factors 
might both determine the distribution of adipose tissue and the degree of adiposity. 
The persistent relationship between parity and BMI and WC despite controlling for 
socio-economic factors, lifestyle risk factors and reproductive health factors is a 
finding that needs further exploration among Palestinian women in urban and rural 
areas and possibly among a larger sample of refugee women. Further studies might be 
needed to explore additional mechanisms and use more accurate measurements of 
mediators. 
The next sections look at the confounders and mediators, and at issues of causality, 
for these relationships in more detail 
14.2.1.3 Parity, Obesity and Socio-Demographic Factors 
Age: Both parity and the prevalence of obesity are age dependent. Parity increases 
with increasing age and obesity increases with increasing age, yet both were 
correlated independently of age. The results showed slight age confounding but this 
had only a small effect on the magnitude of the association. 
The study showed parity increasing with increasing age. Older women tended to have 
more children than younger women in spite of the fact that all women participating 
had finished their child bearing. This probably reflects the fall in total fertility in 
recent years. One notes that in some studies, the association between obesity and age 
was explained in part by a decrease in the degree of physical activity with age among 
women [261,269]. This does not seem to be the case here since activity levels were 
low for all age groups, although it is possible that the fact that physical activity was 
not measured exhaustively did not allow this to be seen clearly enough. 
Educational levels: Several investigators have found that educational level 
confounds the relationships between high parity, early age at first live birth and risk 
for obesity [94]. Women with less education may be poorer and at higher risk for 
obesity because of their health behaviours (excessive caloric intake and less physical 
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activity). In this population of older women, education was inversely associated with 
obesity. Women in the camps are less likely to attain a higher education in view of 
early marriage and reproduction. This in turn makes obtaining a job more difficult for 
these women, since they become occupied with the care of a larger number of 
children. When husband's years of schooling was used as a proxy to socio-economic 
status there was little variation found between families. 
Marital status: The influence of marital status is probably related to age and parity 
since marriage traditionally takes place at a relatively young age and reproduction is 
encouraged in the refugee camps. Marital status is also related to obesity; one study 
found the prevalence of obesity to be higher in widowed and married women than in 
single women [270). The large majority of women in this study were found to be 
married so power to detect effects of marital status was limited. 
These reasons give background to the findings that the above socio-demographic 
variables did not appear much to confound associations between parity and BMI and 
WC. 
14.2.1.4 Parity, Obesity and Physical Activity 
Physical activity has been reported as a determinant of body weight [107,145]. Our 
findings show that it is an important correlate of BMI and WC in these women, but 
does not reduce the magnitude of association between parity and obesity. Other 
variables such as assistance in housework which seems to be a proxy for less physical 
activity and was associated with parity reduced the magnitude of the association, 
although it remained quite significant. 
This could be explained by the fact that the refugee camps in Palestine are socially 
different from Western countries. There are limited outdoor sport and leisure 
activities, especially for women, and little media reinforcement of healthy body 
weight. The social and cultural environment does not encourage women to think 
about weight reduction. Moreover, traditional Arab culture does not consider obesity 
per se to be a sign of bad health; it is often considered a sign of beauty, wealth and 
good health. The lack of employment opportunities outside the home may also 
contribute to the higher frequency of obesity among Palestinian women. 
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The concept of leisure time physical activity is not a common one in the Palestinian 
context, especially for refugee women, where lack of facilities for women and cultural 
norms are prohibiting factors. Three questions were used in the analysis to reflect 
whether women practice any type of physical activity (yes or no), kind of physical 
activity and the number of hours practiced per week. The 69 women in the sample 
who engaged in physical leisure activity reported that it was restricted to walking for 
an average of 3 hours per week. More sensitive instruments are clearly needed to 
evaluate the physical activity of this largely sedentary group. Imprecise measurement 
of physical activity may lead to inadequate control for it which in turn may lead to 
residual confounding. 
Assistance in the home is usually given by older daughters, which is more common in 
higher parity women. This factor could also create differences in activity levels 
between women who have assistance and those who do not. In view of the results of 
these analyses, it may reflect activity levels more effectively than responses directly 
about activity. 
14.2.1.5 Parity, Obesity and Reproductive Health Factors 
Lifestyle risk factors and other reproductive factors such as age at menarche, age at 
menopause, age at first birth and use of oral contraceptive pills, have been reported to 
be related to obesity. However, the association between parity and BMI was not 
reduced after adjustment for these variables. 
Younger age at menarche was associated with increased BMI among these older 
women. This result is consistent with Bastian et al [106] who found the same 
phenomenon among older women, as well as Symons et al who showed body 
composition measures (percent of lean mass) are linked to the timing of menarche and 
menstrual cycle length [271]. Women are also prone to weight gain during 
menopause. The loss of the menstrual cycle affects calorific intake and slightly lowers 
metabolic consumption, although most weight gain here has been attributed to a 
reduction in physical activity. 
Pregnancy may affect the risk of obesity through insulin resistance. Insulin resistance 
is greater in multigravid women than in women with fewer pregnancies, perhaps as a 
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result of altered glucose metabolism during pregnancy or post-pregnancy alterations 
in the amount and distribution of body fat [122]. Grand multiparity had a highly 
significant effect on BMI. This is probably related to weight gain during repeated 
short-interval pregnancies that do not allow for enough weight loss [136]. 
Various studies which considered the number of pregnancies have included 
spontaneous abortions. However, biological effects can be more prominent in full 
term pregnancies (mainly with live births) in comparison to short term spontaneous 
abortions, if we consider that the biological mechanism mediating the relationship 
between pregnancy and obesity is hormone or insulin resistance related. Although the 
association between gravidity and parity is high, the two factors may not be 
compatible if pregnancy losses affect obesity risk. In this study, the number of 
pregnancies was also related to obesity (data not shown). 
Another main influence on obesity is the effect of parity on the number of ovulatory 
cycles since more pregnancies imply fewer cycles and in consequence less of the 
linked hormonal alterations, with such as a decrease in endogenous oestrogen causing 
an increase in BMI and obesity, and changes in body fat distribution [244]. Hence, an 
independent effect of oral contraceptive use is expected, because oral contraceptives 
function by inhibiting ovulation. In this study, we observed a higher rate of oral 
contraceptive use in obese women compared to non-obese women. Oral contraceptive 
users were found more among women with higher parity. Use of oral contraceptive 
pills is socially and religiously allowed to space children, but not to prevent having 
children, unless there is a medical reason to prevent further pregnancies. Only 40% of 
women ever used CPs; the majority of women preferred to use the IUD. 
Another potential mechanism for the development of obesity is that pregnancy and 
child rearing have an impact on levels of stress and social support. Stress has been 
shown to lead to poor health outcomes, but higher social support may counteract the 
effect of stress [10]. Although social support was not measured in our study, stress 
was measured and a positive association with parity was found. However, no 
significant relationship between stress and BMI was found. 
Further analysis between parity and obesity was adjusted by physical activity, hours 
watching TV and assistance in housework as a proxy to physical activity, as well as 
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plasma insulin. None of these factors mediated the association between parity and 
obesity, except assistance in housework reduced the magnitude of the association and 
could partially reduce the effect of parity on BMI. As has been indicated, this could 
imply that a sedentary life style might add to the relationship between parity and 
obesity. Plasma insulin was also adjusted for, but did not reduce the magnitude of the 
association of parity and obesity. Insulin levels did not differ markedly among the 
different parity groups. 
14.2.1.6 Public health implications relevant to obesity prevention, health 
policies and programmes 
The results of this study indicate the prevalence of obesity and high WC among 
women aged 40-65 with the maximum rate among the most multiparous women. 
What kind of health policies are needed to prevent or reduce this increase of obesity 
in Palestine? 
The first point to note is that fertility is declining in this population which, in itself, 
can be expected to impact favourably on obesity and overweight. However, further 
consideration needs to be given as to how to reduce the impact of pregnancy and 
childbearing on obesity. 
Immediate attention should be given to the management of female overweight, 
obesity and central adiposity in the refugee camps of Palestine as an increasingly 
serious public health problem and a risk factor for many chronic diseases that develop 
later in life. Quality improvement is necessary in the pre-natal programmes currently 
implemented at the public health centres, especially concerning nutritional guidelines. 
The results of this study suggest the need for the development and implementation of 
programmes to prevent and treat the problem of parity-related overweight and obesity. 
Such programmes could help women avoid excessive gestational weight gain through 
each pregnancy and birth and encourage postpartum weight loss by promoting dietary 
changes and physical activity alongside exclusive breastfeeding. They should be 
targeted at young women, women of childbearing age and beyond childbearing age. 
Interventions to reduce and prevent obesity should also target women who are 
overweight prior to their initiation of childbearing. 
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Policies should be supported by effective research. More studies are needed to 
examine determinants of excessive weight gain and postpartum weight retention and 
its effect on body fat distribution among women in later years after childbearing. 
However, with the rising prevalence of obesity among women of childbearing age and 
after childbearing age and the high proportion of women who are gaining excess 
weight, a shift in research and services focus must occur to include consideration of 
the mother's long term health status in addition to the child's health status. Long term 
studies to identify the relationship between parity and obesity are needed as well. The 
impact of excess WC gain associated with childbearing on women's future health risk 
should be evaluated further. 
14.2.1.7 Study limitations relevant to parity and obesity 
The present study controlled for a number of variables that might be expected to 
influence weight gain, such as behavioural factors and in particular physical activity. 
There are other factors that were not included in this analysis that may account for 
some of the differences in weight gain among the parity groups such as maternal 
weight gain during pregnancy and food intake. 
The basic concept underlying interpretation of these results is that pregnancy or 
repeated pregnancy (or births) changes the physiology in a woman's body, possibly 
making her more prone to diseases including heart disease. Correcting completely for 
confounders is desirable but seldom possible. 
Zero parity is used in many studies as the baseline comparison group, in order to 
detect where the change occurs and at what parity level effects can be seen. However 
the zero parity group is numerically few, and is culturally and physiologically unique 
in this community and differs from the same group in other parts of the world where 
many women are voluntarily childless, so where not having children can be a more 
specific choice. Non-gravid women here may differ in other respects that were not 
measured in this study. Here many of the women who remain nulliparous may be 
subject to couple infertility or to hormonal disorders affecting fertility. Aside from 
their uniqueness, more comparisons with the zero parity group was not possible since 
this group was so small. 
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Due to the political situation at the time of data collection, and due to financial 
constraints, the study could not be expanded to include more than two refugee camps. 
Including additional camps and also increasing the sample size would have increased 
the number of women in the zero parity group and the statistical power to detect 
associations by comparing to this group. 
Another limitation is possible error in the women's statements of their age at 
menarche, age at menopause, number of abortions/miscarriages, and number of still 
births the woman had throughout her life. This is due to inaccurate recall among some 
women of events that occurred in the distant past. We have focused on live births 
because pregnancy losses are less likely to be fully recalled than the number of live 
births. Many pregnancy losses are clinically unrecognized and therefore not recalled. 
Additionally, women may have reported physical activity and smoking behaviours 
inaccurately because of social norms. 
It remained unclear whether the association between the number of children and 
obesity is primarily mediated though biological or behavioural mechanisms or both. 
One of the drawbacks of this study is that men were not included. Inclusion of men 
could have helped to identify associations mediated through behavioural (lifestyle risk 
factors associated with having large families) or biological mechanisms, though only 
partly because of different lifestyle norms for fathers and mothers. 
Finally, a theme that recurs throughout this work is that many comparisons and 
statistical tests are made. The chance of an erroneous positive finding is increased. 
Comparison of the results of this study with finings in the literature is an important 
check here. 
14.2.2 Parity and Hyperlipidemia (Hypothesis 4) 
The relationship between an increasing number of children and the risk of elevated 
lipids and lipoproteins was examined. No association was observed between parity 
and elevated total cholesterol, LDL-C and HDL-C in this sample of women. An 
apparent association between triglycerides and parity was observed when both were 
measured on a continuous scale. The mean TG increased by 0.038 mmol/L (3.4 
mg/dl) per extra child, p= 0.003. Adjustment for age, the woman's education and 
husband's years of schooling, and marital status slightly reduced the magnitude of 
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change in mean TG, but the association remained significant, p=0.03. This degree of 
significance was not strong so caution is needed because of the multiple testing 
problem. But if it is accepted, then confounders could not fully explain the association 
between triglycerides and parity. Assistance in housework, waist circumference, BMI, 
diabetes and to a lesser extent W/H ratio partially mediated the association between 
parity and triglycerides. BMI and assistance in housework seemed to have the 
strongest mediating effect. 
An apparent association between T-CHOL/ HDL-C ratio and parity was observed 
when both variables were measured on a continuous scale. The unadjusted mean T- 
CHOL/ HDL-C increased by 0.001 mmol/L (0.05 mg/dl) per extra child, p=0.020. 
This association was attenuated after adjustment for age, and was completely 
abolished after adjustment for women's educational level, husband's years of 
schooling and marital status as in Table 9-17. 
The results of this study cautiously suggest that of all the lipid and lipoprotein 
variables, triglycerides may have been associated with parity. Increased triglycerides 
levels in women with more children appeared to be mediated by greater obesity 
represented by BMI and sedentary lifestyle represented by assistance in housework. 
These results suggest that the relationship between parity and triglycerides levels 
could be associated with either the long term biological consequences of pregnancy 
through the alterations of lipid levels and/or the weight increase associated with 
pregnancy or the women's sedentary life style and the stress of childbearing. 
Most of the studies reviewed focused on HDL-C levels as being the most powerful 
predictor among all the lipids and lipoproteins in determining cardiovascular diseases 
in women [252] [82]. Furthermore, in the few studies available on the long term 
effects of pregnancy on lipid and lipoprotein levels, there has been agreement that 
multigravid/multiparous women have lower HDL-C levels than nulligravid/ 
nulliparous women. The magnitude of the effect has been shown across various 
studies to be of the order 0.03 mmol/L (1 mg/dl) and to decrease with each pregnancy 
or birth, after controlling for the effect of confounders and correlates such as age, 
smoking, alcohol use, physical activity, oral contraceptive use, education and marital 
status. However, there has been disagreement about the linearity of the association 
among these studies, as can be seen in the literature review on parity and lipids. 
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Our results confirm a trend of decreased HDL-C with increasing parity groups, 
starting from parity 1-3, but the trend did not attain significant levels. We also found 
age-adjusted HDL-C levels decreased, but by 0.007 mmol/L per extra child 
(coefficient = -0.007 with 95% CI: -0.014 to 0.00008, p=0.053), which is significantly 
less that the 0.03 mmol/L quoted above. Adjustment for educational level attenuated 
the association and it became no more significant. 
The small sample size of the study may have contributed to not finding an association; 
nevertheless the fact that the coefficient was low should be noted. Lawlor et al found 
that the number of children among British women and men participating in the British 
Women's Heart and Health Study and the British regional Heart Study, was inversely 
associated with high density lipoprotein cholesterol and was positively associated 
with triglycerides and diabetes [2]. The sample size used by Lawlor of 3828 women 
was large enough to detect an association of less magnitude. The same applies to 
Kritz-Silverstein et al, where they found women with 5 or more pregnancies had 
significantly lower levels of HDL-C before and after adjustment for age, obesity, 
diabetes, alcohol and cigarette consumption, exercise and estrogen use using a sample 
size of 1275 women, but the association was not linear as in Lawlor et al. [123]. 
Our finding of a significant, though not strongly significant, association between 
parity and triglyceride levels is consistent with Lawlor's et al study where the number 
of children was found to be significantly associated with higher triglycerides levels, 
and that each additional child increased the age-adjusted mean triglycerides by 0.02 
mmol/L, (95% Cl: 0.01 to 0.03, p= 0.001). [2] In our study (data not shown), each 
additional child increases the age-adjusted mean triglycerides levels by 3.3 mg/dl, 
(95% CI: 1.00 to 5.64, p= 0.005), which is equivalent to 0.04 mmol/L, (95% Cl: 0.01 
to 0.06), whereas Kritz-Silverstein et al found no statistically significant differences in 
levels of triglycerides between nulliparous and parous women. [123]. 
Another way in which my study also differs from others is that not all of the women 
involved in the study were postmenopausal. Women have completed their 
childbearing, but some of the women in their 40s and 50s were still pre-menopausal, 
and at less risk for some of the diseases and disorders that I was studying (especially 
heart disease-CHD- and cholesterol differences). That could be part of the reason why 
I don't observe some differences in cholesterol. It could also mean that my results are 
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more conservative, in other words, if I have concentrated on older post menopausal 
women who lose the protection from heart disease that women have until menopause, 
I might have found stronger relationships. 
Results of our study have shown a tendency for triglycerides levels and Chol/HDL-C 
ratio to increase with increasing parity, starting from parity 1-3 (section 7.7). 
Furthermore triglycerides levels increased significantly among women who were 
unemployed, physically inactive, ever used OC pill, less educated, diabetic and had 
elevated BMI, WC and W/H ratio, as well as a positive family history of diabetes. 
Women who were obese and had more central and abdominal adiposity or who were 
diabetic had higher levels of triglycerides. At the same time women with many 
children tended to be less educated, unemployed, leading a more stressful life, had 
higher BMI and WC and higher rate of ever use of the contraceptive pill. 
So we consider that any association between parity and triglycerides could be partially 
explained by obesity and central obesity which in turn are likely to be consequences 
of higher parity, assistance in house work as a proxy to physical inactivity and being 
diabetic, as these covariates tended to mediate the association between parity and 
triglycerides. Both obesity and assistance in housework as a proxy to physical 
inactivity were at higher levels among women who have more children. Palestinian 
women in the refugee camps tended to get considerable assistance in housework as 
the elder daughters will look after the young and will do all the housework, and the 
mothers will lead a sedentary life; this contributes to their elevated BMI and WC and 
would lead to increased triglycerides levels, whereas in western populations one is 
less likely to observe daughters or daughters-in-law help in housework. 
Findings considered further in relation to the existing literature: It seems the 
association between parity and elevated lipid levels are more likely to be observed 
among lean women rather than among obese women. Kritz-Silverstein stated that 
women in the Rancho Bernardo cohort were on average leaner than other US women 
and therefore considered that in populations that are less lean than the Rancho 
Bernardo cohort, the association between parity and high density lipoprotein levels 
might have been noted with fewer pregnancies, where they found a significant 
negative and more linear association between parity and high density lipoprotein 
[123]. In our study we managed to observe a probable association between parity and 
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triglycerides but we were unable to detect any association with HDL-C level although 
the trend for decreased HDL-C with increasing parity was present. The association 
might have existed but either the power of the study was insufficient to detect it or 
women who were obese and less physically active reduced the effect, and the 
association could not be seen, alternatives that requires further investigation. 
During a healthy pregnancy, the progressive rise in blood insulin and gestational 
hormones is accompanied by elevations in blood lipids, insulin resistance and weight 
gain [272]. Whether this association persists years after childbearing has been 
examined in several studies of both pre- and postmenopausal women [114] [2] [184] 
[273]. These studies have reported an inverse relationship between parity and HDL-C, 
and lower HDL-C levels at a threshold of high parity (five or more births vs. four or 
less births [123] [274]. Van Stiphout found that lower levels of HDL-C persisted up to 
6 years after child birth [176]. Kritz-Silverstein observed an inverse association 
between higher parity and HDL-C 10 or more years after the last pregnancy [ 123] and 
Humphries et at provided evidence that lower HDL-C levels following pregnancy 
persist for decades after childbearing has ceased [114]. In our study we could not 
identify a significant association with lower HDL-C but a significant association was 
observed between elevated triglycerides and increasing number of children in this 
group of women. 
14.2.2.1 Public Health Implications Relevant to Hyperlipidemia 
Regular check ups and routine examinations of lipid profile should be part of an 
overall programme for the assessment of risk factors for CHD among women and 
men in Palestine. This should include awareness programmes for women about the 
long-term effect of pregnancy and child bearing on women's health and in particular 
on hyperlipidemia that leads to CHD mortality and morbidity. 
14.2.2.2 Study Limitations 
This study is cross-sectional and as such might have been affected by several sources 
of bias that could have influenced the results: 
Participation bias: Participation bias would have been an unlikely reason for the 
observed association between parity and triglycerides levels. The study selected all 
women in the camps aged 40-65 years and then chose a random sample without 
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knowing the number of children borne by women or whether or not they have 
elevated lipid levels. 
Reverse causality: It seems unlikely that elevated triglycerides could lead to an 
increased number of children. 
Survival bias: It is unlikely that the association between parity and elevated 
triglycerides was due to survival bias; women with a greater number of children dying 
prematurely of elevated triglycerides would lead to underestimation of the strength of 
association between number of children and triglycerides levels. 
Inclusion of women who were taking medication for diabetes and hypertension and 
lipid-lowering drugs in the analysis might have masked the association between parity 
and the mentioned outcome variables. However, it is unlikely that happened since we 
found women on medication had more elevated lipids, fasting blood sugar and 
hypertension than those who were not on medication; also these women had the 
highest parity. This would be consistent with low levels of drug adherence. The 
results of the analysis excluding those on medication were the same; therefore we 
decided not to exclude these women from the analysis as presented. 
Measurement errors of the confounders and other covariates: The distribution of 
several known risk factors such as age, education for both women and their husbands, 
physical activity, assistance in housework and other covariates varied by parity. These 
factors are therefore potential confounders or mediators of the association between 
parity and lipid levels. Although these factors were controlled in our analysis, residual 
confounding due to imprecise measurement of the confounders may still be present. 
In addition, measurements taken at the time the study was conducted might not reflect 
exposure levels during childbearing years. 
Measurement errors of the outcome variables: Women with elevated lipids were 
confirmed in the laboratory and therefore the chance of having the elevated lipid 
levels or not having elevated lipid levels is minimized. Yet there might be other 
measurement errors in the laboratory, but that was also unlikely since a sub sample 
was sent to another laboratory for validation of the results. 
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Exposure information obtained through self-reporting can be susceptible to 
systematic error. Parity, gravidity and several other variables were reported by the 
women. Women might have reported parity much better than gravidity as gravidity 
includes number of still births and number of miscarriages/abortions (see above). 
However, there is no reason why women with elevated lipid levels would report parity 
differently from those with normal lipid levels. The same principle applies to type II 
diabetes mellitus and all outcome variables. 
14.2.3 Parity and Type II Diabetes Mellitus (Hypothesis 5) 
The objective of this section was to examine the independent relation of parity to type 
II diabetes mellitus in this sample of 40-65 years-old Palestinian women living in 
refugee camps. The literature reviewed has shown that higher parity is unlikely to 
have an important impact on the development of type II diabetes in the US and other 
industrialized countries where few women have more than six children. Exposure to 
high parity may be relevant, however, in developing countries such as in the Middle 
East, South America and Africa, where many more women bear 6 or more children. 
Other studies including parity and the development of type II diabetes mellitus in 
women have not been carried out in the Middle East. This study represents the first 
investigation in the Middle East of the association between parity and the risk of 
developing type II diabetes, in this case among Palestinian women, a population who 
bear many children and among whom type II diabetes mellitus is on the rise. 
In this cross-sectional study no association was observed between parity and type II 
diabetes mellitus after adjustment for age. The results showed a slight statistically 
significant increase in the unadjusted risk of diabetes with increasing parity but this 
increase was reduced and became not significant after adjustment for age. Adjustment 
for other variables such as education of both women and their husbands and marital 
status did not have any effect on the association between parity and diabetes. The 
association between parity and diabetes seems to be explained by age. Parity 
increased significantly with increasing age and the risk of diabetes increased 
significantly with increasing age, but age seemed to have a much stronger effect on 
the development of diabetes than parity. 
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The adjusted analysis of fasting blood sugar (FBS) taken quantitatively, instead of 
diabetes, indicated by raised FBS, on a continuous scale with parity also did not 
suggest any evidence of association. However, one observes in Table 10-2 (Mean 
values of selected characteristics associated with diabetes among Palestinian women) 
that there appears to be an association with gravidity. This is not the case for the other 
metabolic outcome measurements: total cholesterol, LDL-C, HDL-C, and total 
cholesterol/HDL-C ratio. Triglyceride was the exception, as it showed an association 
with gravidity as well as with parity. This relationship was pursued further. However; 
the process here consisted of further analysis based on a hypothesis generated from 
the same data, against a background of many statistical tests being carried out; 
therefore conclusions about associations must be viewed as speculative. 
As a first stage of this analysis, the association of FBS with failed pregnancies (the 
difference between gravidity and parity) was examined. No other significant 
relationship was found to failed pregnancies except for triglycerides, p= 0.028. When 
fasting blood sugar was regressed in the fully adjusted model, allowing for censoring 
among those on medication, on the number of failed pregnancies and parity (live 
births) in the same model, the adjusted coefficient for parity was 0.07 mmol/L, 
p=0.191, and not significant, whereas that for failed pregnancies was 0.29 mmol/L, 
and statistically significant (p= 0.001). 
The relationship between fasting blood sugar and gravidity was next examined with 
both variables being continuous, using ordinary regression as in Table 10-6. An 
apparent significant association between gravidity and type 2 diabetes was observed 
in the unadjusted analysis. The unadjusted regression slope was 0.15 mmol/L, 
denoting the predicted rise in fasting blood sugar for a unit rise in gravidity, (95% Cl: 
0.08 to 0.22, p <0.0001). Adjustment for age, women's education, husband's 
education and marital status reduced the magnitude of the association but it remained 
significant. So confounders could not fully explain this apparent association between 
gravidity and type II diabetes. 
Failed pregnancies seem to have the highest mediating effect amongst all mediating 
variables, reducing the magnitude of the association with gravidity to a great extent. 
This is to be expected, as failed pregnancies are the component of gravidity that most 
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predicts FBS. This confirms that the association between gravidity and type II 
diabetes goes through failed pregnancies. 
WC and the W/H ratio also noticeably reduced the magnitude of the association 
between gravidity and type II diabetes, which indicates that these variables exert a 
partial mediating effect. It has been well documented in the epidemiological studies 
that central and abdominal obesity predict type II diabetes among both men and 
women [275], and that abdominally localized obesity is particularly strongly 
associated with increased risk of developing diabetes. The strongest risk factors for 
the development of type II diabetes in addition to abdominal obesity were low sex 
hormones concentrations and high fasting plasma insulin as cited in the literature. 
This suggests that abdominal obesity is linked to insulin resistance, one of the major 
factors in the development of diabetes mellitus [275]. In addition to that, the WC and 
W/H ratio seems to be associated with a cluster of the metabolic risk factors as well as 
hypertension [275]. It has been documented that abdominal obesity measured by the 
W/H ratio may be an important risk factor for diabetes in rural Palestine as a result of 
the socioeconomic changes and increasing urbanization Palestine is undergoing [276]. 
Results from our study suggests that WC and W/H ratio were strong predictors for 
developing diabetes mellitus among women, but failed to show that they act as 
mediators in the relationship between parity and diabetes, since we found no 
association with parity in the first place. But, for the analysis involving gravidity, the 
mediating effect of W/H ratio and WC was apparent. Our study found also that the 
degree of central and abdominal obesity was significantly related to number of 
children and other variables of reproductive history. 
The results of our study, showing no evidence of an association in an adjusted model, 
between parity and type II diabetes, are consistent with a previous study that 
controlled for age, BMI, educational level, and socio-economic status [197], and with 
another study that controlled for age and BMI and conducted in a relatively 
homogenous population [196]. In both studies no evidence was found of an 
independent association between parity and the development of type II diabetes 
mellitus. 
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Other studies have demonstrated both higher parity and diabetes to be associated with 
lower educational attainment and lower socio-economic status and these could be 
important confounders for the association between parity and diabetes [194] Women 
in our study also showed lower educational attainment and lower socio-economic 
status with increasing parity. Yet confounders including age, women's education, 
husbands' education and marital status could not explain the significant association 
between gravidity and type 11 diabetes mellitus. 
There have been many inconsistencies in the literature regarding the relationship 
between parity/gravidity and type II diabetes. Earlier studies suggested that parity, 
particularly five or more births, might be associated with diabetes [192] [122] [187], 
whereas other investigators have found no association [194,196,197] Potential 
mechanisms include the influence of multiple pregnancies on postpartum weight 
retention [ 153]-[277] and development of obesity [ 167,194,197] or the influence of 
multiple exposures to the metabolic changes of pregnancy [192], including impaired 
insulin sensitivity and central obesity [278]. Other studies [187,273] [279] suggest 
that nulliparity (no live births) may be associated with diabetes. Potential mechanisms 
include underlying insulin resistance and B cell dysfunction [187] related to infertility 
and pregnancy loss [280]. 
There are a number of factors that might have influenced the results in this case. The 
finding here that gravidity rather than parity, and incomplete pregnancies even more 
so, are definite correlates of FBS remains somewhat puzzling. The missing element 
in comparing gravidity and parity is that of the remaining gestation, cut short, and the 
post-partum period which includes breastfeeding, fairly universal in these women. 
Details of gestation at the time of pregnancy loss are not available, and it is hard to 
make more progress in deduction of factors likely to matter here. One must bear in 
mind that this is an additional analysis so the scope for chance effects is greater. 
Nevertheless, the effect of failed pregnancies was strongly significant, at p=0.001. 
Inclusion of women who are taking medication might have masked an underlying 
association between parity and diabetes. However, the study found higher FBS among 
those that reported they were taking the medication compared to those who said they 
were not. We also found that women who said they were on medication tended to be 
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in the high parity group and have the higher FBS. Furthermore, the use of censored 
regression models did not change the basic conclusions. 
Our study has shown that the mean number of children was not significantly higher 
among women who were diagnosed as diabetic compared with women who had 
normal glucose tolerance (7.8 vs. 7.2 children, p=0.108). This result is in agreement 
with a US survey on women aged 55 to 74 years of age, where the mean number of 
children was slightly higher among women with diagnosed diabetes than among 
women with normal glucose tolerance (3.4 vs. 2.7 children) [122]. On the other hand, 
women with high fasting blood sugar were older and women with high 
parity/gravidity were also older; this suggests that the removal of the effect by age 
confounding is needed here also. Whether the process of becoming pregnant and 
having more children might lead to diabetes or whether the association is due to age 
effects was investigated. In our study the age effect component was apparent in the 
association between parity and type II diabetes, and while age confounded this 
association, it could not fully explain the gravidity and fasting blood sugar 
relationship as the association remained significant even after adjustment for age. 
The finding of a relationship between FBS and gravidity but not parity is not in 
agreement with the Rancho Bernardo study where similar patterns of association were 
found between the two exposures (parity and gravidity) and risk of diabetes [122]. 
That study was larger (1186 women) but had fewer women at the upper levels of 
parity and gravidity. 
Reported family history of diabetes did not seem to modify the association between 
gravidity and diabetes mellitus, although women reporting a family history of diabetes 
were at increased risk of developing type 2 diabetes compared to those without a 
family history. This result does indicate that diabetes mellitus has a hereditary 
component; in agreement with Kritz-Silverstien of the Rancho Bernardo study in the 
US where they found women with a family history of diabetes had more than twice 
the risk of having non insulin dependent diabetes mellitus as those without such a 
family history [122]. 
The study results give no evidence that parity influences diabetes, so it is uncertain 
whether increasing parity may influence the later development of type 11 diabetes in 
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the susceptible group of women with gestational diabetes. One study demonstrated 
that women who have had gestational diabetes are at high risk of future diabetes. That 
study found that each additional pregnancy after an episode of gestational diabetes 
(GDM) further increased the likelihood of subsequent diabetes by 3.34 times 
compared to women who did not have a further pregnancy [281]. In our study we 
were not able to analyze the data for women who reported to have gestational diabetes 
because they constituted a small number (4%) of the sample and therefore the 
statistical power of any analysis would be low. 
There are several possible mechanisms to explain an association between parity and 
type II diabetes. 
" Women with higher parity might have a higher caloric intake and lower physical 
activity than women with lower parity. Sedentary lifestyle behaviour could lead to 
higher BMI, insulin resistance and development of diabetes [280,282]. Results 
from our study showed that women with higher parity had a higher BMI, central 
and abdominal obesity than women with lower parity, and therefore postpartum 
weight retention with multiple births coupled with a sedentary lifestyle might lead 
to the development of diabetes. All that has been stated above applies to this 
study, yet we did not find an association between parity and type II diabetes, 
although there was clear association between gravidity and type II diabetes. This 
may be an issue of statistical power for the relationship with parity; the sample 
size in the present study was not large, but the contrast with the relationship with 
gravidity remains something of an enigma, as we saw above. 
While some investigators propose that hormone levels might heighten insulin 
resistance [283], others suggest that hormones might adversely affect insulin 
resistance and increase the risk of diabetes. Our findings did not support any effect 
of menopausal status or oral contraceptive use as potential mediators of the 
association between parity and diabetes. 
In conclusion, despite a diabetogenic effect of pregnancy, we observed no association 
between parity and later development of diabetes mellitus after adjustment for age 
among women aged 40-65 years in the refugee camps, although the association exists 
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between gravidity and development of diabetes mellitus even after adjustment for age 
and Will ratio; socioeconomic factors could not explain this association between 
number of pregnancies and the development of type II diabetes. This association 
seems to be explained by failed pregnancies and partially by WC and Will ratio 
indicating central and abdominal obesity among women. 
14.2.3.1 Public Health Implications Relevant to Parity and Type II Diabetes 
Mellitus 
The main implication of our study is that the association of pregnancy with 
development of type II diabetes whether through biological mechanisms or lifestyle 
behaviours deserves further study. The findings suggest the need to further explore 
patterns of postpartum weight retention. To incorporate effective educational 
initiatives focusing on nutrition and physical activity into prenatal and postnatal care 
may be a reasonable strategy to promote healthy lifestyle behaviours among women. 
This work suggests the need for physicians to discuss potential long term effects of 
pregnancy on health to women and patients who already have diabetes. Multiparous 
women should be counselled about the increased risk of diabetes especially if other 
risk factors are present. 
14.2.4 Parity and Hypertension (Hypothesis 6) 
Hypertension has long been recognized as a risk factor for CHD. Does an increasing 
number of children lead to elevation in diastolic blood pressure (DBP), systolic blood 
pressure (SBP) and hypertension in this group of women? 
The results of previous studies attempting to demonstrate an association between 
gravidity/parity and hypertension have led to inconsistent results. Our results show an 
apparent association between parity and SBP in an unadjusted analysis. Adjustment 
for age and other confounders (women's education, husband's education and marital 
status) attenuated the association. No evidence was found of an association between 
DBP and parity. 
Women with elevated SBP, elevated DBP and hypertension were significantly older, 
less physically active, had more central and abdominal obesity and were more often in 
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the menopausal (post menopausal) state. Furthermore, women with elevated systolic 
blood pressure tended to be more obese (BMI >_ 30 kg/m2), diabetic with higher levels 
of total cholesterol and LDL-C, tended to have more pregnancies that ended as still 
births and were less educated. All these characteristics were consistent with other 
studies that investigated the association between these factors and blood pressure 
among older women. 
The positive association between number of children and elevated SBP became non 
significant after adjustment for age. The change in odds of SBP > 140 mmHg or on 
medication, per extra child (unit change in parity) was 1.06 mmHg (95% CI: 1.01 to 
1.11, p=0.027). After adjustment for age, the change in odds of SBP > 140 mmHg or 
on medication per extra child (unit change in parity) became 1.02 mmHg (95% CI: 
0.97 to 1.07, p=0.442). The same applies to the association between number of 
children and unadjusted censored mean for SBP, where the regression coefficient was 
0.98 mmHg (95% CI: 0.32 to 1.64, p= 0.004), whereas no linear association was 
found between numbers of children and mean censored with age adjustment for both 
systolic and diastolic blood pressure. Difference per increase of one child for SBP was 
= 0.34, (95% Cl: -0.29 to 0.96, p= 0.289) and for DBP was = 0.03 (95% Cl: -0.28 to 
0.34, p= 0.843). 
Findings in relation to existing literature: Most of the studies that examined the 
association between parity/gravidity and blood pressure did not adjust for age or 
included women at younger ages. The studies that included older women and adjusted 
for age, obesity and other covariates could not identify a positive association between 
parity/ gravidity and blood pressure [201] [2] [114] [113]. 
Lawlor et al [2] found no linear association between number of children and mean 
age-adjusted systolic blood pressure or mean age-adjusted diastolic blood pressure 
with both men and women, not even for women with five or more children. 
(Difference per increase of one child was for SBP= 0.31 (95% CI: -0.33 to 0.94, 
p=0.35) and for DBP = 0.05 (95% CI: -0.26 to 0.35, p=0.77). Humphries et at [114] 
found that the mean age-adjusted systolic and diastolic blood pressure and the 
prevalence of hypertension did not vary with parity among a group of post- 
menopausal women aged 55-99 years who participated in the Rotherdam study. 
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Kritz-Silverstein et at [201] found no association between parity or gravidity and 
hypertension or blood pressure after controlling for a variety of covariates such as 
age, obesity, alcohol intake, cigarette smoking and oestrogen use. However the study 
examined a cross-sectional cohort of older white women aged 50 years and above 
who were of relatively high socio-economic status and generally of low gravidity. 
Lee-Feldstein et at [202] found that the blood pressure (SBP or DBP) of white women 
of high and low stress groups that were identified in terms of socio-economic status 
was not associated with women's reported number of live births, after adjusting for 
age, percent overweight, race, and stress effects. Ness et al [215] found a stronger 
association between gravidity and hypertension or SBP for younger premenopausal 
women compared to post-menopausal women 
Overall obesity, and central and abdominal adiposity are risk factors for elevated SBP 
and DBP and they are significantly associated in our study (data not shown). However 
introducing BMI, WC and W/H ratio into the model did not change the non- 
significant association between DBP, SBP and parity. 
14.2.4.1 Study Limitations as related to blood pressure 
It is unlikely that the lack of association between number of children and blood 
pressure observed in this study was due to survival bias whereby women with greater 
number of children had higher blood pressure but died before the study was 
conducted. It is also unlikely that medical treatment could bias the association. In our 
study increased parity was not associated with higher use of antihypertensive 
medication. Also, excluding women on antihypertensive medications had no impact 
on the association between parity and blood pressure. In fact, we found that women 
who have high blood pressure were the women with more children and were the least 
likely to comply with antihypertensive medication. 
Weaknesses of these results include the lack of generalizability; the data were from 
refugee women only and cross sectional. Although a retrospective history of 
pregnancy and parity was included, measurements of blood pressure reflect current 
status only. 
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Smoking is considered a risk factor to hypertension, but we excluded smoking from 
the analysis because very few women in the sample smoke. Ness et al [215] found a 
negative relation of current smoking to blood pressure and hypertension which she 
attributed to physicians recommending smoking cessation to patients with high blood 
pressure. 
In comparison with other studies, women in this study were more obese, had less 
educational attainment, were less physically active, were of relatively low socio- 
economic status and had more children. Whether the same mechanisms found in 
Western countries apply to these women is still not clear. We found a trend of 
increasing SBP with increasing parity, but the power of the study was limited and we 
were not able to detect any significant association between parity and SBP among 
these older women. Thus, we must remain equivocal about the extent of a parity- 
blood-pressure association. The fact that there is a parity-obesity link and also one 
between obesity and blood pressure does, however argue for such an association in 
these women; the lack of direct evidence for it being due to lack of power. 
It is well established that changes in blood pressure may occur during pregnancy, but 
the relationship between parity/gravidity and blood pressure may be different for 
younger women who are closer to childbearing or who are still coping with small 
children compared to older women [201]. In our study all women finished their 
childbearing years and were aged between 40-65 years which could explain in part 
why there was no evidence of an association between parity and SBP, DBP and 
hypertension. 
14.3 Parity and Other Outcome Variables 
14.3.1 Parity and CHD Reported Events (Hypothesis 7) 
The association between parity and CHD risk as reported by women was investigated. 
7.8% of women reported having had CHD events. CHD was defined as self report of 
a doctor's diagnosis of myocardial infarction/heart attack, angina, valve problem, or 
heart failure. 
Women with reported CHD were older, less educated, and either widowed or, among 
those married, the husbands were unemployed. They tended to have more children, 
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and were menopausal. They had elevated SBP, DBP and hypertension. Although 
these reports may not be completely reliable, this last finding and the fact that less 
educated women reported more CHD gives support for reliability. 
We observed a marginally significant association between parity in groups and 
reported CHD events, p=0.043. However, adjustment for age removed this 
association, and it was no longer significant, p= 0.192. 
When parity was fitted into an ordinary regression model as a continuous variable and 
reported CHD was kept as a categorical variable, the change in the unadjusted odds 
of CHD events per extra child was also non-significant, at 1.05 (95% Cl: 0.96-1.15, 
p=0.249). Adjustment for age, women's education, husband's years of schooling and 
marital status slightly reduced the magnitude of the association and it remained non 
significant 
We found no significant association between parity and reported CHD events after 
adjustment for age. Women who reported to have had a CHD event had more children 
and were also older than women who reported not having had a CHD event. 
As has been suggested, there might be unreliability in women's recall of CHD events. 
Women might have a recollection of angina and/or chest pain but not interpret it as a 
CHD event. Usually women do not go for a check up or seek a doctor's advice unless 
they are very sick, and they might have misinterpreted the meaning of symptoms 
unless they sought advice from a health professional. In a regression model, reported 
CHD events were significantly associated with elevated SBP, hypertension and 
elevated W/H ratio. 
There have been conflicting findings among other studies regarding the positive 
association between increasing number of children and the development of CHD 
events in women. These differences could have arisen from the limitation of methods 
used in some of the studies including different age ranges for different studies and 
control for potentially confounding factors. In studies that have included women aged 
less than 60 years few women develop heart disease and, therefore, these studies were 
less powerful and could not identify an association. Studies that found positive 
associations included cases of all ages (see literature review, Tables 5-2,5-3 and 5-4). 
Our study did not find a significant association between parity and reported CHD 
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events perhaps in part because of this age component. Not finding an association in 
our study does not mean that the association does not exist. The large cohort, case 
control and cross sectional studies showed small but consistent significant positive 
association between parity and CHD events among women. (Tables 5-2,5-3 and 5-4 
from the literature review). 
14.3.2 Parity and the Metabolic Syndrome (Hypothesis 8) 
The metabolic syndrome describes the co-occurrence of abnormalities in glucose and 
lipid metabolism, central fat distribution and blood pressure and indicates increased 
risk of future cardiovascular disease as well as diabetes. (For the definition of 
metabolic syndrome, see Appendix 2. ) Whether parity plays a role in the development 
of the metabolic syndrome and therefore in CHD risk is a question not yet answered. 
The metabolic syndrome was present in 58.3% of the women. Women with the 
metabolic syndrome had significantly higher parity and higher gravidity, p= 0.003 and 
p= 0.024 respectively. The association with live births was stronger than that with 
pregnancies. The women were significantly older and less likely to have secondary or 
higher education, were unemployed and more likely to be assisted by their daughters 
or daughters-in-law at home, and therefore more likely to be physically inactive. 
Women with the metabolic syndrome tended to have elevated DBP, SBP and 
hypertension and were menopausal. They tended to have higher rates of overall 
obesity, and central and abdominal obesity compared to those women without the 
metabolic syndrome. The metabolic syndrome was prevalent more among married 
and widowed women. 
A significant association between parity in groups and the prevalence of the metabolic 
syndrome was observed, p=0.024. Adjustment for age slightly increased the 
magnitude of the association and it remained significant, p=0.038. Adjustment for 
educational level attenuated the association and it became non significant. Further 
adjustments for husband's educational level and marital status made no difference to 
the magnitude of the association and it remained non significant. 
Our results based on models with parity as a continuous variable showed a 7% 
increase in the prevalence of the metabolic syndrome per extra child after adjustment 
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for age, women's and husband's education and marital status, marginally significant 
at p= 0.042. Further analysis suggested that physical inactivity as well as obesity 
(overall, central and abdominal obesity) play a vital role in the development of the 
metabolic syndrome on one hand and slightly mediate the association between parity 
and the development of the metabolic syndrome on the other. With such a marginal 
level of significance, and given the multiple testing involved in this study, the 
evidence for this association must be regarded with caution. However, the role of 
mediators is discussed. 
The analysis was taken further, and details of the role of mediators and other 
correlates are shown in Table 13-4. In these regression models, all variables that were 
significantly associated with the metabolic syndrome were introduced into the model 
separately to test their roles individually and to determine if they act as mediators in 
the relationship between parity and the metabolic syndrome. Only those that showed a 
significant level were kept in the model. 
None of the changes in the odds ratio for parity were very marked. Changes for 
physical activity and abdominal obesity were only from 1.07 to 1.06. For overall 
obesity, the change was from 1.07 to 1.05, suggesting small mediation from this 
source. 
In summary, our study has shown as a cautious conclusion that the more children a 
woman has, the higher her risk of developing the metabolic syndrome. Women's 
sedentary lifestyle and lower education play a vital role in such an association by 
encouraging obesity and discouraging these women from seeking medical advice 
regarding their health. Most are unaware of the consequences of having elevated 
lipids, BP and weight increase, which can lead to metabolic syndrome and CHD risk. 
This study shows the prevalence of the metabolic syndrome among Palestinian 
women living in the refugee camps for the first time, with a high prevalence of 58.3% 
using the IDF definition (recently approved by the WHO among others). This 
estimate is higher than that found by Al-Lawati et al among Omani adults where the 
prevalence of the metabolic syndrome was 21% using the ATP III definition [223]. 
Another study by Abdul-Rahim et al found that 17% of the West Bank rural and 
urban population had the metabolic syndrome using the WHO definition [232]. 
285 
Different studies have used a variety of definitions for the metabolic syndrome 
including that of the WHO, the Adult Treatment Panel (ATP) III and the IDF which 
make comparison of findings more difficult and might explain the variation in results. 
Also the high rate of the metabolic syndrome could be linked to the high rate of 
central obesity (an important component of metabolic syndrome) among these 
women. However, none of these studies looked at parity as a risk factor for metabolic 
syndrome. This may be the first study that assesses the association between the 
prevalence of the metabolic syndrome and the number of live births in the Middle- 
East region, including Palestine. 
There is little previous work with which to compare the present results. Only two 
recent studies, one in China and one in the US, have examined the association 
between parity and the metabolic syndrome, using the IDF definition and the ATP III 
definition respectively [164] [234]. The study carried out in China showed that higher 
parity was associated with a consistent increase in the risk of the metabolic syndrome 
among women and men after adjustment for age, socio-demographic, reproductive 
and behavioural factors. When the association was adjusted for BMI, it attenuated in 
men but not in women suggesting that the association with metabolic syndrome in 
women is likely to represent a biological response to pregnancy [164]. The study 
conducted in the US also found that the rate of the metabolic syndrome was 
significantly higher with increasing numbers of children, demonstrating a dose 
response relationship P<0.0001. The odds of having metabolic syndrome increased 
13% with each additional child after controlling for age, race/ethnicity, income, and 
education, reproductive and behavioural risk factors. After adjustment for BMI, the 
strength of the association was decreased suggesting that weight might be an 
important mediator of the effect of parity on the risk of the metabolic syndrome [234]. 
Effective primary prevention requires an assessment of risk to categorize patients for 
selection of appropriate interventions. Therefore, in a separate analysis we have 
quantified the individual risk of developing CHD in 10 years time among these 
women by using the Framingham equation and then calculating the total risk factors 
score for each woman (see Appendix 2 for definition of the Framingham risk score). 
Our analysis has shown that 5.69% (26 women) were at higher risk of developing 
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CHD in 10 years time, 16.85% (77 women) were at medium risk, and 77.46% (345 
women) at lower risk. 
We also found that 10% of women with the MS are at higher risk of developing CHD 
in 10 years according to the Framingham score, while we found 28.9% of women 
with MS are at medium risk. 
On an unadjusted basis we found that women's risk of developing CHD in 10 years 
increased by 0.003 per extra child, (95% CI: 0.002-0.005, p<0.0001). When adjusted 
for age the association became no more significant, but it must be remembered that 
age features in the Framingham score, so adjusting for it will tend to reduce these 
effects. 
Identifying women at increased risk of developing MS and CHD will pave the way 
for primary prevention programmes that will target women and men at the same time 
and will save lives at the individual levels. 
14.3.2.1 Study Limitations as related to the metabolic syndrome 
Conclusions drawn from this cross-sectional design relating parity to the metabolic 
syndrome may be affected by several sources of bias as mentioned in the previous 
discussion sections: 
Survival bias: Women with greater number of children might have an increased risk 
of premature death and also tend to have more of the metabolic syndrome; this would 
lead to underestimation of the strength of association between number of children and 
the metabolic syndrome. However, it seems unlikely that the association between the 
presence of the metabolic syndrome and parity was strongly affected by survival bias. 
Participation bias: Participation bias is unlikely to account for the observed 
association between parity and metabolic syndrome. All women in the camps aged 
40-65 years were recruited without knowing their number of children or whether or 
not they have the metabolic syndrome. 
Reverse causality: It seems unlikely that metabolic syndrome leads to an increased 
number of children. 
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Recall bias: Women might not have been able to recall things that happened in the 
past such as their weight at age 18, and weight gain during each pregnancy. This has 
limited the use of such variables. Self-reporting of pregnancies could also be subject 
to recall bias. Live births are more likely to be fully recalled than number of 
pregnancies, since some pregnancy losses are clinically unrecognized and therefore 
not recalled [10]. Using parity minimizes this recall bias. 
Although we have adjusted for confounders in the analysis, it would have been 
difficult to discount the role of unmeasured confounding factors in studying the 
association of parity with the metabolic syndrome. Socio-economic status may not 
have been adequately controlled by statistical adjustment for education. For example, 
we have used educational level as a proxy to socio-economic status; it was difficult to 
assess income so wealth status was used as a variable that created for the purpose of 
comparison among women. The same applies to physical activity and other 
behavioural risk factors. 
Selection bias: The high response rate (all women recruited participated in the study 
except for 15 women who filled in the questionnaire but refused to give blood 
samples for reasons stated in the methods chapter) in the refugee camps means that 
selection bias is unlikely to be of concern. 
14.3.2.2 Public Health Implications 
The prevention and control of obesity plays a central role in the reduction in risk 
factors that make up the metabolic syndrome. The risk of developing abnormal 
glucose metabolism, dyslipidemia, and hypertension is markedly higher among 
people who are obese compared with people of normal weight [284]. Also, weight 
reduction through dietary and lifestyle modification and regular physical activity are 
shown to be effective in improving insulin sensitivity [285] [286], correcting 
metabolic abnormalities and reducing blood pressure in obese people [284]. Further 
research into those risk factors that can be modified, in particular obesity and physical 
inactivity, is highly recommended. Studies to examine the effect of lost pregnancies 
and breastfeeding on the development of the metabolic syndrome and its components 
would also be of interest. 
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The burden of CHD risk factors including prevention policies and programmes need 
to be addressed at the level of policy makers at the different ministries, WHO and UN 
organizations and NGOs. Prevention should always be the key strategy for avoiding 
the human and financial costs especially where resources are limited. 
14.4. Conclusions 
In the preceding sections of this chapter, we discussed some methodological 
limitations of this cross-sectional study as they emerged regarding parity and each of 
the risk factors for CHD, reported CHD and the metabolic syndrome. The following 
section assesses the strengths and weaknesses of the study as a whole. And, finally, it 
relates the study results to the original conceptual framework developed from the 
literature review 
14.4.1 Overall Strengths of the Study 
The measurements for all outcome variables (lipids and lipoproteins, 
anthropometric outcomes, blood pressure, and diabetes) were determined by 
laboratory and physical measurements and not by self reporting. 
" Standard quality control procedures were applied in the study at the level of the 
laboratory, equipment used and the data management analysis. 
9 The high commitment and dedication of the data collection team have added value 
to the study. 
e The high participation rate of women in the study added value to the study. 
Women were very cooperative and participated willingly and cheerfully in spite of 
all the difficulties and the unstable environment they were living under. This was 
the first time in the lives of these women that someone was approaching them to 
study their health and well being. 
" All authority bodies such as the Palestinian Ministry of Health, UNRWA, health 
professionals and health care providers, laboratory personnel, community leaders 
and women activists in the camps cooperated with the study. 
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" This study presents for the first time data on central and abdominal obesity at a 
time where data from the Arab region countries is scarce. Also this is the first 
study to present data on the prevalence of the metabolic syndrome in Palestinian 
refugee camps. 
" For the study of parity, the great range of parity among the women has enhanced 
the power of the study 
14.4.2 Overall Weaknesses of the Study 
" Inclusion of men would have added value to the crucial issue of whether the 
observed association between the outcome variables including reported CHD, the 
metabolic syndrome and the 10-years CHD risk and parity was due to biological 
processes initiated by conception, or whether other mechanisms are involved 
including socio-demographic or lifestyle factors in response to pregnancy and/ or 
the raising of children. However, there are enough essential differences between 
men and women, both biological and behavioural, for this to be of only limited 
potential use. 
" The women in this study are unlikely to completely represent older women among 
Palestinian refugees, on one hand, and older women among rural and urban areas 
of Palestine, on the other. Therefore inferring population prevalence from this 
study has to be dealt with cautiously. 
There might be unreliability in women's recall of CHD events and other 
reproductive health factors such as gravidity, pregnancy losses and other 
reproductive health variables and other covariates. CHD incidents were not 
measured clinically, as it was not part of the overall design of the study, but was 
added later as an additional analysis. 
" Measurements of an exposure: there might be inaccuracy of women's recall. 
Pregnancy losses and thereby gravidity are less likely to be fully recalled 
compared to parity. 
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" The sample size, though evaluated at the planning stage, was not large in 
comparison with many other studies, giving less power, although the range of 
parity may have improved the power (see above). 
" Some of the relationships such as parity and fasting blood sugar (FBS), and parity 
and decreased HDL-C levels were not detected in our study, although associations 
were found in other studies. This could be due to a lack of statistical power of this 
study given its smaller sample size. 
" More sensitive instruments are needed to evaluate stress factors and levels (being 
an important risk factor for CHD) of this large group of women living in refugee 
camps and under constant stress. Imprecise measurement of stress may lead to 
inadequate control for it which in turn may lead to residual confounding. 
Retrospective studies with precise measure of stress factors are important to 
consider in future studies. 
" Many hypotheses were investigated and even more statistical tests were carried 
out, leading to a greater chance of a significant result when the hypothesis was 
actually not true. There has been no specific adjustment for this, but we have 
drawn most attention to those findings that are supported by similar results from 
other studies, in the literature. 
14.4.3 Recommendations for Future Studies 
As the fertility rate falls, it would be of interest to assess whether the changes in 
reproductive patterns (decrease in fertility) have any effect on the development of the 
metabolic syndrome or any of its components in the near future, and whether this fall 
in fertility leads to a reduction in BMI, WC and W/H ratio among these women. The 
impact of parity seems to be more of less the same wherever you are, whether in the 
West or the Middle East or any part of the world. 
A woman's education has an impact on limiting the number of children she will have. 
Being educated will offer women greater opportunity for employment which will in 
turn delay the age of marriage and reduce fertility. 
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It is not clear if the finding of the association between gravidity and FBS, which goes 
via failed pregnancies, is due to chance, or is a real association. This finding requires 
further investigation and is discussed further below. 
14.4.4 Final summary and Relevance of the Study Results with the Conceptual 
Framework 
An independent association was found between parity and BMI, on one hand, and 
parity and WC, on the other. These independent associations could not be explained 
by potential confounders and mediators, and are supported in other studies, and are 
more likely to represent a biological response to pregnancy. Changes in lifestyle 
accompanying raising children such as assistance in housework (a proxy to physical 
inactivity) partially mediated the association, but because it remained significant it 
seems to have an influence beyond these mediators. It is always possible that the 
association is due to unmeasured or residual confounders that we could not control for 
in our analysis. No evidence however was found of an association between parity and 
W/H ratio. 
Among all of the lipids and lipoproteins, triglycerides (TG) showed a significant 
association with parity that was not explained by confounders. Increased TG levels in 
women with more children appeared to be partially mediated by overall obesity 
represented by BMI and sedentary lifestyle represented by assistance in housework. 
This suggests that the relationship between parity and triglycerides levels could be 
associated with the long term biological consequences of pregnancy through the 
alterations of lipid levels. The weight increase associated with pregnancy and/or the 
sedentary life style the women are leading partially transmits some of the effect of 
parity, but the association remained significant. On the other hand, no association 
between parity and decreased HDL-C was seen in our analysis. In view of evidence 
from other studies for this association, this could be due to lack of statistical power. 
An association between parity and FBS did not emerge in our analysis and this also 
could be due to lack of statistical power. Among the confounders that were 
considered, the association seems to be explained most by age. Parity increased 
significantly with increasing age and the risk of diabetes increased significantly with 
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increasing age; age seemed to have a much stronger effect on the development of 
diabetes than parity. 
In contrast, a significant association between gravidity and FBS was observed and 
could not be explained by confounders. This association was mediated mainly by 
failed pregnancies (the component of gravidity that also predicts FBS) and to a lesser 
extent by WC and WHR. It is not clear if this finding of the association between 
gravidity and FBS, which goes via failed pregnancies, is due to chance, or is a real 
association. Chance must be taken seriously because the result was not anticipated 
and because of the general caution over conducting many statistical tests. But the 
finding requires further investigation. Although parity is highly correlated with 
gravidity, these two factors are not interchangeable as the latter included abortions, 
miscarriages and still births and lacks breastfeeding. One would expect that the 
duration of childbearing and the intensity of the hormonal effects of pregnancy would 
be less than for a completed birth, and would therefore have weaker effects of 
pregnancies on FBS compared to that for live births, but this was not the case in this 
study. On the other hand, the whole hormonal profile of an incomplete pregnancy, 
with no subsequent breastfeeding, is basically different 
Our results have also shown a positive crude association between number of children 
and elevated SBP. This association became non-significant after adjustment for age. 
No evidence of an association was observed between parity and DPB and 
hypertension in these older women. It might be that the power of the study was not 
sufficient to detect any significant association between parity and blood pressure 
among these older women. Thus, we must remain equivocal about the extent of a 
parity-hypertension association. The fact that there is a parity-obesity link, and also a 
link between obesity and hypertension might argue for such an association to exist in 
these women. The lack of direct evidence for it might be due to lack of power. 
Only one outcome was not measured during the fieldwork, but was based on 
questionnaire responses. This was reported CHD events. No significant association 
was observed between parity in groups and these events after adjustment for age. 
Although CHD events were significantly associated with elevated SBP, hypertension 
and WHR, we could not detect a significant association and age seemed to exert a 
greater effect than parity on CHD events. 
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A significant age-adjusted association was observed between parity in groups and the 
development of the metabolic syndrome among these women. Women with a higher 
number of pregnancies and live births had a higher prevalence of the metabolic 
syndrome. Adjustment for educational level attenuated the association to the null 
hypothesis and it was no longer significant. 
Clustering of the components of the metabolic syndrome increases the risk of CHD. 
There appears to be an association between parity and metabolic syndrome; there 
seems to be a biological side of the association that goes through pregnancy and 
childbirth, changing the lipid profile and carbohydrate metabolism, and over time this 
might lead to CHD events. This association seems to be confounded by the SES and 
in particular education and is mediated by the sedentary life style some women were 
leading. Central obesity which is a major component of the metabolic syndrome 
seems to exert a large effect, as a high percentage of women had central obesity. This 
could in part translate the higher rate of the metabolic syndrome among these women 
especially those with high parity. This implies again that efforts should be directed to 
the prevention and treatment of obesity in all its forms rather than to only address its 
associated co-morbidities. 
From what has been stated so far, we can conclude that although older Palestinian 
women are different from Western women in bearing many children, being physically 
inactive, unemployed, with less educational attainment and not being smokers, the 
mechanism for the association between parity and CHD risk factors is likely to be the 
same. Parity exerts the same effect and the impact of parity would be the same 
whether among Palestinian women or among women from other countries or ethnic 
groups. Some differences might exist, for example, obesity and physical inactivity 
increasing with increasing number of children. Biologically, this would apply 
anywhere but in a western population obesity is not as directly linked to parity and 
women in Western countries do not commonly have their daughters or daughters-in- 
laws helping them in housework 
The total fertility rate in Palestine has been reduced over recent years. The TFR 
dropped from 6.8 in 1992 to 4.6 in 2006 [287]. Will this decrease in TFR leads to a 
decrease in CHD events in women? Will it lead to a reduction of BMI and WC? Will 
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the lipid profile improve among women and therefore fewer CHD events will be 
observed? Does this fall in TFR have implications on CHD risk? 
Among these Palestinian women, increased parity is significantly associated with 
obesity (as measured by BMI and waist circumference), triglycerides and an increased 
risk of the metabolic syndrome. Any of these, alone or in combination, could result in 
increased CHD risk for this group of women and a fall in average parity would then 
reduce these risks. 
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APPENDICES 
Appendix 1 
Terms Used in the Literature Review Search Strategy 
Coronary Disease/Epidemiolozy* 
" Parity* 
" Pregnancy 
" Body Height 
" Body Mass Index 
" Body Weight 
" Case-Control Studies 
" Coronary Disease/ethnology* 
" Coronary Disease/aetiology* 
" Diabetes Complications 
" Educational Status 
" Female 
" Humans 
" Hypertension/complications 
" Logistic Models 
" Maternal Age 
" Middle Aged 
" Obesity/complications 
" Odds Ratio 
" Parity 
" Prevalence 
" Questionnaires 
" Research Support, U. S. Gov't, 
P. H. S. 
" Risk Factors 
" Smoking/adverse effects 
" United States/epidemiology 
" Women's Health* 
" Adult 
" Coronary Disease/psychology* 
" Family Characteristics 
" Female 
" Humans 
" Infant, Newborn 
" Life Change Events 
" Life Style 
" Menopause/psychology 
" Parity* 
" Pregnancy 
" Prospective Studies 
" Research Support, U. S. Gov't, 
P. H. S. 
" Social Support* 
" Stress, 
Psychological/complications* 
MeSH Terms: 
" Adult 
" Aged 
" Coronary Disease/epidemiology* 
" Coronary Disease/aetiology 
" Coronary Disease/genetics 
" Estrogens/blood 
" Female 
" Health Behaviour 
" Humans 
" Male 
" Menopause 
" Parity 
" Pregnancy 
" Research Support, U. S. Gov't, 
P. H. S. 
" Risk Factors 
" Sex Characteristics 
" Se Factors* 
" Social Support 
" Middle Aged 
Appendix 2 
Definitions, computations and coding of exposure, outcome variables, 
confounders and other covariates used in the study 
1. Definition of CHD 
CHD was defined as self report of a doctor diagnosis of myocardial infarction, angina, 
heart failure, valve problem and /or a record of a diagnosis of any one of these 
conditions. 
2. Definition of the Metabolic Syndrome: 
The Metabolic Syndrome is a clustering of metabolic derangements that cause 
affected subjects to have an increased risk for developing diabetes, cardiovascular 
disease, and, according to recent epidemiologic studies, chronic kidney disease. [1] 
There have been four definitions of metabolic syndrome published by different 
national and international committees. In an effort to bridge the differences existent in 
those classifications, a unified definition that recognizes the increased biologic 
activity of the upper visceral fatty tissue and the strong association of abdominal 
obesity as a leading part of metabolic syndrome has been proposed by the 
International Diabetes Association. [2] 
The International Diabetes Federation has proposed a new definition that requires the 
presence of central obesity with specific ethnic cut-points: 
Central obesity (defined as waist circumference > 94 cm for Europid men and >_ 80 
cm for Europid women, with ethnicity specific values for other groups) 
Plus any two of the following four factors: 
" raised triglycerides 2150 mg/dl (1.7 mmol/L), or specific treatment for this 
lipid abnormality 
" reduced HDL cholesterol: < 40 mg/dL (1.03 mmol/L) in males and < 50 
mg/dL (1.29 mmol/L) in females, or specific treatment for this lipid 
abnormality 
" raised blood pressure: systolic BP > 130 or diastolic BP >_ 85 mmHg, or 
treatment of previously diagnosed hypertension 
" raised fasting plasma glucose (FPG) ? 100 mg/dL (5.6 mmol/L), or previously 
diagnosed type 2 diabetes. 
These values apply to Eastern Mediterranean and Middle East (Arab) populations. 
3. Definition of 10 years risk for developing CHD 
Estimation of CHD risk for the next 10 years for each woman was based on 
Framingham risk scoring equation which accounts the following risk factors: age, 
current smoker, diabetic, SBP, total cholesterol, HDL-C. 
Two steps were used to calculate the risk score: 
(1) The first step was to calculate the number of points for each risk factor and 
then counting the total risk factors score for each woman. 
(2) The second step was to classify women into 3 categories: a. those with 10 
years risk for CHD of > 20% defined as high risk, b. 10-< 20% defined as 
moderate risk, and c. those with < 10% defined as low risk. [3] 
The following algorithm was used for estimating the 10 years risk for developing 
CHD, expressed in Stata code: 
" generate Inage=ln(exact ag) 
" recode g129 1=0 2=1 3=0, gene(currsmoke) 
" gene diabetic=gluc>=126 
" generate muchd=15.5305+28.441-15.938*lnage+1.8515*(Inage^2)- 
0.9119*log(q 149_h)-0.2767*currsmoke-0.7181 *ln(chol/hdl)- 
0.3758*diabetic 
" gene sigmachd=exp(0.9145-0.2784*muchd) 
" gene uchd=(ln(10)-muchd)/sigmachd 
" gene rI Ochd=1-exp(-exp(uchd)) 
4. Computation of Further Variables: 
Family Affluence Scale (FAS) variable computation: 
We created a new variable called household crowdedness which was computed by 
dividing the number of people living in the household by the number of rooms 
excluding the kitchen and bathrooms. (Q5/Q29) 
This measure of household crowdedness was recoded as (lowest through 1= not 
crowded) (1.01 through 2= moderate) (2.01 through highest = crowded) -and this 
three-point scale was called household crowded scale (crowding scale). 
Another variable was created called household amenities. It was computed as the sum 
of all the amenities mentioned in q31 (q31-1 to q31-17). 
This household amenities variable was recoded into a three-point scale, with those 
with 0 to 5 amenities in the household given a code of 1, those with 6 amenities given 
a code of 2 and those with 7 or more amenities were coded as 3. This new variable 
was called household amenities recoded. 
A further scale, called the Family Affluence Scale (FAS), was constructed from the 
crowding scale combined with the count of amenities for the household. The FAS had 
three values defined as follows: 
A. For uncrowded households (one person per room or less) and for any number of 
amenities, the FAS was coded 3. 
B. For households of moderate crowding (more than one and up to two persons per 
room), the FAS was also coded 3 if the number of amenities exceeded 5, but was 
coded 2 if there were 5 or less amenities reported. 
C. For the most crowded households, with more than two persons per room, and with 
more than 6 amenities, the FAS was again coded as 2, but with less amenities, the 
FAS was coded 1. 
Stress Variable Computation: 
Women were asked about a series of life events that might have occurred in the past 
six months of their lives such as death of a family member, separation, loss of a job, 
etc.. Although some life events are more stressful than others, yet these life events 
were divided into five categories based on the effect they might exert as in A, B, C, D 
and E. These five categories constituted the basis for the construction of the stress 
scale index as follows: 
A. Human loss and trauma to study subject, if a person has experienced any 
one of the items listed below or all combined 
1. This category includes death of a spouse, and/or 
2. Divorce, and /or 
3. Addition of a family member, and/or 
4. Marriage of spouse, and/or 
5. Major personal injury or illness 
6. Major change in argument with spouse 
7. In-law troubles 
B. Human loss and trauma to family member, if a person has experienced 
any one of the items listed below or all combined 
1. Death of a close family member, and for 
2. Detention of any family member 
3. Injury or shot of a family member 
4. Major change in living conditions 
C. Property loss to subject 
1. Demolition of your house 
D. Work related problems, if a person has experienced any one of the items 
listed below or all combined 
1. Spouse ending work 
2. Being fired from work 
3. Major changes in working conditions 
E. All stress events combined 
A woman is coded as positive for this all events combined, if she is positive for one or 
more of the categories A, B, C or D. 
5 _Definitions and categorization of confounders and other covariates: 
5.1 Definitions of confounders: 
Women's age in years. Age of women was divided into 5 categories: 
" 40-44 years 
" 45-49 years 
" 50-54 years 
" 55-59 years 
" 60+ years 
Years of schooling for both women and their husbands were categorized as follows: 
" No formal education: 0 years of schooling 
" Elementary: 1-6 years of schooling 
" Secondary: 7-12 years of schooling 
" Higher: 12+ years of schooling 
Marital status was categorized as follows: 
" Single 
" Married and currently living with husband 
" Divorced 
" Separated 
" Widowed 
5.2 Definitions of Other Covariates: 
Occupation of women was categorized into: 
" Unskilled worker 
" Skilled worker 
" Employee 
" Private business 
* Physical activity was assessed by three questions: 
" Do women practice any kind of physical exercise (yes or no)? 
" If yes what kind of physical exercise do they practice? 
" How many hours per week they practice? 
" The first question was only used in assessing physical activity, as few 
women (69) were walking with a mean of 3 hours per week. 
0 Smoking was categorized as current, ex-smoker and never smoked. 
Hours per week watching TV was categorized into: 
"<4 hours 
" 5-10 hours 
" 11-20 hours 
" 21+ hours 
Assistance in housework was categorized as yes or no. 
Age at first marriage was categorized as < 18 years, and 18+ years. 
Age at first birth was categorized as < 18 years, and > 18 years. 
Gravidity was defined as the total number of pregnancies including lost 
pregnancies and stillbirths. 
Age at menarche in years was categorized as: 
<11 
" 12 
" 13 
" 14 
" 15+ 
History of infertility was defined as the women have ever tried to become 
pregnant for one straight year or more and did not become pregnant during that 
time. It was categorized as yes or no. 
Pregnancy ended as a miscarriage or abortion was categorized as yes or no. 
Pregnancy ended as a stillbirth was categorized as yes or no. 
Ever had polycystic ovaries was categorized as yes or no. 
Ever uses contraceptive pill (yes or no). 
Periods stopped now as yes or no. 
Age at menopause in years was categorized as: 
" 5544 
" 45-49 
" 50-54 
" 55+ 
Family history of diabetes, hypertension and CHD was classified as yes or no 
according to the woman's report. 
Gravidity was defined as the total number of pregnancies including lost 
pregnancies and stillbirths. 
I. Reisen Efrain MD and Alpert Martin A MD, American Journal of the Medical 
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metabolic syndrome. Available on line at: www. idforg. 2005 [cited. 
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Appendix 3 
Women's Health Questionnaire 
Principal Investigator: Najwa Rizkallah 
1. SERIAL NUMBER: 
............................................... 
2. RESPONDENT'S NAME: 
........................................ 
3. RESPONDENT DATE OF BIRTH: YEAR MONTH DAY m 
4. AGE IN YEARS 
............ 
m, U 
5. NUMBER OF PEOPLE LIVING IN THE HOUSEHOLD: ...................... 
6. ARE YOU: El 
1. married 2. single 3. divorced 
4. separated 5. widowed 6. others, specify .................. 
7. ARE YOU NOW 
1. Pregnant 
3. Not sure 
2. Not pregnant 
4. Breastfeeding for the last 12 month 
0 
C slit, Hot sure, or lire. 
If not LO to the next 
CONSENT OF PARTICIPANT 
Please sign below if you are interested and willing to participate in this reseii1(li We J, )stjw you 
that all information given by you will be kept absolutely confidential. Please note tl ntº rio nmnies of 
participants will be used at any stage of the research. 
Thank you. 
SIGNED BY 
............................................... DATE... 
11 INTERVIEWER'S NAME .................. DATE OF IN I ERVIEW ... 
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PART ONE: SOCIO-DEMOGRAPHIC CHARACTERISTICS 
8. Place of birth: U 
1. Jerusalem 2. West Bank 3. Gaza Strip 
4. Palestine 1948 5. Arab country 6. Foreign country 
9. Name the city/village/camp that you were born in ........................ 
m 
10. How long have you been living in the camp ........................... 
m, U 
MARITAL STATUS 
11. Number of marriages ................ 
12. Age at first marriage ......... years 
m, E1 
13. How many children altogether did you have from your first or 
all your marriages? ............ 
m 
14. How many pregnancies altogether did you go through from your 
first or all your marriages? ............. 
m 
PART TWO: EDUCATION AND ECONOMIC STATUS 
15. Years of schooling.......... m 
16. Do you work? 1. Yes 2. No (go to Q 21) jJ 
17. What is your occupation? El 
1- Unskilled worker 2- Skilled worker (dresser, weaving, etc) 
(cleaning, work in a factory, etc) 
3- Employee 4- Retired 
5- Private business 6- Others, specify ................... 
18. Is your paid work at: 
1. Home 2. Outside home 3. others, please specify ................. 
19. Do you work at: U 
1. UNRWA 2. Palestinian NGO 3. Palestinian GO 
4. International Organization 5. Private organization 6. Private business 
7. Others, specify ................... 
20. Place of work: U 
1. Jerusalem 2. West Bank 3. Israel 
4. NA 5. Others: specify ......................................... 
21. What were your husband's years of schooling? .......................... 
m 
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22. Does your husband work 1. Yes 2. No, go to Q. 26 3. NA U 
23. What is your husband's occupation? EI 
1. Unskilled laborer 2. Skilled laborer 3. Employee 
4. Private business 5. Retired 6. NA 
7. Others, specify ......................... 
24. Does your husband work at: 
1. UNRWA 2. Palestinian NGO 3. Palestinian GO 
4. International organization 5. Private organization 6. Private business 
7. NA 8. Others, specify ......................... 
25. Place of your husband's work E1 
1. Jerusalem 2. West Bank 
3. Israel 4. Outside the country, specify .......... 5. NA 6. Others (specify) ........... 
26. How many people altogether are working and living in this household? ...... 
27. Do you have any sources of income other than the salaries? 1. Yes 2. No 
PART THREE: HOUSEHOLD CONDITIONS 
28. Do you own your house? 1. Yes 2. No ID 
29. Number of rooms in the household excluding the kitchen and bathrooms ................... 
30. How much is the area of your house? .................... M2 
31. What household amenities do you have? 
1. Colored TV 1. Yes 2. No El 
2. Video 1. Yes 2. No El 
3. Fridge 1. Yes 2. No 
4. Dip freeze 1, Yes 2. No El 
5. Washing machine (full automatic) 1. Yes 2. No 17 
6. Dryer 1. Yes 2. No 
7, Dish washer 1. Yes 2. No 
8. Microwave 1. Yes 2. No U 
9. Air condition 1. Yes 2. No UJ 
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10. TV dish 1. Yes 2. No U 
11. Lands, Real-estate 1. Yes 2. No JJ 
12. Commercial buildings 1. Yes 2. No F1 
13. Workshop 1. Yes 2. No 0 
14. Factory/ company 1. Yes 2. No El 
15. Truck 1. Yes 2. No 
16. Private car, if yes specify model ....... 1. Yes 
2. No 
17. Taxi, if yes specify model ....... 1. Yes 
2. No 
PART FOUR: QUESTIONS ABOUT REPRODUCTIVE HISTORY 
32. Have you ever being pregnant, even if the pregnancy lasted for a short while? U 
1. Yes 2. No, go to Q. 67 3. NA, go to Q. 70 
33. How old were you when you first became pregnant? ....... years 
m, E1 
34. What was the interval in months between marriage and becoming pregnant? ....... 
m 
35. How many times did you become pregnant? ............ 
m 
36. How old were you at the time of your first live birth? ................ years 
m, EI 
37. How old were you at the time of your last live birth? ................. years 
m, EI 
38. How many live births have you ever had? .......................... 
live births m 
39. Have you ever experienced a pregnancy that ended as a miscarriage or as an abortion 
before it was due? 1. Yes 2. No, go to Q 42 El 
40. How many of your pregnancies ended as a miscarriage or as an abortion? .............. 
El 
41. Please list the date of every abortion or miscarriage that you have ever experienced 
..................... 
Do 
..................... 
m 
..................... 
m 
..................... 
QQ 
..................... 
m 
............ ...... ... 
m 
42. Have you ever experienced a pregnancy that ended as a stillbirth? 13 
1. Yes 2. No, go to Q 45 
43. How many of your pregnancies ended as stillbirth (the baby didn't cry at birth)? ...... 
FI 
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44. Please list the date of every stillbirth you have ever experienced 
..................... SCI ..................... m 
..................... oa 
............ ... ...... 
m 
45. Please list the sex and year of birth of your children and state whether breast fed or not 
and the duration of hrPactfApriinn 
No Name 
Sex 
1. Male 
2. Female 
Date of 
Birth 
Breastfed 
1. Yes 
2. No 
Duration 
in 
Months 
S 
Date 
DDMMYY 
BF DBF 
1. p 1111 13 Q Qý 1 1 2. p 1- 11 1-71 Q 1= 
3. Q Qý 
4. El I-I Q QJ 
p i-T- Q CD 
El Q m 
8. p Q m 
9. p p Cp 
10. p p pý 
11. p p pý 
12. p Q pý 
13. El i p M 14. Ö riiiiii Ö Hii 
15, p p ýp 
16. p p pý 
17.1 1 El l El Cp 
46. Just to make sure that I am right: you have had in total 
1. Pregnancies throughout your life m 
2. Live births throughout your life [[I 
3. MISCARRIAGES and or abortions throughout your life m 
4. Stillbirths throughout your life m 
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47. What is the average gain in weight, in kg, during each pregnancy? 
1. ......... kg 1St pregnancy 
Q] 
2. 
......... 
kg 2nd pregnancy IQ 
3. 
......... kg 
3rd pregnancy Qý 
4. ......... kg 4th pregnancy 
[Q 
5. ......... 
kg 5th pregnancy 
Qý 
6. ......... kg 6th pregnancy 
QJ 
7. ......... 
kg 7th pregnancy Qý 
8. 
......... 
kg 8th pregnancy Qý 
9. 
......... 
kg 9th pregnancy 
IQ 
10.......... kg 10th pregnancy Q] 
11.......... kg 11th pregnancy 
Qý 
12.......... kg 12th pregnancy 
[Q 
13.......... kg 13th pregnancy 
m 
14.......... kg 14th pregnancy 
m 
15.......... kg 15th pregnancy 
Qý 
16.......... kg 16th pregnancy 
Q] 
17.......... kg 17th pregnancy 
IQ 
48. What is the birth weight of your children? 
1. First ............. kg 
QýQ 
2. Second ............. kg 
Q1Q 
3. Third ............. kg 
0,0 
4. Fourth ............. kg 
Q 
5. Fifth ............. kg 
Q 
iQ 
6. Sixth ............. kg 
Q1Q 
7. Seventh ............. kg 
Q'Q 
8. Eighth ............. kg 
Q, Q 
9. Ninth ............. kg 
Q, Q 
10. Tenth ............. kg 
Q, Q 
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11. Eleventh ............. kg EJEJ 
12. Twelfth ............. kg 
LJ, LJ 
13. Thirteenth ............. kg [: ]I[] 
14. Fourteenth 
............. 
kg 1: 1, 
15. Fifteenth ............. kg 
E EJ 
16. Sixteenth ............. kg , 
17. Seventeenth ............. kg 
U' EJ 
49. Do you think increasing your weight improves the course of pregnancy? 0 
1. Yes 2. No 3. Do not remember 
50. Did you have any food cravings during any of your pregnancies? U 
1. Yes 2. No, go to 0 52 3. Do not remember 
51. If yes, what was it? 
1. Salty foods (pickles and salted fish) 1. Yes 2. No 3. do not remember U 
2. Sweet foods 1. Yes 2. No 3. do not remember ED 
3. Fruits and/ or vegetables 1. Yes 2. No 3. do not remember 
4. Dairy products 1. Yes 2. No 3. do not remember U 
5. Fish 1. Yes 2. No 3. do not remember 
6. Meat 1. Yes 2. No 3. do not remember 
7. Others, please specify .................. 1. Yes 
2. No 3. do not remember 
52. Did any of the children have any diseas es or accidents at bi rth? 
1. Yes 2. No 3. Not sure 
PART FIVE: BREAST FEEDING PRACTICES 
53. How long do you think a mother should breastfeed her child? ............ months 
m 
54. In your opinion, breast milk is: El 
1. More nutritional and healthier 2. The same 
3. Less nutritional than bottle milk for the child 4. Don't know 
55. What are/were your sources of information on breastfeeding? 
1. Mother 1. Yes 2. No 0 
2. Friends 1. Yes 2. No 
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3. TV/ magazines 1. Yes 2. No U 
4. Books/education 1. Yes 2. No U 
5. Doctor/nurse 1. Yes 2. No 
6. Experience 1. Yes 2. No F] 
7. Holy Quran 1. Yes 2. No EI 
8. mother in law 1. Yes 2. No 1J 
9. Others, specify .................. 1. Yes 
2. No U 
56. Following the first delivery, what were your feelings towards breastfeeding prior to 
initiation? 
1. Anxiety 2. Shyness 3. Confidence 
4. Inconvenience 5. I don't know 6. Others, specify ........................ 
57. Did you experience any problems with the initiation of b reastfeeding? 
1. No problems 2. Pain 3. Poor flow 
4. Cracked nipple 5. Inverted nipple 6. Others, specify ........................ 
58. What effects did breastfeeding have on you? EI 
1. physically tiring 2. loss of weight 3. breast engorgement 
4. gain weight 5. insufficient flow 6. embarrassment 
7. others, specify ................................................... 
59. Are you aware that breastfeeding has a contraceptive effect? EI 
1. Yes 2. No, 3. Not sure 
60. Are you aware that that weight gain during pregnancy is partly for breastfeeding? 1J 
1. Yes 2. No 3. Not sure 
61. Were there special groups of foods consumed (e. g. to increase milk flow) during 
lactation? El 
1. Yes 2. No, go toQ64 3. Not sure, go to Q 64 
62. If yes, is it 
1. Dairy milk 1. Yes 2. No El 
2. Vegetables! fruits 1. Yes 2. No EI 
3. Carbohydrates 1. Yes 2. No U 
4. Meat group, eggs and legumes 1. Yes 2, No 
5. Liquids 1. Yes 2. No U 
6. Sweets and confectionaries 1. Yes 2. No El 
7. Others, specify ........................... 1. Yes 
2. No 
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63. The source of advice to consume these foods is from 
1. Mother in law 1. Yes 2. No 
2. Mother 1. Yes 2. No 
3. Friends/neighbors 1. Yes 2. No 
4. Formal education 1. Yes 2. No 
5. Doctor/nurse 1. Yes 2. No U 
6. Experience 1. Yes 2. No EJ 
7. Family 1. Yes 2. No El 
8. TV/radio/magazines 1. Yes 2. No 
9. Dietition 1. Yes 2. No 
10. Others, specify .......................................................... ..................... 
[] 
64. Were there special groups of foods avoided (e. g. that affec t milk flow) du ring lactation? 
1. Yes 2. No, go to Q. 67 3. Not sure, g o to Q. 67 
65. If the answer is yes to the above question, what are/were the food groups 
1. Hot chilies, Pickles, Spices, Onion, Legumes 1. Yes 2. No 
2. Tea, Coffee, Fizzy drinks, Fruits & Vegetables juices 1. Yes 2. No El 
3. Water 1. Yes 2. No 13 
4. Fish 1. Yes 2. No El 
5. Meat 1. Yes 2. No 
6. Others, specify ............................................ 
1. Yes 2. No EJ 
66. The source of advice to avoid these special foods is from 
1. Mother in law 1. Yes 2. No 
2. Mother 1. Yes 2. No El 
3. Friends 1. Yes 2. No 
4. Formal education 1. Yes 2. No 
5. Doctor/nurse 1. Yes 2. No EJ 
6. Experience 1. Yes 2. No 
7. Family 1. Yes 2. No 13 
8. TV, magazines 1. Yes 2. No El 
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9. Dietitian 1. Yes 2. No U 
10. Others, specify ............................................. 1. Yes 2. No 
History of Infertility 
67. Did you have any problems getting pregnant (Have you ever tried for one straight year 
or more to become pregnant and during that time not become pregnant? 
1. Yes 2. No 
If the answer is yes, please specify .................................................................. 
U 
68. Have you had any tests because of difficulty getting pregnant? 1. Yes 2. No U 
If the answer is yes, please specify .................................................................. 
69. Have you had any treatment for fertility problems? 1. Yes 2. No 
If the answer is yes, please specify .................................................................. 
70. About how old were you when you had your first period? .......... years 
m, M 
71. Have your periods generally been 
1. Regular 2. Slightly irregular (sometimes missing a period when not pregnant 
3. Not sure 4. Very irregular (often missing one or more periods when not pregnant 
72. Have your periods stopped now? 0 
1. Yes 2. No, please go to Q. 75 
73. About how old were you when you had your last period? .......... Years 
m, U 
74. Why did your period stop? El 
1. Natural menopause 2. Hysterectomy (womb removed at operation) 
3. Ovaries removed at operation 4. Hysterectomy and ovaries removed at same operation 
5. Prescribed medical treatment 6. Other, please specify .......................... 
75. Have you ever had a cervical smear test? 
4. Yes 5. No, go to Q. 77 6. Not sure, go to Q. 77 
76. If the answer is yes, when was that? (before how many years) ................. , 
EI 
77. Have you ever had a mammogram (an X-ray of your breasts)? EI 
1. Yes 2. No, go to Q. 79 3. Not sure 
78. If the answer is yes, when was that? (Before how many years) ................. 
m, EI 
79. Have you ever use the contraceptive pill? EI 
1. Yes, but not taking it now 2. Yes, taking it now 3. No, please go to Q. 81 
80. For how long have you been taking the pill? ...................... 
m, El 
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81. Have you ever used Hormone replacement Therapy (HRT)? 
1. Yes, but not taking it now 2. Yes, taking it now 
82. What type of HRT did you use? 
1. Estrogen 1. Yes 
2. Progesterone 1. Yes 
3. Both 1. Yes 
0 
3. No, please go to Q. 84 
2. No 
2, No 
2. No 
83. Roughly for what total length of time have you used HRT? ............ years 
84. Have you ever had polycystic ovaries? 
1. Yes 2. No 3. Not sure 
PART SEVEN: QUESTIONS ABOUT YOUR HEALTH 
85. How would you describe your general health? 
1. Very good 2. Good 3. Average 
4. Poor 5. Very poor 
86. Have you been told by a doctor or a nurse that you have any of the following: 
EI 
EI 
EI 
m. Q 
EI 
0 
86/1 HIGH BLOOD PRESSURE 1. Yes 2. No F1 
A. Were you pregnant when you were told that you had high blood pressure? 1. Yes 2. No 
B. Have you ever had high BP apart from when you were pregnant? 1. Yes 2. No 
If No, go to Q. 86/2 
C. Apart from when you were pregnant, approximately how old were you when a doctor told you 
that you had high BP? Age.......... years m, EI 
D. Are you receiving treatment for high BP? 1. Yes 2. No EJ 
If No, go to Q. 86/2 
E. If the answer is yes to Q. D, was the treatment 
1. Diet 1. Yes 2. No E1 
2. Tablets 1. Yes 2. No 
3. If the answer is yes, please specify the name of the tablets .................................. 
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86/2 DIABETES 1. Yes 2. No F1 
A. Were you pregnant when you were told that you had diabetes? 1. Yes 2. No U 
B. Have you ever had diabetes apart from when you were pregnant? 1. Yes 2. No 
go to Q. 86/. 3 
C. Apart from when you were pregnant, approximately how old were you when a doctor told you 
that you had diabetes? Age.......... years m, 
D. Are you receiving treatment for diabetes? 1. Yes 2. No 
No, go to Q. 86/3 
E. If the answer is yes to Q. D, was the treatment 
1. Diet 1. Yes 2. No 0 
2. Insulin 1. Yes 2. No ED 
3. Tablets 1. Yes 2. No U 
4. If the answer is yes, please specify the name of the tablets .................................. 
86/3 HEART CONDITION 1. Yes 2. No 0 
No, go to Q. 86/4 
A. How old were you? Age....... years m, E1 
B. What was the condition called? 
1. Heart attack/ myocardial infarction 1. Yes 2. No 
2. Angina 1. Yes 2. No 
3. Valve problem 1. Yes 2. No U 
4. Heart failure 1. Yes 2. No 
5. Other, specify ............................................................... .................. r7l 86/4 STROKE/ Transient Ischaemic Attack 1. Yes 2. No, go to Q 86/5 U 
A. How old were you? Age....... years , 
UJ 
86/5 CANCER 1. Yes 2. No, go to Q. 86/6 
A. How old were you? Age ...... years 
m, U 
B. Which part of your body was the cancer? ....................... 
U 
86/6 HAVE YOU ANY OTHER CHRONIC DISEASE? 1. Yes 2. No, go to Q 87 El 
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1 /a. If the answer is yes, please specify the condition ............................................. 
11 
1/b. Age at diagnosis ............................ 
m, U 
2/a. If the answer is yes, please specify the condition ..................................... 
U 
2/b. Age at diagnosis ............................ 
U 
87. Are you taking any other prescribed medicine now? 1. Yes 2. No, go to 0.89 U 
88. Please list the medicines you are taking and you have not mentioned them before and 
the reason for taking them 
1. Name of medicine ................................................................. 
F1 
Reason .............................................................................. 
u 
F1 
2. Name of medicine ................................................................. 
U 
Reason .............................................................................. 
3. Name of medicine ................................................................. 
Reason .............................................................................. 
4. Name of medicine ................................................................. 
Reason 
.............................................................................. 
U 
89. Have you ever had your cholesterol level measured? U 
1. Yes 2. No, go to Q 91 3. Don't remember 
90. What was your cholesterol level; U 
1. Low 2. Normal 3. High 4. Don't know 
please give the number if you know ...... 
91. Have you ever had your Triglyceride level measured? El 
1. Yes 2. No, go to 0 93 3. Don't remember 
92. What was your Triglyceride level; El 
1. Low 2. Normal 3. High 4. Don't know 
please give the number if you know ........ 
93. Did you have your blood pressure measured? U 
1. Yes 2. No, go to Q 97 3. Don't remember 
94. When was the last time you have had your blood pressure measured? ......... 
m, El 
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95. Was your blood pressure measure F1 
1. Low 2. Normal 3. High 4. Don't know 
96. Do you remember the reading of your blood pressure? 
1. Systolic 
................. 
2. Diastolic ................. 
SECTION EIGHT: FAMILY HISTORY 
97. Has anyone in your family ever had high blood pressure (hypertension)? 
I Yes 2. No, go to Q. 99 F1 
98. If the answer is yes, was he/ she your: 
1. Father 1. Yes 2. No D 2. Mother 1. Yes 2, No U 
3. Brother 1. Yes 2. No M 4. Sister 1. Yes 2. No U 
5. Children 1. Yes 2. No E] 6. Other, specify ... ................... 
99. Has anyone in your family ever had dia betes? 1. Yes 2. No, go to 101 El 
100. If the answer is yes, was he/ she your: 
1. Father 1. Yes 2. No 2. Mother 1. Yes 2. No 
3. Brother 1. Yes 2. No F1 4. Sister 1. Yes 2. No 
5. Children 1. Yes 2. No [] 6. Other, specify ... ................... 
101. Has anyone in your family ever had hyperlipedemia? 1. Yes 2. No, go to 103 
102. If the answer is yes, was he/ she your: 
1. Father 1. Yes 2. No 2. Mother 1. Yes 2. No 
3. Brother 1. Yes 2. No F1 4. Sister 1. Yes 2. No E1 
5. Children 1. Yes 2. No Fj 6. Other, specify ... ................... 
103. Has any in your family ever had heart d isease? 1. Yes 2. No, go to 105 
104. If the answer is yes, was he/ she your: 
1. Father 1. Yes 2. No EJ 2. Mother 1. Yes 2. No 
What was it? ......................................... 
E1 What was it? ......................................... 
3. Brother 1. Yes 2. No 0 4. Sister 1. Yes 2. No 
What was it? ......................................... 
. What was it? ......................................... 
El 
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5. Children I. Yes 2. No EJ 6. Other, specify ...................... 
U 
What was it? ..................................................... What was it? ......................................... F1 What was it? ......................................... 
105. Was there a blood relationship (consanguinity) between your father and your mother? 
1 Yes 2. No, go to Q. 107 U 
106. What was the relationship? i 
1. First cousin 2. Second cousin 3. Other relationship 
107. Describe your father's weight while you were growing up (12-15 years) U 
1. Very overweight 2. Slightly overweight 3. About average 
4. Slightly underweight 5. Very underweight 6. Don't remember 
108. Describe your mother's weight while you were growing up (12-15 years) 
1. Very overweight 2. Slightly overweight 3. About average 
4. Slightly underweight 5. Very underweight 6. Don't remember 
109. Describe your husband's weight El 
1. Very overweight 2. Slightly overweight 3. About average 
4. Slightly underweight 5. Very underweight 6. No applicable 
110. Can you remember how much did you weigh when you were 18 years old? ...... 
kg , 
EJ 
111. When you were about 18 years old would you say you were? U 
1. Very overweight 2. Slightly overweight 3. About average 
4. Slightly underweight 5. Very underweight 6. No applicable 
112. Do you think you are U 
1. Underweight 2. Normal weight 
3. Overweight 4. Obese 
5. Very obese 
113. What weight do you think is appropriate for you? ............. 
kg m, U 
114. What does your husband think of your weight? El 
1. Very underweight 2. About average 3. overweight 
4. Obese 5. Very obese 6. Doesn't comment 
7. NA 
115. Have you gained weight after marriage? 
1. Yes 2. No, go to Q. 117 3. Don't remember 
116. If yes, how much weight in kg did you gain after marriage? .............. 
kg m, U 
117. In your opinion, what is the reason behind putting on weight? 
1. Marriage 1. Yes 2. No 
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2. Pregnancy 1. Yes 2. No U 
3. Overeating 1. Yes 2. No U 
4. Not enough exercise 1. Yes 2. No 
5. Other, specify ............................... 
U 
118. a. What is the average weight you usually gain during pregnancy? .......... 
Kg m, U 
b. What is the average birth weight of your children? ............... 
Kg 
119. After delivery, were you able to return to your original weight before pregnancy? U 
1. Yes 2. No, go to Q. 121 3. Not always 4. NA 
120. If yes, what contributed to your return back to your original weight? 
1. Exercise 1. Yes 2. No 
2. Going on reducing diet 1. Yes 2. No 
3. Returned naturally 1. Yes 2. No 
4. Other, specify: ................................................... 
SECTION NINE: PHYSICAL ACTIVITY 
121. Do you practice any kind of physical exercise? 1. Yes 2. No, go to Q 124 M 
122. If yes, what type of exercise do you do: ................................. 
El 
123. If you are practicing any kind of physical activity, on average how many hours per week 
do you practice physical exercise, to improve your physical fitness and health? 
........... hours 
m, F1 
124. Do you have any physical disability which hinders you from practicing exercise? 
1. Yes 2. No 13 
125. Do you usually watch TV? 1. Yes 2. No, go to Q 127 
126. For how many hours per week do you watch TV? ........................ 
m, U 
127.126. Do you have someone to assist you with the housework? 1. Yes 2. No 
128. How many hours per day on average do you spend doing the housework 
................ Hours 
m, 1 
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SECTION TEN: BEHAVIOURAL RISK FACTORS 
129. How best do you describe your smoking habits? 
1. Never smoked, go to Q. 130 2. Current smoker 
3. Ex- smoker 
2. Current smoker El 
1. Light= < 10 cig/day 2. Moderate=10-20 cig/day 3. Heavy= > 20 cig/day 
3. Ex-smoker 1. Smoked 1-20 ciglday 2. Smoked > 20 cig/day U 
130. Are you a passive smoker? 1. Yes 2. No, go to Q. 131 El 
a. Does your husband or children living with you smoke at home? EJ 
1. Yes 2. No, go to Q. 131 
b. On average, how many hours per day are you exposed to tobacco smoke of other people 
such as husband, children, etc? ............ Hours/day 
m, U 
131. A. Do you smoke nargeleh? 1. Yes 2. No, go to Q 134 U 
132. How many times a day do you smoke nargeleh? m 
133. For how long have you been smoking cigarettes or tobacco? .................. 
m 
SECTION ELEVEN: STRESS 
134. In the past six months have you experienced? 
1. Death of a spouse 1. Yes 2. No 
2. Divorce 1. Yes 2. No 
3. Death of a close family member 1. Yes 2. No EJ 
4. Major change in argument with spouse 1. Yes 2. No U 
5. Addition of a new family member 1. Yes 2. No EJ 
6. In-law troubles 1. Yes 2. No 
7. Marriage of your husband 1. Yes 2. No 
8. Spouse ending work 1. Yes 2. No 
9. Detention of any family member 1. Yes 2. No 
10. Major personal injury or illness 1. Yes 2. No 
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11. Major change in living conditions 1. Yes 2. No U 
12. demolition of your house 1. Yes 2. No F] 
13. Being fired from work 1. Yes 2. No n 
14. Major change in working conditions 1. Yes 2. No 
El 
15. Injury or shot of a family member 1. Yes 2. No EJ 
16. Others, specify ............................................... 
El 
SECTION TWELVE: DIET 
135. Women will be divided into 5 categories according to their consumption of particular 
food items: 
1. On most days 
2.2 or 3 times per week 
3. Once a week 
4. Once every two weeks or three weeks or once in a month 
.. i 
Nnt at qII 
No Food items Daily 
Two or three 
days in a week 
Once a 
week 
Less than 
once a week 
Not at all 
1 Dairy Products 
Milk 
Cheese 
Laban (yogurt) 
Labaneh 
2 Animal Proteins 
Eggs 
Lamb meat 
Beef 
Fish 
Chicken 
Turkey 
3 Plant Proteins 
Lentils 
Peas 
0 
r-l 
r-l 
r-l 
F'l 
R 
El 
U 
U 
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No Food items Daily 
Iwo or three 
days in a week 
Once a 
week 
Less than 
once a week 
Not at all 
Dried beans 
Homous 
4 Cereal 
Bread 
Rice 
Spaghetti 
Burghul 
Potatoes 
5 Fruits 
Fresh fruits 
Fruit juices 
Canned/dried fruits 
6 Vegetables 
Fresh vegetables 
Green leafy vegetables 
7 Sweets and confectionary, 
honey and jam 
8 Oil, butter and ghee 
9 Nuts 
10 Soft drinks 
11 Coffee or tea 
0 
0 
0 
0 
0 
0 
0 
El 
El 
136. How many teaspoons of sugar do you usually add to 
1- a cup of tea No of teaspoons........... 
Ell LI 
2- a cup of coffee No of teaspoons.......... 
11' El 
3- a cup of milk No of teaspoons.......... Ell 
LI 
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137. In total, how many cups of the following do you drink per day? 
1- Tea m 
2- Coffee 
3- Milk m 
138. Which of the following kinds of oil do you use at home? 
1. Corn oil 1. Yes 2. No U 
2. Sunflower oil I. Yes 2. No 1i 
3. Soya oil 1. Yes 2. No U 
4. Olive oil 1. Yes 2. No 1J 
5. Butter 1. Yes 2. No EJ 
6. Pure animal fat (Samn baladi) 1. Yes 2. No 11 
7. Ghee from plant origin (Samn Nabati) 1. Yes 2. No EJ 
139. What do you do with the visible fat on your meat? 
1. Eat most of it 2. Eat some of it 3. Eat as little as possible 4. Don't eat it 
140. What kind of fat do you usually use for cooking and baki ng? 
1. Olive oil 1. Yes 2. No 
2. Corn oil 1. Yes 2. No 
3. Samn Nabati 1. Yes 2. No U 
4. lard (Samn Baladi) 1. Yes 2. No 
5. Others, specify ...................................... 
141. What kind of fat do you usually use for frying? 
1. Olive oil 1. Yes 2. No 
2. Corn oil 1. Yes 2. No EJ 
3. Samn Nabati 1. Yes 2. No 
4. lard (Samn Baladi) 1. Yes 2. No El 
5. others, specify ...................................... 
EJ 
142. How often do you eat red meat in a week? ................. 
El 
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143. Do you regularly use? 
1. Full cream milk 2. Half cream milk 3. Skimmed milk 
4. NA 5. others, specify ...................................... 
144. How often do you eat fruits and vegetables in a week? .............. 
145. How often do you eat sweets and confectionaries in a week? ............... 
146. Are you currently on a special diet? 1. Yes 2. No. go to Q 149 
147. Which of the following best describe th e diet you are on? 
1. Slimming diet 1. Yes 2. No 
3. Diabetic diet 1. Yes 2. No 
3. Cholesterol lowering diet 1. Yes 2. No 
4. Low salt diet 1. Yes 2. No 
5. High fiber diet 1. Yes 2. No 
6. Vegetarian diet 1. Yes 2. No 
7. Others specify ......................... 1. Yes 
2. No 
148. How many years are you on it? ................... 
Years 
149. BLOOD PRESSURE MEASUREMENTS: 
SYSTOLIC DIASTOLIC 
READING 1. 
............. ............. 
READING 2. 
............. ............. 
150. Pulse: ................ 
READING 1. ............. 
m 
READING 2. ............. 
m 
0 
m, Q 
m. Q 
EI 
EI 
EI 
EI 
EI 
EI 
EI 
m, Q 
SECTION TWELVE: ANTHROPOMETRIC DATA SHEET 
151. HEIGHT AND WEIGHT MEASUREMENTS 
a. Standing Height without shoes 
b. Weight without shoes 
Reading ............. cm 
Reading ............. kg 
F-1 
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152. GIRTH MEASURES: 
a. Waist 
b. Thigh 
c. Hip 
Reading ............. cm 
Reading ............. cm 
Reading ............. cm 
ii119 f-1 
EI 
BLOOD WITHDRAWAL 
We will be taking a blood sample now in order to test for cholesterol, trigycerides, and blood sugar 
levels. 
- When did you last have anything other than water to eat or drink? ........ : ........ 
AM/PM 
- If less than 10 hours from clinic appointment, the interviewer should reschedule for blood 
withdrawal. 
- Not done ............ 
- Reason ................................................................................ 
153. LABORATORY RESULTS OF BLOOD 
No Type of Test Result 
1. Fasting blood sugar . ... ........................................ 
2. Insulin 
... ........................................ 
m 
3. Total Cholesterol 
... ........................................ 
4. HDL-C 
... ........................................ 
m 
5. LDL-C 
... ........................................ 
6. Triglycerides 
... ........................................ 
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Appendix 4 
Blood Pressure Measurements and Procedures 
Women were asked to roll up the sleeve of the blouse so that the upper right arm will be 
bare for the sphygmomanometer cuff. Each woman sat at the end of the desk with the 
right arm allowed to rest, palm up, and the elbow on the desk so that the anticubital fossa 
will level with the heart. The research nurse who was trained in hypertension detection, 
sat facing the sphygmomanometer, which was positioned so that the mercury column will 
not be visible to the participant. Two cuff sizes were available: adult and large adult. The 
adult cuff was wrapped around the arm and if the index line fell within the range lines it 
was appropriately sized, if not the larger sized cuff was used. The brachial pulse was 
located by palpating the artery just medial to the biceps tendon and the cuff placed so that 
the centre of the inflation bag as marked on the cuff laid over the artery. The cuff was 
connected to the sphygmomanometer, and the systolic pressure was ascertained by 
palpation. The bronchial artery again localized and the diaphragm of the stethoscope 
placed on the point of maximal impulse immediately below the cuff. Systolic and 
diastolic blood pressures were ascertained by auscultation of the first and fifth Korotkoff 
sounds respectively. All readings were taken at the top of mercury meniscus (to the 
nearest 2 mmHg). The measurement was repeated and the second systolic and diastolic 
values were recorded. The average systolic and diastolic blood pressures were 
subsequently calculated. The women were informed about the results and in case of a 
problem, women were referred to UNRWA general practitioner for further medical 
advice. 
Appendix 5 
Informed Consent Form 
*Translated from Arabic* 
Good morning! My name is ...... and my colleague's name 
is .......... We are 
performing a study on women's health. The study is looking at the long-term effect of 
reproduction on women's health. Here is a letter of approval for conducting the study in 
the Amaari and Kalandia refugee camps from UNRWA health department. If you 
remember that we have discussed the objectives of the study as well as the benefits and 
risks and the overall importance of this study before when we visited you the first time 
with the community leader. Would you like to participate? Of course it is up to you to 
decide. Everything you will tell us will be confidential, and the results of the blood tests 
will be confidential too. You will not be given any reward for responding to the questions 
that we will ask you; also no reward will be offered for performing the blood tests. Please 
note that there is a possibility of mild discomfort and hematoma at venipuncture. It is just 
a possibility but you should be aware of it. If you accept to participate, you will be given 
a set of written and verbal instructions about the study measurements including 
preparation for blood tests. An appointment will be set for my colleague and me to visit 
you at home again to administer the questionnaire. If the physician determines you have a 
condition that needs further treatment, you will be referred accordingly. If you accept to 
participate, we need your written consent. Please remember that all answers and 
laboratory investigation will be private and confidential. Thank you for being patient and 
thank you for accepting to participate in the study. 
Appendix 6 
Informed Consent Form from UNRWA 
*Translated from Arabic* 
Hello! We are happy to inform you that our colleague Ms. Rizkallah will be performing a 
study on women's health. She will be looking at the long-term effect of reproduction on 
women's health at the Amaari and Kalandia Refugee Camps. This study is very important 
to UNRWA and to the health of Palestinian women. As for the first time someone will 
explore the relationship between reproduction and coronary heart disease risk factors 
among women in Palestine. The study will provide data on the prevalence of CHD risk 
factors, it will help to understand their impact on women's lives, and will clarify the 
relationship between women child-bearing patterns and CHD risk factors. The study will 
provide basic data to support UNRWA in evidence-based decision making and allocation 
of health care resources, to contribute to health promotion and primary prevention of 
CHD among Palestinian refugee women, and to increase general awareness of the burden 
placed by chronic diseases, and to provide one more health rationale for reducing high 
fertility. 
This research would also help to prioritize what is most important for women's health 
within limited resources available, (not just another argument for family planning, but 
what interventions could be most effective in the prevention and treatment of these 
women). 
Understanding the unique aspects of risk for Palestinian women will increase the 
awareness of women and medical caregivers and will pave the way for primary 
prevention efforts. 
So will you like to participate in the study? If you do, you will be given a set of written 
and verbal instructions about all study measurements including preparation for blood 
tests. An appointment will be set for a trained interviewer and the principal investigator, 
to visit you at home and administer the questionnaire, and as UNRWA Health 
Department, we will be involved in the different stages of the research. 
If you happen to be a case, you will be referred to UNRWA clinic for further 
investigation. 
Remember that all study procedures including the laboratory tests to be performed, the 
administration of the questionnaire, will be confidential. If you accept to participate, we 
need your written consent. Please remember that all answers and laboratory investigation 
will be private and confidential. 
Thank you for your participation and cooperation. 
Health Department 
UNRWA West Bank field of operations 
Appendix 7 
INFORMED CONSENT FORM Signed by Participants 
This is to certify that I, , hereby agree to participate as a 
volunteer in the study under the supervision of the principal investigator Ms. Rizkallah. 
This study has been defined and fully explained to me by UNRWA medical officer and 
the principal investigator. 
Health department at UNRWA Study participant 
Signature Signature 
